{
  "experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750
  },
  "results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron held a 39.2 percent ownership interest in Petroboscan as of the 2022 reporting period and had an outstanding long-term loan to Petroboscan of $560, which was fully provisioned for at year-end 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Petroboscan (COMP)",
        "Petroboscan (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5146,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1924,
        "completion_tokens": 51,
        "total_tokens": 1975
      }
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "The total financial impact on Target Corporation from the sale of Dermstore LLC was $691 million, which includes $356 million in cash received and a $335 million pretax gain recognized, as disclosed in both Chunk 1 and Chunk 2. The transaction occurred in February 2021 and was reported under Net Other (Income) / Expense. Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Sells]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Dermstore LLC (COMP)",
        "Dermstore LLC (COMP) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4727,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1815,
        "completion_tokens": 108,
        "total_tokens": 1923
      }
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement was $261 million, calculated as $125 million in 2023, $64 million in 2022, and $72 million in 2021. These figures reflect Amgen's sales of collaboration products to BeiGene for commercialization in China, as outlined in the collaboration agreement where Amgen manufactures and supplies the products to BeiGene.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays_Royalties]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> BeiGene (COMP)",
        "BeiGene (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8228,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2690,
        "completion_tokens": 114,
        "total_tokens": 2805
      }
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "Under the 2007 Omnibus Incentive Plan, Danaher Corporation authorized approximately 127 million shares of common stock for issuance, and as of December 31, 2021, approximately 50 million shares remained available for future grants, as disclosed in the Stock-Based Compensation section of the 2022 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "DHR (ORG) -> 2007 Omnibus Incentive Plan (ACCOUNTING_POLICY)",
        "2007 Omnibus Incentive Plan (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12052,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3670,
        "completion_tokens": 77,
        "total_tokens": 3747
      }
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, with $1.05 billion received in 2023 and an additional $305 million received in 2024. The transaction was accounted for in 2023, and the proceeds contributed to collaboration and other revenue as disclosed in LLY's 2024 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Zyprexa (PRODUCT)",
        "Zyprexa (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4794,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1839,
        "completion_tokens": 87,
        "total_tokens": 1926
      }
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded a total goodwill of $298 million as a result of its acquisition of Terran Orbital, which operates within its Space business segment. The total purchase consideration was $314 million, of which $83 million consisted of previously held investments in Terran Orbital, and the remaining $231 million was paid in cash on hand (net of cash acquired).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Terran Orbital (COMP)",
        "Terran Orbital (COMP) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11970,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3634,
        "completion_tokens": 92,
        "total_tokens": 3726
      }
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, as reported in the Downstream section of the investments and advances table in Chunk 1. According to Chunk 2, Chevron owns a 50 percent equity interest in GS Caltex Corporation, a joint venture with GS Energy in South Korea. Thus, the carrying value of $3,616 million reflects Chevron's 50% ownership stake in the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> GS Caltex Corporation (COMP)",
        "GS Caltex Corporation (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8737,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2831,
        "completion_tokens": 108,
        "total_tokens": 2939
      }
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, as shown by the figures of $1,160 million in 2020 and $1,357 million in 2021. The corresponding change in average revenue per car for Forest Products during the same period was an increase of $155, from $5,269 in 2020 to $5,424 in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Forest products (PRODUCT)",
        "Forest products (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3804,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 80,
        "total_tokens": 1681
      }
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, as disclosed in both the revenue table and the percentage change table. Compared to 2023, when its total net revenue was $436 million, Restasis experienced a decline of 48.7% at actual currency rates in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Restasis (PRODUCT)",
        "Restasis (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11334,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3466,
        "completion_tokens": 70,
        "total_tokens": 3537
      }
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "Capital One Financial Corp's Common Equity Tier 1 capital ratio as of December 31, 2023, is 12.9%, as shown in both chunks. The Minimum Capital Adequacy requirement for this metric is 4.5%, as specified in the \"Minimum Capital Adequacy\" column. The difference between the company's ratio and the minimum requirement is 8.4% (12.9% - 4.5%).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> Minimum Capital Adequacy (REGULATORY_REQUIREMENT)",
        "Minimum Capital Adequacy (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5462,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2025,
        "completion_tokens": 84,
        "total_tokens": 2110
      }
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount was lower than the $81 million recognized in 2022 but higher than the $56 million in 2021, indicating some fluctuation in the expense over the three-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Nonqualified Defined Benefit Pension Plans (FIN_INST)",
        "Nonqualified Defined Benefit Pension Plans (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5585,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2058,
        "completion_tokens": 74,
        "total_tokens": 2132
      }
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of BlackRock's investor/customer relationships decreased from $492 million as of December 31, 2022, to $447 million as of December 31, 2023, representing a $45 million decline. This decrease is primarily driven by accumulated amortization, which increased from $254 million in 2022 to $338 million in 2023, resulting in an additional $84 million in amortization over the period. The gross carrying amount of investor/customer relationships also increased slightly from $746 million to $785 million, contributing to a net reduction of $45 million in the net carrying amount due to the higher amortization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Investor/Customer Relationships (FIN_INST)",
        "Investor/Customer Relationships (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3183,
        "completion_tokens": 157,
        "total_tokens": 3340
      }
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million, as shown in Chunk 1. Despite the notes maturing in September 2024, UPS classifies this debt as long-term on its consolidated balance sheet, as stated in Chunk 2, based on its intent and ability to refinance the debt. This classification is consistent with UPS's broader treatment of certain short-term maturities as long-term liabilities when refinancing is both intended and feasible.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> 2.200% Senior Notes (FIN_INST)",
        "2.200% Senior Notes (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7204,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2452,
        "completion_tokens": 123,
        "total_tokens": 2575
      }
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024, as shown in both provided chunks. This decrease, combined with a $2,615 million reduction in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in an overall decrease of $8,292 million in the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1294,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 995,
        "completion_tokens": 113,
        "total_tokens": 1109
      }
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan. Of these, 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LIN (ORG) -> 2021 Linde plc Long Term Incentive Plan (ACCOUNTING_POLICY)",
        "2021 Linde plc Long Term Incentive Plan (ACCOUNTING_POLICY) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4908,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1903,
        "completion_tokens": 58,
        "total_tokens": 1961
      }
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes was $247 million, $143 million, and $136 million, respectively, summing to $526 million. These settlements reflect a positive cash flow impact for the company, as the cash inflows from the settlements offset potential interest rate risks associated with the debt issuances, thereby enhancing liquidity and supporting the company’s financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Settles]-> FIN_INST <-[Settles]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Forward Interest Rate Swap Contracts (FIN_INST)",
        "Forward Interest Rate Swap Contracts (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3390,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 136,
        "total_tokens": 1667
      }
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "NextEra Energy's ownership interest in XPLR (XPLR Infrastructure, LP) ranges from approximately 33.3% to 85.0%, as disclosed in the 2024 10-K filing. The principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> XPLR (COMP)",
        "XPLR (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11522,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3525,
        "completion_tokens": 68,
        "total_tokens": 3593
      }
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The total fair value of Corporate notes and obligations is $3,354, as reported in the fair value hierarchy table (Chunk 1). According to the amortized cost and fair value reconciliation table (Chunk 2), the amortized cost of these obligations is $3,442, resulting in unrealized losses of $92. This indicates that the fair value is $92 less than the amortized cost for these instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Corporate Notes and Obligations (FIN_INST)",
        "Corporate Notes and Obligations (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5187,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1951,
        "completion_tokens": 96,
        "total_tokens": 2047
      }
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "In 2024, UNP operated a total of 7,026 locomotives, as reported in both provided chunks. This total is composed of 6,106 owned locomotives and 920 leased locomotives, reflecting the combination of ownership and leasing arrangements. The consistency between the two chunks confirms the accuracy of the total locomotive count and the contribution of both owned and leased units to UNP's operational fleet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Leases]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Total Locomotives (PRODUCT)",
        "Total Locomotives (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1004,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 887,
        "completion_tokens": 100,
        "total_tokens": 987
      }
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net change in the value of Brands/Tradenames for LIN in 2024 was a decrease of $76 million, from $2,609 million at the beginning of the year to $2,239 million at year-end. This change was primarily driven by a $36 million amortization expense and a $107 million decrease due to foreign currency translation adjustments under the cost section. These factors collectively contributed to the reduction in the net value of Brands/Tradenames during the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Brands/Tradenames (ACCOUNTING_POLICY)",
        "Brands/Tradenames (ACCOUNTING_POLICY) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5292,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1975,
        "completion_tokens": 114,
        "total_tokens": 2089
      }
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "The total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 was $1,023 million. This represents a decrease of $19 million compared to the previous year, which had a total fair value of $1,042 million as of December 31, 2020. The decline is primarily attributed to a reduction in Level 2 fair value from $1,011 million to $994 million, partially offset by a decrease in Level 3 fair value from $31 million to $29 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Corporate bonds and debt securities (FIN_INST)",
        "Corporate bonds and debt securities (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8412,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2757,
        "completion_tokens": 114,
        "total_tokens": 2871
      }
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million, as disclosed in Chunk 1. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, as stated in Chunk 2, no securities had a material dilutive effect for the year, and the LTIP units have not yet vested or been determined to have been earned under the applicable performance conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2869,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 132,
        "total_tokens": 1520
      }
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105, while their fair value is $101, resulting in a difference of $4. Additionally, the unrealized loss on these bonds is $4, as shown in Chunk 2. This aligns with the fair value adjustment in the amortized cost-to-fair value reconciliation table.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Covered Bonds (FIN_INST)",
        "Covered Bonds (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5187,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1932,
        "completion_tokens": 76,
        "total_tokens": 2008
      }
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "To determine the percentage of Union Pacific's Multiple Purpose locomotives that are leased, we calculate (920 leased / 6,893 total) × 100 = approximately 13.34%. In contrast, the 'Switching' and 'Other' categories combined have 122 + 11 = 133 total locomotives, all of which are owned, resulting in 0% leased. Thus, the proportion of leased locomotives is significantly higher in the Multiple Purpose category compared to the combined 'Switching' and 'Other' categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Leases]-> PRODUCT <-[Owns]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Multiple Purpose Locomotives (PRODUCT)",
        "Multiple Purpose Locomotives (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1004,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 907,
        "completion_tokens": 117,
        "total_tokens": 1025
      }
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 was 797 million barrels, compared to 230 million barrels at the end of 2020, representing an increase of 567 million barrels. The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 amounted to $5,729 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12911,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3880,
        "completion_tokens": 81,
        "total_tokens": 3961
      }
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, with $0.4 billion allocated to each acquisition. In fiscal 2025, Alert Innovation was sold and deconsolidated, as reflected in the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Sells]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4824,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1865,
        "completion_tokens": 70,
        "total_tokens": 1936
      }
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "To calculate the total revenue generated from Metals & minerals shipments for UNP in 2021, we multiply the number of carloads (697,000) by the average revenue per car ($2,598). This results in total revenue of $1,811,306,000 for 2021. This figure reflects the combined data from both chunks, which disclose the carload volume and average revenue per car for the Metals & minerals category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Metals & minerals (PRODUCT)",
        "Metals & minerals (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3756,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 97,
        "total_tokens": 1679
      }
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion, as disclosed in both Chunk 1 and Chunk 2. This issuance was used to repay the entire $1.3 billion aggregate principal amount of the Series 2013-2A Securities, which were repaid in March 2023, as stated in Chunk 1 and confirmed by the balance sheet data in Chunk 2 showing the Series 2013-2A Securities at $1,299.7 million (approximately $1.3 billion). Thus, the principal amount issued in the 2023 Securitization is nearly equivalent to the amount repaid for the Series 2013-2A Securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Series 2023-1A Securities (FIN_INST)",
        "Series 2023-1A Securities (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7973,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2649,
        "completion_tokens": 150,
        "total_tokens": 2799
      }
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During the year ended December 31, 2023, American Tower Corporation borrowed an aggregate of $3.0 billion and repaid an aggregate of $6.1 billion under the 2021 Multicurrency Credit Facility. The facility's total borrowing capacity as of December 31, 2023, was $6.0 billion, which includes sublimits for multicurrency borrowings, letters of credit, and swingline loans. Thus, repayments exceeded borrowings by $3.1 billion, and the total revolving indebtedness activity occurred within the facility's $6.0 billion capacity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5445,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2024,
        "completion_tokens": 130,
        "total_tokens": 2155
      }
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "The total Intermodal revenue for Union Pacific (UNP) increased by $515 million in 2021 compared to 2020, representing a 13% growth (from $3,989 million to $4,504 million). During the same period, the average revenue per car for Intermodal increased by 11%, from $1,267 in 2020 to $1,403 in 2021. Thus, the growth in total Intermodal revenue (13%) slightly outpaced the increase in average revenue per car (11%).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Intermodal (PRODUCT)",
        "Intermodal (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3804,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 102,
        "total_tokens": 1700
      }
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "The total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021 was $534 million, as reported in Chunk 1. In the same year, the region reported a net loss from operations of $24 million, as shown in Chunk 2. This indicates that while significant capital was invested in the region, the operations resulted in a modest net loss for 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> EMENA (GPE)",
        "EMENA (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2353,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 92,
        "total_tokens": 1326
      }
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft positions Copilot Pro as a consumer subscription service that enhances productivity by offering faster and more powerful AI assistance within Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In its financial reporting, Copilot Pro is classified under the **Office Consumer products and cloud services** revenue category, which includes Microsoft 365 Consumer and Copilot Pro subscriptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Copilot Pro (PRODUCT)",
        "Copilot Pro (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7627,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2558,
        "completion_tokens": 115,
        "total_tokens": 2673
      }
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment was **128,000 shares**. This increase was determined based on the proportional adjustment required by the 2019 Incentive Plan, following the adjustment of outstanding RSUs. The adjustment factor of **1.018** was calculated as the ratio of the Nasdaq closing price of **$674.62** on December 26, 2023 (the last trading day before the ex-dividend date) to the Nasdaq opening price of **$662.70** on the ex-dividend date, December 27, 2023. This adjustment preserved the value of the RSUs without affecting the fair value or resulting in additional compensation expense.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "COST (ORG) -> 2019 Incentive Plan (ACCOUNTING_POLICY)",
        "2019 Incentive Plan (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5448,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2028,
        "completion_tokens": 176,
        "total_tokens": 2204
      }
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "The headwinds from PFAS manufactured products quantitatively affected 3M's Transportation and Electronics segment in 2024 by reducing reported sales by 1.4% in U.S. dollars, compared to a 3.1% increase in non-GAAP adjusted sales (excluding PFAS-related impacts). This indicates that the exclusion of PFAS-related sales, which 3M plans to exit by the end of 2025, revealed stronger underlying performance, with the segment's organic growth negatively impacted by PFAS headwinds and automotive OEM build rates, partially offset by new product launches and market share gains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> PFAS Manufactured Products (PRODUCT)",
        "PFAS Manufactured Products (PRODUCT) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4962,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1899,
        "completion_tokens": 143,
        "total_tokens": 2042
      }
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, as reported in Chunk 1 under the \"Recognized Earnings\" section. Additionally, the fair value of these contracts as of December 31, 2021, was $(3) million, as stated in Chunk 2 under the \"Equity method investment contracts\" row. These figures are connected through the disclosed financial instrument relationship between MDLZ and its equity method investment contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Equity Method Investment Contracts (FIN_INST)",
        "Equity Method Investment Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5063,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1913,
        "completion_tokens": 114,
        "total_tokens": 2027
      }
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott Laboratories uses interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, to manage its exposure to changes in the fair value of its fixed-rate debt. These contracts are designated as fair value hedges, and their effect is to convert a portion of the fixed-rate debt to a variable rate. As a result, Abbott adjusts the carrying value of the hedged debt by an offsetting amount to reflect the fair value changes, thereby stabilizing the overall fair value of its long-term debt. With long-term debt amounting to $13.7 billion as of the same date, the hedges help mitigate the impact of interest rate fluctuations on the debt's fair value, aligning it more closely with the company's risk management objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7987,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2659,
        "completion_tokens": 189,
        "total_tokens": 2849
      }
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "The total oil-equivalent proved reserves for equity companies in Asia, based on ExxonMobil's 2024 10-K filing, amount to **1,276 million barrels**. In comparison, the total proved reserves for consolidated subsidiaries in Asia are **2,286 million barrels**. This indicates that consolidated subsidiaries in Asia hold significantly more proved reserves than equity companies in the same region. The data is derived from the detailed reserves table in the 10-K filing, which separates reserves by consolidated subsidiaries and equity companies, and is further contextualized by ExxonMobil's operational approach to managing both types of reserves as part of its business strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Equity Companies (COMP)",
        "Equity Companies (COMP) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14649,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4322,
        "completion_tokens": 169,
        "total_tokens": 4491
      }
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss Tax Reform significantly impacted Mondelēz International's effective tax rate in 2019, reducing it to 0.1%, as shown in the 2019 effective tax rate table. This was primarily due to the reform's effects, which contributed a (22.3)% adjustment to the tax rate for that year. As a result of the Swiss Tax Reform, Mondelēz recorded a net financial benefit of $767 million in the third quarter of 2019, consisting of a $769 million reduction in deferred tax expense, partially offset by a $2 million indirect tax impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Swiss Tax Reform (REGULATORY_REQUIREMENT)",
        "Swiss Tax Reform (REGULATORY_REQUIREMENT) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8441,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2766,
        "completion_tokens": 131,
        "total_tokens": 2897
      }
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "In 2022, PepsiCo transferred pension and retiree medical obligations of $145 million to TBG as part of the Juice Transaction. Additionally, PepsiCo recognized a $520 million gain from the remeasurement of its 39% ownership stake in TBG at fair value. Therefore, the total financial impact on PepsiCo in 2022 from both the pension obligation transfer and the gain was a net positive of $375 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> TBG (COMP)",
        "TBG (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5879,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2107,
        "completion_tokens": 99,
        "total_tokens": 2207
      }
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "The total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021 was $200 million. As of December 31, 2021, the accrued but unpaid sales-based milestone payments totaled $600 million, indicating that Merck had recognized these payments as liabilities but had not yet disbursed the full amount. This information is derived from the collaboration agreement disclosed by Merck in its 2022 10-K filing, which outlines the financial terms related to Lenvima, an oncology product co-developed with Eisai.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lenvima (PRODUCT)",
        "Lenvima (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4859,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1863,
        "completion_tokens": 131,
        "total_tokens": 1994
      }
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners in the first quarter of 2022, subject to purchase price adjustments. As part of the transaction, PepsiCo retained a 39% noncontrolling interest in The Beverage Group (TBG), which operates across North America and Europe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Sold]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Naked (PRODUCT)",
        "Naked (PRODUCT) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6436,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2251,
        "completion_tokens": 86,
        "total_tokens": 2337
      }
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities, effective January 1, 2020, results in the immediate recognition of changes in the market value of those plan assets in the expected return on plan assets, which directly affects the measurement of net periodic pension cost. This contrasts with the calculated value approach previously used, which smoothed returns by amortizing gains and losses over five years. As a result, the fair value approach provides a more current reflection of asset value changes in the net periodic pension cost, aligning more closely with the changes in related pension obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "SO (ORG) -> Fair Value Approach (ACCOUNTING_POLICY)",
        "Fair Value Approach (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_287",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_287",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4470,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1794,
        "completion_tokens": 162,
        "total_tokens": 1957
      }
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "Netflix's total content spending increased from $9,216,247 thousand in 2019 to $12,230,367 thousand in 2021, representing a total increase of $3,014,120 thousand. Over this period, produced content grew from $1,973,448 thousand in 2019 to $4,174,556 thousand in 2021, showing a significant increase compared to licensed content, which grew from $7,242,799 thousand to $8,055,811 thousand. This highlights a strategic shift toward higher investment in produced content relative to licensed content.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Total Content (PRODUCT)",
        "Total Content (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1564,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1034,
        "completion_tokens": 124,
        "total_tokens": 1158
      }
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "In 2023, PepsiCo recorded a total pre-tax impairment charge of $321 million related to its 39% noncontrolling interest in TBG, which included an impairment of TBG's indefinite-lived intangible assets and an other-than-temporary impairment of the investment. This contrasts with 2022, where PepsiCo recognized a $520 million pre-tax gain from the remeasurement of the same 39% ownership in TBG at fair value following the sale of its juice brands to PAI Partners. The 2022 gain was part of the overall income statement activity related to the Juice Transaction, reflecting the initial valuation and subsequent adjustments of the retained stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> TBG (COMP)",
        "TBG (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3260,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 160,
        "total_tokens": 1624
      }
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million rise in content amortization, as stated in Chunk 2, due to the production and acquisition of more exclusive and original content. This investment also contributed to a $633 million increase in other costs of revenues, driven by higher production activities and delivery expenses. Despite the higher absolute costs, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily because delays in content releases caused by the COVID-19 pandemic slowed the growth of amortization relative to the growth in revenue. This highlights the interplay between increased content investment and external factors like the pandemic in shaping Netflix's financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Original Programming (PRODUCT)",
        "Original Programming (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5475,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2007,
        "completion_tokens": 193,
        "total_tokens": 2200
      }
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million, as shown in Chunk 1, with $138 million from the United States and $356 million from international markets. According to Chunk 2, international revenue for Ozurdex grew by 8.3% at actual currency rates in 2024 compared to 2023, which reflects a significant increase relative to the previous year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Ozurdex (PRODUCT)",
        "Ozurdex (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11334,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3476,
        "completion_tokens": 91,
        "total_tokens": 3567
      }
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC in February 2021. This gain was included in Net Other Income in the financial statements, as disclosed in the notes to the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Dermstore LLC (COMP)",
        "Dermstore LLC (COMP) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4978,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1885,
        "completion_tokens": 63,
        "total_tokens": 1948
      }
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "The difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations is $8 million ($244 million - $236 million). This difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Mortgage-Backed Obligations (FIN_INST)",
        "Mortgage-Backed Obligations (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5187,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1964,
        "completion_tokens": 66,
        "total_tokens": 2030
      }
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "The adoption of the new LDTI accounting guidance by MetLife resulted in retrospective adjustments to both the consolidated balance sheet and the consolidated statements of comprehensive income, as disclosed in the 2023 10-K filing. These adjustments cover the time period ending December 31, 2022, reflecting the impact of the new guidance on previously reported financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> LDTI Guidance (ACCOUNTING_POLICY)",
        "LDTI Guidance (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_164",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_162",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 938,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 894,
        "completion_tokens": 96,
        "total_tokens": 990
      }
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities, with $1.1 billion allocated for the Disney Treasure and another $1.1 billion for the Disney Destiny. The interest rate structure differs slightly between the two: the Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%. Both loans are payable semi-annually over 12 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Disney Destiny Credit Facility (FIN_INST)",
        "Disney Destiny Credit Facility (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4788,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1858,
        "completion_tokens": 122,
        "total_tokens": 1980
      }
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited in 2024 was $405 million, contributing approximately 11.3% to its total upstream equity earnings of $3,580 million. This significant contribution indicates that Chevron has a substantial production involvement in Angola, as evidenced by the mention of Angola LNG in the context of Chevron's share of production by affiliates in the second chunk. The mutual investment relationship between Chevron and Angola LNG, as shown in the knowledge graph, further underscores the strategic and operational importance of Angola to Chevron's upstream activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG (COMP)",
        "Angola LNG (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6826,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2351,
        "completion_tokens": 150,
        "total_tokens": 2502
      }
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "As of September 28, 2024, Disney had Canadian $2.6 billion ($1.9 billion) in Canadian dollar denominated notes outstanding, consisting of Canadian $1.3 billion ($0.9 billion) and Canadian $1.3 billion ($1.0 billion). The Company has entered into cross-currency swaps to convert these borrowings into variable-rate U.S. dollar denominated borrowings indexed to SOFR, effectively converting the entire Canadian $2.6 billion ($1.9 billion) into U.S. dollar denominated borrowings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Canadian Dollar Denominated Notes (FIN_INST)",
        "Canadian Dollar Denominated Notes (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4788,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1861,
        "completion_tokens": 119,
        "total_tokens": 1980
      }
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,373. This includes $1,265 in private funds under U.S. Plans and $115 in private funds under Non-U.S. Plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Private funds (FIN_INST)",
        "Private funds (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2517,
        "completion_tokens": 62,
        "total_tokens": 2579
      }
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, significantly impacts its revenue recognition structure by differentiating between cloud-based and license-based offerings. For Oracle Cloud Services, revenue is generally recognized ratably over the contractual period of the cloud contract or as services are consumed, reflecting the ongoing nature of these subscription-based arrangements. In contrast, cloud license and on-premise license revenues are typically recognized up front at the point in time when the software is made available to the customer, as these are generally perpetual licenses. This distinction results in cloud services and license support revenues, which represented 71% of total revenues in fiscal 2022, being recognized more consistently over time, while license revenues can be more volatile due to the point-in-time recognition of large transactions. This strategic shift toward cloud services aligns with customer demand and supports Oracle's long-term growth and investment in cloud infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Services (PRODUCT)",
        "Oracle Cloud Services (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9470,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3017,
        "completion_tokens": 267,
        "total_tokens": 3285
      }
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "The total worldwide sales growth percentage of ERLEADA from 2021 to 2023 was 45.7% (from $1,291 million in 2021 to $2,387 million in 2023). In 2023, ERLEADA contributed to the overall performance of the Oncology segment by delivering 26.9% growth compared to 2022, as disclosed in the JNJ 10-K 2023 report. This strong growth positively impacted the Oncology segment's total 10.5% increase in sales in 2023 compared to 2022, despite declines in other products like IMBRUVICA and ZYTIGA.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> ERLEADA (PRODUCT)",
        "ERLEADA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9971,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3136,
        "completion_tokens": 121,
        "total_tokens": 3257
      }
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "As of December 31, 2023, the total notional amount of net investment hedge derivative contracts used by MDLZ was $7,456 million, and the total notional amount of non-U.S. dollar denominated debt designated as net investment hedges was $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes). This brings the combined notional amount to $11,811 million. In comparison, the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date was $1,347 million and $250 million, respectively, totaling $1,597 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Net Investment Hedge Derivative Contracts (FIN_INST)",
        "Net Investment Hedge Derivative Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1684,
        "completion_tokens": 164,
        "total_tokens": 1849
      }
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by summing $676 million in Mortgage/Asset-backed securities from the U.S. plans (Chunk 2) and $10 million from the Non-U.S. plans (Chunk 1).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Mortgage/Asset-backed securities (FIN_INST)",
        "Mortgage/Asset-backed securities (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2528,
        "completion_tokens": 79,
        "total_tokens": 2607
      }
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29, 2024, Starbucks has $177.0 million in current deferred revenue and $5.8 billion in long-term deferred revenue related to the up-front $7 billion prepaid royalty from Nestlé under the Global Coffee Alliance's 40-year arrangement. This total remaining deferred revenue of $5.977 billion reflects the portion yet to be recognized as revenue over the estimated economic life of the arrangement, which is being recognized on a straight-line basis. The Global Coffee Alliance, a partnership between Starbucks and Nestlé, grants Nestlé the right to sell and market Starbucks products, with Starbucks maintaining ongoing obligations to support the alliance, including brand and intellectual property access.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Global Coffee Alliance (COMP)",
        "Global Coffee Alliance (COMP) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4025,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1657,
        "completion_tokens": 179,
        "total_tokens": 1837
      }
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "The total fair value of long-term obligations to equity companies, as disclosed by XOM in its 2023 10-K filing, is $1,896 million (from Chunk 1). Additionally, the guarantees related to equity company obligations amount to $1,862 million (from Chunk 2). Therefore, the combined total of long-term obligations to equity companies and guarantees related to equity company obligations is $3,758 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Equity Obligations (FIN_INST)",
        "Equity Obligations (FIN_INST) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4024,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 100,
        "total_tokens": 1750
      }
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "As of December 31, 2023, the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans was $686 million, with $676 million allocated to the U.S. plans and $10 million allocated to the Non-U.S. plans. This indicates that the U.S. plans held significantly more of these securities compared to the Non-U.S. plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Mortgage/Asset-backed securities (FIN_INST)",
        "Mortgage/Asset-backed securities (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2540,
        "completion_tokens": 89,
        "total_tokens": 2629
      }
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. In fiscal year 2021, the adjustment was $83 million, and in fiscal year 2022, it was $102 million. These figures reflect the pre-tax adjustments related to medical device regulations disclosed in Medtronic's 10-K filings for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Medical device regulations (REGULATORY_REQUIREMENT)",
        "Medical device regulations (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6820,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2364,
        "completion_tokens": 104,
        "total_tokens": 2468
      }
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "The total goodwill impairment recognized for the OpenTable and KAYAK reporting unit during 2020 was $1,062 million, comprising a $489 million impairment charge in the interim test at March 31, 2020, and a $573 million impairment charge in the annual test as of September 30, 2020. The key factor leading to the continued impairment in the annual test was the prolonged and material adverse impact of the COVID-19 pandemic, particularly the slower-than-expected recovery in airline travel (a key vertical for KAYAK) and reduced monetization opportunities in restaurant reservation services (for OpenTable). These factors extended the expected recovery period beyond the initial 2023 forecast to more than five years from September 30, 2020.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> OpenTable (COMP)",
        "OpenTable (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9755,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3090,
        "completion_tokens": 184,
        "total_tokens": 3275
      }
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart's ownership stake in Flipkart increased from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024, representing a 10% increase. This change was supported by a $3.5 billion financial transaction during fiscal 2024, where Walmart acquired shares from certain Flipkart noncontrolling interest holders and settled the liability to former noncontrolling interest holders of PhonePe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Flipkart (COMP)",
        "Flipkart (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7849,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2594,
        "completion_tokens": 104,
        "total_tokens": 2699
      }
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment represents **24% of Procter & Gamble's total net sales**, as shown in Chunk 1. Within this segment, the **Bounty brand holds over 40% market share in the North American paper towel category**, as detailed in Chunk 2. These figures highlight the segment's contribution to P&G's overall revenue and the strong market position of the Bounty brand in its category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Bounty (PRODUCT)",
        "Bounty (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2123,
        "completion_tokens": 100,
        "total_tokens": 2223
      }
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "RTX recorded a total pre-tax charge of $364 million in 2024 specifically related to resolving Thales-Raytheon Systems and Related Matters, as disclosed in the second quarter of 2024. This resolution is directly connected to the SEC Administrative Order, which was part of the broader settlement to address criminal and civil government investigations into payments made by Raytheon Company and its joint venture, Thales-Raytheon Systems, in connection with certain Middle East contracts since 2012. The SEC Administrative Order, along with the deferred prosecution agreements, required RTX to implement compliance measures and retain an independent compliance monitor, underscoring the regulatory and financial implications of the resolution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Settles]-> REGULATORY_REQUIREMENT <-[Faces]- ORG",
      "triplets_used": [
        "RTX (ORG) -> SEC Administrative Order (REGULATORY_REQUIREMENT)",
        "SEC Administrative Order (REGULATORY_REQUIREMENT) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12764,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3853,
        "completion_tokens": 185,
        "total_tokens": 4038
      }
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "As of April 2021, Trodelvy had **two approved indications**: one for the treatment of **metastatic triple-negative breast cancer (TNBC)** and another for **metastatic urothelial cancer (UC)**. By September 2021, the drug was approved for the treatment of metastatic TNBC in **Canada**, joining **Australia, Great Britain, Switzerland, and the United States**—all of which had previously approved Trodelvy under the Project Orbis initiative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7846,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2610,
        "completion_tokens": 110,
        "total_tokens": 2720
      }
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million. Of this amount, $9.5 million is expected to be reclassified from AOCI into earnings within the next 12 months. This indicates that the majority of the unrealized gain is anticipated to be realized in the near term, with a remaining $2.0 million expected to be recognized beyond 12 months.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7213,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2466,
        "completion_tokens": 102,
        "total_tokens": 2569
      }
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "As of the end of fiscal 2024, the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks is $103.6 million (¥15.0 billion, comprising ¥5.0 billion or $34.5 million and ¥10.0 billion or $69.1 million). These facilities differ in terms of maturity dates and interest rate margins: the ¥5.0 billion facility matures on December 30, 2024, with an interest rate margin of 0.400% over TIBOR, while the ¥10.0 billion facility matures on March 27, 2025, with a lower interest rate margin of 0.300% over TIBOR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Japanese Yen Credit Facilities (FIN_INST)",
        "Japanese Yen Credit Facilities (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8456,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2779,
        "completion_tokens": 135,
        "total_tokens": 2914
      }
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "In the fourth quarter of fiscal 2024, Accenture plc purchased a total of 2,072,563 Class A ordinary shares, which includes 2,000,308 shares under the publicly announced open-market share purchase program and 72,255 shares in transactions unrelated to publicly announced share plans or programs. The average price paid per share under the open-market program was $299.95, calculated as $605 million divided by 2,000,308 shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3066,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 106,
        "total_tokens": 1560
      }
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, as reported in the December 31, 2021, and 2020 columns in Chunk 1. According to Chunk 2, the principal amount of these notes that was exchanged is $74 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 6.375% 2037 Notes (FIN_INST)",
        "6.375% 2037 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1983,
        "completion_tokens": 56,
        "total_tokens": 2039
      }
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "The expected average amortization period for Netflix's content assets is the shorter of the title's contractual window of availability or an estimated period of use of up to ten years. However, due to the accelerated amortization policy, over 90% of a licensed or produced content asset is expected to be amortized within four years after its month of first availability. The accelerated amortization reflects the higher expected viewing activity in the initial period, with film amortization being more accelerated than TV series. This results in a front-loaded distribution of amortization expense, significantly impacting the early years—particularly the first four years—of a content asset's life, as the majority of the expense is recognized upfront rather than evenly over the full amortization period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reviews]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Amortization Factors (ACCOUNTING_POLICY)",
        "Amortization Factors (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12031,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3679,
        "completion_tokens": 202,
        "total_tokens": 3881
      }
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on the disclosed exposure in the 2023 10-K filing, BLK's Foreign Exchange Rate Risk Investments had an exposure of $1,125 million as of December 31, 2023. If all investments experience a -10% change in exchange rates, the potential financial impact would be $112 million. This figure reflects the estimated effect of such a change on BLK's financial position, as disclosed in the filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Impacts]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Foreign Exchange Rate Risk Investments (FIN_INST)",
        "Foreign Exchange Rate Risk Investments (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1736,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1093,
        "completion_tokens": 98,
        "total_tokens": 1192
      }
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "The 2022 10-K filing lists four amendments to the Target Corporation Deferred Compensation Trust Agreement. Their effective dates are January 1, 2009 (the original restatement), and subsequent amendments effective June 8, 2011, October 25, 2017, and December 18, 2020.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Def. Comp. Trust Amend. (FIN_INST)",
        "Def. Comp. Trust Amend. (FIN_INST) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16480,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4763,
        "completion_tokens": 67,
        "total_tokens": 4830
      }
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, as shown in Chunk 1 under the December 31, 2021, and 2020 columns. According to Chunk 2, the principal amount of these notes that was exchanged in the debt exchange transactions is $37 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 6.90% 2038 Notes (FIN_INST)",
        "6.90% 2038 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1979,
        "completion_tokens": 64,
        "total_tokens": 2044
      }
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The Fleet Ballistic Missile (FBM) program contributed approximately $940 million to the increase in product sales at Space in 2023 and also led to an increase in product costs of $815 million at Space, as noted in both chunks. The net financial impact on Lockheed Martin's operations from these changes is an increase in operating profit of $25 million ($940 million increase in sales minus $815 million increase in costs).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Fleet Ballistic Missile Program (PRODUCT)",
        "Fleet Ballistic Missile Program (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4522,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1796,
        "completion_tokens": 105,
        "total_tokens": 1901
      }
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The total carrying value of the 5.375% 2043 Notes in 2022 was $185 million. The total carrying value of all debt reported by AMGN in 2022 was $33,309 million. Therefore, the 5.375% 2043 Notes represented approximately 0.55% of the total debt ($185 / $33,309). Additionally, $76 million in principal of these notes was exchanged during the period, as reported in Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 5.375% 2043 Notes (FIN_INST)",
        "5.375% 2043 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1990,
        "completion_tokens": 92,
        "total_tokens": 2082
      }
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "The total value of securities on loan subject to indemnification as of December 31, 2023, was approximately $259 billion, with $276 billion in cash and securities held as collateral. If significant borrower defaults occur simultaneously with rapid declines in collateral value, it could result in material liabilities under these indemnities, potentially causing a decline in BlackRock's revenue and earnings due to collateral shortfalls.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Securities Lending Clients (COMP)",
        "Securities Lending Clients (COMP) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12640,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3834,
        "completion_tokens": 109,
        "total_tokens": 3944
      }
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc., as documented in the 2022 10-K filing, is two. The original agreement was dated December 16, 2015, followed by the First Amendment on November 30, 2016, and the Second Amendment on January 9, 2018. Both amendments are explicitly listed in the provided text chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Pharmacy Operating Agreement (ACCOUNTING_POLICY)",
        "Pharmacy Operating Agreement (ACCOUNTING_POLICY) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2790,
        "completion_tokens": 96,
        "total_tokens": 2887
      }
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased from $180 million at December 31, 2022, to $142 million at December 31, 2023, representing a decrease of $38 million. Over the same period, the accumulated amortization for this category increased from $81 million to $118 million, reflecting an increase of $37 million. The decrease in the net carrying amount is primarily driven by the increase in accumulated amortization, with a slight additional impact from changes in the gross carrying amount (from $261 million to $260 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Technology-Related (FIN_INST)",
        "Technology-Related (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3181,
        "completion_tokens": 143,
        "total_tokens": 3324
      }
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was from $657 million in Fiscal Year 2023 to $2,203 million in Fiscal Year 2024, representing a $1,546 million increase. In comparison, the same category in the Americas region increased from $5,678 million in Fiscal Year 2023 to $12,726 million in Fiscal Year 2024, reflecting a $7,048 million increase. Thus, while both regions showed significant growth, the Americas region experienced a much larger dollar increase in Subscriptions and Services revenue compared to the Asia Pacific region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Subscriptions & Services (PRODUCT)",
        "Subscriptions & Services (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1928,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 147,
        "total_tokens": 1281
      }
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is **$20 million**, as shown in the \"Fair Value\" column for redeemable preferred securities in Chunk 1. Additionally, the unrealized loss on these securities, which has been recognized in fair value as of the same date, is **$1 million**, as indicated in the \"Gross Unrealized Losses\" column in Chunk 1 and further detailed in Chunk 2 under the \"Unrealized Losses\" column for the total period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Redeemable preferred securities (FIN_INST)",
        "Redeemable preferred securities (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_147",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11565,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3551,
        "completion_tokens": 121,
        "total_tokens": 3673
      }
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "At January 30, 2022, the total amount of borrowings under HD's commercial paper programs was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a $2.0 billion five-year credit facility and a $1.0 billion 364-day credit facility, reflecting a significant cushion beyond the outstanding borrowings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> 364-Day $1.0 Billion Credit Facility (FIN_INST)",
        "364-Day $1.0 Billion Credit Facility (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2148,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 90,
        "total_tokens": 1287
      }
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, as reported under the collaboration for product sales. Additionally, Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year, as recorded in SG&A expenses in the Consolidated Statements of Income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> BeiGene (COMP)",
        "BeiGene (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6981,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2382,
        "completion_tokens": 79,
        "total_tokens": 2461
      }
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million, calculated as $2,886 million (2024) minus $1,241 million (2023). As of December 31, 2023, the corresponding Crypto Asset Safeguarding Asset was valued at $1,241 million and was classified under Level 2 inputs (Significant Other Observable Inputs), as shown in Chunk 2. This indicates that the asset's valuation was based on observable market data rather than quoted prices in active markets (Level 1). The liability and asset are directly matched in value as disclosed in Chunk 1, reflecting the safeguarding obligations and related assets held on behalf of customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Crypto Asset Safeguarding Liability (FIN_INST)",
        "Crypto Asset Safeguarding Liability (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8012,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2673,
        "completion_tokens": 171,
        "total_tokens": 2845
      }
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "As of December 31, 2024, UnitedHealth Group had **48 million shares** available for future grants under its **2020 Stock Incentive Plan**. The plan documentation explicitly references **non-qualified stock options**, **restricted stock units (RSUs)**, and **performance-based restricted stock units (PRSUs)** as the types of share-based awards offered under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2733,
        "completion_tokens": 91,
        "total_tokens": 2825
      }
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "The remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028 is approximately $1 billion, as disclosed in Chunk 2. In comparison, the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner was $129 million, as noted in Chunk 2. Thus, the expected Paxlovid revenue over 2025–2028 is significantly higher than the 2024 one-time settlement revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15330,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4494,
        "completion_tokens": 112,
        "total_tokens": 4606
      }
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "As of December 31, 2023, AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were $12.4 billion. Under this agreement, AIG transferred 80% of the reserve risk on its U.S. Commercial long-tail exposures for accident years 2015 and prior. Berkshire Hathaway Inc. provided a parental guarantee to secure NICO's obligations under the agreement, thereby covering the full $12.4 billion of ceded loss reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Parental Guarantee (FIN_INST)",
        "Parental Guarantee (FIN_INST) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_184",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7073,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2419,
        "completion_tokens": 111,
        "total_tokens": 2531
      }
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "PayPal purchased approximately $1.8 billion in credit receivables for its merchant finance offerings in both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the $63 million participation interest sold to WebBank. This indicates that while PayPal acquired $1.8 billion in receivables over the two years, the net outstanding balance as of the end of 2021 reflects repayments and the portion of the portfolio sold to WebBank.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Finance Products (PRODUCT)",
        "Merchant Finance Products (PRODUCT) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5356,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2015,
        "completion_tokens": 140,
        "total_tokens": 2155
      }
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "The total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023 was approximately $500. By July 2024, $77 of this debt had been repaid.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6420,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2249,
        "completion_tokens": 42,
        "total_tokens": 2292
      }
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 (from $15,206 to $11,947), while the net gains realized from these investments during the same period were $9 (as reported in the 2022 results). Therefore, the decrease in value exceeded the net gains by $3,250.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1844,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 76,
        "total_tokens": 1191
      }
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "As of December 31, 2021, Amazon had a $7.0 billion unsecured revolving credit facility with no borrowings outstanding, meaning the full $7.0 billion was unused. Additionally, Amazon had $7.2 billion of unused letters of credit. Combining these, the total amount of unused short-term credit capacity available to Amazon was $14.2 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Short-Term Credit Facilities (FIN_INST)",
        "Short-Term Credit Facilities (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2914,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 84,
        "total_tokens": 1467
      }
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, which includes $2.70 billion for The Binding Site Group and $0.91 billion for CorEvitas, LLC. Therefore, $2.70 billion of the total outflow was specifically allocated to The Binding Site Group.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> The Binding Site Group (COMP)",
        "The Binding Site Group (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8941,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2886,
        "completion_tokens": 68,
        "total_tokens": 2954
      }
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Union Pacific's chassis units consist of 30,635 owned units and 17,705 leased units, totaling 48,340, meaning that approximately 36.6% (17,705 / 48,340) are leased. In comparison, only 1.1% (545 / 47,984) of containers are leased, highlighting a significantly smaller leased proportion for containers compared to chassis in their highway revenue equipment fleet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Leases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Chassis (PRODUCT)",
        "Chassis (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_8",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 990,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 891,
        "completion_tokens": 90,
        "total_tokens": 982
      }
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "Across the referenced exhibits, a total of **11** different supplemental indentures related to Senior Notes that include the **2035 Note** were identified (Exhibit Numbers 4.2 through 4.11). The most recent of these agreements is the **Tenth Supplemental Indenture**, dated **November 20, 2024**, which was between the Company and **Computershare Trust Company, National Association**, as successor to Wells Fargo Bank, National Association, as Trustee.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> 2035 Note (FIN_INST)",
        "2035 Note (FIN_INST) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15842,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4611,
        "completion_tokens": 113,
        "total_tokens": 4724
      }
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The expensing methodology for non-employee director deferred stock units granted in 2023 differs from those granted prior to 2022 in that the 2023 awards are expensed on a straight-line basis over the requisite service period, while awards granted prior to 2022 were expensed on the grant date. Additionally, the 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to potential acceleration in certain circumstances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Expensed]-> FIN_INST <-[Vests]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Non-Employee Directors Awards (FIN_INST)",
        "Non-Employee Directors Awards (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1410,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1006,
        "completion_tokens": 130,
        "total_tokens": 1136
      }
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets for this business unit and region were $698 million. Therefore, the operating profit represented approximately 36.4% of the total identifiable assets ($254 / $698 * 100).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Eurasia (GPE)",
        "Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3474,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 80,
        "total_tokens": 1601
      }
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "In fiscal year 2024, AMD's total purchases from the ATMP JV amounted to $1.7 billion, and resales to the ATMP JV totaled $121 million. Additionally, AMD provided a $100 million loan to one of the ATMP JVs during the same year. Thus, the total purchases and resales combined to $1.821 billion, significantly exceeding the $100 million loan provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4814,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1846,
        "completion_tokens": 87,
        "total_tokens": 1933
      }
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The revenue for the Analytical and physical instrumentation product line increased from $2,464 million in 2019 to $2,620 million in 2021, representing a total increase of $156 million. Over the same period, the Research and medical products segment saw a significantly larger increase, rising from $13,512 million in 2019 to $24,802 million in 2021, a total increase of $11,290 million. Thus, while the Analytical and physical instrumentation segment experienced modest growth, the Research and medical products segment demonstrated substantial revenue expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Analytical and physical instrumentation (PRODUCT)",
        "Analytical and physical instrumentation (PRODUCT) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1840,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 140,
        "total_tokens": 1270
      }
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "Microsoft's SQL Server product line contributes to the Intelligent Cloud segment's financial performance by being a key component of the segment's Server Products and Cloud Services category. As stated in Chunk 1, SQL Server is included among the server products and cloud services that power modern business and developers, and its revenue is influenced by volume licensing programs, OEM licenses, and retail sales. Additionally, CALs related to SQL Server are reported alongside the associated server product, further integrating its revenue into the segment. The Intelligent Cloud segment, as outlined in Chunk 2, is one of the three primary reportable segments reviewed by Microsoft’s management, and SQL Server's inclusion within it underscores its role in supporting the company's broader cloud and server infrastructure strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> SQL Server (PRODUCT)",
        "SQL Server (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8491,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2763,
        "completion_tokens": 209,
        "total_tokens": 2972
      }
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, is a decrease of $560 million, from $950 million to $1,390 million. This reflects a $655 million increase in the year ending December 31, 2023 (from $950 million to $1,605 million), primarily driven by purchases of $587 million and a positive return of $68 million, partially offset by sales and settlements of $247 million and a negative return of $115 million on other assets. In 2024, the balance decreased by $215 million to $1,390 million, due to a negative return of $215 million on assets still held at year-end, with no additional purchases or sales related to Insurance Buy-in Contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> Insurance Buy-in Contracts (FIN_INST)",
        "Insurance Buy-in Contracts (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5470,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2017,
        "completion_tokens": 174,
        "total_tokens": 2192
      }
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "As of December 31, 2024, the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans was $852 million (U.S.) plus $34 million (non-U.S.), totaling $886 million. During 2024, dividends paid on these shares amounted to $26 million (U.S.) and were not material for non-U.S. plans, as stated in the provided disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "TXN (ORG) -> TI Common Stock (FIN_INST)",
        "TI Common Stock (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4626,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1804,
        "completion_tokens": 87,
        "total_tokens": 1891
      }
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050, as disclosed in their 2022 10-K, was $1,250 million. This amount is higher than the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes, which totaled $2,250 million ($1,000 million + $750 million + $500 million). Thus, the 5.300% Senior Notes due 2050 had a principal amount that was $1,000 million less than the combined total of the other three senior notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> 5.300% Senior Notes (FIN_INST)",
        "5.300% Senior Notes (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_170",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5855,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2122,
        "completion_tokens": 109,
        "total_tokens": 2231
      }
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "The total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024 is $159.95 per RSU. This figure is derived from the \"Outstanding as of December 31, 2023\" row in both chunks, which shows 1,827 thousand Service-Based RSUs with a weighted-average grant-date fair value of $159.95. These RSUs were not fully vested or forfeited by year-end, as confirmed by the consistent data across both provided chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Service-Based RSUs (FIN_INST)",
        "Service-Based RSUs (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_135",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_135",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5792,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2108,
        "completion_tokens": 127,
        "total_tokens": 2235
      }
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS's estimation process for uncertain tax positions, as detailed in both the notes to the financial statements and the management discussion section, influences the potential recognition of tax benefits or additional charges to the tax provision through a two-step evaluation. First, UPS assesses whether the tax position is more likely than not to be sustained on audit, considering available evidence and potential litigation or appeals. If the position meets this recognition threshold, UPS then measures the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement. The difference between this measurable benefit and the total tax benefit claimed is recorded as a liability for uncertain tax benefits. This process is inherently subjective and reevaluated quarterly, with changes in facts, tax law, audit settlements, or new audit activity potentially leading to the recognition of a tax benefit or an additional charge to the tax provision.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Tax Benefit Estimation (ACCOUNTING_POLICY)",
        "Tax Benefit Estimation (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8126,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2723,
        "completion_tokens": 247,
        "total_tokens": 2970
      }
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, as shown in Chunk 2. Additionally, organic sales in this region increased by 7.0% during the same year, as reported in Chunk 1.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Africa/Eurasia (GPE)",
        "Africa/Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2267,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 50,
        "total_tokens": 1250
      }
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "The increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021 was $446 million (from $2,994 million to $3,440 million), representing a 14.9% growth. This growth contributed to the 19.6% overall increase in Vision segment sales during the same period, which rose from $3,919 million in 2020 to $4,688 million in 2021, highlighting the significant role of Contact Lenses/Other in driving Vision segment performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Contact Lenses (PRODUCT)",
        "Contact Lenses (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2132,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 108,
        "total_tokens": 1288
      }
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "The consolidation of AspenTech into Emerson's financial statements in 2023 had a mixed impact on the Control Systems & Software segment's earnings and margin performance. While the segment's sales increased by 11% in 2023 compared to 2022, driven by the acquisition of Heritage AspenTech, the earnings for the Control Systems & Software segment rose by 21% from $437 million in 2022 to $529 million in 2023. However, the segment's margin declined by 3.1 percentage points to 11.6% in 2023 from 14.7% in 2022, primarily due to the negative impact of amortization of intangibles and restructuring costs associated with the AspenTech acquisition. Despite these challenges, the overall Adjusted EBITA margin for the segment improved by 2.3 percentage points to 25.8% in 2023, reflecting operational efficiencies and favorable pricing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7395,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2490,
        "completion_tokens": 207,
        "total_tokens": 2697
      }
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation, as noted in the litigation provision section of Chunk 1. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the rate at which shares of Visa's Class B common stock convert into shares of Class A common stock, as described in both Chunk 1 and the regulatory relationship established in the knowledge graph triplets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "V (ORG) -> U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT)",
        "U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5082,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1936,
        "completion_tokens": 118,
        "total_tokens": 2055
      }
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 includes both operational results and post-closing adjustments. From Chunk 1, we learn that the second quarter of 2021 included a pre-tax charge of $345 million to resolve a legal matter related to Meridian, and the fourth quarter included an after-tax loss of $167 million related to the sale of Meridian. Chunk 2 confirms that Meridian is presented as a discontinued operation in all periods. Combining these, the total financial impact is a pre-tax charge of $345 million and an after-tax loss of $167 million, reflecting both operational and post-closing adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Sells]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Meridian (COMP)",
        "Meridian (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3894,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 164,
        "total_tokens": 1770
      }
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "Bank of America Corporation (BAC) must maintain a minimum supplementary leverage ratio (SLR) of 3.0% under Basel 3, plus a leverage buffer of 2.0%, resulting in a total required SLR of 5.0% to avoid restrictions on capital distributions and executive bonuses. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0% to be considered \"well capitalized\" under the Prompt Corrective Action (PCA) framework. This difference reflects the distinct regulatory capital requirements applied to the parent financial holding company versus its subsidiary banks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Basel 3 (REGULATORY_REQUIREMENT)",
        "Basel 3 (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3788,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 152,
        "total_tokens": 1771
      }
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "The adoption of the credit loss guidance on January 1, 2020, significantly changed MetLife's accounting treatment for mortgage loans by requiring the recognition of an Allowance for Credit Losses (ACL) based on expected lifetime credit losses at the time of purchase, rather than under the prior incurred loss model, where credit losses were recognized only when it was probable that all amounts due would not be collected. Under the new guidance, MetLife recognizes the ACL in earnings within net investment gains (losses) and presents mortgage loans at the net amount expected to be collected. This approach involves significant judgment in estimating expected credit losses over the contractual term of the loans, adjusted for prepayments and economic conditions, as detailed in Notes 1 and 8 of the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Credit Loss Guidance (ACCOUNTING_POLICY)",
        "Credit Loss Guidance (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_172",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9452,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3028,
        "completion_tokens": 206,
        "total_tokens": 3234
      }
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans by shifting from the incurred loss model to the expected credit loss model. Under the new guidance, the Company records an allowance for expected lifetime credit loss (ACL) based on estimates that incorporate past events, current conditions, and forecasted economic conditions, rather than recognizing losses only when they are incurred. For leveraged lease receivables, the ACL is estimated using a probability of default and loss given default model, incorporating third-party credit ratings and historical default data. For mortgage loans, the ACL is determined similarly, with significant judgment applied to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions. Both methodologies reflect a forward-looking approach compared to the prior backward-looking incurred loss model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Credit Loss Guidance (ACCOUNTING_POLICY)",
        "Credit Loss Guidance (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_233",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7607,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2574,
        "completion_tokens": 251,
        "total_tokens": 2826
      }
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contributes significantly to its ability to generate and return substantial cash to shareholders, as outlined in its business model and competitive advantages. By leveraging advanced 300-millimeter wafer technology, TXN reduces the cost of producing unpackaged chips by approximately 40% compared to 200-millimeter wafers, enhancing its manufacturing efficiency and cost control. This cost advantage, combined with a strong foundation in manufacturing and technology, is one of TXN's four sustainable competitive advantages, which also include a broad product portfolio, extensive market reach, and product diversity. These factors together enable TI to generate strong free cash flow per share, which is the central metric for long-term value creation for owners. The company’s disciplined capital allocation and focus on efficiency further reinforce its ability to sustain and return significant cash to shareholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Analog Products (PRODUCT)",
        "Analog Products (PRODUCT) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7932,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2648,
        "completion_tokens": 257,
        "total_tokens": 2906
      }
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "As of December 31, 2021, the total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO was $1,000 million, as shown in both Chunk 1 and Chunk 2. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, was $500 million, also reflected consistently in both chunks. Thus, the 1.5-Year Senior Notes had double the value of the 2-Year Senior Notes as of the same date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "TMO (ORG) -> Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes (FIN_INST)",
        "Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2626,
        "completion_tokens": 106,
        "total_tokens": 2732
      }
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "As of December 31, 2023, UnitedHealth Group had 53 million shares available for future issuance under the 2020 Stock Incentive Plan and 17 million shares available under the 1993 Employee Stock Purchase Plan (ESPP), for a combined total of 70 million shares. The 2020 Stock Incentive Plan had significantly more shares available than the ESPP.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5998,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2174,
        "completion_tokens": 85,
        "total_tokens": 2260
      }
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "The total liability for postemployment benefits reported by Caterpillar (CAT) in 2023 was $621 million, comprising $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective on December 31, 2019, eliminated service cost and rendered certain assumptions no longer applicable, impacting the financial reporting by simplifying the calculation and reducing ongoing liabilities related to pension benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Pension Benefits Frozen (RISK_FACTOR)",
        "Pension Benefits Frozen (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 925,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 882,
        "completion_tokens": 126,
        "total_tokens": 1008
      }
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "The total fair value of Merck's investments in developed markets equities in 2024 for U.S. Pension Plans was $2,555, which includes $170 under Level 1 and $2,385 under NAV. This represents a decrease from the prior year (2023), where the total fair value was $2,797, consisting of $224 under Level 1 and $2,573 under NAV.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Developed markets equities (FIN_INST)",
        "Developed markets equities (FIN_INST) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16339,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4742,
        "completion_tokens": 80,
        "total_tokens": 4822
      }
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "As of December 31, 2024, a total of approximately 135 million shares of Danaher common stock have been authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance under the plan (excluding shares underlying outstanding awards). The plan has been used to issue stock options, RSUs, and PSUs to directors, officers, and employees, as outlined in the stock-based compensation disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> 2007 Omnibus Incentive Plan (ACCOUNTING_POLICY)",
        "2007 Omnibus Incentive Plan (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10716,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3378,
        "completion_tokens": 118,
        "total_tokens": 3496
      }
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The growth in Google Play's revenue contribution, as part of non-advertising revenues, may potentially lower Google's overall profit margins due to the differing margin profiles between advertising and non-advertising revenue streams. As stated in Chunk 2, non-advertising revenues—such as those from Google Play—have grown over time and are expected to continue increasing, but these revenues typically have lower margins compared to advertising revenues. Chunk 1 highlights that Google Play generates revenue from sales of apps, in-app purchases, and digital content, which likely carry thinner margins than the high-margin advertising business. Given this shift toward lower-margin non-advertising revenue, the overall profit margin for Google could be negatively impacted unless offset by higher growth or cost efficiencies in these non-advertising segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Generates_Revenue]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Play (PRODUCT)",
        "Google Play (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3071,
        "completion_tokens": 215,
        "total_tokens": 3287
      }
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS uses a variety of derivative financial instruments to hedge against credit quality risk, including interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps. These instruments are employed to align with the company's investment and risk management objectives, and although they individually carry interest rate, equity price, and credit risk, CVS expects their use for hedging purposes to reduce overall risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacts]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Credit Quality Risk (RISK_FACTOR)",
        "Credit Quality Risk (RISK_FACTOR) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3216,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 123,
        "total_tokens": 1574
      }
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by adding $682 million from the U.S. Pension Plans (Chunk 1) and $9 million from the Other Postretirement Benefit Plans (Chunk 2). The relationship between KO and Hedge funds/limited partnerships is disclosed in both plans, as shown in the provided knowledge graph triplets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Hedge funds/limited partnerships (FIN_INST)",
        "Hedge funds/limited partnerships (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3358,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 112,
        "total_tokens": 1597
      }
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "As of 2024, UNP owns 33,704 freight cars and leases 22,472 freight cars, resulting in a total of 56,176 freight cars. Based on their capital plan and lease buyout figures, UNP spent $143 million in 2024 on acquiring freight cars, which includes lease buyouts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Acquires]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Freight Cars (PRODUCT)",
        "Freight Cars (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2691,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 64,
        "total_tokens": 1383
      }
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "Changes in non-marketable equity securities contributed $6.9 billion to the overall $5.2 billion increase in other income (expense), net, from 2020 to 2021, as net unrealized gains from both marketable and non-marketable equity securities were a primary driver of this increase. Given Google's (GOOGL) investments in non-marketable equity securities and their mutual dependency, these gains reflect the performance of privately held companies within Google's equity portfolio and their impact on consolidated financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Non-Marketable Equity Secs (FIN_INST)",
        "Non-Marketable Equity Secs (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2674,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 131,
        "total_tokens": 1459
      }
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.3 billion for the 2022 ASR with Barclays Bank PLC and $0.4 billion for the 2023 ASR with Citibank, N.A., totaling $0.7 billion. Upon final settlement, these forward contracts were classified as equity instruments and initially recorded within capital surplus, later reclassified to treasury stock as the remaining shares were delivered.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Classifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Forward Contract (FIN_INST)",
        "Forward Contract (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6091,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2178,
        "completion_tokens": 113,
        "total_tokens": 2292
      }
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, is designed to supplement the defined contribution retirement plan (401(k) Plan) by addressing restrictions imposed under the Internal Revenue Code of 1986. Specifically, it provides additional benefits to eligible employees whose retirement plan benefits are limited due to these IRS provisions, allowing for salary deferrals and employer contributions in the form of a Company Match. This restoration plan ensures that high-compensation employees can still receive retirement benefits comparable to those available under the 401(k) Plan, despite IRS limitations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Benefit Restoration Plan (ACCOUNTING_POLICY)",
        "Benefit Restoration Plan (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6773,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2369,
        "completion_tokens": 165,
        "total_tokens": 2535
      }
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, consisting of $950 million for CS&Co and $700 million for TDAC. The total borrowing capacity under these facilities is not explicitly stated for each entity, but for CS&Co and TDAC collectively, the provided information does not specify an aggregate borrowing limit, only the individual amounts outstanding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Secured Uncommitted Lines of Credit (FIN_INST)",
        "Secured Uncommitted Lines of Credit (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6742,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2350,
        "completion_tokens": 105,
        "total_tokens": 2456
      }
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "At the end of 2021, the total value of Coca-Cola's investments in mutual, pooled, and commingled funds was $87 million, as shown in both Chunk 1 and Chunk 2. In the same year, the combined value of hedge funds/limited partnerships and real estate investments was $14 million ($9 million + $5 million). This indicates that Coca-Cola's investments in mutual, pooled, and commingled funds were significantly larger than its combined investments in hedge funds/limited partnerships and real estate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Mutual, pooled and commingled funds (FIN_INST)",
        "Mutual, pooled and commingled funds (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4326,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1752,
        "completion_tokens": 123,
        "total_tokens": 1876
      }
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "The treatment of LTIP units as participating securities impacts Simon Property Group's earnings per share (EPS) calculation by requiring the company to use the two-class method. This is because LTIP unit holders are entitled to distributions equal to 10% of the regular quarterly distributions on Operating Partnership units, making them participating securities. As disclosed in Chunk 1, this distribution right means LTIP units share in the dividends declared on common units, and thus must be considered in the EPS computation. Chunk 2 confirms that LTIP units are classified as potentially dilutive securities, though no material dilutive effect was observed in 2023. Therefore, Simon Property Group accounts for LTIP units under the two-class method, which adjusts EPS to reflect the allocation of earnings between common shareholders and participating securities holders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5636,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2070,
        "completion_tokens": 219,
        "total_tokens": 2290
      }
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "The total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, is approximately $3,315 million. XPLR OpCo is classified as a variable interest entity (VIE) in NEE's financial reporting structure, and NEE does not consolidate it because it does not have a controlling financial interest or substantive rights over the significant activities of the entity. Instead, NEE accounts for its noncontrolling interest in XPLR OpCo using the equity method.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> XPLR OpCo (COMP)",
        "XPLR OpCo (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15641,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4562,
        "completion_tokens": 120,
        "total_tokens": 4683
      }
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde uses **three distribution methods** to supply process gases: **on-site**, **merchant**, and **packaged gases**. The **on-site delivery method** differs from the other methods in that it typically involves **longer contract durations (10–20 years)** and **requires the largest volumes of product** with relatively constant demand patterns. In contrast, **merchant** and **packaged gases** methods involve **shorter contract terms (3–7 years and 1–3 years, respectively)** and **lower customer volume requirements**, with the latter often serving small-volume customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Process Gases (PRODUCT)",
        "Process Gases (PRODUCT) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10569,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3297,
        "completion_tokens": 143,
        "total_tokens": 3441
      }
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, is related to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, as both actions pertain to the management of Alphabet's capital structure and shareholder value. The stock split was subject to the condition of obtaining stockholder approval for an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock to accommodate the split.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7707,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2603,
        "completion_tokens": 146,
        "total_tokens": 2750
      }
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "In 2023, GM's total equity earnings contribution from Ultium Cells Holdings LLC was $293 million. As of December 31, 2023, GM had committed capital contributions of $0.8 billion outstanding to Ultium Cells Holdings LLC.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1647,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1065,
        "completion_tokens": 54,
        "total_tokens": 1119
      }
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "The total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 was $720 million, as reported in its consolidated financial statements (Chunk 1), and $9 million, as reported in its other postretirement benefit plan assets (Chunk 2). This dual reporting reflects the company's exposure to such investment vehicles across both its core investment portfolio and its employee benefit obligations, indicating that hedge funds and limited partnerships are used both for strategic asset allocation and for managing retirement-related liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Hedge funds/limited partnerships (FIN_INST)",
        "Hedge funds/limited partnerships (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5246,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1999,
        "completion_tokens": 144,
        "total_tokens": 2143
      }
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The increased use of e-commerce by retail tenants, as noted in the risk factors, contributes to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates by reducing demand for physical retail space. This shift has given creditworthy retail tenants greater bargaining power, leading to downward pressure on occupancy levels and rental rates. Additionally, the resulting vacant space at SPG's properties, often due to store closures and bankruptcies, further complicates leasing efforts and may require costly redevelopments to re-tenant effectively, all of which could materially and adversely affect SPG's financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Vacant Space (RISK_FACTOR)",
        "Vacant Space (RISK_FACTOR) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10747,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3347,
        "completion_tokens": 166,
        "total_tokens": 3513
      }
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The cumulative impact on UNP's deferred tax expense in 2024 from Arkansas corporate income tax legislation was a $34 million reduction, while in 2023, it contributed to an $114 million reduction alongside legislation in other states. In comparison, the 2022 impact from Arkansas legislation was part of a $95 million reduction. Thus, the impact from Arkansas legislation increased from 2022 to 2023 but decreased in 2024 relative to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Arkansas Tax Legislation (REGULATORY_REQUIREMENT)",
        "Arkansas Tax Legislation (REGULATORY_REQUIREMENT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1014,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 921,
        "completion_tokens": 112,
        "total_tokens": 1033
      }
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE's limited partner interest in XPLR OpCo could negatively impact its financial obligations and liquidity if XPLR is unable to access capital on commercially reasonable terms, as this would hinder XPLR's ability to pursue acquisitions or growth opportunities, thereby reducing its cash distributions to NEE. As a holding company reliant on its subsidiaries and investments for liquidity, NEE's financial condition and ability to meet obligations or pay dividends could be materially adversely affected if XPLR's performance declines. Additionally, if XPLR issues more common units or converts securities, NEE's ownership percentage and future cash distributions could be diluted, further impacting the value of its investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> XPLR OpCo (COMP)",
        "XPLR OpCo (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16082,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4663,
        "completion_tokens": 182,
        "total_tokens": 4845
      }
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "The difference between the fair value of mortgage-backed obligations reported in the \"Marketable securities\" section and the \"Fair Value\" column of the marketable securities table is $58. In the \"Marketable securities\" section (Chunk 1), the fair value of mortgage-backed obligations is reported as $236. In the marketable securities table (Chunk 2), the fair value is listed as $178. This results in a $58 difference, which reflects adjustments for unrealized losses and potential valuation methodologies across the two sections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Mortgage-Backed Obligations (FIN_INST)",
        "Mortgage-Backed Obligations (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5187,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1949,
        "completion_tokens": 132,
        "total_tokens": 2082
      }
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "The revenue recognition method for Google Play, which reports app sales and in-app purchases on a net basis as a service fee, impacts the financial reporting of non-advertising revenues by reducing the gross revenue amount recognized compared to a gross reporting model. This net reporting approach, as outlined in Chunk 1, reflects Google’s role as a facilitator rather than a principal in these transactions. Given the increasing portion of non-advertising revenues—such as those from Google Play, hardware, and YouTube subscriptions—as noted in Chunk 2, this recognition method can affect overall revenue growth visibility. Additionally, since non-advertising revenues generally carry lower margins than advertising revenues, as stated in Chunk 2, the net recognition of Google Play revenues further influences the margin profile of the company, contributing to potential margin compression as these non-advertising segments grow.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Play (PRODUCT)",
        "Google Play (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8256,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2709,
        "completion_tokens": 233,
        "total_tokens": 2943
      }
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "In 2023, General Motors made committed capital contributions of $0.8 billion to Ultium Cells Holdings LLC, as compared to $1.4 billion in the previous year (2022). This represents a decrease of $0.6 billion in GM's committed capital contributions to Ultium Cells Holdings LLC from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1986,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 73,
        "total_tokens": 1216
      }
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "In 2024, Mastercard paid a total cash consideration of $2.8 billion for all acquisitions, with $2.7 billion attributed to the acquisition of RF UlEmate Parent, Inc. (Recorded Future). Of the total cash consideration, $1.7 billion was allocated to goodwill, primarily due to the synergies expected from the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MA (ORG) -> RF UlEmate Parent,Inc. (COMP)",
        "RF UlEmate Parent,Inc. (COMP) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6498,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2274,
        "completion_tokens": 79,
        "total_tokens": 2353
      }
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "The total amount spent by Union Pacific (UNP) on freight car lease buyouts from 2022 to 2024 was $143 million in 2024, $57 million in 2023, and $70 million in 2022, summing to **$270 million**. This spending aligns with the company's capital plan for 2025, which is expected to be approximately **$3.4 billion**, with a focus on acquiring freight cars to support replacement and growth opportunities, consistent with the ongoing strategy to modernize and expand its rail operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Leases]-> PRODUCT <-[Acquires]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Freight Cars (PRODUCT)",
        "Freight Cars (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5175,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1941,
        "completion_tokens": 120,
        "total_tokens": 2061
      }
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "The total notional amount of accelerated share repurchase (ASR) agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This includes a $2.0 billion ASR, which involved an initial treasury stock transaction for $1.6 billion and a forward contract for $0.4 billion (as disclosed in the 2023 transaction), and a $1.5 billion ASR with Barclays Bank PLC, which was accounted for as an initial treasury stock transaction for $1.2 billion and a forward contract for $0.3 billion (as disclosed in the 2022 transaction). Both ASRs were completed in their respective years, with the remaining 20% of shares received in February 2022 and February 2023, respectively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Forward Contract (FIN_INST)",
        "Forward Contract (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4050,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1676,
        "completion_tokens": 175,
        "total_tokens": 1852
      }
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "General Motors' (GM) near-term profitability is heavily reliant on its full-size internal combustion engine (ICE) pickup trucks, which generate the highest profit margins for the company. However, this reliance on ICE vehicles, particularly full-size pickups, poses a challenge to its long-term financial stability as it transitions toward electric vehicles (EVs). The company's strategic shift to EVs is critical for its future, but it faces risks such as high development costs, scaling manufacturing capabilities, and achieving consumer adoption. These risks are compounded by the fact that GM is using cash flows from its profitable ICE vehicles to fund its EV growth initiatives. If consumer demand for full-size ICE trucks declines due to economic, regulatory, or environmental factors, or if the EV strategy encounters delays or fails to gain traction, it could negatively impact GM's financial condition and growth prospects. Thus, the company must balance its current profitability from ICE trucks with the long-term transition to EVs to ensure sustained financial stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GM (ORG) -> Full-Size Pickup Trucks (PRODUCT)",
        "Full-Size Pickup Trucks (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12012,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3679,
        "completion_tokens": 271,
        "total_tokens": 3950
      }
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "Chevron's asset impairment assessments and upstream investment decisions are significantly influenced by the uncertainty surrounding the pace of the energy transition, which is shaped by changing commodity prices and regulatory developments. As outlined in Chunk 1, the company's financial performance is highly sensitive to volatile crude oil prices and the evolving regulatory landscape, both of which impact its ability to plan and forecast future cash flows. This uncertainty affects the evaluation of future undiscounted cash flows used in impairment assessments, as noted in Chunk 2, where management estimates—such as commodity price outlooks, production profiles, and the pace of the energy transition—directly influence whether upstream assets are impaired. Additionally, regulatory changes, such as environmental laws, can trigger impairment reviews by altering the economic viability of oil and gas projects. Consequently, Chevron must continuously reassess its asset valuations and investment strategies in light of these macroeconomic and regulatory uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Energy Transition Pace (MACRO_CONDITION)",
        "Energy Transition Pace (MACRO_CONDITION) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11718,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3593,
        "completion_tokens": 269,
        "total_tokens": 3862
      }
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard's provision of Consumer Engagement Services supports its global payments network operations and financial performance by enhancing consumer acquisition, retention, and interaction with payment products, which in turn drives transaction volume and revenue. As outlined in both chunks, these services are part of Mastercard's broader suite of payment solutions and security offerings, leveraging its secure data capabilities and interdependent technological infrastructure. By strengthening consumer relationships and engagement, Mastercard reinforces the usage of its global payments network, which is central to its business model of switching and settling transactions, thereby contributing to its operational efficiency and financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Consumer Engagement Services (PRODUCT)",
        "Consumer Engagement Services (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8012,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2652,
        "completion_tokens": 188,
        "total_tokens": 2841
      }
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and later sold and deconsolidated the entity in fiscal 2025. Since no specific cash inflow from the sale is mentioned in the provided chunks, the total net cash outflow impact across fiscal years 2023 and 2025 is primarily represented by the initial acquisition cost of $0.4 billion, as the deconsolidation does not indicate a corresponding cash inflow in the disclosed information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Sells]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3812,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 112,
        "total_tokens": 1718
      }
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP units granted under SPG's long-term incentive programs. However, no adjustment was made to net income attributable to common stockholders because no securities had a material dilutive effect, and such adjustments would have no dilutive impact. Both disclosures confirm this lack of materiality and the company's practice of accruing dividends or distributions when declared.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1222,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 966,
        "completion_tokens": 130,
        "total_tokens": 1096
      }
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from Chunk 1 and $5 million from Chunk 2). This compares to total investments at fair value of $441 million (Chunk 1) and $461 million (Chunk 2), indicating that Investments measured at NAV represent a small portion (approximately 2.0% and 1.1%, respectively) of the total investments at fair value in each category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> Investments measured at NAV (FIN_INST)",
        "Investments measured at NAV (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2846,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 115,
        "total_tokens": 1483
      }
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "GM reported equity earnings of $293 million from Ultium Cells Holdings LLC in 2023, and these earnings were disclosed in the \"Automotive and other cost of sales\" category. This information is consistently mentioned in both Chunk 1 and Chunk 2, emphasizing the integral role Ultium Cells Holdings LLC plays in GM's operations by supplying battery cells for electric vehicles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1114,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 919,
        "completion_tokens": 93,
        "total_tokens": 1012
      }
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "The equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) in Mastercard (MA) decreased from 0.8% in 2023 to 0.7% in 2024, reflecting a 0.1% decline. This reduction corresponds to a proportional increase in ownership by Public Investors (Class A stockholders), rising from 88.8% to 89.9%, while the Mastercard Foundation's share slightly declined from 10.4% to 9.3%. The shift underscores a continued centralization of ownership toward public investors, with minimal voting power attributed to Class B stockholders in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "MA (ORG) -> Principal or Affiliate Customers (FIN_INST)",
        "Principal or Affiliate Customers (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1818,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 140,
        "total_tokens": 1253
      }
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "In fiscal 2023, Walmart (WMT) had a total cash outflow of $0.4 billion related to the acquisition of Alert Innovation, bringing its ownership to 100%. In the following fiscal year (2025), the Alert Innovation entity was sold and deconsolidated, indicating a reversal of the prior acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Sells]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4824,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1849,
        "completion_tokens": 73,
        "total_tokens": 1922
      }
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "In early 2024, American Tower Corporation repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility, which included $500 million for the 0.600% Senior Notes on January 12, 2024, and $1.0 billion for the 5.00% Senior Notes on February 14, 2024. As of December 31, 2023, the 2021 Multicurrency Credit Facility had a total borrowing capacity of $6.0 billion, with $3.0 billion borrowed and $6.1 billion repaid during the year, indicating that the facility's remaining borrowing capacity was not directly impacted by the early 2024 repayments, as those occurred after the December 31 reporting date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4982,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1905,
        "completion_tokens": 159,
        "total_tokens": 2065
      }
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel's use of EUV in its Intel 4 and Intel 3 process nodes is a critical enabler of its broader roadmap for advanced transistor architectures, allowing for the printing of increasingly smaller features and improved performance-per-watt. Intel 4 utilizes EUV for Meteor Lake client processors, while Intel 3 builds on this with further FinFET optimizations and increased EUV usage. Looking ahead, the Intel 20A node will introduce Ribbon FET (a gate-all-around transistor) and PowerVia, marking a major architectural shift. Beyond 20A, the Intel 18A node is expected to refine Ribbon FET and incorporate High Numerical Aperture EUV as part of the progression toward next-generation lithography and advanced process technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "INTC (ORG) -> EUV (PRODUCT)",
        "EUV (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17960,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5142,
        "completion_tokens": 182,
        "total_tokens": 5324
      }
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ is $101 million (from Chunk 1) and $138 million (from Chunk 2), summing to $239 million. This compares to total cash and cash equivalents of $30 million (Chunk 1) and $27 million (Chunk 2), indicating that the investments in U.S. Treasuries and agencies are significantly larger than the cash and cash equivalents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> U.S. Treasuries and agencies (FIN_INST)",
        "U.S. Treasuries and agencies (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2846,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 116,
        "total_tokens": 1489
      }
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "The total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021 was $9,561 million for Aldevron and $1,340 million for the other businesses, totaling $10,901 million. Of the total goodwill from these acquisitions, $6.1 billion (or $6,149 million) was specifically attributed to Aldevron.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5023,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1902,
        "completion_tokens": 81,
        "total_tokens": 1984
      }
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "As of December 31, 2023, GM's total committed capital contribution to Ultium Cells Holdings LLC was $0.8 billion. This committed capital contribution is distinct from the carrying amount of GM's investment in Ultium Cells Holdings LLC, which was reported as $2,268 million on GM's balance sheet for the same date. The carrying amount reflects the equity value of the investment, while the committed capital represents GM's potential future funding obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1079,
        "completion_tokens": 115,
        "total_tokens": 1194
      }
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "The total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 is $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, is $37,185 million (calculated as total proved and unproved properties of $74,014 million minus accumulated depreciation, depletion, and amortization of $36,829 million). This indicates that the accumulated depreciation, depletion, and amortization account for a significant portion of the total asset value in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_157",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9841,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3112,
        "completion_tokens": 137,
        "total_tokens": 3249
      }
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which includes $5.18 billion in USD and 842.6 million EUR ($919.1 million as of the repayment date). This repayment activity significantly reduced the company's overall revolving indebtedness under the facility, as repayments exceeded borrowings ($6.1 billion repaid vs. $3.0 billion borrowed), leading to a net reduction in outstanding debt and improving the company’s leverage position under this credit facility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Repays]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5856,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2134,
        "completion_tokens": 127,
        "total_tokens": 2261
      }
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and business section, significantly impacts its operational costs and closure activities at coal ash impoundments. The Act, along with federal EPA CCR regulations, mandates the closure and remediation of coal ash basins, requiring excavation and relocation of materials to lined landfills or approved beneficial uses. Closure activities began in 2015, with Duke Energy having completed excavation at three of the four high-priority North Carolina sites. These compliance efforts are factored into estimated retirement and management costs, which are included in rate proceedings to recover expenditures through regulatory processes, as outlined in the business section. This regulatory compliance, therefore, directly influences Duke Energy's financial commitments and operational planning for coal ash impoundment closure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Coal Ash Act (REGULATORY_REQUIREMENT)",
        "Coal Ash Act (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 19630,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5574,
        "completion_tokens": 235,
        "total_tokens": 5809
      }
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel's Agilex FPGA family, built on 10nm SuperFin technology, plays a central role in Intel's IPU (Infrastructure Processing Unit) platforms by enabling high-performance, reconfigurable acceleration for dynamic cloud and network workloads. Specifically, Agilex FPGAs allow cloud and communications service providers to offload infrastructure processing tasks from CPUs, thereby reducing overhead and improving CPU performance, as highlighted in the IPU reference platform \"Oak Springs Canyon,\" which integrates the Agilex FPGA with the Intel Xeon D processor. In this context, the Intel eASIC N5X, as part of Intel's structured ASIC portfolio, serves as an intermediary technology between FPGAs and standard-cell ASICs, offering a balance of lower unit cost, faster time-to-market, and reduced power consumption. This makes it suitable for applications like 5G, where scalability and cost-efficiency are critical, thus complementing the Agilex FPGAs in Intel's broader programmable solutions ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "INTC (ORG) -> FPGA (PRODUCT)",
        "FPGA (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17840,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5093,
        "completion_tokens": 250,
        "total_tokens": 5344
      }
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "As of December 31, 2023, Danaher had approximately 24,000 employees in North America and 3,000 employees in Other Developed Markets. These regions collectively represent approximately 43% of the total global workforce of 63,000 employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Other Developed Markets (GPE)",
        "Other Developed Markets (GPE) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5775,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2089,
        "completion_tokens": 59,
        "total_tokens": 2149
      }
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million, as reported in the Level 2 fair value category in Chunk 2. This amount matches the total derivative assets reported on the balance sheet for the same year, which also amounts to $557 million, as shown in Chunk 1. Thus, the fair value of these specific derivative instruments aligns directly with the total derivative assets disclosed for fiscal year 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2551,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 115,
        "total_tokens": 1414
      }
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, representing an increase of $1,662 million. Over the same period, the number of productive wells in the Lower 48 region rose from 87 in 2021 to 118 in 2022 and further to 38 in 2023, showing a decline in productive wells from 2022 to 2023, despite the overall increase in expenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_154",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1903,
        "completion_tokens": 109,
        "total_tokens": 2012
      }
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies reported across both tables is $2,953 million ($1,412 million in Chunk 1 and $1,541 million in Chunk 2). In terms of allocation between the two categorizations of investments at fair value, U.S. Treasuries and agencies are primarily classified under Level 1 and Level 2. In Chunk 1, $1,274 million is categorized as Level 1 and $138 million as Level 2, while in Chunk 2, $1,312 million is Level 1 and $229 million is Level 2. This shows a consistent allocation strategy, with the majority of these investments classified at Level 1, indicating high transparency and market-based valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> U.S. Treasuries and agencies (FIN_INST)",
        "U.S. Treasuries and agencies (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3796,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 165,
        "total_tokens": 1782
      }
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Nike's timed deposits classified as cash and equivalents decreased from $502 million as of May 31, 2023, to $347 million as of May 31, 2024, representing a decrease of $155 million. This information is derived from the \"CASHANDEQUIVALENTS\" column in both the 2023 and 2024 financial tables provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Timed deposits (FIN_INST)",
        "Timed deposits (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2588,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 74,
        "total_tokens": 1349
      }
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "In 2023, the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million ($1,061 million for Alaska + $5,729 million for Lower 48). In 2022, the combined total was $5,795 million ($941 million for Alaska + $4,854 million for Lower 48). This represents an increase of $995 million from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_139",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6619,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2295,
        "completion_tokens": 90,
        "total_tokens": 2385
      }
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "As of December 31, 2022, PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset, as shown in the financial assets and liabilities section of the fair value disclosures. These amounts are categorized under Level 2 fair value measurements, as they are based on significant other observable inputs, and are detailed in the footnotes referencing 'Note 7 - Other Financial Statement Details' and 'Note 9 - Fair Value Measurement of Assets and Liabilities' for further information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Crypto Asset Safeguarding Liability (FIN_INST)",
        "Crypto Asset Safeguarding Liability (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3523,
        "completion_tokens": 144,
        "total_tokens": 3667
      }
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "The net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024 was a cash outflow of $2.8 billion. This was calculated by combining the $3.5 billion paid to acquire shares from noncontrolling interest holders and settle the liability from the prior year, which increased Walmart's ownership in PhonePe from 75% to 85%, and subtracting the $0.7 billion received from new equity funding rounds in PhonePe, which diluted Walmart's ownership from 89% to 84%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> PhonePe (COMP)",
        "PhonePe (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8151,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2682,
        "completion_tokens": 121,
        "total_tokens": 2803
      }
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $77 million, driven by a $79 million increase in wholesale revenues from affiliate sales and a $87 million decrease in revenues from non-affiliate sales. The IIC-approved affiliate sales mechanism significantly influenced this outcome by enabling a 165.5% increase in the volume of KWH sales to affiliated companies, as these transactions are conducted in accordance with the IIC and FERC approval, typically at marginal cost, thereby amplifying affiliate sales revenues without significantly impacting earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "SO (ORG) -> IIC (ACCOUNTING_POLICY)",
        "IIC (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4326,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1737,
        "completion_tokens": 155,
        "total_tokens": 1892
      }
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Intel plans to invest a total of **$50.5 billion** in manufacturing expansion under the IDM 2.0 strategy. This includes **$20 billion for the Arizona fabs**, **more than $20 billion for the Ohio fabs**, and **$10.5 billion for advanced packaging at the Rio Rancho, New Mexico, and Malaysia sites**, as outlined in the provided text chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> CONCEPT <-[Introduces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> IDM 2.0 (CONCEPT)",
        "IDM 2.0 (CONCEPT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8312,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2720,
        "completion_tokens": 84,
        "total_tokens": 2805
      }
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher recorded approximately **$3.9 billion of goodwill** from the acquisition of Abcam. Additionally, the Veralto separation had a significant impact on Danaher's cash position, as the company received **net cash distributions of approximately $2.6 billion** from Veralto prior to the distribution date. A portion of these proceeds, **$1.0 billion**, was used to redeem commercial paper, with the remaining funds intended to satisfy bond maturities and fund regular quarterly dividends to shareholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Abcam (COMP)",
        "Abcam (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8485,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2758,
        "completion_tokens": 126,
        "total_tokens": 2885
      }
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "In fiscal year 2024, Nike (NKE) recognized a total net gain of $24 million from foreign exchange forwards and options in its income. At year-end, the fair value of these derivative assets and liabilities was reported as $557 million in assets and $180 million in liabilities, indicating a significant net asset position of $377 million compared to the $24 million net gain recognized during the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2707,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 100,
        "total_tokens": 1443
      }
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million (from consolidated operations) + $0 million (from equity affiliates) = **$55,912 million**. In comparison, the 2022 depreciation, depletion, amortization, and impairments for the Lower 48 region were **$4,854 million**. Thus, the discounted future net cash flows significantly exceed the 2022 DD&A and impairments for the Lower 48 region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7400,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2509,
        "completion_tokens": 125,
        "total_tokens": 2634
      }
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "The total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023 was **$563 million**. According to the fair value hierarchy, the entire amount is categorized under **Level 3**, which reflects the use of **significant unobservable inputs** for valuation. This indicates that the fair value of these receivables is based on internal assumptions and models due to the lack of observable market data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Loans and Interest Receivable, Held for Sale (FIN_INST)",
        "Loans and Interest Receivable, Held for Sale (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6879,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2388,
        "completion_tokens": 108,
        "total_tokens": 2496
      }
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During the year ended December 31, 2023, under the 2021 Multicurrency Credit Facility, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion (including 842.6 million EUR, equivalent to $919.1 million at the repayment date) of revolving indebtedness. In comparison, under the 2021 Credit Facility, the company borrowed $3.1 billion and repaid $2.6 billion during the same period. This indicates that the 2021 Multicurrency Credit Facility saw a significantly higher net repayment compared to the 2021 Credit Facility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4686,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1844,
        "completion_tokens": 134,
        "total_tokens": 1978
      }
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "The specific audit procedures applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs included testing management's controls over the evaluation of recovery likelihood, reviewing regulatory orders and precedents, verifying the completeness and accuracy of recorded costs, and obtaining management representations on recoverability and potential refunds. These procedures reflect the subjectivity involved in assessing future regulatory orders by emphasizing the evaluation of assumptions about future regulatory outcomes and the inherent complexities in the rate-setting process, which require specialized knowledge and judgment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "SO (ORG) -> Regulatory Rate Changes (RISK_FACTOR)",
        "Regulatory Rate Changes (RISK_FACTOR) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5491,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2040,
        "completion_tokens": 173,
        "total_tokens": 2213
      }
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The decline in Comirnaty's global revenue in 2023, which fell by 70% to $11,220 million from $37,806 million in 2022, was primarily driven by lower contracted deliveries and demand in international markets, as well as the transition to new variant vaccines and the shift to traditional U.S. commercial market sales. This significant drop in revenue from Comirnaty, Pfizer’s flagship product during the pandemic, negatively impacted its operational results. \n\nThe collaboration agreement with BioNTech, under which Comirnaty was co-developed, stipulates shared R&D costs and revenue-sharing terms. While Pfizer retains commercialization rights globally (excluding Germany and Turkey, where BioNTech handles distribution), the revenue decline would have reduced the gross profits recognized by Pfizer and, by extension, the share of profits recorded as alliance revenues from BioNTech’s sales in Germany and Turkey. \n\nAdditionally, the agreement with BioNTech for the development of a potential shingles vaccine involves upfront and milestone payments, with future regulatory and sales milestones of up to $200 million for BioNTech. While this collaboration introduces future financial obligations and potential R&D expenses, it also reflects Pfizer’s ongoing investment in new vaccine development to offset declining revenue from Comirnaty.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Comirnaty (PRODUCT)",
        "Comirnaty (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 23862,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6606,
        "completion_tokens": 334,
        "total_tokens": 6941
      }
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "The value of U.S. Agency securities held as short-term investments by NKE was $35 million as of May 31, 2024, and $46 million as of May 31, 2023. This represents a year-over-year decrease of $11 million, or approximately 23.9%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> U.S. Agency securities (FIN_INST)",
        "U.S. Agency securities (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2588,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 56,
        "total_tokens": 1346
      }
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "To determine the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, we consider both new issuances and repayments. In November 2023, the Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500, and in July 2024, it repaid $77 of these notes. The net change is calculated as $500 (issuances) minus $77 (repayments), resulting in a net increase of $423 in the total principal amount of Guaranteed Senior Notes during 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6401,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2247,
        "completion_tokens": 127,
        "total_tokens": 2374
      }
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "The total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments as of December 31, 2024, is $0.5 billion. In comparison, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the U.S. as of the same date. This indicates that the U.S. cash and marketable securities significantly exceed the outstanding letters of credit and guarantees, suggesting a strong liquidity position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Stand-Alone Letters of Credit (FIN_INST)",
        "Stand-Alone Letters of Credit (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7707,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2597,
        "completion_tokens": 109,
        "total_tokens": 2707
      }
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "In Q4 2023, Meta estimated that duplicate accounts may have represented approximately 10% of its worldwide MAUs, while false accounts may have represented approximately 4% of its worldwide MAUs. This indicates that the percentage of duplicate accounts was higher than that of false accounts during the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Duplicate Accounts (RISK_FACTOR)",
        "Duplicate Accounts (RISK_FACTOR) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11846,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3610,
        "completion_tokens": 78,
        "total_tokens": 3688
      }
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Pfizer paid an upfront cash payment of **$75 million** to BioNTech for the shingles mRNA vaccine collaboration. In comparison, the upfront payment made to Biohaven for migraine treatment rights outside the U.S. was **$150 million**. Thus, the upfront payment to Biohaven was double the amount paid to BioNTech for the shingles vaccine collaboration. Both payments were part of broader agreements that also included equity investments and shared development responsibilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Comirnaty (PRODUCT)",
        "Comirnaty (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7011,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2401,
        "completion_tokens": 118,
        "total_tokens": 2519
      }
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million in accrued liabilities and $5 million in deferred income taxes and other liabilities for instruments formally designated as hedging instruments, and $5 million in accrued liabilities for instruments not designated as hedging instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3781,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 95,
        "total_tokens": 1696
      }
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard customer-held cryptocurrencies, which are not its assets and are not recorded on its balance sheet. This liability is directly connected to its disclosure of risk concentrations, as the company holds customer funds and investments—both fiat and crypto—primarily in highly liquid but uninsured instruments at financial institutions deemed to be of high credit quality. These funds, including those used to fund credit activities, are subject to credit risk concentrations, particularly as corporate deposit balances exceed FDIC insurance limits. The recognition of the crypto safeguarding liability, therefore, implies that PayPal's exposure to credit risk extends to the institutions where customer-held crypto assets are indirectly managed or stored, highlighting the company's reliance on third-party financial institutions and the potential impact of their creditworthiness on PayPal's financial stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Recognizes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Crypto Asset Safeguarding Liability (FIN_INST)",
        "Crypto Asset Safeguarding Liability (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9471,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3036,
        "completion_tokens": 251,
        "total_tokens": 3287
      }
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "For the year ended December 31, 2024, SPG issued 689,202 LTIP units net of forfeitures under the 2019 Plan. While these LTIP units are considered potentially dilutive securities, the 10-K filing states that no securities, including these LTIP units, had a material dilutive effect for the year ended December 31, 2024. Thus, while the issuance of these units could impact stock dilution, the effect was not material for the reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4755,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1829,
        "completion_tokens": 110,
        "total_tokens": 1939
      }
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "In 2024, the financial impact of 3M's manufactured PFAS products on earnings per diluted share was a negative $0.20, as shown in the special items section of the earnings per diluted share table in Chunk 1. In 2022, the impact was a negative $0.90 per diluted share, as detailed in the special items section of Chunk 2. This indicates that the negative impact on earnings per share decreased from 2022 to 2024, reflecting a $0.70 per share improvement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Manufactured PFAS Products (PRODUCT)",
        "Manufactured PFAS Products (PRODUCT) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15422,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4499,
        "completion_tokens": 113,
        "total_tokens": 4612
      }
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "In 2024, the Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from sales to non-affiliates, primarily due to a 30.8% drop in KWH sales volume following the expiration of power sales agreements in May 2023. Conversely, wholesale revenues from sales to affiliates increased by $79 million (131.7%) due to a 165.5% rise in KWH sales volume driven by affiliated company energy needs. These transactions were governed by the Intercompany Interchange Contract (IIC), which is subject to FERC approval and ensures structured intercompany energy exchanges. The contrasting volume trends between affiliate and non-affiliate sales under the IIC significantly influenced the overall wholesale revenue performance for the Southern Company system in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "SO (ORG) -> IIC (ACCOUNTING_POLICY)",
        "IIC (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12216,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3709,
        "completion_tokens": 195,
        "total_tokens": 3904
      }
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission (IDPC) imposed a total financial penalty of €1.2 billion alongside corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and bring its processing operations into compliance with the GDPR. Compliance with these orders may increase Meta's operational costs in Europe by necessitating additional measures to ensure lawful data processing, which could add complexity and expense to delivering its services in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "META (ORG) -> Corrective Orders (REGULATORY_REQUIREMENT)",
        "Corrective Orders (REGULATORY_REQUIREMENT) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13194,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3970,
        "completion_tokens": 121,
        "total_tokens": 4091
      }
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "The Home Depot's emphasis on product depth and job lot quantities directly supports its strategy to meet the needs of professional customers (Pros) by providing them with the extensive product assortments and bulk purchasing options necessary for complex projects. This is highlighted in the document as Pros specifically seek these attributes for their specialized and large-scale purchase requirements. However, the document also underscores that failure to effectively maintain this aspect of competitiveness—particularly in combination with other factors like delivery and pickup capabilities—could negatively impact demand for The Home Depot’s products and services, as well as its profit margins. This risk is tied to the evolving competitive landscape and the increasing customer expectations around product availability, pricing, and fulfillment, which are essential for sustaining The Home Depot’s market position and financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> CONCEPT <-[Depends_On]- ORG",
      "triplets_used": [
        "HD (ORG) -> Product Depth and Job Lot Quantities (CONCEPT)",
        "Product Depth and Job Lot Quantities (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11461,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3543,
        "completion_tokens": 237,
        "total_tokens": 3780
      }
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures is $177 million ($94 million from Chunk 1 and $83 million from Chunk 2). This exclusion suggests that these investments are valued using the net asset value per share practical expedient under FASB ASC Topic 715, indicating that they may not have a readily determinable fair value through active markets, and their valuation likely involves greater complexity or reliance on internal or contractual measures rather than observable market inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Insurance Annuity Contract (FIN_INST)",
        "Insurance Annuity Contract (FIN_INST) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1908,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 147,
        "total_tokens": 1292
      }
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal uses loss curves in conjunction with macroeconomic forecasts to determine the allowance for credit losses on both merchant and consumer receivables. For **merchant receivables**, macroeconomic factors such as **unemployment rates** and **retail e-commerce sales** are applied, while for **consumer receivables**, particularly revolving credit products, the factors include **household disposable income** and **retail e-commerce sales** (with unemployment rates used through Q1 2023). These macroeconomic forecasts are sourced externally and applied using a single scenario deemed most appropriate for the economic conditions of the period. The forecast periods differ, with merchant products covering approximately **2.5 to 3.5 years** and revolving consumer products covering **up to 5 years**, reflecting the estimated life of the respective loans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Loss Curves (ACCOUNTING_POLICY)",
        "Loss Curves (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11672,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3581,
        "completion_tokens": 214,
        "total_tokens": 3795
      }
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco's investment in the development and protection of the Kirkland Signature brand, along with its reliance on manufacturing and distribution facilities for private-label items, exposes the company to several risks that could impact brand loyalty and gross margin performance. First, the success of Kirkland Signature products—known for higher margins and quality—depends on maintaining consistent product quality and member confidence; any loss of acceptance could directly reduce sales and gross margins (Chunk 2). Additionally, disruptions in manufacturing, packaging, or distribution facilities—whether due to extreme weather, labor issues, or supply chain problems—could delay product availability, leading to member dissatisfaction and potential sales losses (Chunk 2). Furthermore, Costco's reliance on these private-label operations means that any failure to efficiently manage these investments or respond to shifting consumer preferences could result in inventory markdowns, out-of-stock situations, and reduced gross margin performance (Chunk 2). Thus, both brand reputation and operational efficiency are critical to sustaining Kirkland Signature's contribution to Costco's profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Kirkland Signature (PRODUCT)",
        "Kirkland Signature (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8104,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2695,
        "completion_tokens": 300,
        "total_tokens": 2996
      }
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million for 2021 and $20.6 million for 2022). In comparison, the total grant date fair value of the time-based restricted stock units granted in the same years is $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). This indicates that the performance-based LTIP units had a significantly higher value compared to the time-based restricted stock units in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11118,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3429,
        "completion_tokens": 126,
        "total_tokens": 3555
      }
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "As of December 31, 2024, the total fair value of U.S. municipal securities held by 3M is $20 million, combining $4 million in current marketable securities and $16 million in non-current marketable securities. These U.S. municipal securities are classified as Level 3 in the fair value hierarchy because their valuation methodology references the carrying value of the corresponding finance lease obligation, and they are not valued using observable market inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> U.S. Municipal Securities (FIN_INST)",
        "U.S. Municipal Securities (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5220,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1959,
        "completion_tokens": 116,
        "total_tokens": 2075
      }
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "In Q4 2023, approximately 3% of Meta's worldwide Monthly Active Users (MAP) consisted solely of violating accounts, which are defined as accounts intended for purposes that violate Meta's terms of service, such as bots and spam. This estimation process is inherently challenging, particularly across encrypted platforms like WhatsApp, where Meta has limited visibility into user activity and relies primarily on phone numbers and device information for account matching. The estimation involves significant judgment, as it is based on an internal review of a limited sample of accounts and is subject to data limitations and evolving methodologies. These challenges underscore the difficulty in accurately identifying and measuring violating accounts at Meta's scale, especially on products with reduced data signals due to encryption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "META (ORG) -> Violating Accounts (RISK_FACTOR)",
        "Violating Accounts (RISK_FACTOR) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12453,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3780,
        "completion_tokens": 208,
        "total_tokens": 3989
      }
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "As of December 31, 2023, Pfizer made a total of $225 million in upfront payments and equity investments in its collaboration with BioNTech for the shingles vaccine program, which included an upfront payment of $75 million and an equity investment of $150 million. For the Comirnaty (COVID-19 vaccine) program, the collaboration with BioNTech involved shared development costs, with BioNTech paying Pfizer $25 million for antigen technology and Pfizer sharing future profits, although no separate upfront payment or equity investment was disclosed for Comirnaty. Therefore, the total upfront payments and equity investments made by Pfizer for both programs amount to $225 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Comirnaty (PRODUCT)",
        "Comirnaty (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3616,
        "completion_tokens": 169,
        "total_tokens": 3786
      }
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "The total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021 was $ (21) million, calculated as $ (24) million in 2021, $6 million in 2020, and $1 million in 2019. In comparison, the Lower 48 region reported a net loss of $8 million in 2021, but generated net income of $804 million in 2020 and $402 million in 2019, resulting in a cumulative net income of $1,200 million over the same period, significantly outperforming the EMENA region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> EMENA (GPE)",
        "EMENA (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2128,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 131,
        "total_tokens": 1318
      }
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 to $169,192). This decrease, along with the $7,500 decline in the '7.50% Cumulative Redeemable Preferred Units' (from $23,037 to $15,537), contributes to the overall $11,220 decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Other Noncontrolling Redeemable Interests (FIN_INST)",
        "Other Noncontrolling Redeemable Interests (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1644,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1096,
        "completion_tokens": 111,
        "total_tokens": 1207
      }
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million for foreign corporate debt and $24 million for asset-backed securities). This compares to a combined fair value of $0 for these two asset categories in the prior year (December 31, 2023), indicating a significant increase of $55 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Foreign Corporate Debt (FIN_INST)",
        "Foreign Corporate Debt (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4596,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1808,
        "completion_tokens": 96,
        "total_tokens": 1904
      }
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "Technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics by introducing potential errors due to the complexity of identifying unique individuals across multiple accounts and products. These errors stem from challenges in matching user accounts using data signals like device information, IP addresses, and user names, as well as limitations in survey data used for calibration. Meta estimates that the error margin for its Family metrics, including MAP, is approximately 3% of its worldwide MAP. Additionally, inaccuracies in identifying duplicate and false accounts, particularly in developing markets, and limitations in geographic and age data further contribute to potential inaccuracies in these metrics. As a result, the actual MAP and ARPP figures could vary by roughly 3% or more due to these technical and data-related challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Technical Errors (RISK_FACTOR)",
        "Technical Errors (RISK_FACTOR) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11928,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3653,
        "completion_tokens": 241,
        "total_tokens": 3894
      }
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to purchase products online and pick them up at a physical store location, thereby leveraging its extensive retail network for fulfillment. This strategy contributes to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section, by utilizing stores as convenient pickup and delivery points, reducing delivery costs, and improving customer experience through faster access to products. The interconnected retail programs, including BOPIS, are part of The Home Depot's broader supply chain strategy to optimize order fulfillment and delivery based on customer needs and inventory availability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "HD (ORG) -> BOPIS (PRODUCT)",
        "BOPIS (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8881,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2862,
        "completion_tokens": 187,
        "total_tokens": 3049
      }
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley recognizes compensation expense for Deferred Cash-Based Compensation (DCP) awards based on the notional value of the award, adjusted for changes in the fair value of the referenced investments selected by employees, with the expense recognized over the vesting period of the awards. In contrast, carried interest compensation is recognized for any portion allocated to employees, including both realized and unrealized gains, without a specific vesting period, and is generally recognized when the related performance-based fees are earned. Additionally, DCP compensation involves direct investments by the Firm to hedge obligations, resulting in timing differences between gains/losses on these investments and the deferred recognition of compensation expense, whereas carried interest expense aligns more directly with the timing of performance-based fee recognition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> Deferred Cash-Based Compensation (ACCOUNTING_POLICY)",
        "Deferred Cash-Based Compensation (ACCOUNTING_POLICY) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_138",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6651,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2338,
        "completion_tokens": 221,
        "total_tokens": 2559
      }
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group (SPG) and the Operating Partnership as of December 31, 2024, is provided in the tables referenced in both chunks. While the exact numerical value is not explicitly stated in the text provided, both chunks confirm that the noncontrolling redeemable interests in properties are classified as temporary equity and that there were no noncontrolling interests redeemable at amounts in excess of fair value as of December 31, 2024. The precise figure would be found in the referenced table, which is essential for completing the answer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Noncontrolling Redeemable Interests (FIN_INST)",
        "Noncontrolling Redeemable Interests (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4567,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1808,
        "completion_tokens": 165,
        "total_tokens": 1973
      }
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE's nuclear decommissioning fund and $76 million for FPL's storm fund). This combined fair value is significantly higher than the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date, which is $2,505 million. The discrepancy reflects the fact that the carrying amount represents the amortized cost of the debt securities within the funds, while the fair value includes the full valuation of all assets in the special use funds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Special Use Funds (FIN_INST)",
        "Special Use Funds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5139,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1954,
        "completion_tokens": 161,
        "total_tokens": 2115
      }
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC (Asia Pacific, Japan, and China) is significant as both a geographic segment in which Cisco operates and a region tied to its consolidated financial reporting. As a geographic segment, APJC is one of three primary regions (alongside the Americas and EMEA) through which Cisco manages its global business and evaluates performance, with revenue attributed based on the customer’s ordering location. Additionally, APJC is integrated into Cisco’s consolidated financial statements, reflecting the inclusion of Cisco’s accounts and investments in this region under the voting interest model. This dual role influences Cisco’s internal performance measurement by structuring financial decisions and resource allocation around segment-based revenue and gross margin data, while excluding certain expenses and charges that are not used to assess segment performance. Thus, APJC serves as both a strategic operational unit and a financial reporting entity, shaping how Cisco evaluates its global business performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6300,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2225,
        "completion_tokens": 253,
        "total_tokens": 2478
      }
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024, the Business Markets and Other segment generated $13.1 billion in revenues, representing approximately 44% of Verizon Business Group's total revenues. This segment incorporates FWA broadband into its offerings by providing fixed connectivity solutions comparable to residential fixed services, tailored for small and medium businesses, as described in Chunk 2. Additionally, Chunk 1 highlights that FWA broadband is a key product offered by the Business segment, delivered through 5G or 4G LTE networks as an alternative to traditional landline internet access. The KG triplets further confirm the relationship between Verizon (VZ) and FWA Broadband, emphasizing that VZ both produces and discloses FWA broadband as a core product.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> FWA Broadband (PRODUCT)",
        "FWA Broadband (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7559,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2534,
        "completion_tokens": 185,
        "total_tokens": 2719
      }
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $1 million (Receivable position) minus $51 million (Payable position), resulting in a net fair value of $(50) million. The total notional amount of all foreign currency forward exchange contracts held by Abbott as of December 31, 2024, is $23.2 billion, which includes $7.0 billion for cash flow hedges and $16.2 billion for other foreign currency exposures. Thus, the fair value of interest rate hedges is significantly smaller in scale compared to the notional amount of foreign currency contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4683,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1833,
        "completion_tokens": 143,
        "total_tokens": 1976
      }
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "The relationship between proved undeveloped reserves and net undeveloped acreage in Asia suggests that Equity Companies have a relatively high development potential in the region, as they hold 272 million barrels of oil-equivalent in undeveloped reserves on just 19 net acres, compared to consolidated subsidiaries with 1,186 million barrels of oil-equivalent on 227 net acres. This indicates that Equity Companies are significantly more efficient in utilizing land for reserves in Asia, achieving a much higher reserves-per-acre ratio (14,316 bbls/acre vs. 5,227 bbls/acre). In contrast, consolidated subsidiaries show lower efficiency in converting land to reserves, highlighting the superior resource concentration and development potential of Equity Companies in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Equity Companies (COMP)",
        "Equity Companies (COMP) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10754,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3351,
        "completion_tokens": 194,
        "total_tokens": 3546
      }
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company's unconditional guarantee of the securities issued by Morgan Stanley Finance LLC underscores its full financial commitment to the obligations of this wholly owned finance subsidiary, ensuring the subsidiary's ability to meet its financial commitments without relying on third-party support. This guarantee is directly linked to the broader obligations under the amended and restated support agreement, which outlines the Parent Company's responsibility to contribute its contributable assets to its supported entities, including the Funding IHC, in the event of a resolution scenario. The Funding IHC, in turn, is obligated to provide necessary capital and liquidity to its supported entities, with these obligations generally secured by the Parent Company's and Funding IHC's assets. This interconnected framework ensures systemic resilience and regulatory compliance, particularly in scenarios requiring resolution under the Firm's recovery and resolution planning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Complies_With]- ORG",
      "triplets_used": [
        "MS (ORG) -> Securities Issued by Morgan Stanley Finance LLC (FIN_INST)",
        "Securities Issued by Morgan Stanley Finance LLC (FIN_INST) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_147",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4847,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1899,
        "completion_tokens": 246,
        "total_tokens": 2146
      }
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The Bipartisan Budget Act of 2015’s partnership tax audit rules could materially increase Simon Property Group’s (SPG) financial obligations by requiring partnerships in which SPG holds an interest—such as its joint ventures with third parties like Klépierre and The Taubman Realty Group, LLC—to bear the economic burden of audit adjustments at the partnership level. As SPG has limited control over many of these joint ventures, particularly those managed by third parties, it may be obligated to cover additional taxes, interest, or penalties even if it would not have been liable had it owned the assets directly. This risk is compounded by the fact that SPG applies the equity method to 84 joint venture properties, many of which involve shared or limited decision-making authority, potentially leading to conflicts or delays in addressing audit-related liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Partnership Tax Audit Rules (REGULATORY_REQUIREMENT)",
        "Partnership Tax Audit Rules (REGULATORY_REQUIREMENT) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11750,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3625,
        "completion_tokens": 217,
        "total_tokens": 3842
      }
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "In 2020, Lockheed Martin recognized a $128 million noncash impairment charge on its investment in AMMROC, which reduced net earnings by $96 million, or $0.34 per share after-tax. In 2021, the company incurred $36 million in severance and restructuring charges within its RMS segment, resulting in a $28 million, or $0.10 per share, after-tax impact. Collectively, these charges reduced net earnings by $124 million and diluted earnings per share by $0.44 over the two years, reflecting the combined impact of the AMMROC impairment and RMS restructuring on financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> AMMROC (COMP)",
        "AMMROC (COMP) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7164,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2430,
        "completion_tokens": 144,
        "total_tokens": 2575
      }
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The year-over-year change in the balance of channel partner financing subject to guarantees was a decrease of $500 million, from $1.7 billion as of July 29, 2023, to $1.2 billion as of July 27, 2024. This decline indicates a reduction in Cisco's exposure under these financing arrangements. According to the MD&A section, Cisco's liquidity and capital resource requirements are well-supported by its cash and cash equivalents, operating cash flow, and access to capital markets, and the company expects these resources to meet all obligations, including those related to financing guarantees and other commitments, for at least the next 12 months.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Guarantees]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Financing Guarantees (FIN_INST)",
        "Financing Guarantees (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5775,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2101,
        "completion_tokens": 161,
        "total_tokens": 2263
      }
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The total value of \"Investments measured at NAV\" is $2,656 million in the first asset category (Chunk 1) and $3 million in the second asset category (Chunk 2). The difference between the two is $2,653 million, with the first category having the significantly higher value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> Investments measured at NAV (FIN_INST)",
        "Investments measured at NAV (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2916,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 68,
        "total_tokens": 1449
      }
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott's production focus on Diabetes Care Devices, as outlined in its 2024 10-K filing, directly contributes to the 18.1% revenue increase in its Diabetes Care business, which rose from $5,761 million in 2023 to $6,805 million in 2024. This increase is attributed to the successful development, manufacture, and sale of these devices, which are a core part of Abbott's healthcare product portfolio. The revenue recognition for this business is supported by Abbott's accounting policy, which recognizes revenue from product sales upon the transfer of control, typically at shipment or delivery, with provisions for discounts, rebates, and returns estimated and recorded in the same period as the related sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Diabetes Care Devices (PRODUCT)",
        "Diabetes Care Devices (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8386,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2756,
        "completion_tokens": 177,
        "total_tokens": 2933
      }
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "The Home Depot's emphasis on project planning tools enhances its competitive positioning with Pros by directly addressing their specific expectations for complex purchase needs, as outlined in the 2024 10-K filing. Pros seek dedicated sales support, competitive credit and pricing options, and project planning tools to streamline their purchasing and project management processes. By integrating these tools into its interconnected shopping experience—both in-store and online—The Home Depot meets the demand for a seamless, personalized, and efficient customer journey. This strategic focus on digital capabilities and project-specific support strengthens its differentiation in a highly competitive market, where Pros increasingly rely on technology to optimize their purchasing decisions and execution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "HD (ORG) -> Project Planning Tools (PRODUCT)",
        "Project Planning Tools (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11461,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3519,
        "completion_tokens": 201,
        "total_tokens": 3720
      }
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "The total number of shares available for award under the three incentive programs as of the end of 2024 is 56,663,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan, as disclosed in the provided text chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "XOM (ORG) -> 2003 Incentive Program (ACCOUNTING_POLICY)",
        "2003 Incentive Program (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6144,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2210,
        "completion_tokens": 104,
        "total_tokens": 2315
      }
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The reclassification of Customer receivables in 2023, which involved separating interest-bearing Cash and cash equivalents and adjusting prior-year amounts for consistency in presentation, resulted in a $4,432 million decrease in both interest income and interest expense for the year ended December 31, 2023. This adjustment had no impact on net interest income and was entirely recorded within the Institutional Securities segment. The specific financial adjustment amount explicitly tied to this change is $4,432 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> Customer receivables (FIN_INST)",
        "Customer receivables (FIN_INST) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3390,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 131,
        "total_tokens": 1641
      }
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 + $75 million in 2021). According to the disclosures, the category of net investment hedge derivatives includes cross-currency interest rate swaps and forward contracts, as well as certain non-U.S. dollar denominated debt designated to hedge a portion of the company’s net investments in non-U.S. operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Net Investment Hedge Derivatives (FIN_INST)",
        "Net Investment Hedge Derivatives (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2029,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 118,
        "total_tokens": 1298
      }
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective 2021 amendments is $5.0 billion for the Credit Facility (expandable by up to $1.0 billion) and $3.5 billion for the Supplemental Facility (expandable to $4.5 billion), resulting in a combined maximum capacity of $8.0 billion. During the year ended December 31, 2021, the maximum aggregate outstanding balance under these facilities was $2.1 billion, which is significantly lower than the total available borrowing capacity, indicating substantial unused capacity at that time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Impacts]- ORG",
      "triplets_used": [
        "SPG (ORG) -> RFR Loans (FIN_INST)",
        "RFR Loans (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11498,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3539,
        "completion_tokens": 151,
        "total_tokens": 3690
      }
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs in 2021 positively contributed to RMS' operating profit by approximately $140 million, as stated in Chunk 2. This contribution is part of the broader $80 million increase in adjustments not related to volume, including net profit booking rate adjustments, which further enhanced RMS' operating profit in 2021 compared to 2020. These adjustments and risk retirements are directly tied to the accounting policy of risk retirements, as highlighted in the knowledge graph, where Lockheed Martin (LMT) and its RMS segment are positively impacted by such changes in estimated costs and profit booking rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Risk Retirements (ACCOUNTING_POLICY)",
        "Risk Retirements (ACCOUNTING_POLICY) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7328,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2495,
        "completion_tokens": 170,
        "total_tokens": 2666
      }
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "In 2021, energy-related derivatives negatively impacted Southern Company's (SO) natural gas revenues by $117 million and increased the cost of natural gas by $27 million, resulting in a total negative impact of $144 million. In comparison, the combined impact in 2019 was a total negative effect of $233 million, with energy-related derivatives contributing a $223 million gain to natural gas revenues and a $10 million increase in the cost of natural gas. Thus, the total financial impact decreased from $233 million in 2019 to $144 million in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2472,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 137,
        "total_tokens": 1415
      }
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "Cisco's losses from privately held investments decreased by $29 million between 2023 and 2024, from a loss of $193 million in 2023 to a loss of $164 million in 2024. This improvement positively contributed to the overall net gains (losses) on investments, which improved by $11 million, from a loss of $177 million in 2023 to a loss of $166 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Privately held investments (FIN_INST)",
        "Privately held investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2294,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 89,
        "total_tokens": 1309
      }
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "The total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024 was $800 million, as specified in Chunk 1. As of December 31, 2024, the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities was $13.0 billion, comprising $8.0 billion for the 2021 facility and $5.0 billion for the 2022 facility, as disclosed in Chunk 1. Thus, the $800 million repayment is significantly smaller than the combined $13.0 billion outstanding balance of the two ABS Financing Facilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> ABS Notes (FIN_INST)",
        "ABS Notes (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3147,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 132,
        "total_tokens": 1577
      }
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL capital transition provisions impact JPMorgan Chase's Tier 1 leverage ratio by adjusting the calculation of quarterly average assets, which includes deductions for on-balance sheet assets such as goodwill and other intangible assets, as well as adjustments for the CECL transition provisions. Additionally, these provisions influence the application of the Standardized approach to First Republic-related assets, which are permitted under U.S. capital rules and incorporated into capital metrics, thereby affecting the capital allocation and risk-weighted asset calculations for the Firm.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> CECL Capital Transition Provisions (ACCOUNTING_POLICY)",
        "CECL Capital Transition Provisions (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_303",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2445,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 149,
        "total_tokens": 1426
      }
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon Property Group (SPG) has implemented governance principles and a Code of Business Conduct and Ethics to maintain board independence and ethical conduct. These policies govern the function, conduct, and selection of directors and apply to all officers, directors, and employees. At least a majority of the board members qualify as independent under NYSE listing standards, and the Audit and Compensation and Human Capital Committees are entirely composed of independent members meeting NYSE financial expert requirements. These governance policies align with NYSE requirements by ensuring board independence, mitigating conflicts of interest, and maintaining ethical standards in line with regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Governance Principles (ACCOUNTING_POLICY)",
        "Governance Principles (ACCOUNTING_POLICY) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10412,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3251,
        "completion_tokens": 179,
        "total_tokens": 3431
      }
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "Lockheed Martin (LMT) uses the percentage-of-completion cost-to-cost method to recognize revenue over time, with profit booking rates directly tied to the ratio of costs incurred to estimated total costs. Changes in cost estimates significantly impact these profit booking rates: if estimated total costs decrease (e.g., through successful risk retirement), profit booking rates increase, enhancing reported profits in the period the change is determined. Conversely, if estimated costs increase, profit booking rates decrease, reducing profits in that period. These changes are recognized immediately in the period they are identified, which can have a material effect on LMT’s results of operations and segment operating profit, as described in both chunks. The method thus introduces volatility in financial results due to ongoing reassessments of contract performance and risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Percentage-of-Completion Cost-to-Cost Method (ACCOUNTING_POLICY)",
        "Percentage-of-Completion Cost-to-Cost Method (ACCOUNTING_POLICY) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11529,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3568,
        "completion_tokens": 220,
        "total_tokens": 3788
      }
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The Services Revenue for the APJC region increased by $89 million (4%) from 2023 to 2024, as shown in Chunk 1. From Chunk 2, the Total Balance for APJC rose from $5,382 million in 2023 to $8,208 million in 2024, representing an increase of $2,826 million. The combined increase in both Services Revenue and Total Balance is $2,915 million. This combined growth significantly outpaces the 4% growth in Services Revenue for the same region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2362,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 109,
        "total_tokens": 1342
      }
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "The total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, is $18.4 billion, comprising $2.2 billion in interest rate hedge contracts and $16.2 billion in foreign currency forward exchange contracts. This combined exposure reflects Abbott's strategy to actively manage market risk by hedging against fluctuations in interest rates and foreign exchange rates, particularly for intercompany transactions, trade payables/receivables, and debt obligations, thereby stabilizing cash flows and reducing financial volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9534,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3054,
        "completion_tokens": 149,
        "total_tokens": 3203
      }
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "McDonald's (MCD) accounting treatment of franchisees significantly impacts its consolidated financial statements by determining which entities are consolidated and how operational materiality is assessed. As outlined in the 2024 10-K, MCD evaluates its relationships with franchisees and other entities for consolidation under variable interest entity (VIE) guidance, but generally applies scope exceptions, concluding that consolidation is not appropriate. This policy ensures that only entities where MCD holds a controlling financial interest are included in the consolidated financial statements. Additionally, the 10-K notes that results of operations from transactions with franchisees are not material individually or in the aggregate, reinforcing that franchisee activities do not significantly affect the consolidated financial statements. This approach aligns with MCD’s business model, where franchisees operate the majority of restaurants, and the Company retains oversight without consolidating their financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2702,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 258,
        "total_tokens": 1583
      }
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "The inclusion of off-balance sheet exposures and adjusted average assets directly affects JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation by expanding the denominator of the SLR formula, which is Tier 1 capital divided by total leverage exposure. Total leverage exposure includes adjusted average on-balance sheet assets (net of permitted deductions such as goodwill and intangible assets) and certain off-balance sheet exposures, which are calculated as the average of three month-end spot balances during the reporting quarter. If the resulting SLR falls below the required 3.0% minimum (plus an additional 2.0% buffer for the Firm), JPMorgan Chase would face regulatory consequences, including restrictions on capital distributions such as dividends and share repurchases, as well as limitations on discretionary executive compensation. These constraints are designed to ensure the Firm maintains sufficient capital to absorb losses and meet regulatory capital adequacy standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> SLR Calculation (ACCOUNTING_POLICY)",
        "SLR Calculation (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4225,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1720,
        "completion_tokens": 249,
        "total_tokens": 1970
      }
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31, 2021, the total amount of borrowings under the Credit Facilities was $1.175 billion, consisting of $125.0 million under the Credit Facility and $1.05 billion under the Supplemental Facility. The amended terms of the Supplemental Facility provide for an initial borrowing capacity of $3.5 billion, which may be increased to $4.5 billion during its term. Thus, the outstanding borrowings under the Supplemental Facility represented approximately 29.7% of its initial maximum capacity as of December 31, 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3368,
        "completion_tokens": 131,
        "total_tokens": 3499
      }
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021 was $500 million, compared to $572 million at the end of 2020. This represents a decrease of $72 million, or a **12.6% decrease** from 2020 to 2021. The information is explicitly provided in both Chunk 1 and Chunk 2, and the relationship between Lockheed Martin (LMT) and its variable interest rate swaps is confirmed by the knowledge graph triplets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Variable Interest Rate Swaps (FIN_INST)",
        "Variable Interest Rate Swaps (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10911,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3381,
        "completion_tokens": 112,
        "total_tokens": 3493
      }
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions has significantly increased Georgia Power's financial exposure, as it has already recorded a pre-tax charge of $440 million in the fourth quarter of 2021 related to these provisions, with potential for an additional $460 million in charges based on the current project capital cost forecast. These incremental charges are not recoverable from retail customers, compounding the financial impact. The cost-sharing dispute centers on differing interpretations of the starting dollar amount for cost increases and the effect of COVID-19-related costs, which further complicates the financial outlook for the Vogtle project.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Faces]- ORG",
      "triplets_used": [
        "SO (ORG) -> Cost-Sharing Provisions (ACCOUNTING_POLICY)",
        "Cost-Sharing Provisions (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7414,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2508,
        "completion_tokens": 178,
        "total_tokens": 2687
      }
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The specific Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence for businesses, as part of Adobe's strategy to strengthen its competitive advantage, is Journey Optimizer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Experience Cloud (PRODUCT)",
        "Adobe Experience Cloud (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9066,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2938,
        "completion_tokens": 74,
        "total_tokens": 3013
      }
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "As of December 31, 2024, the total fair value of Abbott's interest rate hedge contracts is $-50 million (comprising a $1 million receivable position and a $-51 million payable position). In comparison, as of December 31, 2023, the total fair value was $-95 million (with no receivable position and a $-95 million payable position). This indicates that the fair value of these contracts improved by $45 million from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6230,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2223,
        "completion_tokens": 107,
        "total_tokens": 2330
      }
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "To calculate the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, we use the following data from the provided chunks:\n\n1. From **Chunk 1**, the discounted future net cash flows for equity companies in Asia is **60,780 million dollars**.\n2. From **Chunk 2**, the total proved reserves (oil-equivalent) for equity companies in Asia is **1,276 million bbls**.\n\nThe calculation is:\n$$\n\\frac{60,780}{1,276} \\times 100 = 4,763\\%\n$$\n\nThus, the combined total of discounted future net cash flows from equity companies in Asia is **4,763%** of the total proved reserves (oil-equivalent) for equity companies in Asia.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Equity Companies (COMP)",
        "Equity Companies (COMP) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13003,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3903,
        "completion_tokens": 181,
        "total_tokens": 4085
      }
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase's allocation of capital to its Lines of Business (LOBs) and Corporate is influenced by Basel III Standardized Risk-Weighted Assets (RWA) and the Global Systemically Important Bank (GSIB) surcharge, reflecting its adherence to leverage-based capital regulatory requirements, including the Supplementary Leverage Ratio (SLR) of 3.0% and an additional 2.0% leverage buffer. The Firm incorporates these regulatory capital requirements into its capital allocation methodology, ensuring that capital is distributed in alignment with both current regulatory standards and potential future capital demands. Failure to maintain the required SLR could restrict capital distributions such as dividends and share repurchases, emphasizing the importance of maintaining sufficient Tier 1 capital relative to total leverage exposure, as disclosed under Pillar 3 Regulatory Capital Disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Pillar 3 Regulatory Capital Disclosures (REGULATORY_REQUIREMENT)",
        "Pillar 3 Regulatory Capital Disclosures (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4225,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1760,
        "completion_tokens": 223,
        "total_tokens": 1983
      }
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "The total potential borrowing capacity available to Simon Property Group (SPG) after considering both the Credit Facility and the Supplemental Facility post their respective 2021 amendments is $5.8 billion. The Credit Facility has an aggregate size of up to $5.0 billion, while the Supplemental Facility has an initial borrowing capacity of $3.5 billion, which can be increased to $4.5 billion. \n\nRegarding the interest rate structure under Daily SOFR Loans, both facilities offer similar terms. Under both the Credit Facility and the Supplemental Facility, Daily SOFR Loans accrue interest based on the Adjusted Floating Overnight Daily SOFR Rate, plus a margin determined by SPG’s corporate credit rating (ranging between 0.650% and 1.400%). Based on SPG’s current credit ratings, the interest rate for both facilities is SOFR plus 72.5 basis points, with an additional spread adjustment for the transition from LIBOR to SOFR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Impacts]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Daily SOFR Loans (FIN_INST)",
        "Daily SOFR Loans (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11498,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3547,
        "completion_tokens": 232,
        "total_tokens": 3779
      }
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 led to a $540 million increase in RMS' net sales, as higher production on programs such as Black Hawk, CH-53K, and CRH drove this growth. Additionally, product costs for RMS increased by approximately $560 million due to the same higher production volume on Sikorsky helicopter programs. Thus, the production growth resulted in a $540 million rise in net sales and a $560 million increase in product costs for RMS.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Sikorsky Helicopter Programs (PRODUCT)",
        "Sikorsky Helicopter Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6321,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2239,
        "completion_tokens": 122,
        "total_tokens": 2361
      }
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "McDonald's recurring transactions with franchisees, including the purchase and sale of restaurant businesses, are recorded in operating income because they are considered a recurring part of the Company's business strategy to maintain an optimal ownership mix in each market. These gains and losses are not material to the consolidated financial statements, either individually or in the aggregate. Additionally, under McDonald's consolidation policy, the Company does not consolidate its franchisees or variable interest entities, as they generally qualify for scope exceptions. Instead, investments in affiliates like McDonald's China and Japan are accounted for using the equity method. This approach ensures that gains and losses from these transactions are reflected in operating income without affecting the consolidation of the franchisees' financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1851,
        "completion_tokens": 216,
        "total_tokens": 2068
      }
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "Chevron's (CVX) use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity, as stated in both chunks. These instruments, which include futures, swaps, and options for crude oil, natural gas, and refined products, are used to manage market price risks associated with forecasted sales and commodity price volatility. The company's internal Risk Control group actively monitors these exposures daily in accordance with risk management policies, and the Audit Committee reviews compliance. Fair value measurements of derivative instruments are primarily derived from published market quotes and are not material to Chevron's financial statements, with changes in fair value also being immaterial in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Derivative Commodity Instruments (FIN_INST)",
        "Derivative Commodity Instruments (FIN_INST) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7713,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2602,
        "completion_tokens": 194,
        "total_tokens": 2796
      }
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is a net benefit of $720 million from the associated adjustments recorded in AOCI. Additionally, the allowance for credit losses eligible for inclusion in Tier 2 capital, including the impact of the CECL capital transition provisions, is subject to regulatory limits and adjustments, as described in the disclosures. These provisions are also factored into the calculation of adjusted average assets for the Tier 1 leverage ratio, which includes deductions for goodwill and other intangible assets impacted by the CECL transition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> CECL Capital Transition Provisions (ACCOUNTING_POLICY)",
        "CECL Capital Transition Provisions (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1688,
        "completion_tokens": 162,
        "total_tokens": 1851
      }
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 includes a net income contribution of $2,525 million from AerCap (as noted in Chunk 1) and a realized/unrealized gain of $129 million related to the investment in and note with AerCap (as shown in Chunk 2). Therefore, the combined financial impact was $2,654 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1703,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1066,
        "completion_tokens": 88,
        "total_tokens": 1155
      }
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Based on the fair value of net assets acquired, which included intangible assets of $156 million, cash of $83 million, and other net assets of $42 million, the excess of the consideration over the fair value of net assets was $20 million, which was recorded as goodwill and allocated to the Pharmaceutical segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5553,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2031,
        "completion_tokens": 101,
        "total_tokens": 2133
      }
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees contribute to McDonald's revenue primarily through rent, royalties based on a percentage of sales (with specified minimums), and initial fees upon opening or granting a new franchise. These contributions form a stable and predictable revenue stream for McDonald's, which is largely driven by franchisee sales. When McDonald's co-invests with franchisees in restaurant improvements, the Company records its share of the investment as property and equipment, which results in depreciation expense over the estimated useful life of the assets, typically up to 40 years for buildings. This co-investment, while enhancing brand value and restaurant performance, increases the Company's depreciation expense as the related assets are depreciated using the straight-line method, reflecting the long-term capital commitment and impact on financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12639,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3810,
        "completion_tokens": 215,
        "total_tokens": 4025
      }
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million from December 2023 ($689 million) to December 2024 ($569 million). A primary cause of unrealized losses on Level 3 investments in 2023 related to this category was ongoing weakness in the commercial real estate market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "GS (ORG) -> Securities Backed by Real Estate (FIN_INST)",
        "Securities Backed by Real Estate (FIN_INST) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_174",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_158",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4055,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1681,
        "completion_tokens": 76,
        "total_tokens": 1757
      }
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "American Tower incurred an additional cost of $87.9 million beyond the principal amount when repaying the CoreSite Debt, which included $80.1 million in prepayment consideration and $7.8 million in accrued and unpaid interest, for a total redemption price of $962.9 million. This repayment amount reflects the full settlement of the debt, which had an outstanding balance as of December 31, 2021, consistent with the principal amount disclosed in the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> CoreSite Debt (FIN_INST)",
        "CoreSite Debt (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1315,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 979,
        "completion_tokens": 118,
        "total_tokens": 1097
      }
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "GE's increased collections from CFM International contributed to the $(0.9) billion impact from current receivables in 2024, as noted in Chunk 1, where higher collections partially offset higher volume. Chunk 2 reveals that CFM International is a non-consolidated equity method investment jointly owned by GE and Safran Aircraft Engines, and GE engages in significant related-party transactions with CFM International, primarily through the sale of parts and services. This business relationship, characterized by substantial sales and shared ownership, underpins the financial interaction reflected in the change in cash impacts from current receivables.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GE (ORG) -> CFM International (COMP)",
        "CFM International (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8346,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2746,
        "completion_tokens": 163,
        "total_tokens": 2909
      }
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, including prior year deferrals and current year pricing adjustments, was a **$276 million increase**, as noted in Chunk 2. This increase is attributed to higher pricing resulting from the Ohio electric rate case and the prior year Ohio tax reform deferrals. Additionally, Chunk 1 confirms that these regulatory actions contributed to a **$145 million increase in price** in the prior year, further supporting the cumulative regulatory-driven revenue impact. Together, these chunks illustrate the combined effect of prior year deferrals and current year adjustments on Duke Energy's operating revenues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Ohio Tax Reform Deferrals (REGULATORY_REQUIREMENT)",
        "Ohio Tax Reform Deferrals (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2941,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 188,
        "total_tokens": 1595
      }
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe's Digital Media segment generated total revenue of $11.52 billion in fiscal 2021. Of this, $9.55 billion (or 82.9%) came from Creative Cloud and $1.97 billion (or 17.1%) came from Document Cloud, as disclosed in the 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Experience Cloud (PRODUCT)",
        "Adobe Experience Cloud (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9975,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3155,
        "completion_tokens": 58,
        "total_tokens": 3213
      }
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million, which includes a $222 million increase in advertising expenses and a combined $500 million rise in personnel-related costs across the marketing and technology departments ($116 million in marketing and $384 million in technology). These increases were driven by growth in average headcount to support production activity and continued improvements in the streaming service.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Streaming Service (PRODUCT)",
        "Streaming Service (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1601,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1054,
        "completion_tokens": 119,
        "total_tokens": 1174
      }
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "General Motors includes equity earnings from Ultium Cells Holdings LLC in its Automotive and other cost of sales, as Ultium is integral to GM’s operations by supplying battery cells for its electric vehicles. This financial treatment reflects GM’s strategic reliance on Ultium to support its EV production, indicating a close operational and financial integration between GM and the joint venture. The inclusion of equity income in cost of sales highlights how GM accounts for its stake in Ultium as a key enabler of its electric vehicle strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1527,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1046,
        "completion_tokens": 136,
        "total_tokens": 1183
      }
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average price of U.S. Henry Hub natural gas decreased by 60% in 2023 compared to 2022, falling from $6.36 per MCF to $2.56 per MCF. During the same period, Chevron's international natural gas realizations averaged $7.69 per MCF in 2023, compared to $9.75 per MCF in 2022, representing a 21% decrease. While U.S. natural gas prices experienced a more significant decline due to high storage levels and strong domestic production, international natural gas prices, influenced by long-term contracts and crude-linked pricing, declined at a slower rate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Henry Hub Natural Gas (RAW_MATERIAL)",
        "Henry Hub Natural Gas (RAW_MATERIAL) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8246,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2723,
        "completion_tokens": 138,
        "total_tokens": 2861
      }
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads indicates that an increase in credit spreads or a decrease in recovery rates leads to a higher fair value of its level 3 credit derivatives, as these inputs are strongly tied to the risk profile of the underlying reference obligations. The firm uses a broad range of unobservable inputs, including credit spreads and recovery rates, which vary by underlier, region, sector, and credit quality, contributing to the complexity and variability in valuations. Given that credit derivatives are valued using option pricing, correlation, and discounted cash flow models, the directional sensitivity of fair value to these inputs is not uniform across instruments, reflecting the distinct risk factors and market conditions affecting each derivative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Impacts]- ORG",
      "triplets_used": [
        "GS (ORG) -> CDS Spread (FIN_INST)",
        "CDS Spread (FIN_INST) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_154",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_154",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10778,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3351,
        "completion_tokens": 206,
        "total_tokens": 3557
      }
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The repayment of CoreSite Debt in January 2022, as disclosed in Chunk 1, involved the full repayment of all amounts outstanding using borrowings under the 2021 Multicurrency Credit Facility and cash on hand. This repayment directly decreased AMT's liabilities, thereby improving its capital structure by reducing debt obligations and potentially enhancing financial flexibility. The alignment between the repayment amount and the carrying value of $955.1 million (as shown in Chunk 2) indicates that the debt was carried on AMT's balance sheet at its book value, which closely approximated the actual amount repaid, suggesting no significant valuation adjustments or discounts were necessary for this debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> CoreSite Debt (FIN_INST)",
        "CoreSite Debt (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4162,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1701,
        "completion_tokens": 176,
        "total_tokens": 1878
      }
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "Adobe's potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices could impact its financial position by reducing unrecognized tax benefits, with estimated potential decreases ranging from $0 to approximately $5 million over the next 12 months. The company has established reserves for potential adjustments resulting from these examinations, and while it believes these estimates to be reasonable, the final outcomes could still significantly affect its tax liabilities and operating results. Additionally, the resolution of these examinations or the expiration of statutes of limitations could cause fluctuations in the classification of tax assets and liabilities on Adobe's balance sheet. These uncertainties underscore the importance of the company's ongoing assessments and the inherent risk that audit settlements may differ materially from current provisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Intercompany Transfer Pricing Practices (ACCOUNTING_POLICY)",
        "Intercompany Transfer Pricing Practices (ACCOUNTING_POLICY) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5886,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2158,
        "completion_tokens": 228,
        "total_tokens": 2386
      }
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "The combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020 was 65% (21% in 2021 and 44% in 2020), driven by higher demand in the U.S. and China. This growth reflects Merck’s broader oncology strategy, which emphasizes combination therapies, as exemplified by Keytruda’s use in combination with Lenvima for the treatment of endometrial carcinoma and RCC. These collaborations and strategic partnerships align with Merck’s focus on expanding Keytruda’s utility through combination regimens to enhance treatment efficacy across multiple cancer types.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Approves]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lenvima (PRODUCT)",
        "Lenvima (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6634,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2307,
        "completion_tokens": 143,
        "total_tokens": 2451
      }
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM's investment in Ultium Cells Holdings LLC in 2024 directly contributed positively to its EBIT-adjusted performance, with increased equity earnings of $0.7 billion attributed to Ultium Cells Holdings LLC in the year ended December 31, 2024. This contribution is part of the broader $0.7 billion investment in Ultium Cells Holdings LLC in both 2024 and 2023, as detailed in the investment disclosures. The mutual investment relationship between GM and Ultium Cells Holdings LLC, as shown in the knowledge graph, underscores the strategic and financial integration between the two entities, directly impacting GM's profitability through enhanced equity earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3042,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 165,
        "total_tokens": 1567
      }
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "Goldman Sachs, as a registered security-based swap dealer with the SEC, is subject to a range of regulatory obligations, including record-keeping, financial reporting, and public trade reporting requirements. The SEC’s new monthly short position reporting requirement for institutional investment managers, effective January 2025, adds an additional layer of reporting obligation for Goldman Sachs, particularly for its asset management subsidiaries that meet the specified thresholds. This new requirement will likely influence Goldman Sachs’ derivatives reporting practices by increasing the frequency and specificity of data it must collect and disclose, aligning with the SEC’s broader regulatory focus on transparency in both equity short positions and security-based swaps. As a result, Goldman Sachs must ensure its reporting systems and compliance frameworks accommodate both existing swap dealer obligations and the new short position reporting mandates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "GS (ORG) -> SEC Monthly Short Position Reporting (REGULATORY_REQUIREMENT)",
        "SEC Monthly Short Position Reporting (REGULATORY_REQUIREMENT) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12036,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3698,
        "completion_tokens": 240,
        "total_tokens": 3939
      }
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "PepsiCo recorded a $520 million gain in 2022 related to the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands to PAI Partners. This gain was part of the transaction structure, which included approximately $3.5 billion in cash and the retention of the 39% stake, reflecting both the cash proceeds and continued equity interest in TBG. The fair value measurement utilized the transaction price, discounted cash flows, and an option pricing model, underscoring the significance of the retained equity stake in the overall financial impact of the divestiture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> TBG (COMP)",
        "TBG (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6066,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2172,
        "completion_tokens": 153,
        "total_tokens": 2326
      }
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "In 2023, GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contributed $5,778 million to its total other income. This includes a $10 million realized and unrealized gain (loss) from the investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, reflecting a substantial decline in gains from retained and sold ownership interests. This decline is also evident in the $0 gain from the Baker Hughes investment in 2024 compared to $10 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> Baker Hughes (COMP)",
        "Baker Hughes (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2857,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 134,
        "total_tokens": 1493
      }
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, is $358 million, calculated by summing the $236 million from Chunk 1 and $122 million from Chunk 2. These obligations represent approximately 2.96% of the total assets measured at fair value, which is calculated as $358 million divided by the combined total fair value of $12,079 million (from Chunk 1) and $12,010 million (from Chunk 2), averaged to $12,044.5 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Mortgage-Backed Obligations (FIN_INST)",
        "Mortgage-Backed Obligations (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22887,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6388,
        "completion_tokens": 116,
        "total_tokens": 6504
      }
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix's strategy of offering varied membership plans across different countries contributed to the 7% increase in average monthly revenue per paying membership in 2021 by enabling price changes tailored to local markets and benefiting from favorable foreign exchange rate fluctuations, as noted in Chunk 2. This pricing flexibility, connected to the \"Membership Plans (PRODUCT)\" introduced by Netflix (as shown in the KG triplets), allowed the company to optimize revenue per member in diverse jurisdictions. This increase in revenue per member, combined with an 11% growth in average paying memberships, directly supported the overall 19% revenue growth for the year, despite a 50% decline in paid net membership additions, as highlighted in Chunk 2. The ability to adjust membership plans globally was a key factor in maintaining and enhancing revenue per user, especially as growth in established markets slowed and expansion continued in newer regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Membership Plans (PRODUCT)",
        "Membership Plans (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8744,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2847,
        "completion_tokens": 239,
        "total_tokens": 3086
      }
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue primarily through alliance revenue, which is based on a profit-sharing model where Merck's share is derived from product sales net of cost of sales and commercialization costs. The LEAP program includes multiple Phase 3 trials across various tumor types, with some trials, such as LEAP-002 for advanced HCC, ongoing and potentially pivotal for future regulatory approvals and revenue growth. However, the discontinuation of trials like LEAP-007 (NSCLC) and LEAP-011 (urothelial carcinoma) due to futility and unfavorable benefit/risk profiles may limit the number of successful indications, thereby impacting the potential for expanded market access and revenue from Lenvima. Given the current status of key trials and the alliance revenue model, the success of the LEAP program is critical to enhancing Merck's pharmaceutical segment revenue through broader Lenvima adoption and regulatory approvals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lenvima (PRODUCT)",
        "Lenvima (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7837,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2608,
        "completion_tokens": 256,
        "total_tokens": 2864
      }
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "To determine how much Chevron's total cost incurred by consolidated companies in 2023 exceeded the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost, we use the following figures from Chunk 1:\n\n- Total cost incurred by Consolidated Companies in 2023: $24.6\n- PDC Energy, Inc. acquisition cost in 2023: $10.5\n- Expensed exploration costs in 2023: $0.5\n\nThe combined total of the PDC acquisition cost and expensed exploration costs is $10.5 + $0.5 = $11.0. \n\nThus, Chevron's total cost incurred by consolidated companies in 2023 exceeded this combined total by $24.6 - $11.0 = **$13.6**. \n\nChunk 2 confirms that PDC Energy, Inc. was acquired by Chevron in 2023 and is a wholly-owned subsidiary, aligning with the PDC acquisition cost mentioned in Chunk 1 and supporting the integration of the two entities in the consolidated financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "CVX (ORG) -> PDC Energy, Inc. (COMP)",
        "PDC Energy, Inc. (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6611,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2294,
        "completion_tokens": 220,
        "total_tokens": 2514
      }
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower determines the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component using a Monte Carlo simulation model, which accounts for multiple input variables to assess the probability of satisfying the market condition requirements. The specific market metric used in this valuation is relative total shareholder return (TSR) measured against the REIT constituents included in the S&P 500 Index.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Market Condition Component (ACCOUNTING_POLICY)",
        "Market Condition Component (ACCOUNTING_POLICY) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3138,
        "completion_tokens": 115,
        "total_tokens": 3254
      }
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "Caterpillar Inc. has documented four amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, as disclosed in the filings. The effective date of the fourth amendment is July 1, 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Supplemental Employees' Investment Plan (FIN_INST)",
        "Supplemental Employees' Investment Plan (FIN_INST) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3925,
        "completion_tokens": 50,
        "total_tokens": 3975
      }
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "The amortized cost of Corporate Notes and Obligations held by CRM in 2024 is $3,014, while their fair value is $2,978, resulting in a difference of $36 (amortized cost minus fair value). Additionally, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557, which is lower than the total fair value of $2,978, indicating that a portion of the fair value is derived from sources outside Level 2 inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Corporate Notes and Obligations (FIN_INST)",
        "Corporate Notes and Obligations (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5187,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1964,
        "completion_tokens": 110,
        "total_tokens": 2074
      }
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion allocated for the Disney Treasure and another $1.1 billion available for the anticipated Disney Destiny. The interest rate for the Disney Treasure facility is 3.80%, while the rate for the Disney Destiny facility, if utilized, will be 3.74%. Thus, the interest rate on the Disney Destiny facility is slightly lower than that of the Disney Treasure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Disney Treasure Credit Facility (FIN_INST)",
        "Disney Treasure Credit Facility (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4788,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1858,
        "completion_tokens": 112,
        "total_tokens": 1970
      }
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron's Tengizchevroil stake represents $27,368 million out of total equity method investments of $46,618 million as of December 31, 2024, accounting for approximately **58.7%** of its total equity method investments. This significant investment is closely tied to Chevron's production volumes, as Tengizchevroil in Kazakhstan is highlighted as a key affiliate contributing to Chevron's production, as noted in the disclosures. The production volumes include Chevron's share from such joint ventures, underscoring the material impact of Tengizchevroil on Chevron's operational output.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6826,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2350,
        "completion_tokens": 146,
        "total_tokens": 2496
      }
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A change in credit spreads or upfront credit points impacts the fair value of Goldman Sachs' Level 3 credit derivatives by increasing the fair value of purchased credit protection when credit spreads or upfront credit points rise, or when recovery rates fall. This sensitivity is due to the strong relationship between these inputs and the underlying reference obligations' risk factors, including entity-specific, market-based, and macroeconomic conditions. To determine the fair value of these credit derivatives, Goldman Sachs employs valuation techniques such as option pricing models, correlation models, and discounted cash flow models, often using a combination of these methods for a single instrument. The firm emphasizes that the directional sensitivity of fair value to changes in unobservable inputs is assessed in isolation, and the interrelationship of inputs may vary across derivative types due to their distinctive nature.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Impacts]- ORG",
      "triplets_used": [
        "GS (ORG) -> CDS Upfront Points (FIN_INST)",
        "CDS Upfront Points (FIN_INST) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_154",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_154",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10778,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3347,
        "completion_tokens": 234,
        "total_tokens": 3581
      }
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period is triggered, during which all excess cash flow and funds in the Cash Trap Reserve Account must be used to pay down the principal of the Series 2015-2 Notes or the Loan, as applicable. This significantly limits AMT’s ability to distribute cash for capital expenditures, including the construction of approximately 1,950 to 2,550 communications sites globally, as outlined in their 2024 10-K. Additionally, failure to maintain the required DSCR could lead to an event of default, potentially resulting in the foreclosure on the 3,338 communications sites securing the Series 2015-2 Notes, further impairing AMT’s ability to fund and maintain its global communications site construction and expansion initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Communications Sites (PRODUCT)",
        "Communications Sites (PRODUCT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4366,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1738,
        "completion_tokens": 203,
        "total_tokens": 1941
      }
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "Caterpillar's use of historical claim rates to determine its product warranty liability is a key factor in the critical audit matter identified by PricewaterhouseCoopers LLP, as it involves significant management judgment and a high degree of auditor subjectivity and effort in evaluating the reasonableness of these assumptions. As of December 31, 2024, Caterpillar's resulting financial estimate of this liability was $1,700 million, as disclosed in the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Historical Claim Rates (ACCOUNTING_POLICY)",
        "Historical Claim Rates (ACCOUNTING_POLICY) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6996,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2426,
        "completion_tokens": 122,
        "total_tokens": 2548
      }
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "The difference between Disney's stated interest rate of 7.93% on Asia Theme Parks borrowings and the effective interest rate of 4.71% on its U.S. dollar denominated senior unsecured notes reflects a higher relative cost of capital for the Asia Theme Parks debt. This suggests that the Asia Theme Parks borrowings carry higher risk or are issued in a different market with less favorable terms, leading to a higher stated rate. However, the effective rate on senior unsecured notes is lower, indicating that Disney benefits from more favorable market conditions or credit ratings for its broader corporate debt. This disparity highlights the varying capital costs across different segments of Disney’s debt portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Asia Theme Parks Borrowings (FIN_INST)",
        "Asia Theme Parks Borrowings (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3981,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1658,
        "completion_tokens": 179,
        "total_tokens": 1837
      }
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, as noted in the gross investment and additions at cost for that year. This acquisition was primarily responsible for contributing 2.2 TCF of purchases in the U.S. DJ basin in 2023, as stated in the first chunk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> PDC (COMP)",
        "PDC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1364,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 981,
        "completion_tokens": 75,
        "total_tokens": 1056
      }
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "MetLife retrospectively adjusted its consolidated statement of operations and consolidated statements of comprehensive income as a result of adopting the new Long-Duration Targeted Improvements (LDTI) accounting guidance. This retrospective application reflects the impact of the LDTI guidance on MetLife's consolidated financial reporting by revising previously reported financial results to align with the new accounting standards, thereby enhancing the transparency and consistency of its financial disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> LDTI Guidance (ACCOUNTING_POLICY)",
        "LDTI Guidance (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_163",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_164",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 943,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 908,
        "completion_tokens": 128,
        "total_tokens": 1036
      }
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "In the Caterpillar Inc. 2024 10-K filing, two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented: the First Amendment, dated December 10, 2014, and the Second Amendment, effective January 1, 2022. The most recent amendment, therefore, has an effective date of January 1, 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Managerial Retirement Objective Plan (ACCOUNTING_POLICY)",
        "Managerial Retirement Objective Plan (ACCOUNTING_POLICY) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 20764,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5859,
        "completion_tokens": 80,
        "total_tokens": 5940
      }
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina Rate Case Order had a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, as detailed in Chunk 2: $35 million for Duke Energy Carolinas and $33 million for Duke Energy Progress. This regulatory requirement, as shown in the KG triplet, directly affected Duke Energy (DUK), and the charges were reflected in the consolidated statements of operations under the respective segments' line items. Additionally, Chunk 1 notes a $13 million decrease in impairment of assets and other charges, partially attributed to the prior year's North Carolina rate case order, highlighting the ongoing regulatory influence on financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Faces]- ORG",
      "triplets_used": [
        "DUK (ORG) -> North Carolina Rate Case Order (REGULATORY_REQUIREMENT)",
        "North Carolina Rate Case Order (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2405,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 187,
        "total_tokens": 1470
      }
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "Licensed stores contribute 12% of Starbucks' total net revenues in fiscal 2024. While these stores have a lower gross margin compared to company-operated stores, they generate a higher operating margin due to licensees bearing operating costs and capital investments. Starbucks earns revenue through margins on branded products and supplies sold to licensees, along with royalties on retail sales and license fees. This structure allows Starbucks to leverage local partners' market expertise and retail access, particularly in international markets, while maintaining brand standards through operational training and procedures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Local Licensees (COMP)",
        "Local Licensees (COMP) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6950,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2393,
        "completion_tokens": 157,
        "total_tokens": 2550
      }
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands, it faces significant financial risks, including reduced sales and lower profit margins, as these brands account for approximately one-third of its sales and carry higher margins than national brands. The longer lead times and increased responsible sourcing risks associated with owned brands amplify exposure to supply chain disruptions and reputational harm, particularly given the company's greater involvement in vendor selection and product development. Additionally, any failure in this area could exacerbate inventory shrink risks and negatively impact operational efficiency, further affecting Target's results of operations and financial condition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Owned Brands (PRODUCT)",
        "Owned Brands (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8814,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2887,
        "completion_tokens": 187,
        "total_tokens": 3074
      }
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "Caterpillar Inc. incorporated four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan into its 2024 10-K filing by reference. The most recent two amendments were the Third Amendment, effective January 1, 2022, incorporated by reference from the Annual Report on Form 10-K for the year ended December 31, 2021, and the Fourth Amendment, effective July 1, 2022, incorporated by reference from the Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Deferred Employees' Investment Plan (FIN_INST)",
        "Deferred Employees' Investment Plan (FIN_INST) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3935,
        "completion_tokens": 121,
        "total_tokens": 4057
      }
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "According to the 2024 10-K filing, there were 73 million shares remaining available for future grant or issuance under the 2013 Equity Incentive Plan. Outstanding equity awards related to this plan included options and restricted stock awards and units, as well as performance-based stock units, with 8 million options and 26 million restricted stock awards and units outstanding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> 2013 Equity Incentive Plan (FIN_INST)",
        "2013 Equity Incentive Plan (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1048,
        "completion_tokens": 95,
        "total_tokens": 1143
      }
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Based on the information provided in the text chunks, most of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, specifically through product sales and royalty revenues. However, the exact percentage is not explicitly stated in the provided chunks. To determine the precise percentage, the specific revenue figures for Channel Development and the portion attributable to the Global Coffee Alliance would be required, which are not included in the given text.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Global Coffee Alliance (COMP)",
        "Global Coffee Alliance (COMP) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7464,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2524,
        "completion_tokens": 129,
        "total_tokens": 2654
      }
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "As a result of the adoption of the new LDTI accounting guidance, MetLife retrospectively adjusted its consolidated statement of operations and consolidated statements of cash flows. According to the 2023 10-K filing, the specific effects of these adjustments are illustrated in tables presented as of December 31, which detail the impacts on the previously reported financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> LDTI Guidance (ACCOUNTING_POLICY)",
        "LDTI Guidance (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_163",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_166",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 933,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 903,
        "completion_tokens": 96,
        "total_tokens": 1000
      }
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "In 2022, the value of equity method investment contracts was $3 million, while total asset derivatives amounted to $393 million. This indicates that equity method investment contracts were relatively insignificant in MDLZ's derivative portfolio compared to other asset derivatives, which were over 130 times larger. The small value of equity method investment contracts suggests they played a minor role in MDLZ's overall derivative strategy during that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Equity Method Investment Contracts (FIN_INST)",
        "Equity Method Investment Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1704,
        "completion_tokens": 115,
        "total_tokens": 1820
      }
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly impacts CAT's actuarial assumptions by rendering the expected rate of compensation increase assumption no longer applicable, as noted in the 10-K filing. This change reflects that future pension liabilities are no longer based on anticipated salary growth, simplifying the postemployment benefit plan accounting. The disclosure in Note 12 further supports that this adjustment is a result of the benefit freeze, aligning with the risk factor related to frozen pension benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Pension Benefits Frozen (RISK_FACTOR)",
        "Pension Benefits Frozen (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 603,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 800,
        "completion_tokens": 137,
        "total_tokens": 938
      }
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, enhances its ability to manage supply chain disruptions and maintain profitability by prioritizing higher-margin, strategic products over lower-margin commodity hardware. This focus allows Oracle to better allocate resources and manage production complexity, particularly in a constrained supply chain environment exacerbated by the COVID-19 pandemic. However, the company still faces risks from third-party manufacturing delays, component shortages, and inventory management challenges, which can increase costs and reduce margins. Additionally, the de-emphasis of lower-margin products and the need to secure manufacturing capacity through higher inventory levels have introduced risks of excess and obsolescence, potentially impacting operating cash flows and profitability in the hardware business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9416,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3013,
        "completion_tokens": 226,
        "total_tokens": 3239
      }
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area is $3,555 million (UPTRAVI: $1,582 million + OPSUMIT: $1,973 million). The overall Pulmonary Hypertension category reported a 2023 growth rate of 11.6%. UPTRAVI's 2023 growth rate was 19.7%, while OPSUMIT's was 10.6%, indicating that UPTRAVI outperformed the category's overall growth rate by 8.1 percentage points, whereas OPSUMIT underperformed by 1.0 percentage point.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> UPTRAVI (PRODUCT)",
        "UPTRAVI (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9971,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3147,
        "completion_tokens": 120,
        "total_tokens": 3267
      }
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX in 2024 by $2.2 billion, as part of a total $3.5 billion increase. This contribution also led to a 250,000 barrels per day increase in net oil-equivalent production, representing a 19 percent rise, primarily driven by the full-year inclusion of legacy PDC production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> PDC Energy (COMP)",
        "PDC Energy (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1500,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1018,
        "completion_tokens": 91,
        "total_tokens": 1109
      }
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "MetLife adjusted both its consolidated statements of comprehensive income and consolidated statements of equity as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a significant and broad impact on the company's financial reporting, affecting key measures of both comprehensive income and equity. The need for retrospective adjustments across these statements highlights the materiality of the LDTI guidance on MetLife’s financial disclosures and historical performance presentation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> LDTI Guidance (ACCOUNTING_POLICY)",
        "LDTI Guidance (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_164",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 904,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 892,
        "completion_tokens": 137,
        "total_tokens": 1029
      }
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "As of December 31, 2022, the total fair value of equity method investment contracts was $(3) million, as disclosed in the derivatives fair value table. In comparison, the total fair value of net investment hedge contracts for the same period was $24 million. This indicates that the fair value of net investment hedge contracts was significantly higher than that of equity method investment contracts during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Equity Method Investment Contracts (FIN_INST)",
        "Equity Method Investment Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4240,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1729,
        "completion_tokens": 104,
        "total_tokens": 1834
      }
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "The net assets of Universal Beijing Resort decreased from $600 million as of December 31, 2023 ($7.8 billion assets - $7.2 billion liabilities) to $300 million as of December 31, 2024 ($7.3 billion assets - $7.0 billion liabilities), reflecting a $300 million decline. This reduction in net assets is primarily attributed to a $100 million decrease in total assets and a $200 million decrease in liabilities, as detailed in the consolidated balance sheets of Comcast. The decline in liabilities, particularly the reduction in debt from $3.5 billion to $3.4 billion, suggests potential debt repayments or restructuring, which may indicate improved financial positioning or operational adjustments at Universal Beijing Resort. This change is reflected in Comcast's consolidated financials, as Universal Beijing Resort is a consolidated variable interest entity, and its financial activity is integrated into Comcast's overall reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11272,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3472,
        "completion_tokens": 233,
        "total_tokens": 3706
      }
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, is $103.6 million, comprising a ¥5.0 billion facility ($34.5 million) and a ¥10.0 billion facility ($69.1 million). The 2021 Revolving Credit Agreement explicitly supports the commercial paper program by requiring that amounts outstanding under the program be backstopped by available commitments under the credit facility, which provides a $3.0 billion borrowing capacity. The proceeds from the commercial paper program can be used for working capital needs, capital expenditures, and other corporate purposes, including business expansion, share repurchases, and cash dividends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> 2021 Revolving Credit Agreement (FIN_INST)",
        "2021 Revolving Credit Agreement (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5996,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2170,
        "completion_tokens": 171,
        "total_tokens": 2342
      }
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems within its hardware business positively impacts infrastructure technologies revenue by emphasizing higher-margin, strategic products over lower-margin commodity hardware, which aligns with Oracle's goal to enhance profitability. However, this focus also increases exposure to supply chain risks, as Oracle Engineered Systems rely on complex hardware components sourced from suppliers, some of which are single-source vendors. These supply chain vulnerabilities—exacerbated by the ongoing effects of the COVID-19 pandemic, global shortages, and logistics disruptions—can lead to production delays, increased costs, and potential revenue recognition delays, thereby negatively affecting Oracle's hardware business margins and overall financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9951,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3140,
        "completion_tokens": 202,
        "total_tokens": 3342
      }
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "Universal Beijing Resort's debt decreased slightly from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This decline contributed to an overall decrease in the 'Debt Not Guaranteed' category, which fell from $5.0 billion in 2023 to $4.8 billion in 2024, also a reduction of $0.2 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4856,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1851,
        "completion_tokens": 78,
        "total_tokens": 1930
      }
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts increases the complexity of its audit procedures due to the significant judgment and estimation required in determining total contract costs and recognizing revenue over time. This method relies on estimating total costs at completion, which involves evaluating factors such as inflation, technical risks, subcontractor performance, and labor agreements—each introducing uncertainty. Auditors must perform extensive testing of management’s assumptions, evaluate the consistency of revenue recognition methods, and assess potential biases, particularly for long-duration or high-margin contracts. These procedures are intensified by the inherent subjectivity in estimating future costs and revenues, as highlighted in both the critical audit matter and the discussion of critical accounting estimates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "HON (ORG) -> Cost-to-Cost Input Method (ACCOUNTING_POLICY)",
        "Cost-to-Cost Input Method (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8609,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2823,
        "completion_tokens": 218,
        "total_tokens": 3041
      }
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income is $1,429 million. This reflects the differing treatment of derivative transactions between the two business units: NEER reports non-qualifying hedge gains and losses directly in net income, contributing to earnings volatility due to mark-to-market accounting, while FPL defers substantially all changes in the fair value of energy derivative transactions as regulatory assets or liabilities until contract settlement, with gains or losses passed through the fuel clause. This distinction is highlighted in the 10-K filing, emphasizing how NEE's consolidated net income is more sensitive to market fluctuations at NEER compared to the more regulated and deferred treatment at FPL.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Non-Qualifying Hedges (FIN_INST)",
        "Non-Qualifying Hedges (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9256,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3004,
        "completion_tokens": 211,
        "total_tokens": 3215
      }
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast's 30% ownership stake in Universal Beijing Resort results in the consolidation of the resort's assets and liabilities in its consolidated balance sheets, as it is deemed a variable interest entity (VIE) under GAAP. As of December 31, 2024, Universal Beijing Resort contributed $7.3 billion in assets and $7.0 billion in liabilities to Comcast's consolidated balance sheets. The resort's debt, primarily a ¥29.7 billion RMB ($4.2 billion) financing facility, includes $3.4 billion in outstanding debt, with $3.0 billion as the principal amount of the term loan. Comcast's maximum risk of financial loss is limited to its 30% interest, which represents 30% of the $3.4 billion in debt, or $1.02 billion. This risk constitutes approximately 24.3% of the total debt financing ($1.02 billion ÷ $4.2 billion).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10542,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3307,
        "completion_tokens": 202,
        "total_tokens": 3510
      }
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $489 million for the OpenTable and KAYAK reporting unit during the interim test at March 31, 2020, and an additional $573 million during the annual test at September 30, 2020, totaling $1,062 million. In 2021, OpenTable contributed to the \"advertising and other\" segment, which includes restaurant reservation services and subscription fees, but specific revenue figures for OpenTable in 2021 are not provided in the chunks. However, the 2021 consolidated revenues of Booking Holdings were $11.0 billion, with OpenTable’s contribution being a part of the advertising and other segment. Thus, while the goodwill impairment charges were substantial in 2020, the exact revenue contribution of OpenTable in 2021 is not quantified in the provided data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> OpenTable (COMP)",
        "OpenTable (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2771,
        "completion_tokens": 206,
        "total_tokens": 2977
      }
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil incorporates greenhouse gas (GHG) emission costs into its Corporate Plan by including estimated emission-related expenses in the cash flow assessments used to evaluate the recoverability of asset groups. These assessments are based on the assumptions developed in the Corporate Plan, which are reviewed and approved by the Board of Directors. Specifically, the Corporation factors in the costs associated with its 2030 GHG emission-reduction goals, including its target of achieving net-zero Scope 1 and 2 emissions from unconventional operated assets in the Permian Basin. These costs are considered even in jurisdictions without current GHG pricing policies, ensuring that future emission-reduction commitments are integrated into long-term financial planning and asset valuation decisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Corporate Plan (ACCOUNTING_POLICY)",
        "Corporate Plan (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14146,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4197,
        "completion_tokens": 200,
        "total_tokens": 4398
      }
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in, with $600 million to be phased in on January 1, 2024, and the remaining $600 million on January 1, 2025. This phased-in capital supports the Company's ability to maintain its capital conservation buffer requirements for the period from October 1, 2023, through September 30, 2024, which are set at 4.8% under the stress capital buffer rule, resulting in minimum capital requirements plus buffer of 9.3%, 10.8%, and 12.8% for CET1, Tier 1, and total capital ratios, respectively. As of December 31, 2023, both the Company and the Bank exceeded these requirements and were classified as \"well-capitalized,\" ensuring compliance and avoiding restrictions on capital distributions or executive bonuses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> CECL Transition Rule (REGULATORY_REQUIREMENT)",
        "CECL Transition Rule (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_192",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4025,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1689,
        "completion_tokens": 212,
        "total_tokens": 1901
      }
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million in 2022 minus $9,562 million in 2023). In comparison, the Euro notes increased by $250 million ($7,916 million in 2023 minus $7,666 million in 2022), indicating that while U.S. dollar debt declined significantly, Euro-denominated debt rose over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> U.S. Dollar Notes and Term Loans (FIN_INST)",
        "U.S. Dollar Notes and Term Loans (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4254,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1717,
        "completion_tokens": 94,
        "total_tokens": 1812
      }
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement is **$140 million**, which serves as a cap on the amount payable in any given year. This payment is directly tied to **90% of Honeywell's annual net spending on environmental matters** at certain sites as defined in the agreement. Thus, the payment amount is contingent upon and proportional to Honeywell's actual environmental expenditures, but it cannot exceed the $140 million annual cap.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Receives_Payments_From]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "HON (ORG) -> Resideo Subsidiary (COMP)",
        "Resideo Subsidiary (COMP) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 129,
        "total_tokens": 1519
      }
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "The changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impacted NEE's total financial position for the FPL and NEER segments between December 31, 2022, and December 31, 2023, as reflected in the provided data. For FPL, the total value decreased from $125 million to $113 million, while for NEER, it decreased from $120 million to $111 million. These reductions were driven by declines in the Clauses category, with FPL’s Clauses value dropping from $3 million to $2 million and NEER’s from $148 million to $114 million, indicating a significant negative impact on the overall financial position of both segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Accounting Clauses (ACCOUNTING_POLICY)",
        "Accounting Clauses (ACCOUNTING_POLICY) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10156,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3196,
        "completion_tokens": 158,
        "total_tokens": 3355
      }
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "The net assets of Universal Beijing Resort decreased from $760 million in 2023 ($7.8 billion assets - $7.2 billion liabilities) to $300 million in 2024 ($7.3 billion assets - $7.0 billion liabilities), representing a decline of $460 million. Over the same period, its debt obligations decreased slightly from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $100 million. Thus, the decline in net assets was significantly greater than the reduction in debt, indicating a larger decrease in assets relative to liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8064,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2660,
        "completion_tokens": 133,
        "total_tokens": 2794
      }
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) became eligible for treatment in a new patient population of pediatric patients aged 2 to 12 years with HIV. The filing indicates that the U.S. and EU regulatory regions were targeted for submission, as shown by the \"US Filing\" and \"EU Filing\" entries marked for EDURANT in both provided chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> EDURANT / rilpivirine (PRODUCT)",
        "EDURANT / rilpivirine (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9304,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2982,
        "completion_tokens": 88,
        "total_tokens": 3070
      }
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com's shift to a merchant-based transaction model, as part of Booking Holdings' Connected Trip strategy, increases operating expenses related to payment processing, chargebacks, and personnel, which negatively impacts operating margins despite incremental merchant revenues. Concurrently, ongoing regulatory investigations in Switzerland and the EU, including scrutiny of Booking.com's commission levels and potential restrictions on parity clauses, pose risks of fines, operational changes, and compliance costs that could further pressure margins and alter business practices. Collectively, these factors are driving Booking Holdings to invest in long-term growth initiatives while navigating regulatory headwinds that may constrain near-term profitability and necessitate strategic adjustments in 2022 and beyond.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Booking.com (COMP)",
        "Booking.com (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12105,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3676,
        "completion_tokens": 206,
        "total_tokens": 3882
      }
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, consisting of an initial five-year term and two possible extensions totaling up to 10 years, as outlined in Chunk 2. This regulatory framework, which allows for extended retention periods for gas resources that are not immediately commercially viable, supports ExxonMobil's long-term LNG development strategy in the region, as noted in Chunk 1. Specifically, the ability to retain rights to potentially valuable gas resources aligns with ExxonMobil's focus on developing LNG projects in Papua New Guinea, such as those in its global growth portfolio, and enables the company to manage political and technical risks while pursuing selective, high-value development opportunities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Papua New Guinea (GPE)",
        "Papua New Guinea (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7493,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2547,
        "completion_tokens": 192,
        "total_tokens": 2740
      }
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased from $83 million as of December 31, 2022, to $37 million as of December 31, 2023, representing a year-over-year decline of $46 million. In comparison, their investment in Hedge funds/limited partnerships increased from $14 million in 2022 to $18 million in 2023, reflecting a $4 million increase. Thus, while the company significantly reduced its Level 2 investments in mutual and pooled funds, it modestly increased its exposure to hedge funds and limited partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Mutual, pooled and commingled funds (FIN_INST)",
        "Mutual, pooled and commingled funds (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2310,
        "completion_tokens": 143,
        "total_tokens": 2454
      }
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a reduction of $53 million. This includes a $29 million decrease in net income at gas distribution operations and an additional $24 million earnings adjustment mentioned in the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "SO (ORG) -> Regulatory Disallowances (RISK_FACTOR)",
        "Regulatory Disallowances (RISK_FACTOR) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1310,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1001,
        "completion_tokens": 79,
        "total_tokens": 1080
      }
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "In addition to WarnerMedia, the businesses classified as discontinued operations by AT&T as part of its strategic shift included Vrio, Xandr, and Playdemic. This classification was significant as it reflected AT&T's broader restructuring efforts to streamline its operations, focusing on its core Communications and Latin America segments, while divesting non-core digital and media assets to enhance financial clarity and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "T (ORG) -> Xandr (COMP)",
        "Xandr (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2374,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 111,
        "total_tokens": 1355
      }
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022, as both periods report a fair value of $33 million. Over the same period, the total fair value of available-for-sale debt securities decreased from $7,257 million to $6,893 million, a decline of $364 million. This decrease was primarily driven by significant unrealized losses in Level 2 securities, which fell from $6,696 million to $6,341 million, reflecting a $355 million reduction, while the fair value of auction rate securities at Level 3 remained stable.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Auction rate securities (FIN_INST)",
        "Auction rate securities (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6567,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2300,
        "completion_tokens": 147,
        "total_tokens": 2447
      }
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The goodwill impairment charges related to OpenTable and KAYAK in 2020 significantly reduced the adjusted carrying value of goodwill. Specifically, an interim impairment charge of $489 million was recognized at March 31, 2020, reducing the goodwill to $1.5 billion, and a further annual impairment charge of $573 million was recognized at September 30, 2020, bringing the adjusted carrying value of goodwill down to $1.0 billion. The cumulative impact of these charges was a total goodwill impairment of $1.062 billion ($489 million + $573 million) for the OpenTable and KAYAK reporting unit by September 30, 2020.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> OpenTable (COMP)",
        "OpenTable (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10078,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3167,
        "completion_tokens": 153,
        "total_tokens": 3320
      }
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Nicor Gas's regulatory disallowances negatively impacted Southern Company Gas's 2023 financial performance by reducing net income by $29 million at gas distribution operations, primarily due to decreased revenue from lower volumes sold and these disallowances. Additionally, the disallowances partially offset revenue growth from infrastructure replacement programs and base rate increases, contributing to a complex revenue picture in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SO (ORG) -> Regulatory Disallowances (RISK_FACTOR)",
        "Regulatory Disallowances (RISK_FACTOR) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1076,
        "completion_tokens": 110,
        "total_tokens": 1186
      }
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP (calculated as the maximum of 90,000,000 shares minus the 73,808,772 shares already issued). This represents approximately 17.99% of the total 90,000,000 shares authorized under the 2010 ESPP.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7379,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2496,
        "completion_tokens": 79,
        "total_tokens": 2575
      }
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, announced in December 2023, is expected to influence its 2024 expense trends by increasing spending related to network transformation and deployment, which will pressure expense growth in the short term. This investment, including associated accelerated depreciation, is part of AT&T's broader 2024 focus on efficiency through its cost transformation initiative and 5G/fiber expansion. However, the long-term goal is to achieve improved operational efficiencies and lower network-related expenses through the adoption of Open RAN, which fosters a more robust ecosystem of suppliers and supports AT&T’s shift toward a more agile, programmable wireless network. These efficiencies are anticipated to enhance performance and support AT&T’s growth in fiber and mobile connectivity over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "T (ORG) -> Open RAN Deployment (PRODUCT)",
        "Open RAN Deployment (PRODUCT) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11135,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3433,
        "completion_tokens": 216,
        "total_tokens": 3649
      }
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "As of December 31, 2021, XOM's consolidated subsidiaries had total proved developed bitumen reserves in Canada/Other Americas of 2,635 million barrels. The discounted future net cash flows from this region for the same year were $28,710 million. This indicates the estimated present value of future cash flows attributable to these bitumen reserves, reflecting the company's financial exposure and resource value in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Canada & Americas (GPE)",
        "Canada & Americas (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_142",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 19836,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5616,
        "completion_tokens": 106,
        "total_tokens": 5723
      }
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022-02 by Capital One as of January 1, 2023, impacted its allowance for credit losses and loan modification reporting practices. Capital One's allowance for credit losses increased by $2.1 billion to $15.3 billion as of December 31, 2023, with an allowance coverage ratio of 4.77%. Additionally, the ratio of the allowance for credit losses to total nonperforming loans increased to 1,001% as of December 31, 2023, from 985% in 2022. The adoption also changed the classification of modified loans, with troubled debt restructurings (TDRs) for periods ending on or before December 31, 2022, and financial debt modifications (FDMs) for periods beginning on or after January 1, 2023, now being reported under the revised terms of the ASU.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> ASU No. 2022-02 (REGULATORY_REQUIREMENT)",
        "ASU No. 2022-02 (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_139",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5731,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2083,
        "completion_tokens": 190,
        "total_tokens": 2273
      }
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could adversely affect GE's liquidity position, as these liabilities may need to be recognized and become payable in the future (Chunk 1). These contingent liabilities are part of GE's discontinued operations, which include Bank BPH's mortgage portfolio (Chunk 2). While GE maintains a strong liquidity position with $17.0 billion in cash, cash equivalents, and restricted cash as of December 31, 2023, the company acknowledges that unforeseen liabilities or losses could impact its ability to meet financial obligations or fund operations (Chunk 1). Additionally, GE's liquidity policy emphasizes maintaining sufficient liquidity under both normal and stressed conditions, but contingent liabilities from Bank BPH could strain this position if they result in significant cash outflows or require changes to capital allocation plans (Chunk 1).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "GE (ORG) -> Bank BPH (COMP)",
        "Bank BPH (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9905,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3111,
        "completion_tokens": 234,
        "total_tokens": 3345
      }
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "The total shares issued upon exercise of outstanding options under the Amended and Restated 2010 Share Incentive Plan were 14,830,623, and the total shares still available for future issuance under the same plan were 27,381,461, as disclosed in the 2022 10-K filing. Additionally, the Amended and Restated 2010 Share Incentive Plan is directly associated with Accenture (ACN), as shown in the knowledge graph and referenced in the exhibits listed in the filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Amended and Restated 2010 Share Incentive Plan (ACCOUNTING_POLICY)",
        "Amended and Restated 2010 Share Incentive Plan (ACCOUNTING_POLICY) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6649,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2336,
        "completion_tokens": 115,
        "total_tokens": 2452
      }
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "The total amount of the 2025 Term Loan that AT&T paid off in 2023 was **$2,500**, and the loan was terminated on **March 30, 2023**, as disclosed in both chunks. Chunk 1 provides the context of the loan being due in 2025 and its termination date, while Chunk 2 explicitly states the amount paid off and confirms the termination date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays_Off]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "T (ORG) -> 2025 Term Loan (FIN_INST)",
        "2025 Term Loan (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5207,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1936,
        "completion_tokens": 83,
        "total_tokens": 2019
      }
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "KO's investment in mutual, pooled, and commingled funds decreased from $86 million in 2022 to $39 million in 2023, representing a $47 million decline. Of the 2023 investment, $37 million was categorized under Level 2 valuation inputs, as shown in Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Mutual, pooled and commingled funds (FIN_INST)",
        "Mutual, pooled and commingled funds (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4326,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1735,
        "completion_tokens": 63,
        "total_tokens": 1799
      }
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "For the year ended December 31, 2023, the total pre-tax charge related to ongoing borrower litigation was $1,189 million, as disclosed in the Bank BPH financing receivable portfolio. During the same period, GE paid $203 million in net cash to AerCap related to its continuing involvement with the company, including a note receivable, product and service transactions, and transition services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1786,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1096,
        "completion_tokens": 98,
        "total_tokens": 1194
      }
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture's investment in research and development (R&D), totaling $1.1 billion in fiscal 2022, combined with its focus on delivering 360° value, significantly enhances its competitive positioning in the global IT services market. These investments, along with strategic acquisitions and learning and development, enable Accenture to build a robust portfolio of industry-specific and cross-industry solutions, supported by innovation platforms like MyWizard, MyNav, and SynOps. The 360° value approach not only addresses the financial needs of clients but also emphasizes inclusion, sustainability, and employee reskilling, differentiating Accenture from competitors who may not offer such a comprehensive, integrated value proposition at scale. This holistic strategy, paired with Accenture’s global footprint and ecosystem partnerships, positions it as a unique and trusted partner in a highly competitive market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> CONCEPT <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> 360° Value (CONCEPT)",
        "360° Value (CONCEPT) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8424,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2760,
        "completion_tokens": 228,
        "total_tokens": 2988
      }
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "In addition to WarnerMedia, the entities classified as discontinued operations by AT&T in 2023 were Vrio, Xandr, and Playdemic. This classification means that their financial results are presented separately in AT&T's financial statements as income (loss) from discontinued operations, including for periods prior to their disposition, as part of AT&T's strategic shift and single plan of divestitures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "T (ORG) -> Playdemic (COMP)",
        "Playdemic (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2374,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 100,
        "total_tokens": 1335
      }
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "As of April 29, 2022, the total unrealized loss attributed to Auction Rate Securities held by MDT is $3 million. According to the 2022 10-K filing, this entire unrealized loss is associated with the maturity period of more than 12 months, as no Auction Rate Securities are classified under the \"Less than 12 months\" category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Auction rate securities (FIN_INST)",
        "Auction rate securities (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4537,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1788,
        "completion_tokens": 81,
        "total_tokens": 1869
      }
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "In May 2024, Visa issued 120 million shares of Class B-2 common stock as part of the Class B-1 common stock exchange offer. The total shares issued in the exchange offer amounted to 168 million (120 million Class B-2 + 48 million Class C). Therefore, Class B-2 common stock constituted approximately 71.4% (120 ÷ 168) of the total shares issued in the exchange.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6419,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2260,
        "completion_tokens": 90,
        "total_tokens": 2350
      }
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023 is 3.2 gigawatts (from 11.7 gigawatts in 2021 to 8.5 gigawatts in 2023). This decline reflects a significant drop in the number of Wind Turbines sold during the same period, decreasing from 3,590 in 2021 to 2,225 in 2023, indicating a reduction in both volume and capacity of wind turbines sold over the three-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GE (ORG) -> Wind Turbine Gigawatts (PRODUCT)",
        "Wind Turbine Gigawatts (PRODUCT) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 842,
        "completion_tokens": 101,
        "total_tokens": 943
      }
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "The total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, is $26,782. This includes the upfront deposit of $550 in 2020, cash payments of $22,856 in 2021, incentive payments of $955 in 2021 and $2,112 in 2023, and relocation costs of $650 in 2021, $98 in 2022, and $109 in 2023. These payments are classified under 'Acquisitions, net of cash acquired' on the company's consolidated statements of cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Receives]-> REGULATORY_REQUIREMENT <-[Introduces]- ORG",
      "triplets_used": [
        "T (ORG) -> C-Band Licenses (REGULATORY_REQUIREMENT)",
        "C-Band Licenses (REGULATORY_REQUIREMENT) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10906,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3382,
        "completion_tokens": 114,
        "total_tokens": 3497
      }
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 resulted in its net sales for fiscal year 2021 being $141 million, with no further sales reported in 2022 due to the cessation of distribution and sale. In fiscal year 2022, Medtronic highlighted several growth drivers across its product lines, including the Surgical Innovations division, which saw an 11% increase in net sales driven by the adoption of LigaSure, Sonicision, and Tri-Staple technologies, and the Structural Heart & Aortic division, which experienced an 8% increase in net sales led by growth in TAVR and ECLS devices. Additionally, the Coronary & Peripheral Vascular division reported a 5% increase in net sales, primarily due to strong performance of the Abre venous stent system and VenaSeal Closure System.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discontinues]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> HVAD System (PRODUCT)",
        "HVAD System (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8702,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2822,
        "completion_tokens": 198,
        "total_tokens": 3020
      }
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart paid a total of **$3.5 billion** during fiscal 2024 to acquire additional shares from Flipkart noncontrolling interest holders and to settle the liability to former noncontrolling interest holders of PhonePe. As a result of this transaction, Walmart's ownership in Flipkart increased from approximately **75%** as of January 31, 2023, to approximately **85%** as of January 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Flipkart (COMP)",
        "Flipkart (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9412,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3017,
        "completion_tokens": 97,
        "total_tokens": 3115
      }
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft's treatment of unearned revenue from volume licensing programs, including Software Assurance (SA) and cloud services, involves invoicing annually at the beginning of multi-year agreements, with revenue recognized ratably over the coverage period. This timing difference between invoicing and revenue recognition results in unearned revenue being recorded, which is a significant component of its financial statements. The complexity in determining standalone selling prices (SSP), particularly for products not sold separately, requires significant judgment based on market conditions, customer size, and geographic factors, which affects the accuracy and transparency of revenue recognition. The auditor's focus on revenue recognition, as highlighted in the critical audit matter, underscores the challenges in verifying the SSP estimates and the allocation of discounts, which are essential for ensuring the fair presentation and auditability of Microsoft's financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Volume Licensing Programs (PRODUCT)",
        "Volume Licensing Programs (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13025,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3942,
        "completion_tokens": 247,
        "total_tokens": 4190
      }
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $126 million in 2022, $110 million in 2021, and $107 million in 2020, which are included in Cost of sales or Operating overhead expense. No profit sharing contributions were included in this total because the company did not make any such discretionary contributions for the fiscal years ended May 31, 2022, 2021, and 2020, as recommended by senior management and approved by the Board of Directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Profit Sharing Contributions (ACCOUNTING_POLICY)",
        "Profit Sharing Contributions (ACCOUNTING_POLICY) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 134,
        "total_tokens": 1243
      }
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "The total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024 is a decrease of 16 billion cubic feet (from 312 to 296 billion cubic feet). In comparison, natural gas reserves in Africa increased by 296 billion cubic feet (from 172 to 468 billion cubic feet) over the same period, reflecting a significant regional contrast in reserve changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_143",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15276,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4483,
        "completion_tokens": 107,
        "total_tokens": 4590
      }
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024. In the same fiscal year, the company paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe, resulting in a significantly higher outflow compared to the inflow from equity funding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> PhonePe (COMP)",
        "PhonePe (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8880,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2872,
        "completion_tokens": 74,
        "total_tokens": 2947
      }
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 as a result of resolving the SEC Administrative Order and related legal matters, which included $364 million for Thales-Raytheon Systems and Related Matters and $285 million for Trade Compliance Matters, among others. The compliance monitor will oversee RTX's obligations under these agreements for a term ending three years from the date on which the monitor is engaged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Resolves]-> REGULATORY_REQUIREMENT <-[Faces]- ORG",
      "triplets_used": [
        "RTX (ORG) -> SEC Administrative Order (REGULATORY_REQUIREMENT)",
        "SEC Administrative Order (REGULATORY_REQUIREMENT) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13283,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3991,
        "completion_tokens": 107,
        "total_tokens": 4099
      }
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was contributed by several cloud-based offerings, including Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, and Dynamics 365. Specifically, Dynamics 365 is a unified set of cloud-based intelligent business applications that contributes to this revenue, driven by the number of users licensed, applications consumed, and the shift to cloud-based solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Dynamics 365 (PRODUCT)",
        "Dynamics 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5228,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1944,
        "completion_tokens": 121,
        "total_tokens": 2065
      }
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflects its direct financing arrangements through a syndicate of Chinese financial institutions, which provided debt financing secured by the resort’s assets and equity interests of its investors, with a maximum borrowing limit of approximately $4.2 billion. As Comcast owns a 30% interest in Universal Beijing Resort and consolidates it as a variable interest entity (VIE), the debt is categorized under \"Debt Not Guaranteed\" in Comcast's consolidated debt structure, as shown in the 2023 debt table. This classification indicates that while the resort's debt is consolidated in Comcast’s financial statements, Comcast does not provide guarantees or cross-guarantees for this debt, and its maximum risk of financial loss is limited to its 30% equity stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Consolidates]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8101,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2677,
        "completion_tokens": 209,
        "total_tokens": 2887
      }
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "From May 31, 2021, to May 31, 2022, Nike's investment in commercial paper and bonds decreased from $748 million to $660 million, representing a $88 million decline. This reduction affected the composition of their short-term investments, as the portion allocated to commercial paper and bonds dropped from $691 million to $623 million during the same period. The shift suggests a reallocation of short-term investment funds, likely into other instruments such as U.S. Treasury securities, which saw a significant increase in value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Commercial paper and bonds (FIN_INST)",
        "Commercial paper and bonds (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3563,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 132,
        "total_tokens": 1675
      }
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The introduction of Class B-2 common stock impacts the diluted earnings per share (EPS) calculation for fiscal 2023 by being included in the assumed conversion of participating securities, as outlined in the diluted class A common stock EPS calculation. Since no Class B-2 shares were outstanding prior to the Class B-1 exchange offer, their inclusion in the diluted EPS calculation is based on the as-converted basis, which affects the weighted-average number of shares used in the computation. However, the impact is not material for fiscal 2023, as noted in the disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1361,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 993,
        "completion_tokens": 144,
        "total_tokens": 1138
      }
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Collins and Pratt & Whitney, which generally use Financial Accounting Standards (FAS) under U.S. GAAP. While the ultimate liability for pension and PRB costs is similar under both standards, the timing of expense recognition varies. For Raytheon, these CAS-related costs are typically recovered through pricing of products and services to the U.S. government, whereas Collins and Pratt & Whitney reflect these expenses on a FAS basis, leading to differences in segment operating profit reporting. This distinction is presented as a FAS/CAS operating adjustment outside of segment results in RTX’s financial disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "RTX (ORG) -> US Govt CAS (REGULATORY_REQUIREMENT)",
        "US Govt CAS (REGULATORY_REQUIREMENT) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10236,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3223,
        "completion_tokens": 196,
        "total_tokens": 3419
      }
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Across the provided excerpts, there are **two separate Supplemental Indentures** related to the **1.850% Notes due 2020**:\n\n1. **Ninth Supplemental Indenture** (Exhibit 4.12), dated as of **February 12, 2015**, with **U.S. Bank National Association** as Trustee.\n2. **Twelfth Supplemental Indenture** (Exhibit 4.15), dated as of **February 6, 2017**, with **The Bank of New York Mellon Trust Company, N.A.** as Trustee.\n\nThese indentures are connected to Microsoft Corporation (MSFT) and the 1.850% Notes due 2020, as reflected in the provided knowledge graph triplets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> 1.850% Notes due 2020 (FIN_INST)",
        "1.850% Notes due 2020 (FIN_INST) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8016,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2652,
        "completion_tokens": 142,
        "total_tokens": 2794
      }
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "In fiscal year 2022, the net gain recognized in income from foreign exchange forwards and options was $40 million, as reported in Chunk 1. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million, as shown in Chunk 2. This indicates that while the company recognized a gain in 2022, the fair value of these instruments at the end of the prior fiscal year was significantly higher.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3774,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 105,
        "total_tokens": 1716
      }
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differs in their reserving approaches: U.S. Personal Insurance employs frequency/severity methods, loss development methods, and IBNR factor methods, particularly for short-tail lines like personal auto and property damage, allowing for quicker analysis of emerging trends. In contrast, U.S. Property uses a combination of loss development and IBNR factor methods, with IBNR factors applied to earned premium for low-frequency/high-severity exposures, and expected loss ratio methods for the latest accident year. \n\nIn 2021, U.S. Personal Insurance recognized $412 million of **favorable** prior year development, primarily from subrogation recoveries and favorable outcomes from 2017 and 2018 catastrophes, while U.S. Property is not explicitly mentioned in the 2021 development figures, but related segments like UK/Europe Casualty and Financial Lines showed $210 million of **unfavorable** prior year development due to large loss activity in Financial PI and Commercial D&O. This contrast highlights the differing impacts of prior year developments between the two segments, with U.S. Personal Insurance benefiting from recoveries and U.S. Property-related casualty lines experiencing adverse loss trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Loss Development Methods (ACCOUNTING_POLICY)",
        "Loss Development Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_276",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6490,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2285,
        "completion_tokens": 323,
        "total_tokens": 2608
      }
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes the company to potential financial risks due to ongoing regulatory proceedings by India's Directorate of Enforcement, which has issued a show cause notice to Flipkart and its subsidiaries over alleged violations of India's Foreign Direct Investment rules from 2009 to 2015—before Walmart's acquisition. These proceedings could lead to monetary or non-monetary penalties, and while Walmart notes it cannot predict the outcome, it acknowledges the uncertainty could affect its financial condition. This aligns with Walmart's broader international investment strategy, as outlined in its 2023 10-K, which emphasizes expanding its global retail ecosystem through strategic acquisitions and e-commerce investments, such as Flipkart and PhonePe in India, to enhance its omni-channel presence and serve customers worldwide.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Flipkart (COMP)",
        "Flipkart (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11071,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3440,
        "completion_tokens": 220,
        "total_tokens": 3660
      }
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970, as shown in Chunk 2 under \"Issuances of Class A ordinary shares for employee share programs.\" This issuance contributed to the increase in Accenture plc shareholders' equity, which rose from $25,692,839 as of August 31, 2023, to $28,288,646 as of August 31, 2024, reflecting a $2,595,807 increase, as detailed in Chunk 1.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18609,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5303,
        "completion_tokens": 103,
        "total_tokens": 5406
      }
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, significantly influences its reserving methodology for U.S. Property and aerospace exposures by necessitating a segmented and layered approach. For excess casualty, AIG applies loss development and expected loss ratio methods, with a focus on attachment point bands to account for delayed loss reporting and variability in claim emergence. This approach is similarly adapted for U.S. Property and aerospace lines, where loss development methods are used for short-tail classes, while aviation exposures employ a combination of loss development and expected loss ratio methods due to their high-severity nature. Expected loss ratios play a central role in both analyses, particularly for the most recent accident years where reported loss data lacks credibility. These ratios are derived from historical ultimate loss ratios adjusted for rate changes, inflation, and market conditions, ensuring that reserving reflects both historical trends and current underwriting environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Loss Development Methods (ACCOUNTING_POLICY)",
        "Loss Development Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_263",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2391,
        "completion_tokens": 276,
        "total_tokens": 2667
      }
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, is reflected in the \"Purchases of Class A shares\" line in Chunk 2, which shows a value of $4,107,312. As of August 31, 2024, the remaining share purchase authorization, as stated in Chunk 1, was $2,694,281. This indicates that the repurchase amount in 2022 exceeded the remaining authorization as of 2024, suggesting that additional authorizations were likely approved between these periods to support the repurchase activity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9680,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3089,
        "completion_tokens": 136,
        "total_tokens": 3225
      }
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "Changes in META's advertising policies to comply with regulatory developments in Europe, particularly the shift from 'legitimate interests' to 'consent' for behavioral advertising, have had a dual impact on user engagement and advertising revenue. First, by requiring user consent for behavioral ads, META has reduced its ability to effectively target and measure ad performance, which has adversely affected the relevance and effectiveness of its ad offerings, potentially leading to lower user engagement. Second, this shift, along with the introduction of a \"subscription for no ads\" option and a choice for less personalized ads, has contributed to a decline in advertising revenue by limiting the precision of ad targeting and reducing the value proposition for marketers. These changes, combined with broader regulatory and platform developments, are expected to continue to negatively impact advertising revenue for the foreseeable future.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "META (ORG) -> Advertising Policies (ACCOUNTING_POLICY)",
        "Advertising Policies (ACCOUNTING_POLICY) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10292,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3247,
        "completion_tokens": 236,
        "total_tokens": 3483
      }
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption policy of Accenture plc Class X ordinary shares directly affects the total number of shares outstanding by allowing Accenture plc to redeem these shares at its option for their par value, thereby reducing the number of Class X shares outstanding. This mechanism is specifically aligned with the number of Accenture Canada Holdings Inc. exchangeable shares through a contractual agreement: Accenture plc will redeem Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares to ensure the aggregate number of Class X ordinary shares outstanding never exceeds the number of exchangeable shares outstanding. This alignment is crucial to maintaining the structural relationship between the two share classes, as outlined in the 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class X Ordinary Shares (FIN_INST)",
        "Class X Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6177,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2214,
        "completion_tokens": 200,
        "total_tokens": 2415
      }
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting a $20.1 million decline. This reduction aligns with the amortization practices described in the filing, where milestone payments for Jardiance are capitalized as intangible assets and amortized to cost of sales over the collaboration term, which is determined by factors such as patent expiration or regulatory extensions. The trend indicates ongoing amortization of the capitalized milestones, consistent with the company’s accounting treatment for such payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Jardiance (PRODUCT)",
        "Jardiance (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1591,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1036,
        "completion_tokens": 146,
        "total_tokens": 1183
      }
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "The use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differs primarily due to variations in claim frequency and severity characteristics. In both regions, IBNR factor methods are applied when losses are low frequency/high severity, with factors derived from historical loss costs adjusted for current conditions and inflation. However, in the U.S. Property line, the increasing proportion of non-admitted coverages has led to a less severe aggregate customer profile, potentially affecting the volatility of claim emergence. In contrast, UK/Europe Property claims are influenced by a broader range of exposures, including business interruption and natural disasters, which may result in more unpredictable severity patterns. These differences impact the reserving process, as both regions continually reevaluate IBNR factors in response to emerging claim experience and rate changes, but the U.S. may exhibit more stability in claim severity due to its evolving underwriting mix, while UK/Europe may require more frequent recalibration due to higher exposure variability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "AIG (ORG) -> IBNR Factor Methods (ACCOUNTING_POLICY)",
        "IBNR Factor Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_280",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7239,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2477,
        "completion_tokens": 276,
        "total_tokens": 2753
      }
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Procter & Gamble's Grooming segment holds a combined global market share of more than 60% for blades and razors, primarily driven by the Gillette and Venus brands. In comparison, the segment holds over 25% of the global market share in male electric shavers, which is significantly lower than the blades and razors market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Venus (PRODUCT)",
        "Venus (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2112,
        "completion_tokens": 82,
        "total_tokens": 2194
      }
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. To offset a portion of these costs, the company utilizes cost-sharing arrangements with suppliers, under which suppliers contribute funds based on predefined milestones. These contributions are applied as a direct reduction of General Dynamics' R&D expenses and are not refundable, regardless of the outcome of the development efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Munitions (PRODUCT)",
        "Munitions (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6795,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2335,
        "completion_tokens": 106,
        "total_tokens": 2441
      }
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent $4,107,312 on purchases of Class A Ordinary Shares during fiscal 2024, as indicated in the \"Purchases of Class A shares\" row in Chunk 2. This amount increased the total value of treasury shares held by the company, as reflected in the \"Treasury Shares\" column, which shows an additional $4,111,266 in value (comprising $4,111,266 in value for 12,181 shares). Thus, the share repurchases directly contributed to the growth in the total value of Accenture’s treasury shares during the fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Purchases]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6424,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2251,
        "completion_tokens": 127,
        "total_tokens": 2378
      }
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "The year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, was $21,559 million (from $46,838 million to $68,397 million). This increase reflects the capitalization of new assets placed in service, which are then subject to depreciation under META's depreciation policy. According to the disclosure, Servers and Network Assets are depreciated over their estimated useful lives, with depreciation accounted for prospectively when assets are placed in service. Thus, the increase in asset value will result in higher depreciation expenses in future periods, in line with the company's depreciation practices for such assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depreciates]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Servers and Network Assets (PRODUCT)",
        "Servers and Network Assets (PRODUCT) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5767,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2103,
        "completion_tokens": 173,
        "total_tokens": 2276
      }
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "In 2022, Eli Lilly had **two drug indications** with FDA Breakthrough Therapy designation in the **submitted status**:  \n- **Empagliflozin (Jardiance®)** for **heart failure with preserved ejection fraction** (Diabetes therapeutic area).  \n- **Baricitinib (Olumiant®)** for **alopecia areata** (Immunology therapeutic area).  \n\nAdditionally, there was **one indication in discontinued development**:  \n- **Baricitinib (Olumiant®)** for **systemic lupus erythematosus** (Immunology therapeutic area).  \n\nThese designations and statuses are disclosed in the provided 10-K filings and reflect Eli Lilly’s regulatory and development activities for 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> FDA Breakthrough Therapy designation (REGULATORY_REQUIREMENT)",
        "FDA Breakthrough Therapy designation (REGULATORY_REQUIREMENT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10284,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3256,
        "completion_tokens": 162,
        "total_tokens": 3418
      }
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG's reliance on loss development methods differs between U.S. Other Casualty and U.S. Property lines due to the nature of each line. U.S. Other Casualty, being long-tail, relies on a combination of loss development, frequency/severity, and expected loss ratio methods, with less credibility given to reported losses and more reliance on expected loss ratio methods for recent accident years. In contrast, U.S. Property, a short-tail line, primarily uses loss development methods, IBNR factor methods, and expected loss ratio methods, with IBNR factors applied to earned premium for low frequency/high severity losses. For U.S. Personal Insurance in 2021, AIG recognized $412 million of favorable prior year development, net of external reinsurance, primarily due to subrogation recoveries and favorable development from the 2017 and 2018 catastrophe years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Loss Development Methods (ACCOUNTING_POLICY)",
        "Loss Development Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_266",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7602,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2573,
        "completion_tokens": 214,
        "total_tokens": 2787
      }
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "Procter & Gamble's Baby, Feminine & Family Care segment contributed 24% of its fiscal year 2024 net sales. Within this segment, the Charmin brand, which operates under the family care sub-category, holds over 25% of the North American toilet paper market. Given that Charmin is a major brand within the segment and a primary contributor to family care sales, it is reasonable to estimate that Charmin accounts for approximately 10-15% of the segment's net sales, translating to roughly 2.4% to 3.6% of P&G's total fiscal year 2024 net sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Charmin (PRODUCT)",
        "Charmin (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2132,
        "completion_tokens": 135,
        "total_tokens": 2267
      }
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "General Dynamics' $510 million R&D investment in 2023 directly supports the Combat Systems segment's development and modernization of platforms like the M1E3 Abrams tank by funding technological advancements in communications, power generation, armor, and system architecture. This investment enables Land Systems, a key business unit within Combat Systems, to deliver next-generation upgrades such as the SEPv3 configuration and to develop the M1E3 Abrams, which is designed for enhanced battlefield efficacy, reduced sustainment footprint, and increased tactical mobility. The financial outcomes of this investment are reflected in the segment’s ability to maintain a market-leading position through innovation and affordability, while the strategic outcomes include strengthening the U.S. Army's multi-domain warfighting capabilities and supporting long-term contracts and sustainment opportunities tied to the large installed base of combat vehicles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Munitions (PRODUCT)",
        "Munitions (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7389,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2510,
        "completion_tokens": 238,
        "total_tokens": 2749
      }
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "To determine the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, we combine the purchases under the publicly announced open-market share purchase program and those unrelated to such programs. From **Chunk 1**, Accenture purchased **2,000,308 shares** under the open-market program for **$605 million**, and **72,255 shares** in unrelated transactions, primarily for employee tax obligations. From **Chunk 2**, the \"Purchases of Class A shares\" line shows a **$4,107,312 reduction in retained earnings**, representing the total cost of all Class A share purchases during the period. Therefore, the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 is **$4,107.312 million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Purchases]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7675,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2579,
        "completion_tokens": 188,
        "total_tokens": 2767
      }
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T's 2021 payment to Crown Castle under their sublease arrangement was $253, as disclosed in Chunk 1. This payment is part of an ongoing sublease agreement where AT&T continues to use the towers it transferred to Crown Castle in the 2013 transaction. In contrast, the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827, as stated in Chunk 2. Thus, the 2021 payment is significantly lower than the initial cash proceeds, reflecting the ongoing nature of the sublease rather than a one-time transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "T (ORG) -> Crown Castle (COMP)",
        "Crown Castle (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5067,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1903,
        "completion_tokens": 135,
        "total_tokens": 2038
      }
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "General Motors values its investment in Stellantis warrants using a Black-Scholes formula, with significant inputs including the Stellantis stock price and estimated dividend yield. As disclosed in 2021, the fair value of GM’s equity price risk exposure, primarily from these warrants, was $1.5 billion. GM estimates that a 10% adverse change in Stellantis stock price would have had an \"insignificant effect\" on the fair value of these investments at December 31, 2021. Gains or losses from changes in the fair value of the Stellantis warrants are recorded in \"Interest income and other non-operating income, net,\" indicating that while the warrants are subject to equity price risk, the potential financial impact on GM’s equity investments from such a change is considered minimal.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis Warrants (FIN_INST)",
        "Stellantis Warrants (FIN_INST) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8779,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2855,
        "completion_tokens": 196,
        "total_tokens": 3051
      }
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "The Always Discreet brand, which is part of P&G's Baby, Feminine & Family Care segment, accounts for the adult incontinence sub-category. According to the provided data, P&G holds about 15% market share in the adult incontinence sub-category through Always Discreet. Since the Baby, Feminine & Family Care segment represents 24% of P&G's total net sales, the adult incontinence sub-category accounts for approximately 6.25% of the segment's total global market share (15% of 24% = 6.25%).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Always Discreet (PRODUCT)",
        "Always Discreet (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2120,
        "completion_tokens": 122,
        "total_tokens": 2242
      }
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "To calculate the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, we combine the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and unrelated transactions. From Chunk 2, Accenture spent $605 million to purchase 2,000,308 shares under the open-market program and an additional $2.1 million (calculated as 72,255 shares × average price) for unrelated transactions, totaling approximately $607.1 million for 2,072,563 shares. The average price per share is therefore approximately $292.53 ($607.1 million ÷ 2,072,563 shares).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2265,
        "completion_tokens": 162,
        "total_tokens": 2428
      }
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The difference in net milestones capitalized for Jardiance between 2020 and 2021 is $156.2 million - $136.1 million = $20.1 million, showing a decrease in 2021. In 2021, the collaboration revenue reported for Jardiance and related products was part of the total collaboration and other revenue of $175.0 million. This indicates that while the capitalized milestones for Jardiance declined, the collaboration revenue for the Jardiance family remained a significant contributor to LLY's collaboration income in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Jardiance (PRODUCT)",
        "Jardiance (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 128,
        "total_tokens": 1211
      }
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "In 2021, GM recorded gains of $316 million from its Stellantis warrants, which are included in Interest income and other non-operating income. Additionally, GM maintains an ongoing business relationship with Stellantis, involving the purchase and supply of vehicles, parts, and engineering services, which affects GM's post-sale operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis (COMP)",
        "Stellantis (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1458,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 999,
        "completion_tokens": 85,
        "total_tokens": 1084
      }
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) in connection with its Chapter 11 reorganization, which was reported in Net gain (loss) on divestitures and other. Despite the deconsolidation, AIGFP’s net operating losses remain available to offset AIG’s consolidated U.S. federal income tax group’s taxable income, and the related deferred tax assets are retained by AIG as of December 31, 2024, with no additional valuation allowance required. This reflects that while AIGFP’s reorganization resulted in a direct loss from deconsolidation, it did not materially impact AIG’s consolidated balance sheet and retained certain tax benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> AIG Financial Products Corp. (COMP)",
        "AIG Financial Products Corp. (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_204",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_204",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7666,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2579,
        "completion_tokens": 175,
        "total_tokens": 2754
      }
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million, as shown in Chunk 1 under the \"Net\" column for 2024. This represents a decrease from the prior year's reported gross value of $840 million in 2023, indicating a reduction in the overall value of this asset category from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Acquired Franchise Rights (FIN_INST)",
        "Acquired Franchise Rights (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2148,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 76,
        "total_tokens": 1260
      }
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "The total financial commitment made by AT&T for the C-Band licenses, as disclosed in the 10-K filing, includes the auction payment of $23,406, an estimated $2,112 for the clearing of Phase II spectrum, and approximately $1,000 in compensable relocation costs over the next several years. This results in a total estimated commitment of $26,518.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Bids_On]-> REGULATORY_REQUIREMENT <-[Introduces]- ORG",
      "triplets_used": [
        "T (ORG) -> C-Band Licenses (REGULATORY_REQUIREMENT)",
        "C-Band Licenses (REGULATORY_REQUIREMENT) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11280,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3482,
        "completion_tokens": 86,
        "total_tokens": 3568
      }
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting a reduction of $20.1 million. This decline, while modest, suggests a potential slowdown in capitalized milestone achievements related to Jardiance during 2021. As a key diabetes product in Lilly's portfolio, this change may indicate a shift in development or commercialization progress for Jardiance, which could impact the overall financial performance and growth trajectory of Lilly's diabetes segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Jardiance (PRODUCT)",
        "Jardiance (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4491,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1764,
        "completion_tokens": 131,
        "total_tokens": 1895
      }
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "The total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis was $1.0 billion, which includes $0.8 billion in non-service pension income and $0.2 billion in gains from Stellantis warrants. This reflects the interconnected financial and investment relationship between the two companies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis (COMP)",
        "Stellantis (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 748,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 825,
        "completion_tokens": 82,
        "total_tokens": 907
      }
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "The impact of changes in Corebridge's stock price on AIG's financial statements, following the initial equity method investment, is reflected in the value of AIG's ownership interest in Corebridge and is recognized as a gain or loss on the sale of Corebridge shares. As stated in Chunk 1, these changes affect the value of AIG's ownership interest and are included in the financial statements. Chunk 2 further clarifies that AIG's equity method income includes both dividends received and changes in Corebridge’s stock price since June 9, 2024. This reflects AIG's ownership interest in Corebridge and demonstrates how fluctuations in Corebridge’s stock price directly influence AIG’s reported earnings under the equity method.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4517,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1774,
        "completion_tokens": 181,
        "total_tokens": 1956
      }
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144 million. This value decreased by $30 million from 2023 to 2024, as the net value in 2023 was $174 million. The reduction reflects the impact of accumulated amortization and ongoing amortization expenses, as disclosed in the 2024 and 2023 financial data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Other Identifiable Intangibles (FIN_INST)",
        "Other Identifiable Intangibles (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3132,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 82,
        "total_tokens": 1518
      }
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "In 2023, the total revenue generated from nuclear-powered submarines was $8,631 million, as reported in the Marine Systems segment. This is significantly higher than the revenue from surface ships, which amounted to $2,698 million in the same year. Given the strategic importance of submarine programs like the Columbia-class and Virginia-class, as highlighted in the Marine Systems segment description, the higher revenue from submarines reflects their critical role in the U.S. Navy's modernization and defense priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Nuclear-Powered Submarines (PRODUCT)",
        "Nuclear-Powered Submarines (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4411,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1764,
        "completion_tokens": 131,
        "total_tokens": 1895
      }
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The fair value of GM's investment in Stellantis warrants increased from $1.2 billion at December 31, 2020, to $1.5 billion at December 31, 2021, representing a $300 million increase. Meanwhile, the fair value of GM's marketable debt securities decreased slightly from $9.0 billion at December 31, 2020, to $8.6 billion at December 31, 2021, a $400 million decline. Thus, while the value of the Stellantis warrants investment rose, the value of marketable debt securities fell over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis Warrants (FIN_INST)",
        "Stellantis Warrants (FIN_INST) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8074,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2680,
        "completion_tokens": 124,
        "total_tokens": 2804
      }
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024 is $28 million, calculated as the net value of $626 million in 2023 minus $598 million in 2024. This decrease is reflected in the company's amortization expense, which slightly decreased to $74 million in 2024 from $75 million in 2023, indicating a modest reduction in amortization charges related to these intangible assets over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Acquired Franchise Rights (FIN_INST)",
        "Acquired Franchise Rights (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3132,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 106,
        "total_tokens": 1539
      }
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The increase in service costs at Aeronautics due to F-35 sustainment contracts contributed approximately $570 million to the overall $775 million (8%) increase in service costs in 2023. Correspondingly, service sales at Aeronautics increased by approximately $600 million, contributing to the overall $788 million (7%) increase in service sales for the year. This indicates that the growth in both service costs and service sales at Aeronautics was largely driven by the higher volume on F-35 sustainment contracts, with the increase in costs closely matching the increase in sales for this business unit and reason.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> F-35 Sustainment Contracts (PRODUCT)",
        "F-35 Sustainment Contracts (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4522,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1800,
        "completion_tokens": 154,
        "total_tokens": 1954
      }
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25, 2024, Accenture plc had a total share repurchase authority of $6,694 million, which includes the $2,694 million in available authorization as of August 31, 2024, and an additional $4,000 million approved by the Board of Directors on September 25, 2024. This reflects the company's ongoing financial strategy to return value to shareholders through its open-market share purchase program and other share repurchase initiatives, particularly focusing on Class A Ordinary Shares, which are publicly traded on the New York Stock Exchange.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4056,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1664,
        "completion_tokens": 138,
        "total_tokens": 1802
      }
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "A failure to meet membership growth expectations would directly impact Netflix's financial flexibility and profitability due to the fixed nature of its content costs, which do not scale proportionally with membership numbers. As outlined in Chunk 2, if membership growth slows or declines, Netflix may not be able to adjust expenditures or increase per-member revenues sufficiently to offset the lower growth rate, leading to adverse effects on margins, liquidity, and results of operations. Additionally, Chunk 1 highlights the significant investment in original and live programming, which requires substantial upfront costs and carries risks related to production, talent, and market reception. If these investments fail to attract or retain members, the inability to recoup fixed content costs across a growing subscriber base could further strain profitability and reduce financial flexibility, especially as Netflix expands into new offerings like live programming and games, as noted in the knowledge graph.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Live Programming (PRODUCT)",
        "Live Programming (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13399,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4002,
        "completion_tokens": 253,
        "total_tokens": 4256
      }
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The total carrying value of the 5.15% 2041 Notes in 2022 was $729 million. The total carrying value of all debt reported by AMGN in 2022 was $33,309 million. Therefore, the 5.15% 2041 Notes represented approximately **2.19%** of AMGN's total debt. Additionally, according to the debt exchange table, **$245 million** of the principal of these notes was exchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 5.15% 2041 Notes (FIN_INST)",
        "5.15% 2041 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1994,
        "completion_tokens": 90,
        "total_tokens": 2085
      }
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "McDonald's treatment of goodwill in its financial reporting depends on the timing of the sale of acquired franchised restaurants. If a Company-operated restaurant is sold within 24 months of acquisition, the associated goodwill is fully written off. However, if the sale occurs beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. These acquisitions typically arise from purchases of McDonald's restaurants from franchisees, with goodwill calculated using a discounted cash flow methodology. This approach reflects the Company's accounting policies and aligns with its strategic focus on optimizing its real estate and operational structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2620,
        "completion_tokens": 184,
        "total_tokens": 2805
      }
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "AIG's equity method income from Corebridge after the deconsolidation date of June 9, 2024, was calculated based on the sum of dividends received and changes in Corebridge's stock price during the post-deconsolidation period from June 10, 2024, to December 31, 2024. Following the deconsolidation, AIG continued to hold 48.4% of Corebridge's common stock and transitioned to accounting for its investment under the equity method, as reflected in AIG's Other Operations segment. This income is reported separately in AIG's financial statements, no longer consolidating Corebridge's results but instead recognizing its share of Corebridge's performance through this equity method approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4623,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1792,
        "completion_tokens": 171,
        "total_tokens": 1963
      }
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Franchisees contribute to approximately 93% of McDonald's global workforce, as the Company employs over 150,000 individuals worldwide, while its franchised restaurants employ over two million individuals. McDonald's recruitment initiative for diverse franchisees aims to increase representation from all backgrounds, including underrepresented groups, by reducing upfront equity requirements and providing learning and development support, aligning with its broader diversity, equity, and inclusion strategy to better reflect the communities it serves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12026,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3694,
        "completion_tokens": 138,
        "total_tokens": 3832
      }
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The unfavorable $100 million profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively reduced RMS' operating profit by $41 million, or 2%, compared to 2022. These negative impacts were partially offset by higher operating profit from IWSS programs. Meanwhile, Sikorsky programs contributed positively to the backlog increase in 2023, primarily due to higher orders, indicating strong future revenue potential despite the near-term operating profit challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Sikorsky Helicopter Programs (PRODUCT)",
        "Sikorsky Helicopter Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4956,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1916,
        "completion_tokens": 132,
        "total_tokens": 2048
      }
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "The total value of Broadcom's acquisition of VMware was approximately $84,186 million, combining $30,788 million in cash and $53,398 million in the fair value of 544 million shares of Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions, as VMware's multi-cloud services complement and enhance Broadcom's existing portfolio, enabling the company to modernize, optimize, and secure complex private and hybrid cloud environments for its customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Infrastructure Software Solutions (PRODUCT)",
        "Infrastructure Software Solutions (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10445,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3261,
        "completion_tokens": 127,
        "total_tokens": 3388
      }
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The introduction of the $6.99 ad-supported tier by Netflix is directly tied to its strategy of balancing average revenue per user (ARPU) with broader market penetration, as outlined in its 10-K filing. This new subscription tier aims to attract price-sensitive customers in both developed and emerging markets, which contributes to the reported 18% year-over-year increase in global paid memberships. By offering a lower-cost option, Netflix expands its user base while maintaining a diversified revenue model, thus supporting growth in membership numbers without necessarily sacrificing long-term ARPU through tiered pricing and ad-supported monetization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> New Subscription Tiers (PRODUCT)",
        "New Subscription Tiers (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 96,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 692,
        "completion_tokens": 164,
        "total_tokens": 856
      }
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "The total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, is approximately 2.15 million, comprising over 150,000 Company employees and over 2 million individuals working in franchised restaurants. This extensive workforce is central to McDonald's purpose of feeding and fostering communities and its mission to make delicious, feel-good moments easy for everyone. By prioritizing inclusion, integrity, and community, McDonald's ensures that its employees and franchisees contribute to a consistent, high-quality customer experience and support the Company's long-term value creation and global impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6500,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2276,
        "completion_tokens": 169,
        "total_tokens": 2445
      }
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, consisting of $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition significantly enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby expanding Broadcom's ability to modernize, optimize, and secure complex private and hybrid cloud environments for its customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Infrastructure Software Solutions (PRODUCT)",
        "Infrastructure Software Solutions (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10445,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3258,
        "completion_tokens": 121,
        "total_tokens": 3379
      }
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "Netflix's pricing strategy for its membership plans, which includes a range of paid plans from $1 to $32 per month and ad-supported options, aims to diversify revenue and attract a broad audience. However, as outlined in the 2024 10-K, rising macroeconomic pressures—such as inflation and household budget constraints—could lead to members canceling due to the need to cut expenses. This creates a conflict, as raising prices or enforcing stricter terms (e.g., limiting shared viewing) to improve revenue per member may be poorly received and could accelerate churn, undermining the company's ability to retain existing members. Thus, while pricing adjustments are a tool to enhance revenue, they risk alienating price-sensitive members during economically challenging times, potentially harming Netflix's growth and financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Membership Plans (PRODUCT)",
        "Membership Plans (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7351,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2493,
        "completion_tokens": 209,
        "total_tokens": 2702
      }
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting in two key ways: during the acquisition of restaurants from franchisees and when subsequently selling those restaurants. When acquiring a restaurant, McDonald's uses a discounted cash flow methodology to value the asset, which depends on the expected profitability and cash flows—factors heavily influenced by franchisee performance and market conditions. If franchisees underperform due to operational, financial, or external risks (such as supply chain issues, labor challenges, or brand misalignment), the projected cash flows may be overstated, leading to potentially inflated goodwill. Furthermore, if a Company-operated restaurant acquired from a franchisee is sold within 24 months, the associated goodwill is fully written off, amplifying the financial impact of short-term underperformance or strategic shifts. Thus, franchisee performance directly affects both the initial goodwill valuation and its subsequent accounting treatment upon disposition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8783,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2854,
        "completion_tokens": 262,
        "total_tokens": 3116
      }
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities by advancing next-generation defense and missile technologies, which are central to the Space segment's focus on strategic, advanced strike, and defensive systems. These programs, which include development of hypersonic strike weapons for the U.S. Army and Navy, support the company's 21st Century Security vision by integrating advanced, open-architecture technologies across defense domains. Furthermore, following successful testing, multiple hypersonics programs are expected to enter early production phases through 2026, contributing to anticipated growth by expanding the company's defense capabilities and securing new program awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Guides_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Hypersonics Programs (PRODUCT)",
        "Hypersonics Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10549,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3276,
        "completion_tokens": 183,
        "total_tokens": 3459
      }
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflects its projected financial contribution by using the **multi-period excess earnings method** under the income approach. This technique estimates the present value of projected cash flows generated by the developed technology, adjusted for the contributions of other assets, thereby capturing the economic benefit over time. The economic useful life was determined based on the technology cycle and cash flows over the forecast period, aligning with the product's lifecycle and expected financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> VMware Cloud Foundation (PRODUCT)",
        "VMware Cloud Foundation (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3544,
        "completion_tokens": 151,
        "total_tokens": 3695
      }
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to an increase in Comcast's Corporate and Other segment expenses in 2021, as noted in the costs related to the product's launch and hardware sales. However, overall Corporate and Other expenses for 2021 were lower compared to 2020 due to prior-year severance charges and cost-saving initiatives. Looking ahead, the company expected to incur increased costs in 2022 related to the continued investment in Sky Glass and XClass TV, reflecting a strategic expectation to expand these initiatives despite the anticipated rise in expenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Sky Glass (PRODUCT)",
        "Sky Glass (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7069,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2408,
        "completion_tokens": 149,
        "total_tokens": 2558
      }
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "McDonald's (MCD) uses a discounted cash flow methodology (Level 3 inputs) to value restaurants acquired from franchisees, based on their expected profitability and cash flows. If a Company-operated restaurant is sold within 24 months of acquisition, the associated goodwill is fully written off, while sales beyond 24 months result in a partial write-off based on the relative fair value of the business sold. This policy has financial implications as it can lead to significant goodwill write-offs in the short term if restaurants are sold soon after acquisition, impacting the Company’s consolidated financial statements. Additionally, the results of operations from such purchased and sold restaurants are not material to the consolidated financial statements, as noted in the 10-K.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5279,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1984,
        "completion_tokens": 196,
        "total_tokens": 2180
      }
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "The concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compounds its financial vulnerability by increasing exposure to defaults from customers facing liquidity challenges due to the COVID-19 pandemic. As of December 31, 2021, $1.8 billion in defaults were linked to the pandemic's impact on airline revenues and cash flows, with Boeing's portfolio concentrated among certain customers and aircraft types, many of which are with less-than-investment-grade credit. This concentration limits Boeing’s ability to redeploy aircraft on favorable terms and increases the risk of significant declines in asset value, thereby exacerbating the negative effects on its financial position, results of operations, and cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BA (ORG) -> Customer Financing Portfolio (FIN_INST)",
        "Customer Financing Portfolio (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8299,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2753,
        "completion_tokens": 191,
        "total_tokens": 2944
      }
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The launch of Sky Glass in the fourth quarter of 2021 had a mixed impact on CMCSA's Corporate and Other segment in 2021. On the revenue side, the segment benefited from sales of Sky Glass televisions, contributing to the overall revenue increase in 2021. However, the launch also introduced additional costs, as noted in the decrease in expenses being partially offset by costs related to Sky Glass and XClass TV. These costs were part of broader business initiatives included in the Corporate and Other segment, indicating that while the product contributed to revenue, it also added to the segment's operational expenses in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Launches]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Sky Glass (PRODUCT)",
        "Sky Glass (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7112,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2431,
        "completion_tokens": 157,
        "total_tokens": 2589
      }
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "As of December 31, 2023, the total fair value of commercial mortgage-backed securities held by CVS is $675 million, as shown in Chunk 2. This category represents an unrealized loss of $100 million. Compared to the total debt securities portfolio, which has a fair value of $12,548 million and an unrealized loss of $836 million, commercial mortgage-backed securities account for approximately 5.38% of the total fair value and 11.96% of the total unrealized loss in the debt securities portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Commercial mortgage-backed securities (FIN_INST)",
        "Commercial mortgage-backed securities (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7516,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2543,
        "completion_tokens": 124,
        "total_tokens": 2667
      }
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "The growth in third-party seller unit sales significantly contributed to Amazon's overall sales increase in 2023, with both North America and International sales rising by 12% and 11%, respectively, driven largely by increased unit sales from third-party sellers, alongside advertising and subscription services. However, Amazon's international expansion strategy faces a notable risk: in countries like the People's Republic of China and India, regulatory restrictions on foreign ownership and operations require Amazon to partner with local third-party entities, which introduces compliance and operational uncertainties that could impact its ability to scale and maintain control over its international marketplace.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Third-Party Sellers (COMP)",
        "Third-Party Sellers (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6204,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2210,
        "completion_tokens": 179,
        "total_tokens": 2390
      }
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023 is 1,712,810 shares (1,853,363 - 140,553). Both plans are disclosed by WFC and are categorized under plans not approved by security holders, with \"Deferral distribution\" as the award type, as shown consistently in both provided text chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Non-Qualified Deferred Compensation Plan for Independent Contractors (ACCOUNTING_POLICY)",
        "Non-Qualified Deferred Compensation Plan for Independent Contractors (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 114,
        "total_tokens": 1289
      }
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, e-vapor products, and oral nicotine products, as outlined in the 2022 10-K filing. Heated tobacco units contribute to this classification because they are specifically identified as part of the reduced-risk category, distinct from combustible products, and are designed to deliver nicotine without combustion, aligning with PMI's strategy to offer alternatives with potentially reduced health risks compared to traditional tobacco products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Heated Tobacco Units (PRODUCT)",
        "Heated Tobacco Units (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3791,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 137,
        "total_tokens": 1734
      }
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "In fiscal year 2025, 12% of NVDA's revenue came from DirectCustomerA. The data for the previous year (fiscal 2024) for DirectCustomerA is not provided in the available chunks, as indicated by the asterisk (*). While DirectCustomerB's contribution decreased from 13% in 2024 to 11% in 2025, no comparable figure is available for DirectCustomerA in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Positively_Impacts]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> DirectCustomerA (COMP)",
        "DirectCustomerA (COMP) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 694,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 812,
        "completion_tokens": 88,
        "total_tokens": 900
      }
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "In Wells Fargo's 2023 10-K filing, there are **two distinct versions** of the Restricted Share Rights Award Agreement: one for grants on or after **January 24, 2023**, and another for grants on or after **January 23, 2024**. The version for 2023 grants is incorporated by reference from the 2022 10-K, while the version for 2024 grants is filed herewith in the 2023 10-K. Both versions are clearly identified in the exhibit descriptions provided in the two text chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Restricted Share Rights Award Agreement (ACCOUNTING_POLICY)",
        "Restricted Share Rights Award Agreement (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12708,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3854,
        "completion_tokens": 117,
        "total_tokens": 3972
      }
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The continued uncertainty in FAA approval timelines for the 787 Program in 2022 significantly impacted Boeing's cost of sales and margin forecasting due to the increased estimation uncertainty in program accounting. As described in the critical audit matter, the difficulty in predicting the resumption of 787 deliveries led to higher risk in revenue forecasts, with potential flowthrough impacts on customer consideration and contractual termination rights. This uncertainty introduced significant judgment into determining which aircraft would reach delivery delay thresholds, potentially resulting in lower margins or further material reach-forward losses. Additionally, the 2021 10-K data shows that the 787 program already contributed to a reach-forward loss, which directly increased cost of sales and negatively affected margins, highlighting the ongoing financial strain from these program challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BA (ORG) -> 787 Program (PRODUCT)",
        "787 Program (PRODUCT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4694,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1833,
        "completion_tokens": 227,
        "total_tokens": 2060
      }
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "In 2023, third-party sellers significantly contributed to both North America and International sales growth, with increased unit sales driven by Amazon's focus on price, selection, and convenience. North America sales rose 12%, and International sales increased 11%, with both regions attributing a major portion of the growth to third-party sellers, along with advertising and subscription services. However, the net effect of foreign exchange rate changes was mixed: while changes reduced overall net sales by $71 million, they increased International net sales by $88 million, partially offsetting the negative impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Third-Party Sellers (COMP)",
        "Third-Party Sellers (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6204,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2203,
        "completion_tokens": 155,
        "total_tokens": 2358
      }
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program, as required under the USA PATRIOT Act, could constrain its ability to pursue future bank acquisitions because federal banking regulators are required to evaluate the effectiveness of an applicant's AML program when determining whether to approve such acquisitions. These deficiencies may lead to regulatory disapproval or impose additional compliance burdens that could hinder the acquisition process. The regulatory body responsible for assessing these deficiencies during the approval process is the Federal Reserve Board (FRB), which regulates the Parent Bank Holding Company and oversees merger and acquisition approvals for bank holding companies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Anti-Money Laundering Policies (ACCOUNTING_POLICY)",
        "Anti-Money Laundering Policies (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14074,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4198,
        "completion_tokens": 179,
        "total_tokens": 4378
      }
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020 was **2.4%**, as stated in Chunk 1. Additionally, heated tobacco units fall under **reduced-risk products** in PMI's financial reporting, as specified in Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Heated Tobacco Units (PRODUCT)",
        "Heated Tobacco Units (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5283,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1979,
        "completion_tokens": 72,
        "total_tokens": 2052
      }
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "If all CCC-rated receivables within Boeing's $1.8 billion customer financing portfolio were to default due to the ongoing impacts of the COVID-19 pandemic, and given the 24.2% default rate applied to CCC-rated receivables, Boeing's potential losses could increase by up to $435.6 million (24.2% of $1.8 billion). This risk is highlighted by the pandemic's severe impact on airline liquidity and financial viability, as outlined in the 10-K filing, which could lead to defaults in Boeing's financing portfolio and further strain its liquidity and financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BA (ORG) -> Customer Financing Portfolio (FIN_INST)",
        "Customer Financing Portfolio (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5569,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2070,
        "completion_tokens": 141,
        "total_tokens": 2211
      }
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. However, the percentage for the previous fiscal year ending January 28, 2024, is not disclosed in the provided data from either Chunk 1 or Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> DirectCustomerC (COMP)",
        "DirectCustomerC (COMP) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 694,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 816,
        "completion_tokens": 61,
        "total_tokens": 877
      }
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "As of December 31, 2023, the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation is **$675 million**, as shown in both chunks. The associated unrealized losses for these securities amount to **$100 million**, which is also consistent across the provided data. This indicates that while the fair value of CMBS is $675 million, the unrealized losses represent a 14.8% reduction in value ($100 million / $675 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Commercial mortgage-backed securities (FIN_INST)",
        "Commercial mortgage-backed securities (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_150",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9405,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3028,
        "completion_tokens": 114,
        "total_tokens": 3142
      }
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "The treatment of changes in the estimated fair value of Unit-linked securities differs between net investment income and net derivative gains (losses) as follows: changes in estimated fair value of Unit-linked securities are included in **net investment income**, as disclosed in Chunk 1. In contrast, **lapses associated with net embedded derivatives** are included in **net derivative gains (losses)**, also per Chunk 1. Furthermore, Chunk 2 highlights that the estimated fair value of these instruments is sensitive to various unobservable inputs, such as mortality rates, lapse rates, utilization rates, and withdrawal rates, which affect the valuation of guarantees and benefits within Unit-linked contracts. These factors influence the fair value measurements, which are reported in accordance with the treatment specified in the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Unit-linked Securities (FIN_INST)",
        "Unit-linked Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_252",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5440,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2019,
        "completion_tokens": 217,
        "total_tokens": 2236
      }
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a financial loss of **$3.5 billion** on the 787 Program in the fourth quarter of 2021, primarily due to extended delivery delays and associated customer considerations driven by rework activities. The uncertainty surrounding the Federal Aviation Administration (FAA) approval to resume deliveries significantly affects future revenue estimates, as the use of **program accounting** requires estimating revenue based on expected delivery timelines. Delays increase the risk of aircraft reaching contractual termination rights, which could lead to additional customer considerations and further reduce margins or result in material reach-forward losses. Given the continued uncertainty in the FAA approval timeline, any changes to the expected resumption date could have a **flowthrough impact** on revenue and cost estimates, potentially leading to additional losses in future periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Impacts]- ORG",
      "triplets_used": [
        "BA (ORG) -> 787 Program (PRODUCT)",
        "787 Program (PRODUCT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8062,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2679,
        "completion_tokens": 225,
        "total_tokens": 2904
      }
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "In the fiscal year ending January 26, 2025, NVDA derived 12% of its revenue from DirectCustomerA. However, the data for the prior fiscal year (ending January 28, 2024) for DirectCustomerA is not available, as indicated by the asterisk (*), suggesting a lack of disclosure or materiality below the reporting threshold in that period. Both chunks confirm the same percentage for DirectCustomerA in the 2025 fiscal year, reinforcing the consistency of the data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> DirectCustomerA (COMP)",
        "DirectCustomerA (COMP) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 694,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 823,
        "completion_tokens": 114,
        "total_tokens": 938
      }
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "The total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023 includes the fair value of the equity investment and the net results from the collaboration. As of December 31, 2023, the fair value of Amgen’s equity investment in BeiGene was $4.2 billion (Chunk 1). For the collaboration, Amgen recorded $125 million in product sales to BeiGene, $109 million in net cost recoveries offsetting R&D expenses, and $40 million in profit and loss share expenses in SG&A during 2023 (Chunk 2). Combining these, the total financial impact in 2023 was $4.2 billion (fair value) plus a net positive of $84 million ($125M + $109M - $40M), totaling approximately $4.284 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> BeiGene (COMP)",
        "BeiGene (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5663,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2074,
        "completion_tokens": 176,
        "total_tokens": 2250
      }
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "MetLife applies different forecast periods for estimated lifetime loss rates depending on the type of mortgage loan. For commercial and agricultural mortgage loans, a two-year forecast period is generally used, after which the company reverts to historical loss experience over two years using a straight-line basis. In contrast, residential mortgage loans use a two-year forecast period as well, but revert to historical loss experience over a one-year period using a straight-line basis. This difference in reversion duration reflects the distinct risk profiles and historical data sensitivity of each loan type, with commercial and agricultural loans requiring a longer transition period due to their more complex and less predictable credit dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Estimated Lifetime Loss Rates (ACCOUNTING_POLICY)",
        "Estimated Lifetime Loss Rates (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_216",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_217",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8997,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2922,
        "completion_tokens": 188,
        "total_tokens": 3110
      }
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, involves retaining significant risk by relying on historical claims data, demographic factors, and severity trends. While this approach allows for cost control and flexibility, the costs are highly unpredictable and subject to fluctuations from inflation, regulatory changes, and unforeseen developments in claims. These uncertainties, combined with broader labor-related risks—such as the need to attract and retain employees amid rising wage pressures and healthcare costs—could strain financial resources and impact Costco's financial condition. Additionally, the company's exposure to property, casualty, and other losses not fully covered by insurance, as well as strong competition and macroeconomic factors, further heighten the potential for adverse effects on its operations and results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Funds]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "COST (ORG) -> Employee Health Care Benefits (FIN_INST)",
        "Employee Health Care Benefits (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8362,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2756,
        "completion_tokens": 226,
        "total_tokens": 2983
      }
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 totaled $4.637 billion, comprising a $4.2 billion pre-tax charge for the CAE Settlement (reflecting the $5.3 billion present value of contributions net of a $1.1 billion existing accrual) and $437 million in restructuring charges. The reconsolidation of the Aearo Entities in the second quarter of 2023 impacted 3M's balance sheet as of December 31, 2023, by removing $0.7 billion in assets (equity and other investments) and $0.6 billion in net liabilities (former intercompany amounts due from 3M to the Aearo Entities) that were previously reported as of December 31, 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reconsolidates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Entities (COMP)",
        "Aearo Entities (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9711,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3081,
        "completion_tokens": 166,
        "total_tokens": 3247
      }
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform significantly expands the capabilities available to developers on the Google Cloud Platform by providing them with access to a highly advanced, natively multimodal AI model that can understand and operate across text, code, audio, image, and video. This integration enables developers to train, tune, augment, test, and deploy applications using Gemini alongside other generative AI models like Imagen and Veo. Additionally, Gemini for Google Cloud offers pre-packaged AI agents that assist developers in writing, documenting, testing, and operating software, while also supporting cybersecurity teams in threat analysis and response. By leveraging Gemini 2.0's capabilities, developers can create more sophisticated and efficient AI-driven solutions, enhancing productivity and innovation on the Google Cloud Platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Vertex AI Platform (PRODUCT)",
        "Vertex AI Platform (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9311,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2966,
        "completion_tokens": 220,
        "total_tokens": 3186
      }
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities impacts MetLife's reported investment income in 2024 by incorporating $205 million in investment income (loss) from FVO securities into the total investment income from fixed maturity securities. This inclusion increases the numerator in the yield calculation, thereby affecting the reported yield. Additionally, since FVO securities are classified under Level 3, their valuation involves significant unobservable inputs, making their fair value sensitive to changes in assumptions such as market volatility, credit spreads, and other factors. This sensitivity means that fluctuations in these inputs can lead to substantial changes in the reported fair value of FVO securities, which in turn affects MetLife's investment income and overall financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Includes]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> FVO Securities (FIN_INST)",
        "FVO Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6235,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2228,
        "completion_tokens": 212,
        "total_tokens": 2440
      }
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023 was a pre-tax charge of $1.2 billion in 2022, which included fees and net of related existing accruals, and an immaterial income statement impact in 2023. These events were directly related to the Combat Arms Earplugs litigation, as 3M and the Aearo Entities were facing claims from approximately 260,000 to 285,000 individual claimants. The deconsolidation in 2022 was part of a bankruptcy proceeding initiated by the Aearo Entities to establish a trust funded by 3M to address these claims, while the reconsolidation in 2023 followed the dismissal of the bankruptcy filing, which lifted the automatic stay on litigation against 3M. Ultimately, the litigation and related financial impacts were resolved through the CAE Settlement in August 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reconsolidates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Entities (COMP)",
        "Aearo Entities (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9945,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3142,
        "completion_tokens": 224,
        "total_tokens": 3367
      }
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "Adobe's integration of Adobe Firefly into Creative Cloud and Document Cloud in fiscal 2023 significantly contributes to its strategy of increasing recurring revenue and expanding its customer base by enhancing product offerings with AI-driven capabilities. Firefly, introduced in September 2023, is a generative AI tool that powers features like Text to Image, Generative Fill, and Text Effects in Photoshop, Illustrator, and Adobe Express, making creative tools more accessible to novice users and increasing engagement among existing subscribers. These AI enhancements, delivered through a subscription model, not only add value to existing Creative Cloud offerings but also attract new users, including communicators and Acrobat customers, through expanded functionalities. Additionally, Firefly's integration into Document Cloud and the use of Generative Credits further drive product-led growth by enabling frictionless content creation and workflow optimization, supporting Adobe’s goal of building a recurring and predictable revenue stream.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Firefly (PRODUCT)",
        "Adobe Firefly (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11944,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3650,
        "completion_tokens": 262,
        "total_tokens": 3912
      }
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount is equivalent to the total fair value of all available-for-sale investments, as disclosed in Chunk 1, indicating that these two categories collectively represent the entirety of Amgen’s available-for-sale investments at that date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> U.S. Treasury bills (FIN_INST)",
        "U.S. Treasury bills (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5850,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2118,
        "completion_tokens": 102,
        "total_tokens": 2220
      }
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The valuation techniques for Unit-linked securities described in MetLife's 2024 10-K indicate that these securities are primarily equity-based and are measured using Level 3 inputs, which rely on significant unobservable factors. Specifically, the fair value of these securities is sensitive to changes in long-term equity volatility (item 12) and nonperformance risk spreads (item 13), as both inputs are used in the cash flow projections for valuing the associated guarantees and benefits. Increases in long-term equity volatility generally increase the estimated fair value of guarantees, while changes in nonperformance risk spreads, which vary by duration and currency, impact the discounting of future cash flows, thereby affecting the overall fair value measurement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Unit-linked Securities (FIN_INST)",
        "Unit-linked Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_296",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5287,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1979,
        "completion_tokens": 193,
        "total_tokens": 2173
      }
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, supports its broader strategy to increase customer engagement and subscription revenue by enhancing the value proposition for both creative professionals and non-creative stakeholders. These credits enable users to generate AI-powered content, integrating Firefly's capabilities into core Creative Cloud apps like Photoshop and Illustrator, thereby deepening usage and encouraging upgrades or expansions of subscriptions. Additionally, by embedding Firefly into Adobe Express and other accessible tools, Adobe broadens its appeal to novice creators and communicators, aligning with its product-led growth strategy to attract a wider customer base. The integration of collaboration tools, such as Frame.io, further extends the reach to stakeholders involved in review and approval processes, fostering cross-functional engagement and reinforcing Adobe's position as a comprehensive platform for creativity and content production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Generative Credits (PRODUCT)",
        "Generative Credits (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11559,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3556,
        "completion_tokens": 257,
        "total_tokens": 3813
      }
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "The integration of Gemini 2.0 across Google's billion-user products and the Vertex AI platform enhances Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services by enabling scalable AI deployment and empowering developers to build and deploy AI-driven applications. By embedding Gemini 2.0 into core products like Android, Chrome, and YouTube, Google leverages its vast user base to refine and expand AI capabilities, which in turn strengthens the AI models available on Vertex AI. This platform allows developers to train, test, and deploy applications using Gemini and other generative AI models, offering businesses access to advanced AI tools that drive innovation and efficiency. As a result, Google Cloud can monetize these capabilities through consumption-based fees and subscriptions for infrastructure, AI development, and cybersecurity services, positioning itself as a leader in enterprise AI solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Gemini (PRODUCT)",
        "Gemini (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10506,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3275,
        "completion_tokens": 239,
        "total_tokens": 3514
      }
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on Fair Value Option (FVO) securities, as the recognition of income on these investments is contingent upon factors such as prepayments and defaults. According to the disclosures in the 10-K filing, fluctuations in these rates can alter the amounts of income to be earned. Additionally, the valuation of FVO securities is influenced by unobservable inputs, such as long-term equity volatilities, mortality and lapse rates, utilization rates, and nonperformance risk spreads, which are used in the fair value measurement of these Level 3 assets. These inputs are inherently subjective and can significantly affect the estimated fair value, particularly in the context of structured products like mortgage-backed securities and other FVO securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> FVO Securities (FIN_INST)",
        "FVO Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_209",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2474,
        "completion_tokens": 208,
        "total_tokens": 2682
      }
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance by offering high-quality, competitively priced private-label items that generally earn higher margins than national brand products. These products help differentiate Costco's merchandise offerings, support member loyalty, and contribute to a growing portion of overall sales. However, the brand's success is contingent on maintaining consistent product quality, availability, and member confidence, as any decline in these areas could adversely affect sales and gross margin results. Additionally, disruptions in production, distribution, or supply chain operations—such as those caused by natural disasters, labor issues, or IT system failures—pose risks to the availability of Kirkland Signature products, which could negatively impact member satisfaction and, consequently, Costco's gross margin performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Kirkland Signature (PRODUCT)",
        "Kirkland Signature (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8249,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2715,
        "completion_tokens": 228,
        "total_tokens": 2943
      }
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair value of \"Other short-term interest-bearing securities\" was $0 as of December 31, 2022, and increased to $138 as of December 31, 2023. This increase contributed to the total available-for-sale investments, which rose from $4,815 (2022) to $10,404 (2023), reflecting the inclusion of these securities in the 2023 balance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Other short-term interest-bearing securities (FIN_INST)",
        "Other short-term interest-bearing securities (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5850,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2136,
        "completion_tokens": 82,
        "total_tokens": 2218
      }
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, significantly influenced the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, by narrowing the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This uncertainty and the positions taken by RBH and other parties were determined to be impairment indicators, prompting PMI to perform a discounted cash flow analysis. As a result, PMI recorded a non-cash impairment charge of $2,316 million in its consolidated statement of earnings for the year ended December 31, 2024, reducing the carrying value of its investment in RBH from $3,280 million to a fair value of $714 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Quantitative Valuation (ACCOUNTING_POLICY)",
        "Quantitative Valuation (ACCOUNTING_POLICY) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_147",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12316,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3767,
        "completion_tokens": 201,
        "total_tokens": 3969
      }
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "If advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022 and the TAC rate remained constant at 22%, the absolute dollar amount of TAC paid to Google Network partners would increase by $2.2 billion ($10 billion × 22%). This aligns with the expectation in Chunk 2 that TAC paid to Google Network partners will increase as revenues grow, and it reflects the relationship outlined in the knowledge graph, where Google (ORG) depends on Google Network Partners (COMP) and supplies them with advertising revenue. Chunk 1 supports this by identifying payments to Google Network partners as a primary use of cash from operating activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8505,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2836,
        "completion_tokens": 168,
        "total_tokens": 3004
      }
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased from $61,449 million on December 31, 2023, to $75,604 million on December 31, 2024, representing a $14,155 million increase. The fair value of these obligations also increased from $59,851 million in 2023 to $70,565 million in 2024, a $10,714 million increase. Thus, the carrying value increased by $3,441 million more than the fair value over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Long-Term Debt and Other Financing Obligations (FIN_INST)",
        "Long-Term Debt and Other Financing Obligations (FIN_INST) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3516,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 115,
        "total_tokens": 1669
      }
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to an increase in merchant transaction costs of $573 million in 2022, as noted in Chunk 2. This expansion also drove higher merchant revenues compared to agency revenues, as stated in Chunk 1, where merchant revenues grew more significantly due to this service expansion. While the rise in merchant transaction costs reflects the operational scale-up, the increase in merchant revenues—relative to agency revenues—demonstrates the broader impact of the service expansion on Booking.com’s revenue mix and overall business strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Merchant Accommodation Reservation Services (PRODUCT)",
        "Merchant Accommodation Reservation Services (PRODUCT) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1626,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 154,
        "total_tokens": 1238
      }
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs represents a strategic expansion within its FPGA and Adaptive SoC product lines, specifically targeting markets requiring high-performance RF data conversion capabilities, such as wireless communications, radar, and cable access. As part of AMD’s broader portfolio of Adaptable Platforms, these RFSoCs integrate high-performance RF data converters with a heterogeneous processing subsystem, enabling real-time control, analytics, and sensor fusion. This aligns with AMD’s strategy to provide flexible, domain-specific solutions that accelerate innovation in embedded systems, particularly in the emerging era of big data and AI, as seen through the integration of hardware and software tools like Vivado and Vitis. The Zynq UltraScale+ RFSoCs further strengthen AMD’s position in the Adaptive SoC segment, complementing its FPGA offerings and enhancing its ability to serve diverse, high-demand markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Zynq UltraScale+ RFSoCs (PRODUCT)",
        "Zynq UltraScale+ RFSoCs (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9151,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2957,
        "completion_tokens": 237,
        "total_tokens": 3195
      }
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value of those securities for the same years is $1,104 million ($596 million in 2023 + $508 million in 2024). Thus, the combined carrying value exceeds the combined fair value by $11 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Debt Securities - Held-to-Maturity (FIN_INST)",
        "Debt Securities - Held-to-Maturity (FIN_INST) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3516,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 95,
        "total_tokens": 1637
      }
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a significant increase in sales and other expenses in 2022, primarily through higher merchant transaction costs of $573 million and third-party call center costs of $235 million, driven by increased merchant transactions. This expansion also directly fueled the growth in merchant gross bookings, which outpaced agency gross bookings due to the shift toward services where Booking.com facilitates payments. The growth in merchant gross bookings was further supported by a 15% increase in accommodation average daily rates (ADRs) and more room nights booked, reflecting stronger travel demand as the pandemic's impact waned.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Merchant Accommodation Reservation Services (PRODUCT)",
        "Merchant Accommodation Reservation Services (PRODUCT) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1975,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 178,
        "total_tokens": 1341
      }
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "As of December 31, 2023, PayPal reported a total value of $1,241 million for both its crypto asset safeguarding asset and the corresponding safeguarding liability. This is evident from Chunk 2, which shows the \"Crypto asset safeguarding asset\" and \"Crypto asset safeguarding liability\" each amounting to $1,241 million under financial assets and liabilities, respectively. This balance reflects PayPal's role in safeguarding customer crypto assets, indicating the company's active involvement in crypto-related financial activities, particularly in managing and securing digital assets on behalf of its users. The disclosure in Chunk 1 further underscores PayPal's broader engagement in managing various financial instruments, including those related to crypto, as part of its overall risk and liquidity management strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Crypto Asset Safeguarding Liability (FIN_INST)",
        "Crypto Asset Safeguarding Liability (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12279,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3736,
        "completion_tokens": 206,
        "total_tokens": 3943
      }
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The aircraft impairment charges recorded by FedEx in 2023 ($70 million pre-tax) and 2024 ($157 million pre-tax) directly reflect the company's Network 2.0 optimization strategy, which aims to modernize the aircraft fleet, improve global network efficiency, and align air network capacity with current shipment volumes. These charges are part of the broader DRIVE transformation program, which includes business optimization and realignment costs. Through 2024, the cumulative financial impact of these impairment charges is $227 million pre-tax ($174 million net of tax), contributing to the overall $855 million in DRIVE-related costs incurred from 2023 to 2024. These actions underscore FedEx's commitment to long-term profitability through strategic fleet modernization and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Optimizes]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Network 2.0 (PRODUCT)",
        "Network 2.0 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10718,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3337,
        "completion_tokens": 200,
        "total_tokens": 3537
      }
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is **$3,627 million**. The gross unrealized losses on these obligations increased from **$234 million as of December 31, 2023**, to **$274 million as of December 31, 2024**, representing an increase of **$40 million**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNH (ORG) -> U.S. Govt & Agency Obligations (FIN_INST)",
        "U.S. Govt & Agency Obligations (FIN_INST) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6450,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2276,
        "completion_tokens": 79,
        "total_tokens": 2356
      }
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "The 54% merchant basis transaction mix in 2023, up from 44% in 2022, increased Booking.com’s merchant-related expenses, including personnel, payment processing, and chargebacks, which are recorded in \"Personnel\" and \"Sales and other expenses.\" These higher costs negatively impacted operating margins despite incremental revenues from merchant activities like payment card rebates. The key cost components contributing to this margin pressure were personnel expenses and payment processing costs, driven by the company’s strategy to expand its merchant-based transaction model to support its Connected Trip vision and enhance consumer payment flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Merchant Basis Transactions (PRODUCT)",
        "Merchant Basis Transactions (PRODUCT) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3647,
        "completion_tokens": 163,
        "total_tokens": 3811
      }
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "PayPal's reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' in May 2023 resulted in the reversal of previously recorded allowances for credit losses, which decreased transaction and credit losses on its consolidated statements of income (loss) for 2023. In 2024, the change in fair value measurement methodology for these held-for-sale loans—from a price-based model with unobservable inputs (Level 3) to observable inputs (Level 2)—improved the transparency and reliability of asset valuation. This shift led to valuation changes and associated charge-offs being recorded in \"restructuring and other\" on the consolidated statements of income (loss), impacting income recognition. Additionally, interest income on these held-for-sale loans continued to be recognized based on contractual rates, maintaining revenue consistency while aligning asset valuation with more observable market prices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reclassifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Loans and Interest Receivable, Held for Sale (FIN_INST)",
        "Loans and Interest Receivable, Held for Sale (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9819,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3144,
        "completion_tokens": 238,
        "total_tokens": 3383
      }
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "The total combined borrowing capacity as of December 31, 2024, is $3.7 billion, which includes the newly established €1.5 billion credit facility (approximately $1.6 billion) and the existing short-term credit arrangements of $2.1 billion. This represents a decrease from the borrowing capacity from short-term credit arrangements as of December 31, 2023, which was $2.7 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Establishes]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> €1.5 billion Credit Facility (FIN_INST)",
        "€1.5 billion Credit Facility (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4186,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1727,
        "completion_tokens": 94,
        "total_tokens": 1822
      }
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "To determine the total revenue contribution of NVIDIA's Compute & Networking segment in fiscal year 2024, we consider that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, both attributable to the Compute & Networking segment. With total company revenue at $27 billion, the combined contribution is 13% + 19% = 32% of $27 billion, which equals $8.64 billion. Thus, the Compute & Networking segment contributed $8.64 billion in fiscal year 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Public Cloud Companies (COMP)",
        "Public Cloud Companies (COMP) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2714,
        "completion_tokens": 130,
        "total_tokens": 2845
      }
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG's Internal Capital Framework, a key component of its Risk Appetite Framework, supports the company's assessment of capital resources by quantifying aggregate economic risk at a given confidence interval while incorporating diversification benefits across risk factors and business lines. This framework works in conjunction with AIG's stress testing framework, which evaluates the company's exposure to significant financial and insurance risks under adverse scenarios. Together, these tools inform the determination of capital resources required at the consolidated level to maintain target capitalization levels and support subsidiaries, aligning with AIG's strategic objectives, regulatory requirements, and risk tolerances established by the Board of Directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Internal Capital Framework (ACCOUNTING_POLICY)",
        "Internal Capital Framework (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9608,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3085,
        "completion_tokens": 192,
        "total_tokens": 3277
      }
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Supply chain disruptions or failure to meet consumer demand for Target's owned brands—approximately one-third of its merchandise sales—could significantly impact its financial performance by increasing inventory markdowns, raising costs, and reducing profitability. As highlighted in the risk factors, owned brands typically require longer lead times and greater involvement in sourcing, making them more vulnerable to supply chain risks and demand forecasting errors. This can result in excess or insufficient inventory, both of which negatively affect inventory management and profitability. Additionally, because owned brands generally carry higher margins than national brands, any underperformance in these products could amplify the impact on Target's results of operations. Combined with the risk of inventory shrink and the importance of higher-margin merchandise in driving net earnings growth, disruptions in this area could hinder Target's ability to maintain or grow its profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Owned Brands (PRODUCT)",
        "Owned Brands (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8919,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2910,
        "completion_tokens": 249,
        "total_tokens": 3160
      }
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "The 2024 carrying value of NVDA's 3.50% Notes Due 2050 is $2,000 million, and the carrying value of the 3.50% Notes Due 2040 is $1,000 million. The difference in their carrying values is $1,000 million. These figures are derived from Chunk 2, which provides the expected remaining term, effective interest rate, and carrying amounts for each note as of January 28, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 3.50% Notes Due 2050 (FIN_INST)",
        "3.50% Notes Due 2050 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5045,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1891,
        "completion_tokens": 92,
        "total_tokens": 1984
      }
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future issuance under the 2020 Stock Incentive Plan and 16 million shares available under the ESPP, totaling 64 million shares. The 2020 Stock Incentive Plan allows for awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards, as detailed in the 2024 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9887,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3154,
        "completion_tokens": 110,
        "total_tokens": 3264
      }
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG employs the Expected Loss Ratio Methods, particularly the Bornhuetter Ferguson approach, to address the challenges of loss emergence volatility in U.S. Workers' Compensation, a line of business characterized by extremely long-tail loss development patterns. This method applies an expected loss ratio to earned premiums, providing a more stable estimate of reserves when reported loss data lacks credibility—such as in early stages of loss development or when large, anomalous losses distort loss development patterns. Given the long-tail nature and extended loss emergence of U.S. Workers' Compensation, which can span decades, the Bornhuetter Ferguson method helps mitigate overreaction to short-term volatility by balancing actual loss experience with prior expectations. This is especially valuable in managing the inherent uncertainty and delayed reporting associated with this line, where risk-sharing features like high deductibles and third-party administrators further complicate loss emergence patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8051,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2692,
        "completion_tokens": 254,
        "total_tokens": 2946
      }
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "The total number of amendments made to the Credit Card Program Agreement between Target Corporation and TD Bank USA, N.A. is two, as documented in the 10-K filings: the First Amendment dated February 24, 2015, and the Second Amendment dated November 19, 2019. This indicates that the financial partnership has evolved over time, with adjustments likely made to address changing business needs, regulatory requirements, or operational efficiencies in their co-branded credit card program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Credit Card Program Agreement (FIN_INST)",
        "Credit Card Program Agreement (FIN_INST) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15652,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4584,
        "completion_tokens": 121,
        "total_tokens": 4705
      }
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "FedEx spent a total of $855 million on business optimization activities related to Network 2.0 in 2023 and 2024 combined ($273 million in 2023 and $582 million in 2024). The primary purpose of these expenditures was to drive efficiency across transportation segments, reduce overhead and support costs, and transform digital capabilities as part of the DRIVE program and Network 2.0 initiative, which aims to optimize the end-to-end package delivery network in the U.S. and Canada.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Network 2.0 (PRODUCT)",
        "Network 2.0 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3456,
        "completion_tokens": 120,
        "total_tokens": 3576
      }
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The introduction of the ad-supported subscription plan, as part of Netflix's competitive strategy, introduces financial forecasting risks highlighted in the 2023 10-K filing. Specifically, the lack of operating history with this new pricing strategy makes it inherently difficult to predict consumer adoption and the resulting financial impact on revenues and operating margins. This uncertainty increases the risk that actual results may differ materially from forecasts, potentially leading to earnings misses or stock price declines. Additionally, the plan's success is tied to Netflix's ability to retain and attract members, which is already under pressure from competitive offerings and macroeconomic factors, further complicating financial projections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Ad-Supported Subscription Plan (PRODUCT)",
        "Ad-Supported Subscription Plan (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11803,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3608,
        "completion_tokens": 189,
        "total_tokens": 3798
      }
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023, as detailed in Chunk 2, was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage, such as Prevnar 20. This decision aligns with the patent expiration timeline for Prevnar 13, listed in Chunk 1, which shows U.S. patent expiration in 2026 and Japanese expiration in 2029, indicating a need to shift focus to newer, more comprehensive vaccines before market exclusivity diminishes. The impairment reflects Pfizer's strategic response to both patent expiration risks and competitive dynamics, as shown by the knowledge graph linking Pfizer (ORG) to Prevnar 13 (PRODUCT) and its impact on the company's financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Prevnar 13 (PRODUCT)",
        "Prevnar 13 (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9384,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3000,
        "completion_tokens": 193,
        "total_tokens": 3194
      }
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald's operational success is heavily reliant on its franchisees, as highlighted by the mutual dependency in the knowledge graph (MCD ↔ Franchisees). However, McDonald's does not consolidate franchisee-related entities in its financial statements because these entities generally qualify for scope exceptions under variable interest entity consolidation guidance, as stated in Chunk 1. This accounting treatment reflects that franchisees operate independently and are not considered part of McDonald's consolidated financial structure. Nevertheless, Chunk 2 underscores that the success of customer experience initiatives—such as digital engagement, delivery services, and drive-thru technologies—depends on Systemwide execution, including by franchisees. If franchisees fail to effectively implement these initiatives, it could lead to diminished customer satisfaction, reduced sales, and a loss of competitive advantage, thereby posing a significant risk to McDonald's overall business performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10517,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3291,
        "completion_tokens": 251,
        "total_tokens": 3542
      }
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG's adoption of the LDTI standard on January 1, 2021, resulted in a net decrease of $1,264 million to its beginning total equity as of that date. For the years ended December 31, 2022 and 2021, the consolidated financial statements were adjusted to reflect a $2 million decrease and a $983 million increase in net income, respectively, along with a $1,219 million increase in total equity as of December 31, 2022. These adjustments were driven by changes related to market risk benefits (MRBs) and the updated discount rate assumptions used to measure the liability for future policy benefits. The adoption involved significant management judgment and was subject to extensive audit procedures, including testing of assumptions and controls, as described in the audit report.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "AIG (ORG) -> LDTI Standard (REGULATORY_REQUIREMENT)",
        "LDTI Standard (REGULATORY_REQUIREMENT) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10915,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3392,
        "completion_tokens": 194,
        "total_tokens": 3586
      }
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "The increase in Gulfstream aircraft orders in 2021 positively impacted General Dynamics' cash flow from operating activities by driving higher customer deposits, as noted in Chunk 1. This contributed to cash provided by operating activities of $4.3 billion in 2021. According to Chunk 2, this cash flow represented 131% of net earnings, which aligns with the strong operating performance highlighted in the Consolidated Overview. The causal relationship between Gulfstream aircraft orders and operating cash flow is further reinforced by the KG triplets, which show a mutual dependency between GD and Gulfstream aircraft orders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GD (ORG) -> Gulfstream Aircraft Orders (PRODUCT)",
        "Gulfstream Aircraft Orders (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3339,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 157,
        "total_tokens": 1650
      }
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, supports the company's internal capital framework by providing granular, detailed risk data that feeds into the quantification of aggregate economic risk at a given confidence interval. This process captures material risks across business units and is complemented by an annual top-down risk assessment to ensure comprehensive risk coverage. These risk assessments enhance AIG's analytical models, which are used to measure and assess risks organization-wide, enabling the internal capital framework to account for diversification benefits between risk factors and business lines. This, in turn, informs the resources required at the AIG Parent level to support subsidiaries and maintain target capitalization levels, aligning with AIG's risk appetite and regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Risk Identification and Measurement Processes (ACCOUNTING_POLICY)",
        "Risk Identification and Measurement Processes (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9608,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3092,
        "completion_tokens": 231,
        "total_tokens": 3323
      }
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interacts with supply chain risks and demand forecasting challenges in several ways that could impact NVDA's financial performance. First, product transitions increase the complexity of managing demand and supply mix, as highlighted in Chunk 2, where inaccurate demand estimation can lead to inventory overprovisioning or shortages, both of which negatively affect gross margins and revenue. Additionally, Chunk 1 emphasizes that NVDA relies heavily on third-party suppliers and subcontractors for manufacturing and assembly, which limits direct control over production and exposes the company to risks such as capacity constraints, delays, and quality issues. These supply chain vulnerabilities, combined with the difficulty of forecasting demand for new products like the RTX 4080—especially in the presence of gray market resales and unpredictable use cases—can lead to financial impacts including inventory write-downs, price reductions, and potential loss of market share. Thus, while the RTX 4080 introduces a new product offering, the associated supply chain and demand forecasting challenges pose significant risks to NVDA’s financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> RTX 4080 (PRODUCT)",
        "RTX 4080 (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11972,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3642,
        "completion_tokens": 308,
        "total_tokens": 3950
      }
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "The Starbucks Rewards loyalty program impacts Starbucks' revenue recognition timing by deferring a portion of revenue when customers earn Stars, which are later redeemable for free products. As each Star is earned, the estimated selling price of the future reward is deferred as a liability in deferred revenue and recognized only upon redemption. This deferral affects the timing of revenue recognition, spreading it out over the period during which Stars are earned and subsequently redeemed, which typically expire after six months. Additionally, Starbucks' total advertising expense in fiscal 2022 was $416.7 million, as disclosed in the advertising section of the 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Starbucks Rewards (PRODUCT)",
        "Starbucks Rewards (PRODUCT) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7560,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2531,
        "completion_tokens": 170,
        "total_tokens": 2701
      }
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024 was an increase of $1,546 million ($4,406 million in 2024 minus $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under \"Interest and other expense, net.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Intercompany Loans and Forecasted Interest Payments (FIN_INST)",
        "Intercompany Loans and Forecasted Interest Payments (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1862,
        "completion_tokens": 83,
        "total_tokens": 1946
      }
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "The Total Marine Systems revenue increased by $547 million from 2020 ($9,979 million) to 2021 ($10,526 million). During the same period, Nuclear-powered submarines revenue increased by $179 million from 2020 ($6,938 million) to 2021 ($7,117 million). This indicates that the growth in Total Marine Systems revenue was significantly higher than the growth in Nuclear-powered submarines revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GD (ORG) -> Total Marine Systems (PRODUCT)",
        "Total Marine Systems (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 834,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 859,
        "completion_tokens": 98,
        "total_tokens": 957
      }
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "The dollar amount change in Mac sales from 2023 to 2024 is an increase of $627 million (from $29,357 million to $29,984 million), representing a 2% growth. In comparison, iPad sales decreased by $1,606 million (from $28,300 million to $26,694 million), reflecting a 6% decline over the same period. Thus, while Mac sales showed modest growth, iPad sales experienced a more significant decline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Mac (PRODUCT)",
        "Mac (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1374,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 971,
        "completion_tokens": 98,
        "total_tokens": 1069
      }
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The unfavorable volume/mix in the chocolate category in 2024 negatively impacted Mondelēz International's total net revenue growth, contributing to a 2.1 percentage point drag on the company's overall net revenue increase of $452 million (3.5%). This contrasts with the prior-year 2023, where chocolate contributed to a favorable volume/mix of 0.7 percentage points, supporting the 12.6% net revenue growth. The 2024 decline in chocolate volume was primarily due to customer price negotiation disruptions, offsetting gains in other categories like cheese & grocery and contributing to the overall weaker performance compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Chocolate (PRODUCT)",
        "Chocolate (PRODUCT) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6478,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2279,
        "completion_tokens": 160,
        "total_tokens": 2440
      }
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Apple's reliance on single-source suppliers and outsourcing partners in Asia, particularly for custom components, exposes it to significant supply chain risks, including initial capacity constraints that can delay product availability and disrupt operations. These constraints often arise when new technologies require suppliers to ramp up yields or expand manufacturing capacity, which can limit the timely availability of components. Given that a substantial portion of Apple's manufacturing is concentrated in a small number of outsourcing partners, often in single locations across China, India, and Southeast Asia, any disruption—whether due to financial instability, geopolitical tensions, or operational challenges—can directly impact Apple's ability to secure sufficient component supply. This, in turn, can lead to production delays, increased costs, and adverse effects on its business performance, as highlighted in both the supply chain risk disclosures and geographic operations details.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Initial Capacity Constraints (RISK_FACTOR)",
        "Initial Capacity Constraints (RISK_FACTOR) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9446,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3029,
        "completion_tokens": 250,
        "total_tokens": 3279
      }
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "In 2022, Disney reported $3,429 million in TV/SVOD distribution licensing revenue after factoring in the $1,023 million content license early termination fee. This represents a decrease from the previous year's TV/SVOD distribution licensing revenue of $5,266 million in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Content License Termination (RISK_FACTOR)",
        "Content License Termination (RISK_FACTOR) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3467,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 69,
        "total_tokens": 1601
      }
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Starbucks integrates its Mobile App with the Starbucks Rewards loyalty program to drive customer engagement and increase store visit frequency by offering a convenient payment method, enabling mobile ordering, and rewarding repeat purchases. According to the 2022 10-K, the Mobile App allows customers to access stored value cards, earn Stars through various payment methods, and place orders in advance for pick-up at participating locations, which enhances convenience and encourages more frequent visits. Additionally, the company's investments in digital innovation, such as Starbucks Now stores in China, further integrate physical and digital touchpoints, aligning with customer preferences for contactless and mobile-driven experiences. These strategies support Starbucks' goal of transforming the customer experience and fostering long-term growth through increased digital adoption and loyalty program participation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Starbucks Mobile App (PRODUCT)",
        "Starbucks Mobile App (PRODUCT) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5017,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1901,
        "completion_tokens": 231,
        "total_tokens": 2133
      }
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "The acquisition of Paidy, Inc. by PayPal in October 2021 resulted in Paidy being excluded from PayPal's 2021 internal control over financial reporting audit, as permitted by SEC guidance for newly acquired subsidiaries in their first year of ownership. This exclusion impacted the scope of the audit, as Paidy's internal controls were not assessed by management or the auditors. Paidy's total assets and revenues, excluding goodwill and intangibles, represented less than 1% of PayPal’s consolidated assets and revenues for the year ended December 31, 2021, indicating that its financial significance was below the materiality threshold for inclusion in the audit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Paidy,Inc. (COMP)",
        "Paidy,Inc. (COMP) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8546,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2788,
        "completion_tokens": 166,
        "total_tokens": 2954
      }
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "MDLZ's Latin America segment experienced only 0.6% operating income growth in 2024 despite pricing actions and cost controls, primarily due to volume/mix challenges in chocolate and refreshment beverages, as noted in Chunk 2. These challenges, driven by consumer softness in key markets like Mexico and Argentina, were exacerbated by unfavourable currency translation impacts and higher raw material costs. While higher net pricing and productivity-driven cost reductions helped offset some pressures, the negative impact of declining sales in chocolate and refreshment beverages—products produced by MDLZ (as per the KG triplet) — limited the overall growth in operating income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Chocolate (PRODUCT)",
        "Chocolate (PRODUCT) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6569,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2295,
        "completion_tokens": 169,
        "total_tokens": 2465
      }
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream's current product line holds a total of 270 city-pair speed records, and the G650ER is explicitly credited with leading this achievement, as it holds the National Aeronautic Association's polar and westbound around-the-world speed records.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GD (ORG) -> G600 (PRODUCT)",
        "G600 (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2110,
        "completion_tokens": 62,
        "total_tokens": 2172
      }
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded a total of $809 million in contingent consideration related to acquisitions in fiscal years 2024 and 2022, with $105 million recorded in 2024 for the Proteologix acquisition and $704 million in 2022 for the Abiomed acquisition. The Abiomed acquisition thus contributed $704 million, or the majority, of the total contingent consideration. The connection between JNJ and Abiomed is further supported by the knowledge graph, which confirms their business relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Abiomed (COMP)",
        "Abiomed (COMP) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3161,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 123,
        "total_tokens": 1558
      }
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "PayPal's sale of participation interests in merchant receivables under the PPWC and PPBL products affects the recognition of credit losses by derecognizing the portion of the asset for which control has been surrendered, with gains or losses on the sale being immaterial due to the carrying amount approximating fair value. Prior to January 1, 2020, credit losses were assessed based on the severity and duration of declines in value and the likelihood of recovery. With the adoption of CECL in 2020, credit losses are now estimated based on current expected credit losses, requiring an allowance for credit losses when the present value of expected cash flows is less than the amortized cost basis. This change impacts how credit losses are recognized for the remaining portion of receivables retained by PayPal, as these are now subject to forward-looking estimates under CECL.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Sells]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Receivables (FIN_INST)",
        "Merchant Receivables (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6617,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2325,
        "completion_tokens": 219,
        "total_tokens": 2545
      }
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The performance of the cheese & grocery product category negatively contributed to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, as it experienced declines, driven by consumer softness in key markets like Mexico and Argentina. This decline in volume and mix, along with similar issues in chocolate, candy, and refreshment beverages, led to an unfavorable volume/mix impact of 2.4 percentage points, despite favorable shifts in other categories like biscuits & baked snacks and gum. As a result, the segment operating income was negatively affected, with the unfavorable volume/mix partially offsetting the benefits of higher net pricing and cost efficiencies, leading to only a modest $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Cheese & Grocery (PRODUCT)",
        "Cheese & Grocery (PRODUCT) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6569,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2301,
        "completion_tokens": 198,
        "total_tokens": 2499
      }
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, as announced in October 2024 for issuance in Q1 2025, and the redemption value of the Mobility noncontrolling interests is $2,000 million, based on the $1,000 per interest for two million issued. Combined, these obligations total $4,250 million. Both instruments impose cash flow commitments through 2028, with the Telco Class A-4 callable starting November 1, 2028, and the Mobility noncontrolling interests subject to redemption or put options beginning March 15, 2028. These obligations will require significant cash outflows, potentially impacting AT&T’s liquidity and capital allocation decisions during that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "T (ORG) -> Telco Class A-4 (FIN_INST)",
        "Telco Class A-4 (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6590,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2299,
        "completion_tokens": 177,
        "total_tokens": 2477
      }
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "The total revenue generated from the Orthopaedics segment in 2024 is $9,158 million. Within this segment, the combined revenue from Hips and Knees is $1,638 million and $1,545 million, respectively, totaling $3,183 million. This means that the Hips and Knees sub-segments account for approximately 34.8% of the total Orthopaedics segment revenue in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Orthopaedics (PRODUCT)",
        "Orthopaedics (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7101,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2415,
        "completion_tokens": 88,
        "total_tokens": 2503
      }
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan's proportional adjustment mechanism, triggered by the 2024 special dividend, increased the number of RSU shares available for grant by 128,000, in line with the proportional adjustment of outstanding RSUs. This adjustment was calculated using the ratio of the Nasdaq closing price before the ex-dividend date to the opening price on the ex-dividend date (1.018), ensuring the value of awards was preserved without additional compensation expense. The 2019 Incentive Plan itself is formally documented in the Company's DEF 14 filing dated December 17, 2019, and the adjustment is detailed in the 2023 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "COST (ORG) -> 2019 Incentive Plan (ACCOUNTING_POLICY)",
        "2019 Incentive Plan (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7546,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2544,
        "completion_tokens": 159,
        "total_tokens": 2703
      }
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly impact Intel's 2025 product portfolio by increasing the proportion of processors built on this node, which offers a 20% performance-per-watt improvement over Intel 7. This shift supports the production of Intel Core Ultra processors and complements the production of Intel 3, which delivers an 18% performance-per-watt improvement over Intel 4 and is optimized for data center products like the Xeon 6 Scalable server processors. As Intel 3 moves to Ireland in 2025, production of Intel 18A—featuring gate-all-around transistors and backside power delivery—will begin for Panther Lake, Intel’s first client processors on this next-generation node, further enhancing performance and efficiency. Collectively, these transitions reflect Intel’s strategic shift in manufacturing and process technology to strengthen its competitive position in both client and data center markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Intel 4 (PRODUCT)",
        "Intel 4 (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12106,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3690,
        "completion_tokens": 244,
        "total_tokens": 3935
      }
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "The book value of AT&T's investment in DIRECTV was $0 at December 31, 2024, and $877 million at December 31, 2023, resulting in a $877 million decrease. This reduction occurred as cash receipts from DIRECTV exceeded AT&T's initial investment and cumulative equity in earnings, leading to a zero book value by the end of 2024. In comparison, AT&T deconsolidated Gigapower on May 12, 2023, and began accounting for it as an equity method investment, which is earlier than the timing of the change in the book value of the DIRECTV investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Gigapower (COMP)",
        "Gigapower (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2790,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 134,
        "total_tokens": 1480
      }
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is reflected in Johnson & Johnson's human capital reporting, as it has been included in the fiscal 2024 headcount, indicating its integration into the Company's employee and human capital management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Shockwave (COMP)",
        "Shockwave (COMP) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4515,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1769,
        "completion_tokens": 83,
        "total_tokens": 1852
      }
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The Optimized Application Experiences category increased by 11%, or $75 million, in fiscal 2022 compared to fiscal 2021, driven by growth in Cisco's ThousandEyes and Intersight offerings. This growth was partially offset by a decline in the AppDynamics offerings, which are produced by Cisco and were specifically noted as contributing to the decline within the category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> AppDynamics (PRODUCT)",
        "AppDynamics (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7937,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2641,
        "completion_tokens": 92,
        "total_tokens": 2734
      }
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T paid a total of $5,414 million to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption eliminated the noncontrolling interest related to the Mobility preferred interests from the consolidated balance sheets, as the interests were previously classified under \"Noncontrolling interest.\" The transaction also resulted in an adjustment to additional paid-in capital to reflect the difference between the carrying value and the fair value of the instrument upon settlement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6620,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2323,
        "completion_tokens": 134,
        "total_tokens": 2457
      }
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit, acquired by Johnson & Johnson in 2022, reported year-over-year revenue growth of 14.5% in fiscal 2024 compared to fiscal 2023. This growth was driven by the integration of Abiomed into J&J’s MedTech segment and its inclusion in the Cardiovascular segment. In comparison, the overall Cardiovascular segment grew by 21.4% year-over-year in the same period, with Electrophysiology contributing 12.3% growth and Other Cardiovascular contributing 6.9%. Thus, while Abiomed's growth was strong, it was slightly below the segment's overall performance, which was also fueled by the inclusion of Shockwave Medical and continued momentum in Electrophysiology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Abiomed (COMP)",
        "Abiomed (COMP) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7105,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2426,
        "completion_tokens": 169,
        "total_tokens": 2595
      }
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The 2022 10-K filing lists seven amendments to the Lowe's Companies Benefit Restoration Plan, as detailed in exhibits 10.4 through 10.9 and 10.1. The most recent amendment referenced is Amendment No. 7, which was filed on April 4, 2017.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Amends]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Benefit Restoration Plan (ACCOUNTING_POLICY)",
        "Benefit Restoration Plan (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 24332,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6738,
        "completion_tokens": 59,
        "total_tokens": 6797
      }
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount into its regulatory capital by January 1, 2024, as disclosed in Chunk 1. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital requirement of 10.0%, which includes the 5.5% stress capital buffer added to the minimum capital requirements, as outlined in Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> CECL Transition Rule (REGULATORY_REQUIREMENT)",
        "CECL Transition Rule (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 103,
        "total_tokens": 1751
      }
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney's use of time-based vesting Restricted Stock Unit (RSU) Award Agreements provides a fixed schedule for executives to vest in shares, typically over a multi-year period, which encourages long-term retention and alignment with shareholder interests through sustained employment. In contrast, Disney's performance-based vesting agreements, such as Performance-Based Restricted Stock Units (PRSUs), are tied to specific financial metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), directly linking executive compensation to the achievement of long-term financial goals that drive shareholder value. The prevalence of multiple PRSU agreements with three-year vesting periods and performance conditions in the provided exhibits indicates a stronger emphasis on aligning executive incentives with measurable outcomes that reflect long-term value creation, compared to the more passive retention focus of time-based RSUs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Restricted Stock Unit Award Agreement (Time-Based Vesting) (FIN_INST)",
        "Restricted Stock Unit Award Agreement (Time-Based Vesting) (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4161,
        "completion_tokens": 238,
        "total_tokens": 4399
      }
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "The Hips and Knees products contributed positively to the overall growth of the Orthopaedics segment in 2024 compared to 2023. Specifically, Hips revenue increased by 5.0% (from $1,560 million to $1,638 million), and Knees revenue grew by 6.1% (from $1,456 million to $1,545 million), driven by 5.6% and 6.5% operational growth, respectively. These strong performances supported the Orthopaedics segment's overall 2.4% revenue growth (from $8,942 million to $9,158 million) in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Knees (PRODUCT)",
        "Knees (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4120,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1659,
        "completion_tokens": 120,
        "total_tokens": 1779
      }
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Capital One added $2.4 billion to its regulatory capital under the CECL Transition Rule, with 75% ($1.8 billion) phased in by January 1, 2024, and the remaining $600 million phased in by January 1, 2025. This optional transition relief, as described in the rule, allows banking institutions like Capital One a five-year period to phase in the impact of the CECL standard on their regulatory capital, thereby mitigating the immediate effect on their capital ratios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> CECL Transition Rule (REGULATORY_REQUIREMENT)",
        "CECL Transition Rule (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4631,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1828,
        "completion_tokens": 116,
        "total_tokens": 1944
      }
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The issuance of $500 in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023 contributed to the financing activities by providing cash inflows, as noted in the 2024 financing activities section. However, in July 2024, the partial repayment of $77 of these Guaranteed Senior Notes, along with the repayment of the $1,000 Senior Notes in May 2024, resulted in cash outflows that increased net cash used in financing activities to $10,764 in 2024. These activities, combined with the use of Level 3 inputs for valuing the Guaranteed Senior Notes, likely influenced the decrease in the fair value of long-term debt from $5,738 in 2023 to $5,412 in 2024, reflecting the reduction in outstanding debt balances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6420,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2268,
        "completion_tokens": 181,
        "total_tokens": 2449
      }
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "Caterpillar does not disclose a specific total estimated environmental remediation liability for all sites, as it states that the amount recorded for environmental remediation is not material and is included in \"Accrued expenses.\" Regarding methodology, Caterpillar estimates costs for individual sites based on available data, including technologies, regulations, and prior experience, and accrues the minimum if no amount in a range is more likely. For multi-party sites, Caterpillar considers its proportionate share of the probable costs. Importantly, these estimates exclude any amounts expected to be recovered from insurance or other parties, and the company reassesses these accruals quarterly.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Remedial Activities (RISK_FACTOR)",
        "Remedial Activities (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7033,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2413,
        "completion_tokens": 175,
        "total_tokens": 2589
      }
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "The revenue for Cisco's 'Other Products' category decreased from $15 million in fiscal 2021 to $11 million in fiscal 2022, representing a 29% decline. This significant drop highlights the underperformance of this category. The company's updated reporting structure, introduced in fiscal 2022, reflects a strategic realignment to better focus on core and high-priority product areas, as stated in the 10-K, by categorizing revenue into segments that align with strategic priorities. This suggests a shift in emphasis away from underperforming categories like 'Other Products' toward more impactful business areas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Misc Products (PRODUCT)",
        "Misc Products (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2694,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 153,
        "total_tokens": 1490
      }
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The timing and frequency of amendments to executive employment agreements at Costco show a pattern of annual renewals for W. Craig Jelinek, with his agreement initially effective January 1, 2017, and subsequently extended each year on January 1, 2019, 2020, 2021, 2022, and 2023, as disclosed in filings from 2016 through 2022. In contrast, the agreement with Ron Vachris, effective January 1, 2024, appears to be a new executive employment agreement rather than an amendment or extension of a prior agreement, as indicated by its filing in late 2023. This suggests a shift in the executive employment strategy, with Jelinek's agreement being annually renewed over six years, while Vachris's agreement marks a new start without prior amendments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Enters_Into_Agreement]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Executive Employment Agreement (ACCOUNTING_POLICY)",
        "Executive Employment Agreement (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9460,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3044,
        "completion_tokens": 186,
        "total_tokens": 3231
      }
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net value of Customer Relationships decreased from $893 million on December 31, 2020, to $712 million on December 31, 2021, representing a decrease of $181 million. Meanwhile, the net value of Intellectual Property declined from $366 million to $280 million over the same period, a decrease of $86 million. This indicates that the decline in Customer Relationships was significantly larger than the decline in Intellectual Property during the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Weighted Amortizable Life (ACCOUNTING_POLICY)",
        "Weighted Amortizable Life (ACCOUNTING_POLICY) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2194,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 113,
        "total_tokens": 1326
      }
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "The total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022 is not explicitly provided in the given chunks, but the category is identified as one of the key product groups under Cisco’s revenue reporting structure. Regarding revenue recognition, for hardware and perpetual software in this category, revenue is recognized upfront upon transfer of control. In contrast, SaaS arrangements in this category are recognized ratably over the contract term, as they represent a single distinct performance obligation satisfied over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Secure Networks (PRODUCT)",
        "Secure Networks (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 141,
        "total_tokens": 1583
      }
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "Amazon's revenue from third-party seller fees in 2022 is not explicitly stated in the provided chunks; however, it is included within the broader category of \"Service sales,\" which encompasses third-party seller fees, AWS sales, advertising services, and Amazon Prime membership fees. The knowledge graph and textual information confirm that Amazon partners with third-party sellers, who in turn supply products through Amazon's platform, aligning with Amazon's stated business model of enabling sellers to grow their businesses. This revenue stream reflects Amazon's role as a facilitator, generating income through commissions and services while supporting sellers' growth, consistent with its mission to be customer- and seller-centric.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Third-Party Sellers (COMP)",
        "Third-Party Sellers (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3863,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 184,
        "total_tokens": 1801
      }
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "As of December 31, 2024, Capital One Financial Corp's Common Equity Tier 1 capital ratio is 13.5%, while the Minimum Capital Adequacy requirement for this metric is 4.5%. The difference between the two is 9.0 percentage points (13.5% - 4.5%). This highlights that Capital One significantly exceeds the regulatory minimum requirement, demonstrating a strong capital position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> Minimum Capital Adequacy (REGULATORY_REQUIREMENT)",
        "Minimum Capital Adequacy (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5462,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2025,
        "completion_tokens": 93,
        "total_tokens": 2119
      }
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Altria's $1.7 billion investment in JUUL as of 2021 faces significant regulatory risks, primarily stemming from the Federal Trade Commission's (FTC) challenge alleging antitrust violations related to the investment. This challenge could lead to resolutions such as divestiture or rescission of the transaction, which would directly threaten Altria's financial position and strategic objectives, including its long-term growth in the alternative nicotine category. Additionally, such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and reduce access to capital markets, further undermining its ability to achieve financial and strategic goals. These risks are compounded by broader challenges in attracting investors due to declining social acceptance of tobacco and ESG-related concerns, which could exacerbate financial and reputational impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> JUUL Investment (FIN_INST)",
        "JUUL Investment (FIN_INST) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6536,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2275,
        "completion_tokens": 223,
        "total_tokens": 2498
      }
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million Notes Due 2060 contribute to NVIDIA's potential adverse effects on financial flexibility by requiring future debt service obligations that could limit cash flow availability for operations, capital expenditures, acquisitions, and shareholder returns. As part of NVIDIA's $11 billion in long-term debt, these notes increase vulnerability to economic and market conditions and may necessitate refinancing at less favorable terms, which could negatively impact financial condition. Additionally, compliance with covenants and the risk of credit rating downgrades could restrict NVIDIA’s ability to access future financing, further constraining its strategic and operational flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Notes Due 2060 (FIN_INST)",
        "Notes Due 2060 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9281,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2992,
        "completion_tokens": 175,
        "total_tokens": 3167
      }
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The expanded FDA approval of Vemlidy for pediatric patients aged six years and older (weighing at least 25 kg) with chronic HBV infection broadens Gilead's market potential by extending treatment access to a younger patient demographic, complementing its existing HBV portfolio that includes Viread for patients as young as two years. This expansion strengthens Gilead’s competitive position in the HBV treatment landscape by offering a more comprehensive age-based treatment continuum, leveraging its established leadership in liver disease through products like Epclusa and Harvoni for HCV. The approval also enhances the therapeutic profile of Vemlidy, which is part of Gilead’s broader strategy to advance innovative treatments across its product portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Vemlidy (PRODUCT)",
        "Vemlidy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8647,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2806,
        "completion_tokens": 190,
        "total_tokens": 2997
      }
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "Lowe's installed sales, which include both product and labor, accounted for approximately 5% of total sales in fiscal 2023. These installed sales are offered in categories such as Appliances, Kitchens & Bath, Millwork, Appliances, and Lumber. Additionally, Lowe's extended protection plans cover products in categories including Appliances, Kitchens & Bath, Décor, Millwork, Rough Plumbing, Electrical, Seasonal & Outdoor Living, Tools, and Hardware. The specific product category explicitly mentioned in both the installed sales and extended protection plans is **Appliances**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Rough Plumbing (PRODUCT)",
        "Rough Plumbing (PRODUCT) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9475,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3025,
        "completion_tokens": 144,
        "total_tokens": 3170
      }
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "Capital One made the CECL Transition Election in Q1 2020, allowing it to phase in the impact of the CECL standard on its regulatory capital from 2020 through 2024. Under the CECL Transition Rule, the 'day 1' impact was added back to regulatory capital during 2020–2021, and the 'day 2' ongoing impact was phased in at 25% annually from 2022 to 2024. As a Category III institution subject to PCA capital regulations and Basel III rules, the 25% scaling factor applied to the 'day 2' impact over three years (2022–2024) results in a cumulative 75% phased-in reduction of the CECL-related capital charge by the end of 2024. This election helps mitigate the immediate capital reduction from higher CECL allowances while aligning with regulatory capital requirements and stress capital buffer rules.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> PCA Capital Regulations (REGULATORY_REQUIREMENT)",
        "PCA Capital Regulations (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_204",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9316,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2999,
        "completion_tokens": 198,
        "total_tokens": 3198
      }
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "In 2021, Altria's cost of sales was impacted by $4.3 billion in charges related to its obligations under the State Settlement Agreements and FDA user fees. However, this was partially offset by $21 million in recoveries recorded as a reduction to cost of sales from the 2004 NPM Adjustment. Thus, the net financial impact on cost of sales was approximately $4.298 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> State Settlement Agreements (REGULATORY_REQUIREMENT)",
        "State Settlement Agreements (REGULATORY_REQUIREMENT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13211,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3951,
        "completion_tokens": 93,
        "total_tokens": 4044
      }
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "Following the freeze of U.S. pension benefits in 2019, Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased from $554 million in 2020 ($63 million + $491 million) to $605 million in 2021 ($67 million + $538 million), representing an increase of $51 million. This change is disclosed in the context of postemployment benefit plans and reflects the ongoing impact of the 2019 pension freeze on related liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Pension Benefits Frozen (RISK_FACTOR)",
        "Pension Benefits Frozen (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1207,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 961,
        "completion_tokens": 121,
        "total_tokens": 1083
      }
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1,688 million, calculated by summing the estimated expenses: $585 million (2023), $461 million (2024), $405 million (2025), $121 million (2026), $16 million (2027), and $121 million (2028 and thereafter). The $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development (IPR&D) project is not included in these amortization estimates, as it is not currently amortized but instead subject to annual impairment testing. However, if the project reaches technological feasibility, it will then be amortized over its estimated useful life, which could impact future amortization expenses beyond the 2023–2028 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Mellanox (COMP)",
        "Mellanox (COMP) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2949,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 197,
        "total_tokens": 1600
      }
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "The combined U.S. and EU patent expiration year for Biktarvy is 2033 in both jurisdictions, as indicated in Chunk 1. Additionally, Chunk 2 reveals that the FDA approved an expanded indication for Biktarvy to treat people with HIV who have M184V/I resistance, which broadens its market applicability. This expanded approval can potentially extend the product’s market exclusivity by enhancing its competitive differentiation and delaying generic competition, even as the core patent expires in 2033.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6314,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2227,
        "completion_tokens": 124,
        "total_tokens": 2351
      }
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve's supervisory stress testing modeling directly impacts Capital One Financial Corporation's (COF) ability to return capital to stockholders by influencing the perceived capital adequacy under stress scenarios. If the Federal Reserve's modeling indicates a lower capacity to maintain capital levels under stress, it could lead to restrictions on COF's ability to pay dividends and repurchase shares. This limitation is reinforced by the Dodd-Frank Act's requirement that bank holding companies serve as a source of financial strength to their subsidiary banks, which ties COF's capital actions to the regulatory capital needs of its subsidiaries and the broader stability of the financial system.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> General Federal Regulatory Oversight (REGULATORY_REQUIREMENT)",
        "General Federal Regulatory Oversight (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10841,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3394,
        "completion_tokens": 178,
        "total_tokens": 3572
      }
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined was $12.9 billion ($4.2 billion in 2019 + $4.4 billion in 2020 + $4.3 billion in 2021). The maximum potential NPM Adjustment for 2020 alone was $572 million. Thus, the combined payments significantly exceed the maximum potential NPM Adjustment for 2020 by approximately $3.8 billion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> State Settlement Agreements (REGULATORY_REQUIREMENT)",
        "State Settlement Agreements (REGULATORY_REQUIREMENT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12971,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3911,
        "completion_tokens": 102,
        "total_tokens": 4014
      }
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The fair value of the 2.85% Notes Due 2030 as reported in the first table (Chunk 1) for the fiscal year ending January 30, 2022, is $1,542 million. The second table (Chunk 2) discloses the net carrying amount of the same notes as $1,500 million for the same fiscal year. The difference between the fair value and the net carrying amount is $42 million ($1,542 million - $1,500 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 2.85% Notes Due 2030 (FIN_INST)",
        "2.85% Notes Due 2030 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5875,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2129,
        "completion_tokens": 96,
        "total_tokens": 2225
      }
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is subject to a tailored application of capital requirements, which excludes certain elements of Accumulated Other Comprehensive Income (AOCI) from regulatory capital, as permitted for institutions in its category. This exclusion can positively impact COF’s capital ratios by allowing it to maintain a cleaner capital base. Additionally, COF is subject to the Stress Capital Buffer Rule, which replaces the fixed 2.5% capital conservation buffer with an institution-specific buffer determined annually based on supervisory stress test results. This buffer is recalibrated each year and forms part of COF’s standardized approach capital conservation buffer, which also includes the countercyclical capital buffer (currently 0%) and any G-SIB Surcharge (which does not apply to COF). Thus, the Tailoring Rules and the Stress Capital Buffer Rule together influence COF’s capital requirements by customizing and recalibrating buffers while allowing AOCI exclusions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> Tailoring Rules (REGULATORY_REQUIREMENT)",
        "Tailoring Rules (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7452,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2538,
        "completion_tokens": 264,
        "total_tokens": 2803
      }
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "The total change in the fair value of Altria's JUUL investment from 2020 to 2021 was $0, as the value remained at $1,705 million in both years. This is reflected in Altria's consolidated financial statements under \"investments in equity securities\" on the consolidated balance sheets for both December 31, 2021, and 2020. Additionally, since Altria elected the fair value option for its JUUL investment following the share conversion in 2020, any changes in fair value are included in (income) losses from equity investments in the consolidated statements of earnings (losses). However, as no change in fair value occurred between 2020 and 2021, there was no impact on earnings during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> JUUL Investment (FIN_INST)",
        "JUUL Investment (FIN_INST) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6879,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2361,
        "completion_tokens": 174,
        "total_tokens": 2535
      }
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Union Pacific (UNP) has a total of 7,154 locomotives, of which 1,037 are leased, representing approximately 14.5% of the total fleet. All of the 132 switching locomotives in their fleet are owned, meaning none of the switching locomotives are leased. This highlights that leased locomotives are primarily used for multiple-purpose operations rather than switching activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Leases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Total Locomotives (PRODUCT)",
        "Total Locomotives (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1004,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 892,
        "completion_tokens": 93,
        "total_tokens": 986
      }
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 on January 30, 2022, as disclosed in the fair value table (Chunk 1). This reflects the full repayment or redemption of the notes by the end of the 2022 fiscal year. In the debt-specific maturity and interest rate table (Chunk 2), the January 30, 2022, carrying amount for the 2.20% Notes is $0, consistent with the fair value disclosure, while the January 31, 2021, amount is listed as $1,000 million, closely aligning with the fair value of $1,011 million. This change indicates the notes were fully settled during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 2.20% Notes Due 2021 (FIN_INST)",
        "2.20% Notes Due 2021 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5875,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2127,
        "completion_tokens": 156,
        "total_tokens": 2284
      }
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impacts Capital One's supplementary leverage ratio by reducing the denominator—total leverage exposure—thereby increasing the ratio. This adjustment was made in accordance with an interim final rule issued by the Federal Reserve, as outlined in the 2020 10-K filing. The regulatory framework influencing this adjustment is the Supplementary Leverage Ratio Rule, to which Capital One Financial Corporation (COF) complies, as shown in the knowledge graph relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> Supplementary Leverage Ratio Rule (REGULATORY_REQUIREMENT)",
        "Supplementary Leverage Ratio Rule (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4593,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1829,
        "completion_tokens": 140,
        "total_tokens": 1969
      }
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was **$3,209 million**, as shown in the \"Significant Other Observable Inputs (Level 2)\" column of Chunk 1. These Level 2 assets included **Federal Government Securities ($1,508 million)** and **Bonds and Debentures ($1,696 million)**, both of which were valued using a bid evaluation process with bid data provided by independent pricing sources, as described in Chunk 2. The knowledge graph confirms the connection between Union Pacific (UNP) and the financial instruments \"Bonds and Debentures,\" supporting the valuation methodology applied.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Bonds and Debentures (FIN_INST)",
        "Bonds and Debentures (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7720,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2567,
        "completion_tokens": 160,
        "total_tokens": 2727
      }
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "NVIDIA Omniverse is mentioned in the 10-K filing as a real-time 3D design collaboration and virtual world simulation software used in automotive applications such as virtual car showrooms and simulation workflows for autonomous vehicle development. Its integration with the NVIDIA DRIVE platform supports NVIDIA's end-to-end AI computing strategy by enabling simulation and collaboration for AV development, complementing the DRIVE Hyperion platform’s capabilities in perception, planning, and control. This full-stack approach, from training neural networks using GPUs to deploying AI in vehicles and enabling real-time simulation and updates, reinforces NVIDIA’s vision of a software-defined, continuously evolving autonomous driving ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Omniverse (PRODUCT)",
        "Omniverse (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11907,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3621,
        "completion_tokens": 186,
        "total_tokens": 3808
      }
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "To calculate the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, we use the data from Chunk 2:\n\n- In 2022, Converse contributed $2,346 million to total revenues of $46,710 million, or 5.02%.\n- In 2023, Converse contributed $2,427 million to total revenues of $51,217 million, or 4.74%.\n- The percentage change in contribution is (4.74% - 5.02%) / 5.02% = -5.58%.\n\nFor Converse's operating income, also from Chunk 2:\n\n- In 2022, operating income was $669 million.\n- In 2023, operating income was $676 million.\n- The percentage change in operating income is (676 - 669) / 669 = 1.05%.\n\nThus, while Converse's contribution to total revenues decreased by 5.58%, its operating income increased slightly by 1.05% from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Converse (COMP)",
        "Converse (COMP) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8444,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2758,
        "completion_tokens": 193,
        "total_tokens": 2951
      }
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The changes to the TDR accounting guidance impacted the classification of trial modifications in both the residential real estate and credit card loan portfolios by eliminating the \"reasonably expected\" and \"concession assessment\" criteria. As a result, trial modifications were classified as TDRs but not as Fully Debt Modifications (FDMs) for the year ended December 31, 2023. Specifically, $69 million of residential real estate loans and $27 million of credit card loans were subject to trial modifications under this new guidance, which marked a shift from prior periods where these modifications were not classified as TDRs unless permanently modified. This change affected the reported TDR figures for both portfolios, with residential real estate TDRs at $136 million and credit card TDRs at $648 million for 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> TDR Accounting Guidance (ACCOUNTING_POLICY)",
        "TDR Accounting Guidance (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3408,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 205,
        "total_tokens": 1719
      }
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "As of December 31, 2023, Union Pacific had 245,107 retention shares and stock units outstanding under the 2013 Stock Incentive Plan and 1,059,344 retention shares and stock units outstanding under the 2021 Stock Incentive Plan, totaling **1,304,451 retention shares and units**. In comparison, the Directors Plan had **16,000 restricted shares** outstanding on the same date, indicating that the number of retention shares and units under the employee incentive plans significantly exceeds the restricted shares under the Directors Plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Retention Shares (FIN_INST)",
        "Retention Shares (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6035,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2171,
        "completion_tokens": 134,
        "total_tokens": 2305
      }
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "As of December 28, 2024, the total amount of AMD's investment in the ATMP JV was $249 million, which includes the carrying value of its equity investment of $149 million and the $100 million secured loan it provided to the JV on October 9, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4556,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1779,
        "completion_tokens": 61,
        "total_tokens": 1840
      }
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation includes a **gain on disposition of $451 million**, a **foreign currency translation adjustment loss of $109 million**, and **IPO and Separation-related costs of $69 million**. These components collectively reflect the net financial outcome of the Envista Disposition in 2019, as detailed in the provided disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Envista Holdings Corporation (COMP)",
        "Envista Holdings Corporation (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11308,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3488,
        "completion_tokens": 102,
        "total_tokens": 3590
      }
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, significantly contributed to a 30% decrease in reported EBIT for the segment. This decline was exacerbated by a 130 basis point gross margin contraction, primarily due to unfavorable foreign currency exchange rates, as outlined in the centrally managed foreign exchange risk management program described in Chunk 1. The unfavorable exchange rates increased costs, further squeezing profitability alongside lower average selling prices and reduced traffic in key markets. Thus, both the revenue drop and margin compression had a compounding negative impact on Converse’s EBIT performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Converse (COMP)",
        "Converse (COMP) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5248,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1975,
        "completion_tokens": 171,
        "total_tokens": 2147
      }
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses by December 31, 2023, as the changes eliminated the TDR reasonably expected and concession assessment criteria, leading to the reclassification of trial modifications and Chapter 7 loans as TDRs but not FDMs. This reclassification, combined with a net addition of $3.1 billion to the allowance for credit losses overall, including $1.9 billion in consumer and $675 million in wholesale, reflected an improved outlook for home prices and reduced borrower uncertainty, while also incorporating macroeconomic scenario updates. The changes improved the Firm's financial position by reducing the reserve requirement for certain modified loans, thereby enhancing capital efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> TDR Accounting Guidance (ACCOUNTING_POLICY)",
        "TDR Accounting Guidance (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4722,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1861,
        "completion_tokens": 207,
        "total_tokens": 2068
      }
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million, as shown in the \"Total plan assets at fair value\" row under \"Significant Other Observable Inputs (Level 2)\" in Chunk 2. The specific investment categories that use bid evaluation with independent pricing sources as their valuation methodology are Federal Government Securities, Bonds and Debentures, and Preferred Stock, as described in Chunk 1.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Federal Government Securities (FIN_INST)",
        "Federal Government Securities (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7822,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2612,
        "completion_tokens": 107,
        "total_tokens": 2719
      }
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "To analyze the growth rates, we calculate the compound annual growth rate (CAGR) for both the \"Research and medical products\" segment and DHR's total revenue from 2019 to 2021. The segment revenue grew from $13,512 million in 2019 to $24,802 million in 2021, resulting in a CAGR of approximately 32.6%. Meanwhile, DHR's total revenue increased from $17,911 million to $29,453 million over the same period, yielding a CAGR of approximately 26.7%. This suggests that the \"Research and medical products\" segment outperformed the company's overall revenue growth, playing a significant and increasingly dominant role in driving DHR's financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Research and medical products (PRODUCT)",
        "Research and medical products (PRODUCT) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1840,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 163,
        "total_tokens": 1294
      }
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, reduced JPMorgan's allowance for credit losses by $587 million during the year ended December 31, 2023. Additionally, the revised guidance impacted the classification of trial modifications for credit card loans, such that trial modifications were considered TDRs but not FDMs, resulting in $27 million of loans being subject to trial modification during the year. This change marked a shift from the prior year, where credit card TDRs were $418 million, and it reflects the elimination of the TDR reasonably expected and concession assessment criteria under the new guidance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> TDR Accounting Guidance (ACCOUNTING_POLICY)",
        "TDR Accounting Guidance (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5236,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1981,
        "completion_tokens": 162,
        "total_tokens": 2143
      }
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "3M's adoption of a new accounting principle in the first quarter of 2021 for determining net periodic pension and postretirement plan cost impacted the presentation of pension-related financial metrics by changing the method used to calculate the market-related value of fixed income securities from the calculated value approach to the fair value approach. This change resulted in a more current reflection of asset gains or losses in the expected return on plan assets and the amortization of net unamortized actuarial gains or losses, aligning these components more closely with the funded status of the plans. Applied retrospectively to all periods presented, the change affected previously reported net periodic benefit cost, non-operating other expense (income), net income, earnings per share, and other comprehensive income, while having no impact on consolidated operating income or operating cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Accounting Principle (ACCOUNTING_POLICY)",
        "Accounting Principle (ACCOUNTING_POLICY) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10024,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3173,
        "completion_tokens": 228,
        "total_tokens": 3401
      }
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a reduction of JPMorgan's allowance for credit losses by $587 million in 2023. This change eliminated the criteria for assessing whether a TDR was \"reasonably expected\" and whether concessions were made, leading to trial modifications being classified as TDRs but not as FDMs. This shift affected the calculation of credit loss estimates, particularly in the credit card portfolio, where TDRs increased from $418 million in 2022 to $648 million in 2023 due to normalized delinquencies, contributing to the overall impact on the allowance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> TDR Accounting Guidance (ACCOUNTING_POLICY)",
        "TDR Accounting Guidance (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5236,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1961,
        "completion_tokens": 154,
        "total_tokens": 2116
      }
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "In 2023, Colgate-Palmolive's Africa/Eurasia region experienced a decrease in goodwill from $107 million at the beginning of the year to $88 million, primarily due to a $19 million negative impact from foreign currency translation. The operating profit for the region was $254 million. In comparison, the capital expenditures in the same region were relatively low at $10 million for 2023. Thus, while the region contributed meaningfully to operating profit, its capital expenditures were minimal, and the goodwill was negatively affected by foreign exchange movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Eurasia (GPE)",
        "Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4312,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1727,
        "completion_tokens": 142,
        "total_tokens": 1869
      }
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The 2021 business segment reporting changes at 3M resulted in adjustments to the reporting unit structure, which directly impacted the goodwill reporting framework. To address this, 3M applied the relative fair value method to assess the impact of these changes on goodwill, finding the results to be immaterial. Additionally, in conjunction with the reporting changes, 3M conducted a goodwill impairment assessment and concluded that no impairment existed. The Company also performed its annual goodwill impairment test in the fourth quarter of 2021, reaffirming that no impairment was necessary, indicating that the changes in reporting structure did not introduce material impairment risk to 3M’s goodwill.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Changes]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Business Segment Reporting (ACCOUNTING_POLICY)",
        "Business Segment Reporting (ACCOUNTING_POLICY) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5459,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2019,
        "completion_tokens": 177,
        "total_tokens": 2196
      }
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD's strategic rationale for acquiring Silo AI was to accelerate the deployment and development of AI models and software solutions on its hardware, leveraging Silo AI's workforce and expertise in AI. The $665 million all-cash acquisition, with $577 million allocated to goodwill, underscores AMD's commitment to enhancing its AI capabilities. This investment aligns with AMD's broader goals of strengthening its position in the AI market and supporting its Data Center segment through advanced software development and model deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Silo AI (COMP)",
        "Silo AI (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1788,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1079,
        "completion_tokens": 134,
        "total_tokens": 1214
      }
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "The Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology, effective as of September 2, 2014, underwent six amendments between September 2, 2014, and September 1, 2015. These amendments, numbered from the First through the Sixth, were filed with effective dates ranging from October 31, 2014, to September 1, 2015, as detailed in the exhibits from Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Triex Module Technology (PRODUCT)",
        "Triex Module Technology (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8892,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2871,
        "completion_tokens": 99,
        "total_tokens": 2970
      }
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The timing of PM's acquisition of Swedish Match on November 11, 2022, impacted its operational reporting scope in the 2023 10-K by including Swedish Match's results only from the acquisition date through December 31, 2022, meaning the full-year results for 2023 were not consolidated for the entire year. Additionally, the separate shipment volume commentary for Swedish Match suggests that the business is still being managed and evaluated independently from PM's geographical segments, indicating that full integration had not yet been achieved by the 2023 reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PM (ORG) -> Swedish Match (COMP)",
        "Swedish Match (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 527,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 779,
        "completion_tokens": 144,
        "total_tokens": 923
      }
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million, as disclosed in both chunks. These swaps were designed to hedge $500 million and $300 million of the $1.0 billion and $650 million principal amount of fixed-rate notes due in 2049 and 2050, respectively. Thus, the swaps collectively hedged $800 million of the combined $1.65 billion principal amount of these notes, representing a partial hedge of the total fixed-rate debt exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Interest Rate Swap 4 (FIN_INST)",
        "Interest Rate Swap 4 (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4182,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1705,
        "completion_tokens": 119,
        "total_tokens": 1824
      }
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "The total consideration transferred by AbbVie for the acquisition of Allergan was $64,084 million, and for Soliton, Inc., it was $535 million, resulting in a combined total consideration of $64,619 million. Of this combined amount, the cash payments totaled $39,675 million for Allergan and $535 million for Soliton, summing to $40,210 million attributed to cash.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Allergan (COMP)",
        "Allergan (COMP) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 90,
        "total_tokens": 1670
      }
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute the $25 billion stock repurchase program authorized in 2024, as the Corporation must maintain minimum capital ratios, including a 2.5% capital conservation buffer under Basel 3, to avoid restrictions on capital distributions. As of December 31, 2024, Bank of America’s CET1 capital ratio under the Standardized approach was 11.9%, exceeding the 10.7% requirement, indicating sufficient capital to support the repurchase program. Additionally, the Corporation must maintain a supplementary leverage ratio (SLR) of 6.0% to be considered well capitalized under the PCA framework, and its subsidiaries exceeded this threshold, further supporting its ability to repurchase shares. The stock repurchase program, however, remains subject to ongoing evaluation of capital position, regulatory requirements, and market conditions, as outlined in the 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Basel 3 (REGULATORY_REQUIREMENT)",
        "Basel 3 (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7512,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2525,
        "completion_tokens": 239,
        "total_tokens": 2764
      }
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048, as reported in the MMM 2022 10-K filing, is $1,287 million. This is calculated by summing the 2021 carrying value of $649 million for the 2023 maturity and $638 million for the 2048 maturity, as shown in both chunks provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Medium-term Note ($650 million) (FIN_INST)",
        "Medium-term Note ($650 million) (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15930,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4632,
        "completion_tokens": 81,
        "total_tokens": 4713
      }
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "The 2.900% Notes due 2030 have an interest rate of 2.900%, while the highest-yielding debt instrument listed in IBM's 2024 10-K is the 7.125% Debentures due 2096. The difference in interest rates between these two instruments is 4.225% (7.125% - 2.900%).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues_Financial_Instrument]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 2.900% Notes due 2030 (FIN_INST)",
        "2.900% Notes due 2030 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6961,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2386,
        "completion_tokens": 63,
        "total_tokens": 2449
      }
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $39,675 million in cash consideration paid to Allergan shareholders, $23,979 million in fair value of AbbVie common stock issued, and $430 million in fair value of AbbVie equity awards issued to Allergan equity award holders. As part of the acquisition, AbbVie also acquired $453 million in right-of-use assets related to lease obligations assumed from Allergan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Allergan (COMP)",
        "Allergan (COMP) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1044,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 903,
        "completion_tokens": 115,
        "total_tokens": 1018
      }
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new awards and deferrals, as stated in the filing, which also notes that participants can no longer make new deferrals or receive new stock awards under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Norwest Corporation Directors' Formula Stock Award Plan (ACCOUNTING_POLICY)",
        "Norwest Corporation Directors' Formula Stock Award Plan (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7026,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2442,
        "completion_tokens": 104,
        "total_tokens": 2546
      }
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The amortization of intangible assets associated with the Allergan acquisition increased AbbVie's amortization expense in 2021, which had a negative impact on its gross margin, as noted in Chunk 2, where it is stated that higher amortization of intangible assets from the Allergan acquisition partially offset the gross margin improvement. The total amortization expense for definite-lived intangible assets in 2021 was $7.7 billion, as reported in Chunk 1.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Allergan (COMP)",
        "Allergan (COMP) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1603,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1051,
        "completion_tokens": 114,
        "total_tokens": 1165
      }
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The specific purpose of the Restoration Plans, as disclosed in The Home Depot's 2023 10-K, is to provide certain associates with deferred compensation that they would have otherwise received under the Benefit Plans as a matching contribution, but for the maximum compensation limits imposed by the Internal Revenue Code. To fund these Restoration Plans, The Home Depot contributes to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Invests_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> Restoration Plans (ACCOUNTING_POLICY)",
        "Restoration Plans (ACCOUNTING_POLICY) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1917,
        "completion_tokens": 122,
        "total_tokens": 2039
      }
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024, resulting in a 0% change. Over the same period, total borrowings increased from $20,443 million to $31,099 million, reflecting a significant rise of $10,656 million, or 52.1%. This increase in total borrowings is primarily driven by growth in Fixed Rate Notes, Commercial Paper, and the addition of the Term Loan in 2024, while the Variable Rate Notes remained constant.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> Variable Rate Notes (FIN_INST)",
        "Variable Rate Notes (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1698,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1076,
        "completion_tokens": 120,
        "total_tokens": 1197
      }
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,720 million. This is calculated by summing the carrying amount of the 4.95% Senior Notes due September 2026, which is $744 million (as shown in Chunk 2), and the 4.95% Senior Notes due September 2052, which is $980 million (also from Chunk 2). Chunk 1 provides context on the issuance of the 4.95% Senior Notes due 2026, confirming the $750 million principal amount, while Chunk 2 provides the specific carrying amounts as of January 28, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> 4.95% Senior Notes (FIN_INST)",
        "4.95% Senior Notes (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11814,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3597,
        "completion_tokens": 141,
        "total_tokens": 3738
      }
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "PM experienced a 45.7% decrease in its net derivative asset position from 2022 to 2023, calculated as ($186 - $101) / $186. This decline aligns with the reduction in the total gross amount of derivative contracts, which decreased from $873 million in 2022 to $584 million in 2023, indicating a contraction in the overall derivative exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PM (ORG) -> Total Gross Amount Derivatives Contracts (FIN_INST)",
        "Total Gross Amount Derivatives Contracts (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10332,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3242,
        "completion_tokens": 85,
        "total_tokens": 3327
      }
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31, 2024, the total number of shares available for future issuance under the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors is 27,143,929 and 775,398, respectively, for a combined total of 27,919,327 shares. In comparison, the number of shares of Common Stock to be issued for options and RSUs under these plans includes 10,221,113 shares for options and RSUs under the 2016 Stock Incentive Plan, and 129,854 shares for options and RSUs under the 2016 Stock Plan for Non-Employee Directors, totaling 10,350,967 shares. This indicates that significantly more shares are available for future issuance than are currently allocated for outstanding awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> 2016 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2016 Stock Incentive Plan (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6905,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2413,
        "completion_tokens": 174,
        "total_tokens": 2587
      }
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "In fiscal year 2022, Dynamics 365 revenue grew by 39%, which was a key driver behind the 25% overall growth in Dynamics products and cloud services revenue. This strong performance highlights the increasing adoption of Microsoft's integrated cloud-based business solutions, contributing significantly to the broader cloud services growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Dynamics 365 (PRODUCT)",
        "Dynamics 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8007,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2641,
        "completion_tokens": 86,
        "total_tokens": 2728
      }
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, with the deployment of Megapack being a primary driver of this growth. The Megapack, a large-scale energy storage solution designed for commercial, industrial, and utility customers, plays a central role in Tesla's energy storage product portfolio by replacing the older Powerpack and enabling larger installations with gigawatt-hour capacity. This shift underscores Tesla's strategic focus on scaling its energy storage offerings to meet broader market demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Megapack (PRODUCT)",
        "Megapack (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4531,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1786,
        "completion_tokens": 142,
        "total_tokens": 1928
      }
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda in fiscal 2021 and 2022, comprising an estimated pre-tax loss of $5.5 billion in the fourth quarter of fiscal 2021 and an incremental pre-tax loss of $0.2 billion in the first quarter of fiscal 2022. The $5.5 billion loss in fiscal 2021 included $2.3 billion of accumulated pension components tied to the Asda pension plan, which were included in the disposal group. This reflects the significant financial impact of pension-related obligations on the overall loss, as the derecognition of these obligations directly contributed to the initial loss estimate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Deconsolidates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Asda (COMP)",
        "Asda (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3784,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 162,
        "total_tokens": 1777
      }
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "To determine the percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 represented by the combined revenue from Surface devices and Windows OEM licensing, we start with the total segment revenue of $56.5 billion. Windows OEM licensing contributed 42% of the segment's revenue, which is $56.5 billion × 0.42 = $23.73 billion. The Surface devices are part of the Devices category under the More Personal Computing segment, but no specific revenue figure for Surface is provided. Therefore, the percentage represented by Windows OEM licensing alone is 42%, and the contribution from Surface devices cannot be quantified without additional data from the chunks provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Surface (PRODUCT)",
        "Surface (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7683,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2589,
        "completion_tokens": 174,
        "total_tokens": 2764
      }
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "The total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale includes a $1.0 billion cash contribution made by Asda to the pension plan in fiscal 2020, which eliminated future obligations under the plan, and $2.3 billion in accumulated pension components included in the disposal group upon the sale of Asda. These pension components were part of the financial adjustments recognized during the sale process, with the estimated pre-tax loss related to these components recorded in fiscal 2021. Together, these amounts reflect the comprehensive pension-related financial impact tied to the Asda transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Asda (COMP)",
        "Asda (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2092,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 171,
        "total_tokens": 1368
      }
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The value of pre-owned aircraft inventories increased by $8 million (from $15 million on December 31, 2023, to $23 million on December 31, 2024). The company values these pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "GD (ORG) -> Pre-Owned Aircraft (PRODUCT)",
        "Pre-Owned Aircraft (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1173,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 943,
        "completion_tokens": 65,
        "total_tokens": 1009
      }
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The 3% increase in Xbox content and services revenue is closely tied to the growth in Xbox Game Pass's curated game library, which provides access to over 100 first- and third-party titles, enhancing user engagement and retention. This expansion reflects Microsoft's broader strategic investments in redefining gaming experiences, including cloud gaming and cross-device accessibility, as outlined in their focus on pushing the boundaries of innovation in console and PC gaming. Additionally, Microsoft's acquisitions, such as ZeniMax Media and the pending Activision Blizzard deal, underscore its commitment to strengthening its content portfolio, which directly supports the performance of the Xbox gaming segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Xbox Game Pass (PRODUCT)",
        "Xbox Game Pass (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9064,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2926,
        "completion_tokens": 179,
        "total_tokens": 3105
      }
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "Eli Lilly recognized revenue in 2023 specifically from the sale of rights for the olanzapine portfolio, which is included in the Zyprexa revenue line and is explicitly noted in Chunk 1 as part of the July 2023 transaction. This transaction is also explicitly categorized under the broader \"collaborations and other revenue\" category, as detailed in Chunk 2, which states that the 2023 sales of rights for the olanzapine portfolio are included in collaboration and other revenue, alongside revenue from the Boehringer Ingelheim collaboration and the sale of rights for Baqsimi. While the exact dollar amount from the olanzapine portfolio sale is not specified in the provided text, its inclusion in both Zyprexa revenue and the collaborations and other revenue category highlights its significance in Lilly’s 2023 financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Olanzapine Portfolio (PRODUCT)",
        "Olanzapine Portfolio (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1826,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 208,
        "total_tokens": 1323
      }
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "Tesla's 5.45% Solar Bonds, issued through SolarCity and evidenced by multiple Supplemental Indentures in late 2015 and early 2016, reflect a structured financing strategy to meet recurring capital needs for solar energy projects. The frequent issuance of these bonds, as shown in the exhibit descriptions from both chunks, indicates a deliberate approach to securing project-specific funding through a bond framework that allows for incremental capital deployment. The role of bond-specific trustee agreements, as demonstrated by the repeated Supplemental Indentures between SolarCity and the Trustee, ensures legal and operational clarity for each bond series, enabling Tesla (via SolarCity) to efficiently access capital markets for ongoing solar project financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> 5.45% Solar Bonds (FIN_INST)",
        "5.45% Solar Bonds (FIN_INST) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8180,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2722,
        "completion_tokens": 191,
        "total_tokens": 2914
      }
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. However, this growth was partially offset by a decline in Powerpack deployments, as Tesla phased out the product following the introduction of the Megapack.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Megapack (PRODUCT)",
        "Megapack (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1006,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 899,
        "completion_tokens": 78,
        "total_tokens": 978
      }
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "The combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024 is $20 million. Capital expenditures for Africa/Eurasia in 2024 were $12 million, and Depreciation and Amortization for the same region in 2024 were $8 million. These figures are derived from CL's 2024 10-K disclosures related to the Africa/Eurasia region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Africa/Eurasia (GPE)",
        "Africa/Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1820,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 92,
        "total_tokens": 1173
      }
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "TI's policy explicitly states that none of the plan assets related to the retiree health care benefit plan are directly invested in TI common stock, as disclosed in Chunk 1. However, Chunk 2 reveals that as of December 31, 2024, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million, as a result of employees' investment elections. This indicates that while TI avoids direct stock investment in its retiree health care benefit plan, employees have chosen to hold TI stock in their non-U.S. defined contribution plans, highlighting a key difference in investment policy and employee discretion between the two types of plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Retiree Health Care Benefit Plan (FIN_INST)",
        "Retiree Health Care Benefit Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2025,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 163,
        "total_tokens": 1324
      }
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "LLY's revenue from Baqsimi dropped significantly between 2023 and 2024, from $677.6 million (U.S. $645.7 million + Outside U.S. $31.9 million) in 2023 to $29.2 million (U.S. $2.5 million + Outside U.S. $26.7 million) in 2024. This sharp decline is attributed to the 2023 sale of rights for Baqsimi, as disclosed in the collaboration and other arrangements section, which indicates that revenue recognition for Baqsimi shifted from ongoing product sales to upfront or milestone payments under the new contractual arrangement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Baqsimi (PRODUCT)",
        "Baqsimi (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5573,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2047,
        "completion_tokens": 131,
        "total_tokens": 2178
      }
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard classifies its 'Processing and Gateway' services under the broader category of **value-added services and solutions**, as outlined in its 10-K filing. This classification aligns with the company’s revenue generation structure, which is divided into **(i) payment network** and **(ii) value-added services and solutions**, with the latter encompassing a range of offerings including cyber and intelligence, data and services, and open banking solutions. The 'Processing and Gateway' service is explicitly listed as a key component of these value-added services, which are typically sold either in conjunction with or independently of the payment network services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Processing and Gateway (PRODUCT)",
        "Processing and Gateway (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2068,
        "completion_tokens": 168,
        "total_tokens": 2237
      }
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "The year-over-year change in CL's pension plan investments in international common stocks increased from $15 million in 2023 (Chunk 2) to $20 million in 2024 (Chunk 1), representing a $5 million increase. This shift is reflected in the broader total international investments, which rose from $537 million in 2023 to $566 million in 2024, indicating a $29 million overall growth, with the increase in international common stocks contributing approximately 17% to this total growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> International common stocks (FIN_INST)",
        "International common stocks (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4688,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1827,
        "completion_tokens": 120,
        "total_tokens": 1948
      }
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024 was $26 million, rising from $59 million in 2022 to $78 million in 2023, and further to $85 million in 2024. This upward trend in Restricted Stock/RSUs expense significantly contributed to the overall increase in equity-based compensation expense, which rose from $130 million in 2022 to $145 million in 2024, reflecting a $15 million increase over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "GD (ORG) -> Restricted Stock/RSUs (FIN_INST)",
        "Restricted Stock/RSUs (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 920,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 887,
        "completion_tokens": 115,
        "total_tokens": 1002
      }
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon's decision to utilize an $8.0 billion unsecured 364-day term loan in early 2023, despite having a $20.0 billion Commercial Paper Program available, reflects a strategic preference for securing short-term liquidity through a fixed-term facility with a defined maturity and interest rate structure. The term loan, which was fully repaid by December 31, 2023, provided immediate access to a large, unsecured capital infusion with a clear repayment timeline, offering financial stability and predictability. This choice contrasts with the more flexible but potentially variable nature of commercial paper, which Amazon did not utilize at the time, suggesting a deliberate approach to managing short-term debt with a mix of instruments tailored to its liquidity needs and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Borrows]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> $8.0 billion unsecured 364-day term loan (FIN_INST)",
        "$8.0 billion unsecured 364-day term loan (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 198,
        "total_tokens": 1309
      }
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "In 2024, changes in redemption costs and third-party partner arrangements impacted American Express's Membership Rewards liability, as the company adjusted its liability estimation methodology to reflect updated assumptions. The weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) were key factors in estimating the liability, with the WAC adjusted for changes in redemption costs not representative of future expectations. Additionally, the company considered developments in redemption patterns influenced by product changes and partner contract modifications. These adjustments were necessary to ensure the liability accurately reflected the expected future costs of points earned by Card Members.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Membership Rewards Program (PRODUCT)",
        "Membership Rewards Program (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10312,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3244,
        "completion_tokens": 181,
        "total_tokens": 3425
      }
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Colgate-Palmolive's use of selling price increases, as disclosed in its 2024 10-K, is part of its broader strategy to mitigate the impact of foreign exchange rate volatility on earnings. This approach is integrated with its foreign exchange risk management strategy, which involves derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. By adjusting selling prices, the company aims to offset the effects of currency fluctuations on its global operations, while derivative instruments are used to hedge specific exposures, such as foreign currency purchases, assets, and liabilities. Together, these measures aim to mitigate the financial exposure arising from currency rate movements, particularly in the context of manufacturing and selling products in over 200 countries and territories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Utilizes]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Selling Price Increases (ACCOUNTING_POLICY)",
        "Selling Price Increases (ACCOUNTING_POLICY) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8013,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2678,
        "completion_tokens": 210,
        "total_tokens": 2888
      }
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The increase in business-to-business activity from SMBs and large customers, along with higher residential demand in 2022, contributed to an increase in the average daily volume for UPS's Next Day Air product. This growth was accompanied by an increase in revenue per piece for the product, driven by higher base rates, demand-related surcharges, and favorable shifts in customer mix. However, this revenue growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Next Day Air Product (PRODUCT)",
        "Next Day Air Product (PRODUCT) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5264,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1974,
        "completion_tokens": 121,
        "total_tokens": 2095
      }
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The regulatory exclusivity risk for Opdivo in the U.S., as outlined in the Biologic products section, includes a 12-year data protection period under the 2010 U.S. healthcare legislation, which shields Opdivo from FDA approval of biosimilars until 12 years post-initial approval. This exclusivity is critical in preserving BMY's market position and revenue from Opdivo in the U.S. Meanwhile, the multiple international approvals Opdivo received in 2021, including in Japan and the EU, demonstrate BMY's proactive expansion of Opdivo's indications globally, enhancing its strategic positioning in global oncology markets. These approvals, particularly in key regions like Japan and the EU, allow BMY to diversify its revenue streams and mitigate the impact of potential U.S. exclusivity erosion by leveraging Opdivo's strong international footprint and continued innovation in oncology treatments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13784,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4104,
        "completion_tokens": 224,
        "total_tokens": 4328
      }
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "The total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, is approximately $13.8 billion. The total amount invested in those notes by that date is $1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024, totaling $5.3 billion. This indicates that the fair value of the investments is significantly higher than the total amount invested, reflecting substantial unrealized gains as of December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Invests]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Anthropic, PBC (COMP)",
        "Anthropic, PBC (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9225,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2956,
        "completion_tokens": 120,
        "total_tokens": 3077
      }
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate-Palmolive's accounting treatment of pension enhancements differs from other Employee-Related Costs under its severance policies in that pension enhancements are specifically reflected as Charges against assets within Employee-Related Costs, while severance and termination benefits are recognized based on established benefit practices and statutory requirements. This distinction is reflected differently on the balance sheet because the amounts related to pension enhancements either reduce pension assets or increase pension liabilities, rather than being recorded as standalone liabilities under severance obligations. This approach aligns with the company's broader accounting policies for employee-related costs, as disclosed in its 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Severance Policies (ACCOUNTING_POLICY)",
        "Severance Policies (ACCOUNTING_POLICY) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2168,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 189,
        "total_tokens": 1393
      }
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "The regulatory data protection period for biologic products in the U.S. grants Opdivo 12 years of exclusivity from the date of its first FDA approval, preventing the FDA from approving biosimilar versions during this time. However, after this period, biosimilar manufacturers may file for approval as early as four years post-approval, potentially initiating patent litigation. This framework significantly impacts Opdivo's market exclusivity, as the expiration of this 12-year period exposes the product to biosimilar competition. Based on the observed revenue trends, BMY faces a substantial financial risk, as the loss of exclusivity typically results in a rapid revenue decline in developed markets, particularly in the U.S., where price competition is intense. This risk is further compounded by the increasing regulatory and pricing pressures, which could accelerate revenue erosion and negatively affect BMY's profit margins.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12492,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3783,
        "completion_tokens": 233,
        "total_tokens": 4016
      }
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "To calculate the percentage of Amazon's total advertising services revenue in 2024 derived from display advertising, we use the figures provided: display advertising revenue was $35 billion, and total advertising services revenue was $40 billion. The calculation is $35 billion ÷ $40 billion × 100 = 87.5%. This reflects that 87.5% of Amazon's advertising services revenue in 2024 came from display advertising. The knowledge graph confirms the relationship between Amazon (AMZN) and Display Advertising as a product offering, and the text chunks provide the necessary financial context and breakdown of Amazon's advertising services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Display Advertising (PRODUCT)",
        "Display Advertising (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5423,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2010,
        "completion_tokens": 158,
        "total_tokens": 2169
      }
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "The dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on Level 1 quoted prices in active markets for identical assets, is $164 million. In 2020, the value was $184 million, and in 2021, it decreased to $200 million, resulting in a decrease of $184 - $200 = -$16 million. However, since the question asks for the dollar amount decrease, it is $16 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> U.S. government and agency debt securities (FIN_INST)",
        "U.S. government and agency debt securities (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5644,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2074,
        "completion_tokens": 105,
        "total_tokens": 2179
      }
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The joint development and cost-sharing structure between BMS and Ono for Yervoy, where profits, losses, and development costs are shared equally for combination therapies and split 80/20 for single-party compound activities, mitigates BMS's financial risk exposure to potential biosimilar competition under the U.S. regulatory framework. This shared financial burden reduces the impact of any potential revenue loss due to biosimilar entry, which is legally constrained in the U.S. by 12 years of regulatory data protection from the FDA after initial approval. However, the risk of biosimilar competition remains elevated due to the possibility of patent challenges as early as four years post-approval, increasing uncertainty around market exclusivity. BMS's collaboration with Ono thus serves as a strategic financial hedge in the face of evolving biosimilar regulatory and competitive dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Yervoy (PRODUCT)",
        "Yervoy (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7852,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2611,
        "completion_tokens": 224,
        "total_tokens": 2836
      }
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596 million / $6.03 billion * 100). This FSD revenue is part of the broader revenue stream tied to over-the-air software updates, which are included in upfront vehicle payments and contribute to deferred revenue. Additionally, Tesla provides guarantees related to vehicle residual values under lease programs, with a maximum exposure of $1.45 billion as of December 31, 2024, reflecting the financial risk associated with resale value commitments. These guarantees, along with deferred revenue from software features, highlight the interplay between revenue recognition and liability management in Tesla’s financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Over-the-Air Software Updates (PRODUCT)",
        "Over-the-Air Software Updates (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3622,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 193,
        "total_tokens": 1780
      }
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "In its 2022 10-K filing, PepsiCo adjusts the non-GAAP financial measure of **operating profit** for **items affecting comparability**. This adjustment also accounts for **currency fluctuations** by presenting **operating profit growth adjusted for items affecting comparability on a constant currency basis**, which isolates the impact of foreign exchange rate changes to provide a clearer view of underlying operating performance. These adjustments are disclosed as part of PepsiCo’s accounting policy on comparability items.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Comparability Items (ACCOUNTING_POLICY)",
        "Comparability Items (ACCOUNTING_POLICY) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 877,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 881,
        "completion_tokens": 131,
        "total_tokens": 1013
      }
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "Across the two exhibits, a total of **7 amendments** to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented: one in Chunk 1 (12th Amendment, effective May 1, 2021) and six in Chunk 2 (1st through 5th Amendments, effective October 31, 2014, to June 30, 2015, and the original agreement effective September 2, 2014). The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is **6 years and 8 months**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> TriexModule Technology (PRODUCT)",
        "TriexModule Technology (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9515,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3045,
        "completion_tokens": 129,
        "total_tokens": 3175
      }
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "The combined percentage impact on net revenue growth in the AMESA division in 2022 from the acquisition of Pioneer Foods and favorable foreign exchange was **18.5 percentage points**. Specifically, the Pioneer Foods acquisition contributed **14 percentage points**, and favorable foreign exchange contributed **4.5 percentage points**, as detailed in Chunk 1. Additionally, the KG triplet confirms the relationship between PEP and Pioneer Foods, highlighting that the acquisition was a significant strategic and financial move for PEP, as further supported by the liquidity and capital resources discussion in Chunk 2, which references funding for socioeconomic programs in South Africa related to the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Pioneer Foods (COMP)",
        "Pioneer Foods (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8559,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2776,
        "completion_tokens": 178,
        "total_tokens": 2955
      }
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo, produced by BMY, benefits from both regulatory data protection and patent protections that influence its market exclusivity in the U.S. and EU. In the U.S., Opdivo is protected by 12 years of regulatory data protection from its initial FDA approval, meaning biosimilars cannot be approved until this period ends, even if patents expire earlier. In the EU, under the \"8+2+1\" regime, generic companies may file a marketing authorization application 8 years after approval, but cannot commercialize until 10 or 11 years post-approval, depending on whether Opdivo obtained a significant additional indication. This regulatory framework, combined with ongoing patent protections (which extend beyond 2021 and into 2026 and beyond), supports continued exclusivity and pricing power. This exclusivity environment contributed to Opdivo's 7% U.S. revenue growth in 2021, driven by increased demand for combination therapies and higher net selling prices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10680,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3316,
        "completion_tokens": 238,
        "total_tokens": 3555
      }
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "As a large bank holding company with over $250 billion in consolidated assets, Morgan Stanley is subject to a systemic risk regime that imposes heightened capital and liquidity requirements, significantly constraining its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates that Morgan Stanley conduct internal liquidity stress tests, maintain unencumbered highly liquid assets to cover 30-day net cash outflows, and adhere to liquidity risk management standards, including the Liquidity Coverage Ratio (LCR) and Net Stable Funding Ratio (NSFR). Additionally, the Federal Reserve has authority to restrict or limit capital distributions, such as dividends or stock repurchases, if deemed unsafe or unsound given Morgan Stanley’s financial condition. These prudential standards, combined with the requirement to submit resolution and recovery plans, ensure that Morgan Stanley maintains sufficient capital and liquidity buffers to withstand financial stress and support an orderly resolution in the event of distress, thereby limiting its flexibility in returning capital to shareholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MS (ORG) -> Systemic Risk Regime (REGULATORY_REQUIREMENT)",
        "Systemic Risk Regime (REGULATORY_REQUIREMENT) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12414,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3772,
        "completion_tokens": 283,
        "total_tokens": 4056
      }
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The 0.750% Senior Note due 2033 has a lower interest rate compared to the 1.950% Senior Note due 2031, indicating that PepsiCo secured more favorable borrowing terms for longer-term debt, likely due to lower interest rate expectations or improved credit conditions over time. This suggests a strategy of locking in lower rates for extended maturities while managing near-term obligations at higher rates, reflecting a balanced approach to managing interest costs and refinancing risks across its debt portfolio. Both notes are explicitly referenced in the 10-K filing, with the 2033 note appearing in Exhibit 4.56 and the 2031 note in Exhibit 4.57, and their inclusion in the list of authorized notes in Chunk 2 confirms their formal recognition in PepsiCo’s broader debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 0.750% Senior Note due 2033 (FIN_INST)",
        "0.750% Senior Note due 2033 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_135",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14168,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4204,
        "completion_tokens": 195,
        "total_tokens": 4399
      }
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The fair value of Medtronic's partnership units increased by $159 million from fiscal year 2023 ($992 million) to fiscal year 2024 ($1,151 million). This increase contributed to a rise in total investments measured at net asset value from $2,179 million in 2023 to $3,366 million in 2024, reflecting a significant positive impact of $1,187 million on the net asset value of Medtronic's investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Partnership units (FIN_INST)",
        "Partnership units (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4592,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1796,
        "completion_tokens": 99,
        "total_tokens": 1895
      }
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "UPS employs activity-based costing methods to allocate certain operating expenses, including depreciation and amortization, between its reportable segments, as detailed in the 2024 10-K filing. These methods involve estimates that influence the amount of each expense category attributed to each segment, directly impacting segment operating profits. Specifically, depreciation and amortization totals disclosed by each reportable segment are presented after applying these activity-based costing methods, ensuring that expenses are allocated in a manner reflective of each segment’s actual usage of resources, as outlined in the expense allocations and other segment items sections.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Activity-Based Costing Methods (ACCOUNTING_POLICY)",
        "Activity-Based Costing Methods (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2408,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 170,
        "total_tokens": 1451
      }
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "In fiscal 2022, Qualcomm recorded a total financial benefit of $1.162 billion ($1.1 billion benefit in other income and a $62 million reduction in interest expense) as a result of the reversal of the European Commission fine and the associated interest following the General Court's ruling. This reversal positively impacted Qualcomm's other income and reduced its interest expense, effectively reversing prior charges related to the fine and its interest accrual.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Provides]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Financial Guarantee (FIN_INST)",
        "Financial Guarantee (FIN_INST) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14062,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4169,
        "completion_tokens": 116,
        "total_tokens": 4285
      }
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair value of Fixed Income Commingled Trusts held by MDT increased from $968 million in fiscal year 2023 to $1,273 million in fiscal year 2024, representing an increase of $305 million. The total fair value of all investment categories increased from $3,398 million in 2023 to $3,551 million in 2024, a total increase of $153 million. Therefore, the increase in Fixed Income Commingled Trusts accounted for approximately 199% of the total increase in fair value across all investment categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Fixed income commingled trusts (FIN_INST)",
        "Fixed income commingled trusts (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4592,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1818,
        "completion_tokens": 124,
        "total_tokens": 1943
      }
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley's SPOE (Single Point of Entry) strategy, as outlined in its resolution plan, ensures adequate liquidity for its subsidiaries during a resolution scenario by having the Parent Company provide necessary capital and liquidity to key subsidiaries through a secured amended and restated support agreement. A critical component of this strategy is Morgan Stanley Holdings LLC (Funding IHC), a direct, wholly owned subsidiary of the Parent Company, which serves as a resolution funding vehicle. The Parent Company transfers certain assets to Funding IHC, and in the event of a resolution scenario, the Parent Company is obligated to contribute its material assets (excluding shares in subsidiaries and certain other assets) to Funding IHC, which in turn provides capital and liquidity to supported subsidiaries. This structure is designed to facilitate a rapid and orderly resolution under the U.S. Bankruptcy Code, ensuring that subsidiaries have the resources needed to implement the resolution strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MS (ORG) -> SPOE Strategy (REGULATORY_REQUIREMENT)",
        "SPOE Strategy (REGULATORY_REQUIREMENT) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12911,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3896,
        "completion_tokens": 253,
        "total_tokens": 4149
      }
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm's growth strategy in automotive 5G adoption is heavily dependent on maintaining access to Chinese OEMs, as the company's strategic investments in 5G technologies are critical to enabling the projected 60% of 5G-connected vehicles by 2028. However, the 2022 10-K highlights that government actions in the U.S. or China could restrict Qualcomm's ability to supply integrated circuit products to Chinese OEMs, prompting them to develop or adopt alternative solutions, which could materially harm Qualcomm's revenues. Given China's significant role in Qualcomm's revenue and the long-term, capital-intensive nature of automotive industry investments, the company's ability to expand its 5G automotive technologies into this market is closely tied to its continued access to Chinese OEMs and their adoption of its products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> 5G Technologies (PRODUCT)",
        "5G Technologies (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12840,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3930,
        "completion_tokens": 206,
        "total_tokens": 4137
      }
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased from $2,179 million in fiscal year 2023 to $3,366 million in fiscal year 2024, representing a change of $1,187 million. The category that contributed the most to this change was Fixed Income Commingled Trusts, which increased from $968 million in 2023 to $1,273 million in 2024, a rise of $305 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Net asset value (FIN_INST)",
        "Net asset value (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4592,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1799,
        "completion_tokens": 99,
        "total_tokens": 1898
      }
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab's repurchase liabilities related to client-held fractional shares are valued at fair value using quoted market prices or other observable market data, consistent with the valuation of the related client-held fractional shares. The Company has elected the fair value option under ASC 825 to align the accounting for these liabilities with the related assets, ensuring that unrealized gains and losses on the fractional shares are offset by corresponding gains and losses on the repurchase liabilities. This offsetting treatment results in no impact to the consolidated statements of income, despite market value fluctuations. These liabilities are included in accrued expenses and other liabilities on the consolidated balance sheet and carry no credit risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Repurchase Liabilities (FIN_INST)",
        "Repurchase Liabilities (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7612,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2559,
        "completion_tokens": 191,
        "total_tokens": 2750
      }
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, is not explicitly stated in the provided chunks. However, the chunks confirm that Schwab discloses the plan as a noncontributory, unfunded, nonqualified plan for eligible financial consultants, with obligations contingent on performance, tenure, age, and client transitioning requirements. Additionally, the deferred compensation liability for Schwab increased from $176 million at December 31, 2020, to $194 million at December 31, 2021, reflecting a $18 million increase in related liabilities, which may include obligations tied to the Financial Consultant Career Achievement Plan. While the exact change in projected benefit obligation for the plan is not directly provided, the disclosed increase in deferred compensation liabilities indicates a relevant financial shift during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Financial Consultant Career Achievement Plan (PRODUCT)",
        "Financial Consultant Career Achievement Plan (PRODUCT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4784,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1871,
        "completion_tokens": 237,
        "total_tokens": 2108
      }
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The Beauty segment contributes 18% of Procter & Gamble's total net sales, as stated in Chunk 2, and Pantene, a key brand within this segment, holds a 20% global market share in hair care, as mentioned in Chunk 1. The Fabric & Home Care segment contributes 36% of net sales, also from Chunk 2. Therefore, the combined revenue contribution of the Beauty and Fabric & Home Care segments is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Pantene (PRODUCT)",
        "Pantene (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5993,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2160,
        "completion_tokens": 112,
        "total_tokens": 2272
      }
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was a loss of $410 million, as shown in the 2020 row under \"Income (loss) from discontinued operations attributable to common shareowners\" in Chunk 2. This loss is directly connected to the separation event described in Chunk 1, where UTC separated into three independent companies—UTC, Carrier, and Otis—on April 3, 2020, with the distribution of Carrier and Otis shares to UTC shareholders. The financial impact of this separation and related transactions is reflected in the discontinued operations line items for that year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Carrier (COMP)",
        "Carrier (COMP) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1093,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 918,
        "completion_tokens": 166,
        "total_tokens": 1084
      }
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit in the Diabetes Pump Retainer Ring Litigation. In comparison, the hernia mesh-related lawsuits involve approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in federal multidistrict litigation, totaling around 8,350 plaintiffs, plus six additional one-off cases. While the number of current plaintiffs is significantly higher for the hernia mesh litigation, both litigations face the potential for additional claimants, with law firms indicating the possibility of thousands more lawsuits in both cases. However, the Company has not recorded any expenses for either litigation due to the uncertainty of potential losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> LITIGATION <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Diabetes Pump Retainer Ring Litigation (LITIGATION)",
        "Diabetes Pump Retainer Ring Litigation (LITIGATION) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12154,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3734,
        "completion_tokens": 197,
        "total_tokens": 3931
      }
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement impacts Schwab's capital management strategy by requiring certain brokerage client deposits to be swept off-balance sheet to TD Depository Institutions, which reduces Schwab's balance sheet exposure and allows for more efficient capital utilization. This off-balance sheet treatment aligns with Schwab's objective to maintain its internal capital policy target range of 6.75%-7.00% for the Tier 1 Leverage Ratio at CSC, as it lowers the capital charge associated with these deposits. Schwab's capital management strategy is designed to support business growth, including the migration of IDA balances, while ensuring regulatory compliance and maintaining well-capitalized status, even under stressed scenarios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> IDA Agreement (ACCOUNTING_POLICY)",
        "IDA Agreement (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9129,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2941,
        "completion_tokens": 182,
        "total_tokens": 3123
      }
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "The total net cash inflow from RTX's disposition of the Forcepoint business was $1.9 billion in 2021, which was part of the $1.9 billion in net dispositions of businesses for that year. This contributed to the overall net cash provided by investing activities in 2021, which saw a $4.7 billion change compared to 2020, primarily due to the absence of the $3.2 billion cash acquired in the Raytheon Merger in 2020 and the shift in disposition activity from $2.6 billion in 2020 to $1.9 billion in 2021. Forcepoint, acquired during the Raytheon Merger and disposed of in January 2021, was a key component of this shift.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Forcepoint (COMP)",
        "Forcepoint (COMP) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2953,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 154,
        "total_tokens": 1535
      }
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle's reliance on third-party colocation suppliers for global data centers, as stated in Chunk 1, introduces financial risk due to the long-term lease commitments and potential contract termination fees highlighted in Chunk 2. These leases, which are necessary to support Oracle Cloud Services, require significant upfront investment and could result in substantial costs if Oracle needs to exit the agreements early due to strategic shifts. Additionally, the lack of control over these third-party facilities exposes Oracle to operational risks such as service interruptions, which could impact service delivery and, consequently, revenue. The financial burden of these commitments, combined with the potential for increased costs from delays in infrastructure deployment or unavailability of data centers, could adversely affect Oracle's profitability and cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Services (PRODUCT)",
        "Oracle Cloud Services (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8695,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2838,
        "completion_tokens": 218,
        "total_tokens": 3056
      }
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "As of December 31, 2021, UnitedHealth Group had a total of 82 million shares available for future grants under both the 2020 Stock Incentive Plan (64 million shares) and the 1993 Employee Stock Purchase Plan (18 million shares). This availability supports the Company's share-based compensation strategy by providing flexibility to issue a range of equity awards, including stock options, restricted stock, and performance-based awards, under the 2020 Stock Incentive Plan, while also enabling employee participation through the ESPP, which was expanded with shareholder approval in June 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2820,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 148,
        "total_tokens": 1531
      }
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab accounts for client-held fractional shares under GAAP by including them in \"other securities owned at fair value,\" which are recorded at fair value with unrealized gains and losses included in earnings. These fractional shares are associated with repurchase liabilities that are also accounted for at fair value. According to the 2022 10-K filing, the corresponding repurchase liabilities for these client-held fractional shares are reflected in \"accrued expenses and other liabilities\" on the consolidated balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Accounts_For]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Repurchase Liabilities (FIN_INST)",
        "Repurchase Liabilities (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7959,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2651,
        "completion_tokens": 132,
        "total_tokens": 2783
      }
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle's integration of Autonomous Database with Oracle Cloud Infrastructure (OCI) enables cost reduction for customers through automated database operations, consumption-based pricing, and reduced labor costs by minimizing manual administration tasks. This automation also lowers human error and supports on-demand scaling, aligning expenses with actual resource usage. Strategically, this integration strengthens Oracle's cloud and license business by enabling seamless migration of on-premise and cloud-based applications to Oracle Cloud, enhancing customer retention and expansion. Additionally, the integration with Oracle Cloud services like Java Cloud and APEX fosters innovation and application development, supporting Oracle's broader strategy to grow its cloud offerings and attract a wider ecosystem of businesses and developers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud (PRODUCT)",
        "Oracle Cloud (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9542,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3023,
        "completion_tokens": 210,
        "total_tokens": 3233
      }
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would transfer cash equal to the fair value of the AARP Program assets at the date of transfer, as these assets are managed separately and are not part of the Company's general investment portfolio. These assets are classified as current assets because they are intended to fund the AARP Program's medical costs payable, rate stabilization fund (RSF) liabilities, and other related liabilities. The financial implication for UnitedHealth Group would therefore involve a reduction in its current assets and a corresponding outflow of cash equivalent to the fair value of the AARP Program investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transfers]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "UNH (ORG) -> AARP Program Assets (FIN_INST)",
        "AARP Program Assets (FIN_INST) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11920,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3635,
        "completion_tokens": 170,
        "total_tokens": 3806
      }
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The fair value of Card Member and Other Loans is $113 billion, as disclosed in both chunks under the \"Corresponding Fair Value Amount - Level 3\" column. This is higher than the carrying value of $110 billion. The loans are classified under Level 3 of the fair value hierarchy, indicating that their fair value is determined using unobservable inputs, reflecting the significance of estimation and judgment in their valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Card Member and Other Loans (FIN_INST)",
        "Card Member and Other Loans (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6802,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2347,
        "completion_tokens": 106,
        "total_tokens": 2453
      }
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can be used for future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. The plan is subject to UnitedHealth Group's accounting policies and is administered as part of the company's broader equity compensation framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6968,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2403,
        "completion_tokens": 118,
        "total_tokens": 2521
      }
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The total estimated fair value of foreign government bonds and obligations held by the company in 2023 was $770 million. For maturities of 12 months or more in 2023, the fair value was $0, as all $770 million were categorized under maturities less than 12 months. In 2022, the estimated fair value of the same category was $632 million, with $549 million in maturities less than 12 months and $83 million in unrealized losses for that category. Thus, the fair value of foreign government bonds and obligations increased by $138 million in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Foreign government bonds and obligations (FIN_INST)",
        "Foreign government bonds and obligations (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4819,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1874,
        "completion_tokens": 140,
        "total_tokens": 2015
      }
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The total capital expenditure in the Africa/Eurasia region in 2021 was $33 million. This represents a significant increase compared to the capital expenditure in the same region in 2019, which was $8 million, indicating a growth of $25 million over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Africa/Eurasia (GPE)",
        "Africa/Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3556,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 67,
        "total_tokens": 1591
      }
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "The worldwide sales of Johnson & Johnson's Contact Lenses/Other within the Vision segment increased by 14.9% from 2020 ($2,994 million) to 2021 ($3,440 million). During the same period, the broader Vision segment experienced a higher growth rate of 19.6% (from $3,919 million to $4,688 million). This indicates that while the Contact Lenses/Other category performed well, it grew at a slower pace compared to the overall Vision segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Contact Lenses (PRODUCT)",
        "Contact Lenses (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4285,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1734,
        "completion_tokens": 109,
        "total_tokens": 1843
      }
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "The total weighted-average grant price for Service and Performance-Based RSUs outstanding as of December 31, 2021, was $114.22. This figure accounts for both the beginning balance of 3,146 shares (with a weighted-average grant price of $103.08) and the 1,787 new shares granted during the year (with a weighted-average grant price of $125.02), as detailed in both provided chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Service and Performance-Based RSUs (FIN_INST)",
        "Service and Performance-Based RSUs (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21982,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6155,
        "completion_tokens": 95,
        "total_tokens": 6250
      }
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million from 2023 ($10,135 million) to 2024 ($6,159 million). In 2024, this tranche represented approximately 11.45% of the company's total debt ($6,159 / $53,864).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BA (ORG) -> 1.43%-2.50% Bonds (FIN_INST)",
        "1.43%-2.50% Bonds (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1832,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 66,
        "total_tokens": 1177
      }
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "The combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021 was $2,810 million ($1,325 million for Knees and $1,485 million for Hips). This represented 32.7% of the total Orthopaedics revenue for that year, which was $8,588 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Knees (PRODUCT)",
        "Knees (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2132,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 66,
        "total_tokens": 1240
      }
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 11.6 million for 2024, 5.7 million for 2023, and 3.5 million for 2022. These shares were excluded because their inclusion would have been antidilutive, as a result of Boeing incurring a net loss in each of those periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BA (ORG) -> Potential common shares (FIN_INST)",
        "Potential common shares (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 850,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 867,
        "completion_tokens": 96,
        "total_tokens": 964
      }
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021, by approximately **$1.8 billion**. This change impacts the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them to the Retirement Value formula effective January 1, 2026, which bases benefits on compensation over total years of service, as opposed to the prior Final Average Pay formula that used compensation during the last five years before retirement. The amendment does not affect benefits already accrued under the Final Average Pay formula for service before January 1, 2026.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Retirement Value Formula (ACCOUNTING_POLICY)",
        "Retirement Value Formula (ACCOUNTING_POLICY) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2677,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 162,
        "total_tokens": 1504
      }
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The filing states that the fair value of American Express cannot be estimated by aggregating the figures of financial assets and liabilities carried at amortized cost because these fair value estimates are based on specific market conditions and perceived risks as of December 31, 2021, and 2020. These values require management judgment and may not reflect future fair values. Moreover, the fair value of the company as a whole cannot be derived simply by summing these individual figures due to the complex interplay of risks and the broader context of the company’s operations and market environment, as highlighted by the mutual relationship between AXP and the perceived risks it is subject to.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Subject_To]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Perceived Risks (RISK_FACTOR)",
        "Perceived Risks (RISK_FACTOR) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1462,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1036,
        "completion_tokens": 174,
        "total_tokens": 1210
      }
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The exhibit index explicitly lists one amendment to the Benefits Plan for Members of the Board of Directors, which is \"Amendment Number One\" dated December 16, 2005. The original plan was effective as of April 14, 2004, as noted in its amended and restated form.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "KO (ORG) -> Benefits Plan for Members of the Board of Directors (ACCOUNTING_POLICY)",
        "Benefits Plan for Members of the Board of Directors (ACCOUNTING_POLICY) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_135",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_135",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14454,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4287,
        "completion_tokens": 65,
        "total_tokens": 4353
      }
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, contributed to the cloud and license business representing 84% of total revenues in fiscal 2024 by offering customers flexible and interoperable IT solutions tailored to their specific needs. This model supports Oracle's cloud and license offerings, which include both cloud services and license support revenues. By enabling customers to choose deployment models that best suit their environments, Oracle was able to sustain high renewal rates for license support contracts and drive adoption of Oracle Cloud Services, thereby maintaining a dominant share of total revenues through its cloud and license business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Hybrid Deployments (PRODUCT)",
        "Hybrid Deployments (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9322,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2965,
        "completion_tokens": 177,
        "total_tokens": 3142
      }
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "American Express's deferred fees as of December 31, 2021 include amounts specifically tied to Membership Rewards program participants, as disclosed in the 10-K filing. These deferred fees are linked to the Membership Rewards program, which allows card members to earn and redeem points for various rewards. The liability for these points is estimated using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR), derived from statistical and actuarial models that consider redemption trends, card product types, and other factors. This methodology ensures that the deferred fees and future redemption liability are aligned with expected redemption behaviors and costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Membership Rewards Program (PRODUCT)",
        "Membership Rewards Program (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2583,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 173,
        "total_tokens": 1483
      }
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "Based on the filings listed in the 2024 10-K report, The Coca-Cola Company 2014 Equity Plan had **five different forms of award agreements** documented between February 18, 2015, and February 17, 2021. These include **Stock Option Agreements**, **Restricted Stock Unit Agreements**, and **Performance Share Agreements**, with specific variations such as the **Performance Share (Emerging Stronger) Agreement** also adopted in 2021. Each form was filed on different dates within the specified period, as detailed in the exhibit numbers from 10.5.1 to 10.5.21.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "KO (ORG) -> 2014 Equity Plan (ACCOUNTING_POLICY)",
        "2014 Equity Plan (ACCOUNTING_POLICY) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12122,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3688,
        "completion_tokens": 139,
        "total_tokens": 3828
      }
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "In 2021, AMD's total financial value of its relationship with the ATMP JV included $1.1 billion in purchases from the JV and $28 million in resales to the JV, along with a $6 million equity gain from its 15% ownership. These figures, combined with the significant inventory management support and the strategic role of the ATMP JV in providing essential ATMP services, underscore the JV's critical importance to AMD's supply chain and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7838,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2610,
        "completion_tokens": 114,
        "total_tokens": 2725
      }
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, as this is the year when the U.S. composition of matter patents for DARZALEX expire. While the European patents for DARZALEX expire later, in 2032, the U.S. market is typically a significant contributor to pharmaceutical revenue. DARZALEX FASPRO is covered by a separate Janssen-owned patent portfolio, though no specific expiration date is provided for it in the text. Given that the U.S. patents for DARZALEX expire first, 2029 represents the earliest potential year for material impact on the combined revenue stream.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> DARZALEX FASPRO (PRODUCT)",
        "DARZALEX FASPRO (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3661,
        "completion_tokens": 165,
        "total_tokens": 3827
      }
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing, is two. In 2015, an amendment effective as of June 30, 2015, was filed (Chunk 1), and in 2018, an amendment effective as of November 1, 2018, was filed (Chunk 2). Both amendments are explicitly listed in the exhibit disclosures provided in the respective chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Excess Benefit Plan (ACCOUNTING_POLICY)",
        "Excess Benefit Plan (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7917,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2630,
        "completion_tokens": 106,
        "total_tokens": 2737
      }
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx's Network 2.0 optimization expenditures are a key component of its 2025 capital expenditure plan, which is projected at $5.2 billion and includes investments in network modernization, facility upgrades, and aircraft. These expenditures align with the company's DRIVE transformation program, which aims to improve long-term profitability and operational efficiency, as highlighted by the implementation of Network 2.0 in over 50 U.S. locations. Additionally, the European workforce reduction costs, part of an ongoing effort to reduce structural costs, are expected to range from $250 million to $375 million and will be classified as business optimization expenses through fiscal 2026, further supporting the strategic goals of the DRIVE program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Network 2.0 (PRODUCT)",
        "Network 2.0 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11148,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3433,
        "completion_tokens": 188,
        "total_tokens": 3621
      }
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD's dependency on third-party suppliers for graphics cards and AIB partners significantly affects its financial risk exposure in terms of inventory management and price protection obligations. First, AIB partners and distributors maintain inventory of AMD products, and AMD's agreements with them include price protection provisions that shield their inventory from price reductions, which can lead to a decline in AMD's revenue and gross margin if product prices drop significantly. Additionally, these agreements allow for product returns, particularly for items removed from the price book within 12 months of manufacturing, further increasing financial exposure. Moreover, AMD's reliance on third-party suppliers and AIB partners for design, manufacturing, and distribution introduces operational and financial risks, including potential disruptions in supply, loss of key partners, and challenges in collecting accounts receivable, all of which could materially adversely affect its business performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Graphics Cards (PRODUCT)",
        "Graphics Cards (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5765,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2086,
        "completion_tokens": 252,
        "total_tokens": 2339
      }
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie's total cost of products sold related to Venclexta includes two components: Genentech's share of pre-tax profits from U.S. sales and the royalties paid on net revenues outside the United States. Genentech's share of U.S. profits is included in AbbVie's cost of products sold, as both entities share equally in pre-tax profits and losses for Venclexta in the U.S. Additionally, royalties paid for Venclexta revenues outside the U.S. are also included in AbbVie's cost of products sold. While specific dollar amounts for these costs are not provided in the chunks, the structure of the collaboration and cost allocation is clearly outlined.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Venclexta (PRODUCT)",
        "Venclexta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3186,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 161,
        "total_tokens": 1601
      }
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "In addition to its Committee Charters and Corporate Governance Guidelines, BNY makes its **Directors' Code of Conduct** publicly available. This document is explicitly applicable to **all directors of BNY**. The Directors' Code of Conduct is disclosed by BNY and is accessible on the company's website, as detailed in both the **CODE OF ETHICS** section and the **Available Information** section of the 10-K filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7460,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2530,
        "completion_tokens": 103,
        "total_tokens": 2634
      }
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021 were significantly driven by the launch of the AMD Radeon RX 6600 XT and the broader gaming-focused graphics strategy. The RX 6600 XT, introduced in July 2021, targeted the 1080p gaming market with high-frame-rate performance, contributing to increased demand for AMD's discrete GPU offerings. This product, along with other 2021 graphics launches like the RX 6700 XT and mobile RX 6000M series, supported advanced features such as RDNA 2 architecture and AMD FreeSync, enhancing AMD's competitive position in gaming and professional graphics markets. These innovations, combined with strong product execution and customer demand, directly fueled revenue expansion and margin improvement by capturing a larger share of the high-performance gaming and workstation segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Radeon RX 6600 XT (PRODUCT)",
        "Radeon RX 6600 XT (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10784,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3358,
        "completion_tokens": 217,
        "total_tokens": 3575
      }
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's net revenue from Venclexta in 2023 was $2,288 million, with $1,087 million generated in the United States and $1,201 million from international sales. Under the collaboration agreement with Genentech, AbbVie shares equally with Genentech all pre-tax profits and losses from Venclexta in the United States, meaning Genentech received 50% of the pre-tax profit from U.S. sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Venclexta (PRODUCT)",
        "Venclexta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7639,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2554,
        "completion_tokens": 96,
        "total_tokens": 2650
      }
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "Visa's 10-K reports only 10 Class C common shares outstanding as of September 30, 2024, despite issuing 48 million new Class C shares in the May 2024 exchange offer, because the par value of Class C common stock is $0.0001, and the number of shares listed in the equity section is likely rounded or presented in a simplified format for reporting purposes. Additionally, the 48 million shares issued were part of the Class B-1 common stock exchange offer, which converted into Class C common stock, but the total number of shares outstanding is represented in a summarized manner in the financial statements. The 10 shares figure reflects the nominal par value accounting treatment, while the actual economic impact of the 48 million shares is captured in the broader equity components like additional paid-in capital and accumulated income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17675,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5064,
        "completion_tokens": 210,
        "total_tokens": 5274
      }
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "FedEx incurred a total cost of $582 million in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities. Additionally, in June 2024, FedEx Express announced a European workforce reduction plan, which is expected to result in pre-tax costs ranging from $250 million to $375 million in cash expenditures, to be incurred through fiscal 2026.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Network 2.0 (PRODUCT)",
        "Network 2.0 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10505,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3288,
        "completion_tokens": 97,
        "total_tokens": 3385
      }
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "The total value of AMD's unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021 was $329 million, as reported as of December 25, 2021. This amount reflects work completed for development services and custom products, for which revenue had been recognized but not yet invoiced, and is consistent with the 23% contribution of such revenue to the Company's total revenue in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Custom Products (PRODUCT)",
        "Custom Products (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1478,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1014,
        "completion_tokens": 116,
        "total_tokens": 1130
      }
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million, as shown in Chunk 1. Under the collaboration agreement with Genentech (as outlined in Chunk 2), AbbVie shares equally all pre-tax profits from Venclexta's U.S. sales with Genentech, meaning Genentech receives 50% of the pre-tax profit from these sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Venclexta (PRODUCT)",
        "Venclexta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10471,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3262,
        "completion_tokens": 79,
        "total_tokens": 3341
      }
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased from $171 million on December 31, 2022, to $0 on December 15, 2023, indicating the full repayment of these notes by mid-2023. In comparison, the balance of the 3.700% notes due 2023 remained at $400 million on December 15, 2023, showing that these notes were not repaid and remained outstanding as of that date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 3.650% notes due 2023 (FIN_INST)",
        "3.650% notes due 2023 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2517,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 95,
        "total_tokens": 1384
      }
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "Adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates could reduce transaction volumes and related revenue, as merchants and processors continue to push for lower acceptance costs, potentially leading to reduced cardholder benefits and issuance of Visa products. However, Visa’s U.S. and Europe retrospective responsibility plans offer some financial protection against these impacts by insulating it from certain settlements, judgments, and liabilities. Nonetheless, the failure of these plans to fully cover potential losses could harm Visa’s financial position. Additionally, ongoing tax disputes with the IRS and other jurisdictions could further strain cash flows and increase financial uncertainty, compounding the risks associated with litigation and regulatory pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "V (ORG) -> Operating Rules (ACCOUNTING_POLICY)",
        "Operating Rules (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11412,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3529,
        "completion_tokens": 203,
        "total_tokens": 3733
      }
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "The effective dates for the Performance Share Unit (PSU) award schedules under the United Technologies Corporation Long-Term Incentive Plan are January 2016, as indicated by the \"Rev. January 2016\" revision noted in the Schedule of Terms for PSU awards in both Chunk 1 and Chunk 2. For the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, the PSU award schedules were effective as of March 31, 2021, as disclosed in the Schedule of Terms incorporated by reference from the Company's Quarterly Report on Form 10-Q. These dates reflect distinct governance updates: the United Technologies plan was revised in early 2016, likely in response to internal policy or regulatory changes, while the Raytheon Technologies plan was updated in 2021 following an amendment effective December 6, 2020, indicating a more recent governance adjustment post-merger integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Performance Share Unit Terms (FIN_INST)",
        "Performance Share Unit Terms (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12832,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3893,
        "completion_tokens": 218,
        "total_tokens": 4111
      }
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods, as stated in Chunk 1. These products outperformed other offerings within the segment, such as Apple TV, Beats products, HomePod mini, and accessories, which were also part of the segment but not specifically cited as contributing to the growth. The strong performance of the Apple Watch and AirPods, produced by Apple (as shown in the KG triplet), highlights their significance in driving the segment's overall increase in net sales compared to 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Apple Watch (PRODUCT)",
        "Apple Watch (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1422,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1001,
        "completion_tokens": 142,
        "total_tokens": 1144
      }
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL are expected to follow a historical sales pattern of lower first-quarter sales in 2025 compared to subsequent quarters, driven by the impact of benefit plan changes, insurance reverification, and increased co-pay expenses as U.S. patients work through deductibles. While insurance reverification negatively impacts both products, Otezla is also influenced by a lower net selling price and volume growth, whereas ENBREL faces continued declines in net selling price and relatively flat volumes. Additionally, both products are affected by Medicare pricing pressures, with Otezla facing CMS price setting effective 2027 and ENBREL impacted by the IRA Medicare Part D price reductions starting in 2026.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Insurance Reverification (RISK_FACTOR)",
        "Insurance Reverification (RISK_FACTOR) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1652,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1075,
        "completion_tokens": 180,
        "total_tokens": 1256
      }
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "RTX disclosed a total of **2 distinct stock appreciation rights-related exhibits** in its 2023 10-K filing for the two specified incentive plans: **Exhibit 10.16** for the United Technologies Corporation 2005 Long-Term Incentive Plan and **Exhibit 10.24** for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan. Both exhibits are explicitly referenced in the provided chunks and pertain to the terms of stock appreciation rights awards under their respective plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Stock Appreciation Rights Terms (FIN_INST)",
        "Stock Appreciation Rights Terms (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12832,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3882,
        "completion_tokens": 120,
        "total_tokens": 4003
      }
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "The recurring impact of insurance reverification in the first quarter is expected to negatively affect the combined sales performance of ENBREL and Otezla in 2025, as both products historically experience lower first-quarter sales due to benefit plan changes, increased co-pay expenses, and U.S. patients working through deductibles. For ENBREL, continued declines in net selling price are anticipated, while Otezla faces a similar trend, with an 8% decrease in net selling price in 2024 partially offset by volume growth. Additionally, both products are subject to future Medicare price regulations—ENBREL under the IRA in 2026 and Otezla under CMS price setting in 2027—further pressuring their net selling prices and sales performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Insurance Reverification (RISK_FACTOR)",
        "Insurance Reverification (RISK_FACTOR) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1652,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 184,
        "total_tokens": 1266
      }
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Starting in 2025, AMGN's revenue from Otezla could be negatively impacted by increased co-pay expenses and benefit plan changes, leading to lower first-quarter sales relative to subsequent quarters. Additionally, Otezla's inclusion in Medicare price setting by CMS in January 2025 will result in price reductions effective January 1, 2027. For ENBREL, the impact of increased co-pay expenses and benefit plan changes will similarly affect 2025 sales, with further revenue pressure expected in 2026 due to the implementation of the IRA Medicare Part D price setting. These developments reflect a broader pattern in AMGN's revenue forecasting for its key drugs, where regulatory pricing interventions and U.S. insurance dynamics are increasingly driving downward pressure on both net selling price and quarterly sales volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Increased Co-Pay Expenses (RISK_FACTOR)",
        "Increased Co-Pay Expenses (RISK_FACTOR) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1652,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1097,
        "completion_tokens": 206,
        "total_tokens": 1304
      }
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "As of December 31, 2024, the total fair value of repurchase liabilities related to client-held fractional shares is included in accrued expenses and other liabilities on Schwab’s consolidated balance sheet, with the corresponding fractional shares held in client brokerage accounts. Schwab accounts for these repurchase liabilities using the fair value option under ASC 825, aligning their measurement with the related client-held fractional shares. Unrealized gains and losses on these fractional shares are offset by the unrealized gains and losses on the corresponding repurchase liabilities, resulting in no impact to the consolidated statements of income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Repurchase Liabilities (FIN_INST)",
        "Repurchase Liabilities (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6429,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2276,
        "completion_tokens": 165,
        "total_tokens": 2441
      }
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "The total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares is $15.3 billion, as stated in Chunk 1. AspenTech's 2023 net sales were $1.04 billion, also from Chunk 1. This implies that the proposed acquisition values AspenTech at approximately 14.7 times its 2023 net sales. Chunk 2 provides context on AspenTech's stock-based compensation and equity structure, which is relevant to understanding the fully diluted share count used in the market capitalization calculation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8319,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2722,
        "completion_tokens": 134,
        "total_tokens": 2857
      }
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "AMGN faces a total potential additional federal tax liability, including penalties, of approximately $10.7 billion from the IRS Notices for the years 2010-2012 ($3.6 billion in taxes) and 2013-2015 ($5.1 billion in taxes plus $2.0 billion in penalties). Previously accrued repatriation taxes would reduce this amount by up to approximately $3.1 billion ($900 million for 2010-2012 and $2.2 billion for 2013-2015), resulting in a net potential liability of approximately $7.6 billion, excluding interest.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> LITIGATION <-[Faces]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> RAR (LITIGATION)",
        "RAR (LITIGATION) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9088,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2923,
        "completion_tokens": 125,
        "total_tokens": 3049
      }
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The inclusion of ENBREL in the Medicare price setting program, as outlined in Amgen's 2024 10-K filing, is expected to significantly reduce its profitability in Medicare, beginning January 1, 2026, due to the substantially lower price set by CMS. This regulatory requirement is part of the Inflation Reduction Act (IRA) and is anticipated to have a material adverse effect on Amgen's sales and results of operations, particularly as more of its products are selected for price setting in future cycles. Additionally, the potential inclusion of Otezla in the next phase of Medicare price setting, announced in January 2025 and effective January 1, 2027, poses an additional risk to Amgen’s financial outlook, as it could further reduce revenue from another key product. These developments, combined with broader pressures from state-level pricing actions, formulary restrictions, and expanded 340B Program utilization, underscore the growing regulatory and market challenges impacting Amgen’s business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Medicare Price Setting (REGULATORY_REQUIREMENT)",
        "Medicare Price Setting (REGULATORY_REQUIREMENT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12698,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3847,
        "completion_tokens": 250,
        "total_tokens": 4098
      }
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares, under its election of the fair value option under ASC 825, results in no impact to the consolidated statements of income. This is because the unrealized gains and losses on the client-held fractional shares are offset by the corresponding unrealized gains and losses on the repurchase liabilities. Additionally, since these repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses in the consolidated statements of income or comprehensive income attributable to instrument-specific credit risk. The fair value measurements are based on quoted market prices or other observable market data, consistent with the related client-held fractional shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Measures]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Repurchase Liabilities (FIN_INST)",
        "Repurchase Liabilities (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8466,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2777,
        "completion_tokens": 198,
        "total_tokens": 2975
      }
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method, both of which were disclosed as part of CVS's accounting policy. These valuation methods were used to estimate the fair value of the LTC reporting unit, which was found to be lower than its carrying value due to ongoing challenges such as lower facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Additionally, the specific store closure strategy announced in 2021—planning to close approximately 900 stores over three years—impacted the Retail/LTC segment's long-lived asset impairment analysis by triggering indicators of impairment for the affected stores, leading to a $1.4 billion impairment charge in the fourth quarter of 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Market Multiple Method (ACCOUNTING_POLICY)",
        "Market Multiple Method (ACCOUNTING_POLICY) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_152",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2800,
        "completion_tokens": 213,
        "total_tokens": 3013
      }
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, is $978 ($12,416 - $11,438). Of this increase, $1,205 is attributable to Level 2 assets (from $8,810 in 2023 to $10,015 in 2024), indicating a $1,205 increase in Level 2 assets within this category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Cash and investments segregated and on deposit for regulatory purposes (FIN_INST)",
        "Cash and investments segregated and on deposit for regulatory purposes (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7995,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2682,
        "completion_tokens": 86,
        "total_tokens": 2768
      }
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson allocated AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805 by determining the fair value of the share-based payment awards and attributing the value to the periods based on the services rendered. The fair value of the awards attributable to the pre-combination period was included in the purchase price for Heritage AspenTech, while the portion attributable to the post-combination period is recognized as stock-based compensation expense in Emerson’s consolidated financial statements over the remaining service period. The valuation inputs used included the Black-Scholes model, which incorporated expected stock price volatility, expected life of the option, risk-free interest rate, dividend yield, and the market value of AspenTech’s common stock. Additionally, the ownership figures from the acquisition, where Emerson owned 55% of AspenTech and former Heritage AspenTech stockholders owned 45%, were relevant in determining the fair value of the noncontrolling interest and the allocation of compensation expenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6094,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2176,
        "completion_tokens": 270,
        "total_tokens": 2446
      }
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million as of December 31, 2021, to $170 million as of December 31, 2022, representing a percentage change of -94.5%. This significant decline reduced the proportion of these investments in the overall debt securities portfolio, shifting the portfolio's composition to favor other categories such as U.S. corporate securities. As a result, the debt securities portfolio became more concentrated in corporate and less in municipal investments, impacting the overall risk and yield profile of CVS's investment holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> States, Municipalities and Political Subdivisions (FIN_INST)",
        "States, Municipalities and Political Subdivisions (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_166",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5523,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2062,
        "completion_tokens": 156,
        "total_tokens": 2218
      }
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "The potential conversion of Visa's class B common stock under the U.S. retrospective responsibility plan is contingent on the final resolution of U.S. covered litigation, which is tied to the accrual activity related to that litigation. As outlined in Chunk 2, an accrual is recorded when a loss is deemed probable and reasonably estimable, and the total accrual could differ from the escrow account balance, introducing financial uncertainty. Chunk 1 explains that upon the final resolution of this litigation, all class B common stock will become convertible into class A common stock, which could lead to voting dilution and impact the market price of class A shares. This uncertainty in the timing and outcome of the litigation, as well as the potential variability in the class A common stock price, creates financial risk for class A common stockholders, as the value of their shares could be adversely affected by the conversion process and related market dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "V (ORG) -> U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT)",
        "U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5855,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2162,
        "completion_tokens": 243,
        "total_tokens": 2405
      }
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million from July 29, 2023 ($15,592 million) to July 27, 2024 ($9,865 million). The corresponding change in net losses on these investments year-over-year increased by $46 million, from a net loss of $21 million in 2023 to a net loss of $67 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1916,
        "completion_tokens": 84,
        "total_tokens": 2000
      }
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 impacted CVS's revenue recognition through increases in contract liabilities from customer earnings on ExtraBucks Rewards and gift card issuances, as disclosed in Chunk 1. Decreases in these liabilities occurred as a result of redemptions and gift card breakage, with breakage recognized based on historical redemption patterns, as explained in Chunk 2. These dynamics reflect how customer behavior and redemption trends influence the timing and amount of revenue recognized from these loyalty and gift card programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> ExtraBucks Rewards (PRODUCT)",
        "ExtraBucks Rewards (PRODUCT) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1906,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 147,
        "total_tokens": 1268
      }
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "Funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan results in a downward adjustment to the conversion rate of class B common stock into class A common stock, causing dilution in the value of class B shares. This adjustment is directly tied to deposits made into the escrow account, as reflected in the reduction of the number of as-converted class B common shares for fiscal 2022. Additionally, Visa Inc. records a charge to its litigation provision when losses related to U.S. covered litigation are deemed probable and reasonably estimable, with fiscal 2022 accrual activity impacting the overall litigation provision, though the total accrual may differ from the escrow account balance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "V (ORG) -> U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT)",
        "U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2223,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 183,
        "total_tokens": 1436
      }
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase occurred in each year, the impact on total investments would be a decrease of $15,386 million in 2023 and $9,736 million in 2024, based on the provided valuation scenarios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4460,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1788,
        "completion_tokens": 95,
        "total_tokens": 1883
      }
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "The financial impact on Visa Inc.'s litigation provision from the U.S. Covered Litigation is reflected in the accrual activity, where a charge is recorded when a loss is deemed probable and reasonably estimable. This accrual is directly tied to the mechanisms outlined in the U.S. Retrospective Responsibility Plan, which includes a litigation escrow agreement, interchange judgment sharing, and indemnification obligations, among others, to address potential liabilities from the litigation. The accrual amount may differ from the escrow account balance, as it is based on the Company's ongoing evaluation of legal proceedings and related financial exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "V (ORG) -> U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT)",
        "U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 164,
        "total_tokens": 1532
      }
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's (EMR) gross margin percentage in 2023, as explicitly stated in the \"Cost of Sales\" section of Chunk 1. As a result of this contribution and other factors, Emerson's total gross margin percentage for 2023 was 49.0 percent. This information is consistent across the provided chunks and reflects the positive impact of the acquisition on Emerson’s profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9948,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3137,
        "completion_tokens": 114,
        "total_tokens": 3251
      }
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Cisco's guarantee of channel partner financing arrangements, as described in the financing receivables section, increases its credit loss exposure because the company may be required to make payments under these guarantees if channel partners fail to meet their obligations. This risk is heightened by the potential financial instability of channel partners, which could be exacerbated by challenging global economic conditions, such as rising inflation or credit market disruptions, as outlined in the Risk Factors section. Additionally, Cisco's financing receivables include arrangements where it facilitates third-party financing to channel partners, and while some receivables are derecognized upon transfer, the guarantees expose Cisco to potential losses if the channel partners default. These factors collectively underscore the potential for increased credit losses tied to Cisco's channel partner financing activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Channel Partner Financing (FIN_INST)",
        "Channel Partner Financing (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3542,
        "completion_tokens": 231,
        "total_tokens": 3774
      }
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Emerson's 55% ownership stake in AspenTech entitles it to 55% of AspenTech's $1,093 million in 2024 revenue, which amounts to **$599.65 million** (0.55 × 1,093). This stake significantly contributes to Emerson's total **Software and Control revenue of $5,399 million**, with AspenTech's revenue representing approximately **11.1%** of that total ($1,093 ÷ 5,399). Given Emerson's controlling interest, the proportional share of $599.65 million further reinforces the strategic and financial importance of AspenTech to Emerson's software and control segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5916,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2153,
        "completion_tokens": 139,
        "total_tokens": 2292
      }
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "Pfizer's divestiture of Meridian in 2021 generated approximately $51 million in cash but resulted in a $167 million net loss, impacting its cash position and earnings. The Upjohn spin-off in 2020, structured as a Reverse Morris Trust transaction, involved a $12.0 billion cash payment from Viatris to Pfizer, which was used to pay down debt, including $1.15 billion in notes due in 2021 and $342 million in notes due in 2023. This significantly improved Pfizer’s liquidity and reduced its debt burden, supporting its financial restructuring. Additionally, the spin-off led to a $1.6 billion reduction in retained earnings and a $423 million increase in accumulated other comprehensive loss, reflecting the accounting adjustments and derecognition of certain assets and liabilities. Overall, both transactions contributed to Pfizer’s strategic refocusing and improved financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Sells]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Meridian (COMP)",
        "Meridian (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9970,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3120,
        "completion_tokens": 222,
        "total_tokens": 3342
      }
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022 was $1,450 million, combining the $600 million Amended Settlement Agreement payment and the $850 million annual deposit. This reflects the plan's role in managing litigation liabilities by providing a structured mechanism to address and fund potential future claims and settlements related to U.S. covered litigation, ensuring financial preparedness and compliance with regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "V (ORG) -> U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT)",
        "U.S. Retrospective Responsibility Plan (REGULATORY_REQUIREMENT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6711,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2364,
        "completion_tokens": 121,
        "total_tokens": 2485
      }
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased from 35% in 2022 to 20% in 2023, representing a 15 percentage point decline. This shift reduced the total value of equity securities in the plan from $54 million in 2023 (based on the 20% allocation of total assets of $264 million) compared to the prior year allocation of 35%, which would have implied approximately $78 million in equity securities (assuming similar total assets). Thus, the reallocation resulted in a reduction in the value of equity securities by approximately $24 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3222,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 144,
        "total_tokens": 1613
      }
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, primarily due to the treatment of Tier 2 capital related to the qualifying allowance for credit losses. Under the Advanced approaches, a smaller amount of the allowance for credit losses is permitted in Tier 2 capital compared to the Standardized approach, which allows a larger portion of the adjusted allowance for credit losses to be included in Tier 2 capital. This difference in Tier 2 capital treatment, driven by the CECL standard's impact on allowance calculations, is the specific capital component that explains the divergence in total capital between the two approaches.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> CECL Accounting Standard (ACCOUNTING_POLICY)",
        "CECL Accounting Standard (ACCOUNTING_POLICY) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 189,
        "total_tokens": 1815
      }
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "To calculate the weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all defined benefit and retiree health care plans, we first use the midpoints of the stated ranges: 72.5% for U.S. Defined Benefit, 80% for U.S. Retiree Health Care, and 80% for Non-U.S. Defined Benefit plans. Next, we apply these midpoints to the total asset values from Chunk 1: $421 million for U.S. Defined Benefit, $280 million for U.S. Retiree Health Care, and $1,822 million for Non-U.S. Defined Benefit. The weighted average is calculated as follows: ((72.5% × 421) + (80% × 280) + (80% × 1,822)) / (421 + 280 + 1,822) = (305.23 + 224 + 1,457.6) / 2,523 ≈ 78.3%. Thus, the weighted average allocation is approximately 78.3%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Fixed Income Securities and Cash Equivalents (FIN_INST)",
        "Fixed Income Securities and Cash Equivalents (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2675,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 185,
        "total_tokens": 1541
      }
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "The implementation of Basel 3 capital calculations influences the composition and risk profile of Bank of America's (BAC) covered trading positions by aligning its Value at Risk (VaR) metrics with regulatory requirements that emphasize risk-based capital adequacy. As outlined in the 2023 10-K, Basel 3 requires the use of a 10-day holding period for VaR in regulatory capital calculations, which affects how the bank measures and manages market risk across its trading portfolios, particularly within the Global Markets segment. The covered positions under Basel 3 include foreign exchange and commodity positions, and the VaR results are calibrated using historical data, as seen in the decrease in 2023's average VaR due to the roll-off of March 2020 volatility. This regulatory framework, which BAC is subject to, ensures that its capital levels, including the CET1 capital and capital conservation buffer, are sufficient to cover potential losses reflected in its VaR metrics, thereby shaping a more risk-sensitive and conservatively capitalized trading portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Basel 3 (REGULATORY_REQUIREMENT)",
        "Basel 3 (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5281,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1976,
        "completion_tokens": 267,
        "total_tokens": 2243
      }
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion as of May 31, 2022. In comparison, during 2021, FedEx used proceeds from the issuance of $3.25 billion of senior unsecured debt to redeem $5.8 billion of outstanding debt, effectively eliminating all debt maturities through 2025 and one in 2027. Thus, the amount of debt eliminated through redemptions ($5.8 billion) significantly exceeds the net book value of the aircraft securing the Pass-Through Certificates ($1.8 billion).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Pass-Through Certificates (FIN_INST)",
        "Pass-Through Certificates (FIN_INST) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4277,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1739,
        "completion_tokens": 139,
        "total_tokens": 1878
      }
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "In 2023, Texas Instruments (TI) contributed $75 million to its U.S. defined contribution plans. Notably, while TI's U.S. defined contribution plans held TI common stock valued at $873 million as of December 31, 2023, the plan assets related to the Retiree Health Care Benefit Plan are not directly invested in TI common stock, as explicitly stated in the disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Retiree Health Care Benefit Plan (FIN_INST)",
        "Retiree Health Care Benefit Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4870,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1872,
        "completion_tokens": 91,
        "total_tokens": 1964
      }
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "To determine the percentage of total net sales growth between 2023 and 2024 attributable to the increase in Services revenue, we first calculate the total net sales growth and the Services revenue growth. Total net sales increased from $383.285 billion in 2023 to $391.035 billion in 2024, a growth of $7.75 billion. Services revenue grew from $85.2 billion in 2023 to $96.169 billion in 2024, an increase of $10.969 billion. The contribution of Services revenue growth to total net sales growth is therefore $10.969 billion / $7.75 billion = 141.54%. This indicates that the growth in Services revenue exceeded the total net sales growth, highlighting its significant role in Apple's revenue strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Apple Music (PRODUCT)",
        "Apple Music (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6619,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2347,
        "completion_tokens": 175,
        "total_tokens": 2523
      }
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "Pfizer estimates that the maximum potential decrease in its gross unrecognized tax benefits within the next 12 months could be as much as $75 million, primarily due to settlements with taxing authorities or the expiration of statutes of limitations. The existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contributes to the uncertainty surrounding these tax positions, as Pfizer is currently appealing certain disputed issues related to these RARs. This ongoing appeal process, along with the potential for formal administrative or legal proceedings, makes it difficult to estimate the timing and range of possible changes, which could significantly affect Pfizer’s financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> LITIGATION <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Revenue Agent's Reports (RARs) (LITIGATION)",
        "Revenue Agent's Reports (RARs) (LITIGATION) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5140,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1963,
        "completion_tokens": 179,
        "total_tokens": 2142
      }
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts BAC's TLAC ratios and CET1 capital as of December 31, 2023, by allowing the Corporation to use a transitional regulatory capital rule that smooths the impact of CECL on capital calculations. Specifically, BAC's TLAC ratios and CET1 capital are calculated under this transition framework, which affects the treatment of credit loss allowances in Tier 2 capital and influences the composition of regulatory capital. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, and the CET1 capital regulatory minimum included a 4.5% minimum, a 2.5% G-SIB surcharge, and a 2.5% capital conservation buffer. The TLAC RWA regulatory minimum was 18.0% plus a 2.5% buffer and the Method 1 G-SIB surcharge of 1.5%, with the Standardized approach used for TLAC calculations. This transitional treatment under CECL helps mitigate abrupt changes in capital metrics due to the new accounting standard.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> CECL Accounting Standard (ACCOUNTING_POLICY)",
        "CECL Accounting Standard (ACCOUNTING_POLICY) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8689,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2829,
        "completion_tokens": 247,
        "total_tokens": 3076
      }
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground and FedEx Freight both utilize indexed fuel surcharge mechanisms to respond to fluctuating fuel prices, but they differ in the timing of their adjustments and the implementation dates of their surcharge table updates. FedEx Ground adjusts its fuel surcharge weekly, based on the fuel price from two weeks prior to the week it is assessed, with surcharge tables updated on June 21, 2021, November 1, 2021, and April 4, 2022. In contrast, FedEx Freight also adjusts its fuel surcharge weekly but bases it on the fuel price from two days prior to the day it is assessed, with its surcharge tables updated on November 1, 2021, and April 4, 2022. Thus, FedEx Ground has a two-week lag in fuel price assessment compared to FedEx Freight’s two-day lag, and its surcharge table updates began earlier in the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adjusts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Fuel Surcharge Tables (ACCOUNTING_POLICY)",
        "Fuel Surcharge Tables (ACCOUNTING_POLICY) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10387,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3245,
        "completion_tokens": 204,
        "total_tokens": 3449
      }
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The reorganization of the Ventilator Product Line in fiscal year 2023 resulted in its removal from MDT's Medical Surgical segment and its inclusion in the \"Other\" reporting line, alongside the Rhenal Care Solutions business. This change led to the consolidation of the retained PMRI businesses into a newly named business unit, Acute Care & Monitoring, within Medical Surgical. This restructuring indicates a strategic decision to streamline and focus the Medical Surgical segment on higher-priority, core businesses, with the Acute Care & Monitoring unit being positioned as a central growth area post-reorganization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reorganizes]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Ventilator Product Line (PRODUCT)",
        "Ventilator Product Line (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1208,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 968,
        "completion_tokens": 154,
        "total_tokens": 1123
      }
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023 was $252 million. For fiscal year 2022, the expense was $102 million, and for fiscal year 2023, it was $150 million, as disclosed in both tables. These expenses directly reduced Medtronic's income before income taxes in each respective year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Medical device regulations (REGULATORY_REQUIREMENT)",
        "Medical device regulations (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5964,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2159,
        "completion_tokens": 99,
        "total_tokens": 2258
      }
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Boeing's 2023 10-Q filings disclose four distinct forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions: (1) U.S. Notice of Terms of Long-Term Incentive Restricted Stock Units, (2) U.S. Notice of Terms of Long-Term Incentive Restricted Stock Units - CEO, (3) U.S. Notice of Terms of Long-Term Incentive Performance Restricted Stock Units, and (4) International Notice of Terms of Long-Term Incentive Restricted Stock Units (Stock-Settled). These forms are explicitly listed in both chunks provided, confirming the existence of these four unique structures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BA (ORG) -> International Long-Term Incentive Restricted Stock Units (FIN_INST)",
        "International Long-Term Incentive Restricted Stock Units (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8742,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2846,
        "completion_tokens": 150,
        "total_tokens": 2996
      }
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "Apple's 12.9% year-over-year growth in Services revenue from 2022 to 2023 highlights the importance of its services ecosystem, including Apple Music. However, the company's reliance on third-party developers and content providers introduces potential risks to the sustainability of this growth. As outlined in Chunk 1, Apple's ability to maintain compelling software and digital content depends on developers' willingness to invest in its platforms, which can be influenced by market share, anticipated revenue, and development costs. A smaller market share in smartphones, PCs, and tablets may reduce developers' incentives to prioritize Apple's ecosystem, potentially leading to a decline in the quality and availability of content for Apple Music and other services. Additionally, challenges in securing digital content on commercially reasonable terms—whether due to competition, rising licensing costs, or distribution restrictions—could further hinder Apple's ability to offer a diverse and appealing content library. These factors, combined with the company's minority market position and the rapid pace of technological change, could negatively impact customer satisfaction and, consequently, the long-term growth trajectory of Apple's Services segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Apple Music (PRODUCT)",
        "Apple Music (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2354,
        "completion_tokens": 315,
        "total_tokens": 2669
      }
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife's cash buffer needs, influenced by reinsurance and derivative counterparty risks, play a critical role in its liquidity management, particularly under stress scenarios. The company maintains a $12.4 billion short-term liquidity position at the end of 2021, which, combined with $223.0 billion in liquid assets, supports its ability to meet obligations even if reinsurers or derivative counterparties default. However, the risk of ineffective hedging, unanticipated policyholder behavior, or adverse market events could increase cash buffer needs, potentially limiting MetLife’s flexibility to pay dividends or repurchase stock. These risks are further compounded by uncertainties such as the transition from LIBOR to alternative reference rates, which could impact the value of financial instruments and derivative positions, thereby affecting liquidity and capital planning under stress conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Cash Buffer Needs (RISK_FACTOR)",
        "Cash Buffer Needs (RISK_FACTOR) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10334,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3249,
        "completion_tokens": 226,
        "total_tokens": 3476
      }
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million. According to the 2023 10-K filing, these securities are classified under \"Other Assets\" on the balance sheet rather than under \"Investments.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> ARS (FIN_INST)",
        "ARS (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2145,
        "completion_tokens": 61,
        "total_tokens": 2207
      }
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The adoption of the credit loss guidance on January 1, 2020, significantly changed how MET recognizes and measures credit losses on mortgage loans and fixed maturity securities available-for-sale (AFS). Prior to 2020, credit losses on mortgage loans were recognized under the incurred loss model, where losses were recorded only when it was probable that all amounts due would not be collected. For fixed maturity securities AFS, credit losses were recognized under the other-than-temporary impairment (OTTI) model, with impairment losses reported as OTTI. In 2019, for example, impairment losses across various sectors totaled ($129) million, including ($81) million for foreign government securities. \n\nUnder the new credit loss guidance, MET transitioned to recognizing an allowance for credit losses (ACL) based on expected lifetime credit losses, rather than waiting for losses to be incurred or impairments to be deemed other-than-temporary. For mortgage loans, this means establishing an ACL for both pools of similar-risk loans and individual loans, based on estimates of expected credit losses over the contractual life of the loans, adjusted for prepayments and economic forecasts. For fixed maturity securities AFS, impairment is now measured using a combination of intent-to-sell and direct write-down losses, replacing the prior OTTI model. This change resulted in the reclassification of prior period OTTI losses as impairment losses in 2020. Overall, the guidance increased the timeliness and forward-looking nature of credit loss recognition for both asset classes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Credit Loss Guidance (ACCOUNTING_POLICY)",
        "Credit Loss Guidance (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_241",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6546,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2311,
        "completion_tokens": 395,
        "total_tokens": 2707
      }
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin's obligation to provide consulting support under international offset agreements may impact its ability to recover costs on U.S. government contractual commitments in 2024 by diverting resources and increasing operational complexity. These offset agreements, often tied to international sales, require Lockheed Martin to perform in-country commitments such as consulting support, which can be subjective and outside of its control, potentially leading to penalties or reduced sales if not met. Additionally, these obligations are included in the estimates of total costs to complete contracts, which can affect profitability and cash flows. Given that a significant portion of Lockheed Martin’s purchase obligations—$64.3 billion in 2024—are tied to U.S. government contracts, any resource strain from offset commitments could affect the company’s performance and cost recovery under those contracts, especially if the U.S. government terminates a contract for convenience, as such terminations generally require the government to reimburse incurred costs, subject to available funding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR <-[Provides]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Consulting Support (RISK_FACTOR)",
        "Consulting Support (RISK_FACTOR) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11226,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3458,
        "completion_tokens": 275,
        "total_tokens": 3733
      }
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "TMO's pharma services business drove strong segment revenue performance in 2021, fueled by pandemic-related demand for vaccine and therapy development and production services, which supported pharma and biotech customers. This contributed to increased segment revenues and a higher segment income margin, driven by profit on higher sales, favorable sales mix, and a $20 million credit to cost of product revenue from a change in inventory accounting method. However, the margin improvement was partially offset by strategic growth investments, while the long-term sustainability of these gains remains uncertain due to the evolving nature of pandemic-related demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TMO (ORG) -> Pharma Services (PRODUCT)",
        "Pharma Services (PRODUCT) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2965,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 166,
        "total_tokens": 1552
      }
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, enhances regulatory oversight by fostering collaboration among regulators such as the NYDFS and EIOPA to better understand MetLife's risk profile as an internationally active insurance group. In the U.S., the NYDFS chairs annual Supervisory College meetings that include key U.S. and non-U.S. regulators, aligning with the NAIC's initiatives to improve group-wide supervision and risk management. Similarly, in Europe, EIOPA mandates Supervisory Colleges for EEA-based insurers with significant operations, such as MetLife, to coordinate European supervisors and assess risk across jurisdictions. This collaborative oversight framework ensures a more comprehensive evaluation of MetLife's financial and operational risks, reflecting the interconnected nature of its global insurance business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Participates_In]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Supervisory Colleges (REGULATORY_REQUIREMENT)",
        "Supervisory Colleges (REGULATORY_REQUIREMENT) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11029,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3416,
        "completion_tokens": 217,
        "total_tokens": 3634
      }
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower net ACL build of $295 million in 2024, compared to $406 million in the prior year. This reduction positively impacted Citi's Net Income, which increased to $4.9 billion in 2024, a 27% increase from the prior year. The resulting percentage change in total Net Income was therefore 27%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "C (ORG) -> U.S. Banking Law (REGULATORY_REQUIREMENT)",
        "U.S. Banking Law (REGULATORY_REQUIREMENT) -> C (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_232",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4069,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1685,
        "completion_tokens": 108,
        "total_tokens": 1793
      }
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "Potential disruptions to U.S. government funding due to the debt ceiling expiration in mid-January 2025 could delay or reduce defense spending, including procurement of defense systems like the F-35, which could directly impact Lockheed Martin’s Aeronautics segment. Since international customers accounted for 32% of Aeronautics’ net sales in 2024 and 73% of Lockheed Martin’s international sales are via Foreign Military Sales (FMS), any U.S. government funding delays could slow FMS contract approvals and funding for F-35 deliveries to the twelve FMS customers. This could reduce Aeronautics’ revenue and disrupt production schedules, particularly as the F-35 program involves close coordination between the U.S. government and international partners. Additionally, broader economic and supply chain challenges mentioned in the geopolitical and economic environment section could further compound these risks by increasing costs and reducing operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> GPE <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> FMS Customers (GPE)",
        "FMS Customers (GPE) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12254,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3769,
        "completion_tokens": 242,
        "total_tokens": 4012
      }
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "As of December 31, 2023, UnitedHealth Group had 53 million shares of common stock available for future issuance under the 2020 Stock Incentive Plan and 17 million shares available under the Employee Stock Purchase Plan (ESPP), totaling 70 million shares. In comparison, the company had 191,000 shares underlying stock options assumed through acquisitions, which is significantly lower than the available shares for future issuance. These acquired options have a weighted-average exercise price of $356 and an average remaining term of approximately 3 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10738,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3368,
        "completion_tokens": 139,
        "total_tokens": 3507
      }
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022, $596 million in 2023, and $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million, which is expected to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Multi-Year Equity Awards (FIN_INST)",
        "Multi-Year Equity Awards (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2316,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 108,
        "total_tokens": 1347
      }
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of its risk-weighted assets (RWA). This value is calculated as the greater of (i) 6% of RWA plus Citi's method 2 GSIB surcharge of 3.5%, resulting in 9.5% of RWA, and (ii) 4.5% of total leverage exposure. As stated in the TLAC section, the LTD requirement is directly tied to Citi's RWA and includes its applicable surcharge, which for 2024 is 3.5% under method 2 of the GSIB surcharge rule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "C (ORG) -> LTD Req. (REGULATORY_REQUIREMENT)",
        "LTD Req. (REGULATORY_REQUIREMENT) -> C (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2218,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 112,
        "total_tokens": 1316
      }
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $16,610 million, calculated by summing the annual amounts from 2025 to 2029 ($1,800 + $1,860 + $1,910 + $1,960 + $1,990 = $9,520) and adding the $9,990 million for 2030–2034. The pattern of annual increases from 2025 to 2029 shows a steady but slowing growth trend, rising by $60 million each year until 2027, then by $50 million in 2028 and only $30 million in 2029, indicating a deceleration in the rate of increase in pension obligations over this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Increases]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Qualified defined benefit pension plans (ACCOUNTING_POLICY)",
        "Qualified defined benefit pension plans (ACCOUNTING_POLICY) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 980,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 922,
        "completion_tokens": 146,
        "total_tokens": 1068
      }
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell was $982 million in 2020 and $1,072 million in 2021. In 2020, this category represented approximately 5.1% of total fixed income investments ($982 / $19,203), and in 2021, it represented approximately 5.6% ($1,072 / $19,238), ranking it as a relatively smaller but consistent portion of the fixed income portfolio compared to larger categories like Corporate bonds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> Mortgage/Asset-backed securities (FIN_INST)",
        "Mortgage/Asset-backed securities (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2462,
        "completion_tokens": 111,
        "total_tokens": 2573
      }
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom's shift from annual equity awards to multi-year equity awards with 4-7 year vesting periods extends the period over which stock-based compensation expense is recognized. Under the Multi-Year Equity Awards, compensation expense is recognized from the grant date through the vesting date, which ranges from 4 to 7 years, as opposed to the previous annual recognition pattern tied to each year's grant. This change results in a more protracted expense recognition timeline, aligning compensation costs with the longer vesting periods of the new awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Multi-Year Equity Awards (FIN_INST)",
        "Multi-Year Equity Awards (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1028,
        "completion_tokens": 139,
        "total_tokens": 1168
      }
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "The application of U.S. banking law influences Citi's credit loss provisions by requiring a more conservative approach to the Allowance for Credit Losses (ACL), particularly for exposures outside the U.S., driven by safety and soundness considerations. In the **Legacy Franchises**, provisions were impacted by a smaller ACL build for transfer risk, partially offset by a 7% increase in net credit losses, especially in Mexico Consumer. In the **Markets segment**, provisions rose to $463 million in 2024 from $438 million in 2023, driven by higher net credit losses (notably in spread products) and a reduced ACL build for non-U.S. exposures under U.S. banking law. **Combined**, these segments contributed to Citi’s total provision for credit losses of **$1.563 billion** in 2024 ($1.1 billion from Legacy Franchises and $463 million from Markets).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "C (ORG) -> U.S. Banking Law (REGULATORY_REQUIREMENT)",
        "U.S. Banking Law (REGULATORY_REQUIREMENT) -> C (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6494,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2291,
        "completion_tokens": 212,
        "total_tokens": 2503
      }
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans was $767 million in 2020 and $691 million in 2021, combining to $1,458 million across both years. The total assets at fair value were $8,450 million in 2020 and $8,396 million in 2021, summing to $16,846 million. The combined amount of Insurance buy-in contracts represented approximately 8.65% of the total assets at fair value ($1,458 ÷ $16,846).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> Insurance Buy-In Contracts (FIN_INST)",
        "Insurance Buy-In Contracts (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7863,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2620,
        "completion_tokens": 106,
        "total_tokens": 2726
      }
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom's (AVGO) emphasis on internal research and development, as a core component of its broader business strategy, directly supports its semiconductor segment's ability to maintain technology leadership in AI-related markets. The company's strategy, as outlined in both chunks, combines strategic acquisitions with extensive internal R&D to ensure its products retain market leadership. This focus is particularly critical in AI-related markets, where the semiconductor solutions are designed for high-performance applications such as AI networking and connectivity in enterprise and data center environments. By leveraging its global engineering resources and innovation-driven approach, Broadcom is well-positioned to meet the growing demand for advanced semiconductor technologies in AI, ensuring its competitive edge in this rapidly evolving market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> CONCEPT <-[Guides_On]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Internal Research and Development (CONCEPT)",
        "Internal Research and Development (CONCEPT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10874,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3381,
        "completion_tokens": 214,
        "total_tokens": 3595
      }
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, primarily related to integrated circuit product inventory obligations. As of September 29, 2024, the total advance payments made under its multi-year capacity purchase commitments were $3.0 billion. This means that the expected payments in the next 12 months significantly exceed the total advance payments made, highlighting the ongoing nature and scale of Qualcomm’s procurement commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Multi-Year Capacity Purchase Commitments (FIN_INST)",
        "Multi-Year Capacity Purchase Commitments (FIN_INST) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2115,
        "completion_tokens": 121,
        "total_tokens": 2237
      }
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million increase in reductions. The specific non-U.S. factor contributing to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> GTN Adjustments (ACCOUNTING_POLICY)",
        "GTN Adjustments (ACCOUNTING_POLICY) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2637,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 67,
        "total_tokens": 1372
      }
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send contributes to Mastercard's broader objective of capturing new payment flows by enabling fast and seamless disbursements and remittances through partnerships with digital messaging platforms, central banks, fintechs, and financial institutions. This capability supports the distribution of social and economic assistance, as well as B2C disbursements. To extend this functionality, Mastercard leverages partner ecosystems such as Cross-Border Services, which provides a global distribution network allowing financial institutions, fintechs, and digital partners to send and receive money through multiple channels, including bank accounts, mobile wallets, cards, and cash payouts. These partnerships and multi-rail capabilities are central to Mastercard's strategy for expanding into key payment flows and enhancing its position in the evolving digital payments landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MA (ORG) -> Mastercard Send (PRODUCT)",
        "Mastercard Send (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8475,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2787,
        "completion_tokens": 222,
        "total_tokens": 3009
      }
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard's introduction of Cyber and Intelligence Solutions as part of its value-added services directly influences the composition of its 'Other revenues' category by adding a new revenue stream focused on fraud prevention and transaction safety. These fees are recognized in the period in which the related services are performed, aligning with Mastercard's revenue recognition policy for value-added services. As a result, the timing of revenue recognition for Cyber and Intelligence Solutions is tied to the delivery of these services, contributing to the period-specific nature of 'Other revenues' in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MA (ORG) -> Cyber and Intelligence Solutions (PRODUCT)",
        "Cyber and Intelligence Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10465,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3272,
        "completion_tokens": 153,
        "total_tokens": 3425
      }
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "To determine the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022, and December 31, 2023, we sum the fair values for each category in both periods. In 2022, the total fair value was $327 million (U.S. governmental agency) + $3 million (Residential) + $117 million (Commercial) = $447 million. In 2023, the total fair value was $320 million (U.S. governmental agency) + $0 (Residential) + $123 million (Commercial) = $443 million. Thus, the total change in fair value was a decrease of $4 million.\n\nComparing this to the change in unrealized losses, in 2022 the total unrealized losses were $31 million (U.S. governmental agency) + $1 million (Residential) + $10 million (Commercial) = $42 million. In 2023, the total unrealized losses were $25 million (U.S. governmental agency) + $0 (Residential) + $9 million (Commercial) = $34 million. The change in unrealized losses was a decrease of $8 million. Therefore, the decrease in unrealized losses ($8 million) was greater than the decrease in fair value ($4 million) over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Mortgage-Backed Debt Securities (FIN_INST)",
        "Mortgage-Backed Debt Securities (FIN_INST) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5160,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1957,
        "completion_tokens": 270,
        "total_tokens": 2227
      }
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "The total fair value of Qualcomm's corporate bonds and notes is $4,634 million (Level 2). The fair value of U.S. Treasury securities and government-related securities is $208 million (Level 1 and Level 2 combined). Together with corporate bonds and notes, these categories are part of Qualcomm's total marketable securities, which amount to $5,451 million. As a percentage of total marketable securities, U.S. Treasury and government-related securities represent approximately 3.81% ($208 / $5,451).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Measures]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Corporate Bonds and Notes (FIN_INST)",
        "Corporate Bonds and Notes (FIN_INST) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8693,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2835,
        "completion_tokens": 124,
        "total_tokens": 2960
      }
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "Merck (MRK) utilizes pediatric market exclusivity to extend market protection for Keytruda by qualifying for an additional six months of exclusivity under regulatory requirements, as disclosed in the 10-K filing. This exclusivity, granted for conducting pediatric studies, adds a layer of market protection beyond the compound patent expiration, which is critical for maintaining Keytruda’s dominance in the oncology market. Given Keytruda’s pivotal role in MRK’s oncology revenue—accounting for a significant portion of its sales—this extended exclusivity could help delay generic or biosimilar competition, thereby preserving higher pricing and market share, and sustaining a strong and stable oncology revenue stream for the company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Pediatric Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Pediatric Market Exclusivity (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5128,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1951,
        "completion_tokens": 184,
        "total_tokens": 2135
      }
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "The introduction of Mastercard Installments in 2022 supports Mastercard's strategic goal of expanding digital payment services across multiple channels by offering a buy-now-pay-later solution that connects lenders with merchants through Mastercard’s acceptance network, enabling scalable and flexible payment options for consumers. This innovation aligns with Mastercard’s broader efforts to deliver better digital experiences through secure, seamless technologies and expand its services to new segments and use cases, as outlined in its 2022 10-K. By integrating Mastercard Installments into its multi-rail payment ecosystem and leveraging open-loop solutions, Mastercard enhances its digital value proposition and strengthens its position in evolving digital commerce landscapes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MA (ORG) -> Mastercard Installments (PRODUCT)",
        "Mastercard Installments (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9009,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2905,
        "completion_tokens": 195,
        "total_tokens": 3100
      }
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Merck and Ridgeback Biotherapeutics LP split profits from the Lagevrio collaboration equally, with Merck recording its profit-sharing payments to Ridgeback within Cost of sales. Since profits are split equally between the partners, 50% of the profit-sharing payments were recorded within Cost of sales in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Ridgeback Biotherapeutics LP (COMP)",
        "Ridgeback Biotherapeutics LP (COMP) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3380,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 77,
        "total_tokens": 1579
      }
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) enables BlackRock to market non-UK funds to UK retail investors by allowing these funds to register with the FCA, provided they meet specific requirements. For funds domiciled in the European Union, the OFR mandates that the consumer protection regimes in the EU countries where BlackRock's funds are domiciled must be deemed equivalent to the UK’s regulatory regime. This equivalence is essential for BlackRock to continue marketing its European-domiciled funds in the UK under the OFR. Failure to meet these equivalence requirements could restrict BlackRock’s ability to access the UK market, thereby impacting its business operations and revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> REGULATORY_REQUIREMENT <-[Impacts]- ORG",
      "triplets_used": [
        "BLK (ORG) -> OFR (REGULATORY_REQUIREMENT)",
        "OFR (REGULATORY_REQUIREMENT) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4155,
        "completion_tokens": 170,
        "total_tokens": 4325
      }
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, a key component of its RF semiconductor devices, supports its competitive advantage in the cellular handset market by enabling the protection of its intellectual property (IP) and accelerating time-to-market for its products. By manufacturing FBAR filters in-house using proprietary processes, Broadcom maintains control over its advanced technology, which is critical in a congested RF spectrum where performance and efficiency are paramount. This internal fabrication, primarily conducted in the U.S. and Singapore, contrasts with outsourced commodity processes, allowing Broadcom to differentiate its offerings in a highly competitive market. Additionally, the company's long-standing relationships with OEM customers and its global supply chain infrastructure, including a primary warehouse in Malaysia, ensure timely delivery and support for its RF solutions, further reinforcing its position as a leader in cellular RF transceiver applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> FBAR Filters (PRODUCT)",
        "FBAR Filters (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11815,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3597,
        "completion_tokens": 254,
        "total_tokens": 3851
      }
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck utilizes both patent term extensions (PTE) and regulatory exclusivity to maximize market protection for its biologic products by leveraging available legal mechanisms in the U.S. and other jurisdictions. In the U.S., biologic products are eligible for a 12-year regulatory exclusivity period from the date of first marketing approval, which complements patent protections. Additionally, Merck may qualify for up to five years of PTE to offset time lost during clinical trials and regulatory review, and an additional six months of pediatric exclusivity if required studies are completed. These combined protections help extend market exclusivity beyond standard patent terms, ensuring sustained revenue and competitive advantage for key biologic products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Regulatory Exclusivities (REGULATORY_REQUIREMENT)",
        "Regulatory Exclusivities (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2587,
        "completion_tokens": 190,
        "total_tokens": 2777
      }
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants, which may impact BlackRock's client engagement activities in the UK. These reforms are part of a broader regulatory environment in the UK, including the Financial Services and Markets Act 2023 (FSMA) and the Financial Conduct Authority’s (FCA) focus on conduct regulation, such as the implementation of the Consumer Duty. These regulatory changes collectively increase compliance complexity and costs for BlackRock, requiring additional resources to ensure adherence to evolving standards. Furthermore, as international regulatory reforms, including those in the UK, may prompt clients to alter their investment strategies, BlackRock could face indirect operational and reputational risks, potentially affecting its assets under management (AUM), revenue, and earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Impacts]- ORG",
      "triplets_used": [
        "BLK (ORG) -> UK Stewardship Code Review (REGULATORY_REQUIREMENT)",
        "UK Stewardship Code Review (REGULATORY_REQUIREMENT) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14294,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4236,
        "completion_tokens": 237,
        "total_tokens": 4473
      }
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022 was $147 million (from $95 million to $242 million). This significant increase is directly attributed to the Heritage AspenTech acquisition, as indicated in Chunk 2, which notes that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, implying expanded operations and asset base post-acquisition. The KG triplets further confirm the relationship between EMR and AspenTech, showing that EMR has a stake in AspenTech, and the acquisition is part of the broader strategic and operational context between the entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3566,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 168,
        "total_tokens": 1714
      }
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million, rising from $720 million in Fiscal Year 2021 to $744 million in Fiscal Year 2022. The total global growth in this business segment was $362 million (from $6,564 million to $6,926 million), and the Asia Pacific region contributed approximately 6.6% ($24 million / $362 million) to this global growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Subscriptions & Services (PRODUCT)",
        "Subscriptions & Services (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1983,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 103,
        "total_tokens": 1254
      }
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions by increasing regulatory scrutiny and potentially delaying or blocking strategic investments or acquisitions due to heightened antitrust concerns. Additionally, these guidelines affect funds engaging in HSR-reportable transactions by expanding the information required for HSR filings, which increases pre-merger notification expenses and may prolong transaction timelines, as outlined in the October 2024 amendments to HSR rules. These combined regulatory changes create operational and financial challenges for both BlackRock and its funds involved in such transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Merger Guidelines (REGULATORY_REQUIREMENT)",
        "Merger Guidelines (REGULATORY_REQUIREMENT) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3996,
        "completion_tokens": 175,
        "total_tokens": 4171
      }
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs utilizes both stock-settled and cash-settled Non-Employee Director RSU Award Agreements, which influence its accounting treatment and financial statement classification. Stock-settled RSUs are accounted for as equity awards, with compensation expense recognized over the vesting period and ultimately settled in shares, impacting the equity section of the balance sheet. In contrast, cash-settled RSUs are treated as liability awards, with the fair value of the obligation recognized as an expense and classified as a liability on the balance sheet, subject to remeasurement in each reporting period. This distinction is reflected in the separate forms listed in the 10-K filing (Exhibit 10.31 for stock-settled and Exhibit 10.32 for cash-settled), demonstrating how the accounting treatment and classification differ based on the settlement terms of the awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "GS (ORG) -> Non-Employee Director RSU Award Agreement (ACCOUNTING_POLICY)",
        "Non-Employee Director RSU Award Agreement (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9769,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3106,
        "completion_tokens": 219,
        "total_tokens": 3325
      }
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023, Abbott Laboratories granted 4,981,231 shares in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program. The vesting condition mentioned for these units is that they vest over three years, with the recipient receiving one share of Abbott stock for each vested restricted stock unit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> 2017 Incentive Stock Program (ACCOUNTING_POLICY)",
        "2017 Incentive Stock Program (ACCOUNTING_POLICY) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8176,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2714,
        "completion_tokens": 82,
        "total_tokens": 2797
      }
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "In 2024, 35% of Danaher's Life Sciences segment sales came from regions outside North America and Western Europe (7% from other developed markets and 28% from high-growth markets). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which laid the foundation for Danaher's Life Sciences business and enabled subsequent global expansion through key acquisitions. The segment's presence in high-growth markets underscores Danaher's strategy to leverage its Life Sciences portfolio for international reach and sustained growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Leica Microsystems (COMP)",
        "Leica Microsystems (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7053,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2423,
        "completion_tokens": 146,
        "total_tokens": 2569
      }
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has made a total of 9 acquisitions in the Life Sciences segment since its establishment in 2005. These include the acquisition of Leica Microsystems in 2005, AB Sciex and Molecular Devices in 2010, Beckman Coulter in 2011, Pall in 2015, Phenomenex in 2016, IDT in 2018, Aldevron in 2021, and Abcam in 2023, with Abcam being the most recent acquisition mentioned in the filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Pall (COMP)",
        "Pall (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7053,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2410,
        "completion_tokens": 96,
        "total_tokens": 2506
      }
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "The fair value of Abbott's interest rate hedge contracts decreased by $123 million between December 31, 2020 ($210 million receivable) and December 31, 2021 ($87 million receivable). This decline in fair value corresponds to a reduction in their receivable position for these contracts during the same period, reflecting a decrease in the value of the contracts as a result of changes in long-term benchmark interest rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2438,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 105,
        "total_tokens": 1383
      }
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, directly aligns with the observed doubling of U.S. revenues for Breyanzi in 2023, driven by higher demand. As outlined in BMY's 2023 10-K, the company is actively pursuing new indications for Breyanzi, such as chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and mantle cell lymphoma (MCL), which would further differentiate it as a leader in cell therapy. This strategic expansion, combined with BMY's broader focus on innovation and commercial execution, has translated into strong revenue growth for Breyanzi, reflecting successful market adoption and the product's increasing role in treating relapsed or refractory large B-cell lymphoma.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Breyanzi (PRODUCT)",
        "Breyanzi (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10781,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3340,
        "completion_tokens": 193,
        "total_tokens": 3533
      }
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. Combined with the $0.91 billion cash outflow for the acquisition of CorEvitas, LLC, the total cash used for acquisitions in 2023 was $3.61 billion, as detailed in the investing activities section of the 2023 cash flow statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> The Binding Site Group (COMP)",
        "The Binding Site Group (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3146,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 81,
        "total_tokens": 1515
      }
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The total estimated annual cost savings from restructuring charges incurred in 2024 and 2023 are approximately $0.2 billion and $0.6 billion, respectively, resulting from headcount reductions and facility consolidations. The acquisition of The Binding Site Group in 2023 significantly contributes to the strategic growth of the Specialty Diagnostics segment by expanding its portfolio with pioneering diagnostic assays and instruments for blood cancer, particularly in the area of multiple myeloma, thereby enhancing the segment’s capabilities in diagnosing and managing immune system disorders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> The Binding Site Group (COMP)",
        "The Binding Site Group (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6299,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2240,
        "completion_tokens": 148,
        "total_tokens": 2389
      }
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061, which has a maturity year of 2061. Compared to the other debt instruments disclosed in the filing, such as the 1.125% Notes due 2051 and the 1.625% Notes due 2043, the 2061 notes have the furthest maturity date, extending 10 and 18 years beyond the 2051 and 2043 notes, respectively. This long-term structure reflects Eli Lilly's strategy to manage its debt over an extended horizon.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> 1.375% Notes due 2061 (FIN_INST)",
        "1.375% Notes due 2061 (FIN_INST) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6152,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2185,
        "completion_tokens": 121,
        "total_tokens": 2306
      }
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is under development or regulatory review for **two distinct indications**: early Alzheimer's disease (submitted in the U.S., EU, and Japan) and preclinical Alzheimer's disease (Phase III trial ongoing). In comparison, Lebrikizumab has received approval for atopic dermatitis in the EU and Japan and is under regulatory review in the U.S. for the same indication. Thus, Lebrikizumab has **one approved indication** and is under **regulatory review for a second**, totaling **two indications** in regulatory or approved status, similar to Donanemab.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Donanemab (PRODUCT)",
        "Donanemab (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7799,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2603,
        "completion_tokens": 139,
        "total_tokens": 2743
      }
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The decline in Alimta's U.S. revenue in 2023, caused by the entry of generics in the first half of 2022, negatively impacted the overall U.S. volume growth, as noted in Chunk 1. However, this decline was offset by increased volume from several products, including Verzenio, which is an oncology product that contributed positively to U.S. volume growth. Verzenio is used for the treatment of HR+, HER2- metastatic and early breast cancer, as detailed in Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Alimta (PRODUCT)",
        "Alimta (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8875,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2868,
        "completion_tokens": 115,
        "total_tokens": 2983
      }
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Merck incurred a $250 million payment in 2022 to exercise its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna, which was charged to research and development expenses. Under the collaboration, Merck shares development costs and potential profits equally with Moderna. V940 is currently being evaluated in combination with Keytruda in multiple Phase 3 trials, including adjuvant treatment for melanoma and NSCLC. This ties into Merck’s broader immuno-oncology strategy, as outlined in its 2023 10-K, which emphasizes advancing innovative therapies like V940 to complement Keytruda and expand its presence in immuno-oncology through individualized and combination approaches.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Exercises_Option]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> V940 (mRNA-4157) (PRODUCT)",
        "V940 (mRNA-4157) (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7374,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2503,
        "completion_tokens": 174,
        "total_tokens": 2678
      }
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "Based on the information provided, MK-7962 (sotatercept) is eligible for 12 years of data exclusivity as a biologic, with the standard exclusivity period expiring in 2027. The disclosed patent expiration date is 2037 (absent Patent Term Extension). This means MK-7962 could receive an additional 10 years of U.S. patent protection beyond the standard 12-year data exclusivity period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> MK-7962 (sotatercept) (PRODUCT)",
        "MK-7962 (sotatercept) (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1045,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 917,
        "completion_tokens": 95,
        "total_tokens": 1013
      }
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "To determine the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023 based on NAV measurements:\n\nFrom **Chunk 2**, for **U.S. Pension Plans**:\n- 2023 NAV for Emerging Markets Equities: **$740**\n- 2022 NAV for Emerging Markets Equities: **$707**\n- Increase for U.S. Pension Plans: **$740 - $707 = $33**\n\nFrom **Chunk 2**, for **International Pension Plans**:\n- 2023 NAV for Emerging Markets Equities: **$66**\n- 2022 NAV for Emerging Markets Equities: **$59**\n- Increase for International Pension Plans: **$66 - $59 = $7**\n\nFrom **Chunk 1**, the **Emerging Markets Equities** line item is not directly relevant to the U.S. and International Pension Plans but confirms the broader investment context.\n\n**Total increase across both U.S. and International Pension Plans**: **$33 + $7 = $40**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Emerging markets equities (FIN_INST)",
        "Emerging markets equities (FIN_INST) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16303,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4726,
        "completion_tokens": 220,
        "total_tokens": 4946
      }
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "The estimated fair value of U.S. government agencies securities held by GILD increased from $35 million as of December 31, 2022, to $127 million as of December 31, 2023, representing a $92 million increase. In comparison, the estimated fair value of U.S. treasury securities increased from $410 million to $426 million over the same period, a $16 million increase. Thus, the change in the estimated fair value of U.S. government agencies securities was significantly greater than that of U.S. treasury securities during this time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GILD (ORG) -> U.S. Government Agencies Securities (FIN_INST)",
        "U.S. Government Agencies Securities (FIN_INST) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4554,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1814,
        "completion_tokens": 132,
        "total_tokens": 1946
      }
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy generated $11,850 million in total revenue in 2023, representing a 14% increase compared to $10,390 million in 2022, driven by strong performance across all regions. However, the long-term financial strategy for Gilead may face challenges as the patent for Biktarvy and other principal HIV products is set to expire, potentially exposing the company to generic competition. This underscores the importance of innovation and diversification in Gilead's portfolio to sustain revenue growth beyond the patent expiration timeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4731,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1833,
        "completion_tokens": 133,
        "total_tokens": 1966
      }
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "Gilead's single operating segment structure and centralized resource allocation model enable the company to strategically deploy resources across its R&D portfolio based on unmet medical needs, scientific potential, and market considerations. However, the impending U.S. patent expiration of Truvada in 2023 could significantly impact Gilead's revenue stream from this key HIV product, potentially constraining the funds available for lifecycle management initiatives. Given that Truvada is a core product in Gilead's HIV portfolio and is directly disclosed by the company, the loss of exclusivity may limit the company's ability to reinvest in innovation and development efforts for its HIV treatments, such as next-generation therapies or expanded indications, without reallocation from other areas of the business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Truvada (PRODUCT)",
        "Truvada (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6139,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2192,
        "completion_tokens": 204,
        "total_tokens": 2396
      }
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement impacted Schwab's capital management strategy by supporting the migration of IDA balances to its balance sheet in future periods, contingent on maintaining sufficient capital levels to support incremental deposits. In 2023, Schwab did not move IDA balances to its balance sheet, but the agreement facilitated the creation of contract assets related to the buy-down of fixed-rate obligation amounts, which are amortized over the remaining contractual term as a reduction to bank deposit account fee revenue. The amortization expense associated specifically with these contract assets under the 2023 IDA Agreement was not explicitly stated in the provided chunks, but the total amortization expense related to capitalized contract costs (which includes such amortization) was $85 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> IDA Agreement (ACCOUNTING_POLICY)",
        "IDA Agreement (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6398,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2256,
        "completion_tokens": 204,
        "total_tokens": 2460
      }
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "The changes in LTIP units and other unit issuances during 2023 affected SPG's total equity as reported in its 2023 10-K filing by contributing $14,739 to equity through the issuance of long-term incentive performance units. Additionally, other unit-related activities, such as the issuance of limited partner units and unit equivalents, further impacted equity, with a net effect of $197,426 from limited partner unit issuances and a net effect of $(16,119) from the issuance of unit equivalents and other adjustments. These transactions, as disclosed in SPG's 10-K, are part of SPG's broader equity structure and reflect the entity's use of LTIP units and other unit-based incentives as components of its financial strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6595,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2280,
        "completion_tokens": 181,
        "total_tokens": 2461
      }
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde's distribution of Process Gases through on-site plants significantly influences its long-term contract structure and revenue recognition policy. On-site plants, which supply customers via pipeline and are typically under 10-20 year total requirement contracts with minimum purchase requirements and price escalation provisions, result in long-term, stable revenue streams. Revenue is recognized as product is delivered and the company has the right to invoice, aligning with the performance obligation satisfied over time. This contrasts with shorter-term merchant and packaged gas contracts, which lack minimum commitments and recognize revenue at a point in time. The on-site model thus supports Linde's revenue recognition approach by ensuring ongoing customer demand and consistent invoicing rights under long-term agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Distributes]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Process Gases (PRODUCT)",
        "Process Gases (PRODUCT) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8826,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2865,
        "completion_tokens": 209,
        "total_tokens": 3074
      }
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair value of corporate notes and obligations in the first table is $2,978, while in the second table, it is $3,354, resulting in a difference of $376. The total marketable securities' fair value in the first table is $5,722, and in the second table, it is $5,492, reflecting an overall decrease of $230. Thus, the increase in the fair value of corporate notes and obligations ($376) is greater in magnitude than the overall decline in total marketable securities' fair value ($230).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Corporate Notes and Obligations (FIN_INST)",
        "Corporate Notes and Obligations (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2578,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 121,
        "total_tokens": 1434
      }
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "Changing provider behavior, as described in the Health Care Benefits segment, significantly affects the accuracy of CVS's premium pricing forecasts due to the fixed premium period model, under which premiums are set in advance based on projected costs. Provider behavior changes—such as adjustments in medical claim submission patterns or shifts in utilization in response to economic conditions—introduce volatility and complexity in forecasting medical cost trends. These changes make it more challenging to detect and anticipate cost increases, especially during periods of rapid change like the COVID-19 pandemic. Since cost overruns during the fixed premium period cannot be recovered through higher premiums, even small inaccuracies in forecasting can lead to significant adverse impacts on operating results. This sensitivity is further compounded by external factors such as regulatory constraints and economic conditions, which limit CVS's ability to adjust pricing in response to actual cost trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacts]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Provider Behavior (RISK_FACTOR)",
        "Provider Behavior (RISK_FACTOR) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3571,
        "completion_tokens": 252,
        "total_tokens": 3824
      }
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, enhances its operational flexibility and resource base, contributing to its financial stability. This increased production capacity supports Chevron's ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) by ensuring a more resilient cash flow profile, even during periods of low commodity prices. Additionally, Chevron's strong debt ratings reflect its substantial borrowing capacity and disciplined financial management, allowing it to adjust capital spending and shareholder distributions as needed to preserve its creditworthiness and continue paying dividends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Noble (COMP)",
        "Noble (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2889,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 182,
        "total_tokens": 1566
      }
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab spent $249 million in 2023 to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount is classified as a contract asset and is included in other assets on the consolidated balance sheet. Additionally, these contract assets are amortized over the remaining contractual term as a reduction to bank deposit account fee revenue, as further detailed in Note 14.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> IDA Agreement (ACCOUNTING_POLICY)",
        "IDA Agreement (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9011,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2901,
        "completion_tokens": 101,
        "total_tokens": 3002
      }
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded a store impairment charge of $483 million in 2024 as part of its enterprise-wide restructuring plan. This restructuring initiative is expected to generate cost savings of over $500 million in 2025, indicating that the impairment charges incurred in 2024 are part of the broader cost-reduction strategy aimed at improving long-term operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Impacts]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Enterprise-Wide Restructuring Plan (ACCOUNTING_POLICY)",
        "Enterprise-Wide Restructuring Plan (ACCOUNTING_POLICY) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5933,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2151,
        "completion_tokens": 91,
        "total_tokens": 2243
      }
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited in 2021 was $336 million. This figure, combined with Chevron's 36.4 percent ownership stake in Angola LNG Limited, indicates a significant and ongoing involvement in the liquefied natural gas (LNG) market in Angola. The positive equity earnings suggest that the Angola LNG venture was profitable during the year, reinforcing Chevron's strategic position in the global LNG supply chain and its active role in processing and exporting natural gas from Angola to international markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG Limited (COMP)",
        "Angola LNG Limited (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8737,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2826,
        "completion_tokens": 133,
        "total_tokens": 2960
      }
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources (NEER) faces operational risks due to the significant mismatch between the expected decommissioning timeline of the Duane Arnold facility (projected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033). This mismatch could result in potential challenges in securing sufficient nuclear fuel beyond 2033 if the facility is recommissioned, as current contracts do not extend to the long-term operational horizon required for decommissioning. Additionally, if recommissioning is not approved or delayed, NEER must continue managing spent nuclear fuel in long-term dry storage until the DOE can take possession, which introduces regulatory and logistical risks over the extended decommissioning timeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Duane Arnold (COMP)",
        "Duane Arnold (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15899,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4629,
        "completion_tokens": 192,
        "total_tokens": 4821
      }
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde's involvement in the Amur GPP project, marked by a $0.7 billion contingent liability and contract suspensions due to sanctions and fire incidents, contrasts sharply with its revenue recognition policies for on-site industrial gas contracts, which are typically long-term (10–20 years), stable, and revenue-recognized over time as product is delivered. The Amur GPP project, involving engineering and construction under a subcontract, exposes Linde to significant financial and legal risks, including liability for damages and litigation, which are not inherent in its on-site industrial gas contracts where Linde retains control over plant operations and revenue is tied to ongoing product delivery. This contrast highlights the heightened financial risk exposure in long-term on-site agreements when they involve third-party construction, regulatory uncertainties, or geopolitical factors, as seen in the Amur GPP, compared to the more predictable and internally managed revenue streams of standard on-site industrial gas contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Process Gases (PRODUCT)",
        "Process Gases (PRODUCT) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10775,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3364,
        "completion_tokens": 259,
        "total_tokens": 3624
      }
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "The expected increase in TAC (traffic acquisition costs) paid to Google Network partners, driven by shifts in device and geographic mix, directly impacts the gross advertising revenue recognition model by increasing the cost of revenues associated with advertising. As outlined in Chunk 1, TAC is influenced by factors such as device mix, geographic mix, and partner agreement terms, and as TAC grows, it reduces gross margins. Chunk 2 clarifies that advertising revenues from Google Network properties are generally recognized on a gross basis, with the amounts paid to Google Network partners recorded as cost of revenues. Therefore, as TAC increases due to evolving user behavior and geographic expansion, the cost of revenues will rise, which in turn reduces the gross profit margin on advertising revenues in the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9361,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3000,
        "completion_tokens": 213,
        "total_tokens": 3213
      }
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is significantly influenced by compliance with the Coal Ash Act, as the Act, along with the EPA CCR rule and other state regulations, mandates the closure of coal ash impoundments and dictates the standards for closure methods. The ARO amount is based on estimated closure costs, which are subject to change depending on the approved closure methods and timetables that must align with these regulatory requirements. Additionally, Duke Energy has already begun closure activities at high-priority sites under the Coal Ash Act, and cost recovery for these expenditures is pursued through the normal ratemaking process with state and federal utility commissions, ensuring that compliance with the Act directly impacts both the ARO liability and financial planning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Coal Ash Act (REGULATORY_REQUIREMENT)",
        "Coal Ash Act (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_178",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7840,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2642,
        "completion_tokens": 210,
        "total_tokens": 2853
      }
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM is calculated by subtracting the fair value in Chunk 2 ($178 million) from the fair value in Chunk 1 ($236 million), resulting in a $58 million increase in fair value. This change reflects the difference in valuation across the two tables, as disclosed by CRM for these financial instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Mortgage-Backed Obligations (FIN_INST)",
        "Mortgage-Backed Obligations (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2578,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 105,
        "total_tokens": 1390
      }
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "In 2023, 5% of Danaher's Diagnostics segment sales were attributed to 'other developed markets.' The company classifies Japan, Australia, and New Zealand under this category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Other Developed Markets (GPE)",
        "Other Developed Markets (GPE) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6512,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2276,
        "completion_tokens": 43,
        "total_tokens": 2320
      }
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad can be calculated by multiplying the carload volume (2,014 thousand cars) by the average revenue per car ($3,305). This results in total revenue of $6,655,470,000 (2,014 * 3,305). This figure reflects the combined data from the carload volume and average revenue per car provided in the two chunks, with the \"Bulk\" category being directly connected to Union Pacific Railroad (UNP) in the knowledge graph.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Bulk (PRODUCT)",
        "Bulk (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3756,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 122,
        "total_tokens": 1696
      }
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina, following the settlement agreement with NCDEQ, is approximately **$8 billion to $9 billion**. This reflects a **$1.5 billion reduction** from Duke Energy's initial estimate of **$9.5 billion to $10.5 billion**, which was based on the April 1, 2019 closure determination requiring excavation of all nine remaining impoundments. The settlement agreement allowed for a modified closure approach at two basins (Marshall and Roxboro), reducing the overall cost. Additionally, approximately **$3.1 billion** had been spent through 2021, with the remainder expected to be incurred over the next 15 to 20 years. This cost estimation is subject to the regulatory framework of the **Coal Ash Act**, which governs Duke Energy's obligations and cost recovery processes through normal ratemaking procedures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Coal Ash Act (REGULATORY_REQUIREMENT)",
        "Coal Ash Act (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11314,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3511,
        "completion_tokens": 227,
        "total_tokens": 3739
      }
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024, resulting in a combined total of **$3.025 billion**. These acquisitions reflect Mastercard's strategic focus on growing and diversifying its business by acquiring companies that enhance its capabilities in fraud prevention, cybersecurity, and real-time decision-making. Both acquisitions align with the company's broader objective to build a more comprehensive and innovative payment and data solutions ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MA (ORG) -> Dynamic Yield LTD (COMP)",
        "Dynamic Yield LTD (COMP) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6498,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2269,
        "completion_tokens": 137,
        "total_tokens": 2406
      }
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "The total fair value of International bonds held by VZ is $12 million according to Chunk 1 and $528 million according to Chunk 2. The categorization of these bonds differs between the two disclosures: in Chunk 1, International bonds are included in \"Total investments at fair value\" without Level 3 designations, while in Chunk 2, they are also part of \"Total investments at fair value\" but with a significant portion ($518 million) classified under Level 3, indicating less observable inputs for valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> International bonds (FIN_INST)",
        "International bonds (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3321,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 126,
        "total_tokens": 1601
      }
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard's real-time account-based payments infrastructure supports its global payment network operations by enabling instant, secure, and data-rich transactions between bank accounts, enhancing the efficiency of both domestic and cross-border payment flows. This infrastructure is integral to Mastercard's globally integrated, peer-to-peer network architecture, which allows intelligent routing and real-time processing of transactions, including fraud scoring and tokenization services. According to the provided information, Mastercard switches approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions, thereby leveraging its real-time capabilities to facilitate seamless and secure global payment operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Real-Time Account-Based Payments (PRODUCT)",
        "Real-Time Account-Based Payments (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11346,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3504,
        "completion_tokens": 196,
        "total_tokens": 3700
      }
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. provided **$1.9 billion in net cash consideration** to acquire VIZIO Holding Corp., as disclosed in the acquisition completed in December 2024. According to Walmart's risk disclosures, this acquisition introduces a **data privacy risk** due to VIZIO's collection of consumer data, including **television viewing data**, which increases Walmart's exposure to cybersecurity threats, regulatory scrutiny, and potential liabilities related to the privacy and security of consumer information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "WMT (ORG) -> VIZIO Holding Corp. (COMP)",
        "VIZIO Holding Corp. (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13042,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3907,
        "completion_tokens": 125,
        "total_tokens": 4033
      }
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "The net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022 is a $21 million negative impact. This is calculated by considering the $14 million increase in fuel cost recovery (Chunk 2) that positively affected operating income, offset by a $35 million increase in fuel-related operating expenses (Chunk 2), and further impacted by a $572 million refund of AMT credit carryforwards in the prior year and a $149 million increase in cash outflows from working capital due to under-collected fuel costs (Chunk 1). Collectively, these factors reflect the broader negative impact of the Fuel Price Increase on Duke Energy, as shown in the knowledge graph.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> MACRO_CONDITION <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Fuel Price Increase (MACRO_CONDITION)",
        "Fuel Price Increase (MACRO_CONDITION) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2879,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 176,
        "total_tokens": 1574
      }
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021, Intel incurred $565 million in additional period charges primarily associated with the ramp up of Intel 4. This is directly related to the rebranding of the manufacturing process node announced in July 2021, where Intel 4 became the new name for what was previously referred to as the 7nm process node in its roadmap. The charges reflect the increased investment and operational costs tied to advancing and scaling production under the newly introduced naming structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Intel 4 (PRODUCT)",
        "Intel 4 (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4661,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1809,
        "completion_tokens": 119,
        "total_tokens": 1928
      }
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "In 2023, 5% of Danaher's Diagnostics segment sales were attributed to Other Developed Markets. As of December 31, 2023, the company had approximately 3,000 employees in those same markets. This indicates that a relatively small percentage of the segment's sales came from a region employing a modest portion of the company's global workforce.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Other Developed Markets (GPE)",
        "Other Developed Markets (GPE) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11009,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3407,
        "completion_tokens": 85,
        "total_tokens": 3493
      }
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "To calculate the total revenue generated from Industrial chemicals & plastics in 2021, we multiply the number of carloads (606,000) by the average revenue per car ($3,207). This results in total revenue of $1,943,642,000 for 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Industrial chemicals & plastics (PRODUCT)",
        "Industrial chemicals & plastics (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3756,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 57,
        "total_tokens": 1642
      }
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "The total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing, is $12 million. This figure is consistently reported in both chunks for the \"International bonds\" subcategory under fixed income securities, with the total fair value amounting to $12 million in each of the two disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> International bonds (FIN_INST)",
        "International bonds (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2846,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 92,
        "total_tokens": 1442
      }
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco's production of private-label items, supported by its owned processing, packaging, and manufacturing facilities, plays a strategic role in its ability to leverage SG&A expenses through comparable sales growth. By increasing the penetration of private-label items, Costco enhances its control over pricing and product margins, which supports its ability to offer competitive values while maintaining gross margin stability. This, in turn, drives comparable sales growth by attracting and retaining members through the availability of high-quality, cost-effective products. As comparable sales increase, Costco can spread its fixed SG&A expenses over a larger sales base, reducing SG&A as a percentage of sales and improving overall profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "COST (ORG) -> Private Label Items (PRODUCT)",
        "Private Label Items (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5477,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2015,
        "completion_tokens": 188,
        "total_tokens": 2203
      }
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a key enabler of the company's broader strategy to advance process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy. As a gate-all-around transistor, RibbonFET is expected to deliver faster switching speeds and improved performance-per-watt, supporting Intel's goal of delivering leading-edge products through continuous process innovation. This aligns with the company's intensified R&D focus on areas critical to product leadership, including process and packaging advancements. Furthermore, RibbonFET is a foundational element of Intel's IDM 2.0 strategy, which integrates internal manufacturing, external foundry partnerships, and advanced packaging to drive technology leadership. By investing in next-generation nodes like Intel 20A and beyond, Intel is reinforcing its commitment to reasserting process leadership and leveraging innovations such as RibbonFET to power future products, including those in its xPU architecture and heterogeneous computing roadmap.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> RibbonFET (PRODUCT)",
        "RibbonFET (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8871,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2877,
        "completion_tokens": 271,
        "total_tokens": 3149
      }
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In Q4 2023, Meta estimated that approximately 3% of its Monthly Active Accounts (MAP) consisted of violating accounts, which are defined as accounts intended for purposes that violate its terms of service, such as bots and spam. Additionally, false accounts were estimated to represent approximately 4% of its Monthly Active Users (MAUs), with false accounts including both user-misclassified accounts and violating accounts. These accounts can negatively impact the stability and accuracy of Meta's user metrics, as they rely on limited data signals and involve significant judgment in estimation. Factors such as encryption, product changes, and regulatory requirements may further affect the accuracy of these metrics, and the presence of such accounts could lead to periodic reductions in reported user figures as Meta disables or addresses them.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "META (ORG) -> Violating Accounts (RISK_FACTOR)",
        "Violating Accounts (RISK_FACTOR) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12050,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3673,
        "completion_tokens": 212,
        "total_tokens": 3885
      }
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31, 2023, the total fair value of PayPal's crypto asset safeguarding liability and the corresponding safeguarding asset was the same, as the Company had not incurred any safeguarding loss events during the period. These amounts are recorded at the same value because both the liability and the asset are measured using the fair value of the underlying cryptocurrencies, based on quoted prices from the principal market, and no adjustments for loss events were necessary. This treatment ensures that the obligation to safeguard customer crypto assets is matched by the corresponding asset value held in custodial accounts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Crypto Asset Safeguarding Liability (FIN_INST)",
        "Crypto Asset Safeguarding Liability (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2540,
        "completion_tokens": 159,
        "total_tokens": 2699
      }
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "The total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729, calculated by summing $169,192 and $15,537. For 2023, the combined total is $195,949, calculated by summing $172,912 and $23,037. This indicates a decrease of $11,220 in the combined total from 2023 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Other Noncontrolling Redeemable Interests (FIN_INST)",
        "Other Noncontrolling Redeemable Interests (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1644,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1072,
        "completion_tokens": 85,
        "total_tokens": 1157
      }
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "As of December 31, 2024, the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar was $136 million for 39 million mmBtu. This procurement strategy aligns with their regulated cost recovery framework, as the natural gas distribution utilities (except Atlanta Gas Light) are authorized by state regulatory agencies to use natural gas cost recovery mechanisms that adjust rates to reflect changes in the wholesale cost of natural gas, ensuring recovery of prudently incurred costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "SO (ORG) -> Natural Gas Cost Recovery Mechanisms (ACCOUNTING_POLICY)",
        "Natural Gas Cost Recovery Mechanisms (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5900,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2148,
        "completion_tokens": 131,
        "total_tokens": 2280
      }
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, as shown in Chunk 1. The equity in earnings (losses) from the same region during the same year was $(18) million, also from Chunk 1. Additionally, Chunk 2 provides further context, showing that the Lower 48 region contributed $(8) million to equity in earnings (losses) in 2021. This indicates that while the region generated significant net income, it experienced a small loss in equity earnings from affiliates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6687,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2316,
        "completion_tokens": 129,
        "total_tokens": 2445
      }
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024 is $1,212 and $1,068, respectively, totaling $2,280. This combined exposure reflects the company's strategy to manage financial risks associated with currency and commodity price fluctuations by economically hedging known future expenditures, particularly for U.S. dollar merchandise inventory purchases by international subsidiaries and energy costs for operations in the U.S. and Canada, without engaging in speculative transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Enters_Into]- ORG",
      "triplets_used": [
        "COST (ORG) -> Variable-Priced Contracts (FIN_INST)",
        "Variable-Priced Contracts (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2472,
        "completion_tokens": 144,
        "total_tokens": 2616
      }
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft's internal development structure, particularly the Experiences and Devices engineering group, is responsible for developing Microsoft 365, which includes end-user experiences like Microsoft 365 Consumer offerings. This internal development approach allows Microsoft to maintain technical control and prioritize enhancements, directly influencing how the product evolves and is managed. In fiscal year 2024, this structure supported Microsoft's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning the metric with how the company manages its business and providing greater transparency into subscriber growth trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Microsoft 365 (PRODUCT)",
        "Microsoft 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6832,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2350,
        "completion_tokens": 181,
        "total_tokens": 2532
      }
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "Under Pfizer's 2019 Stock Plan, each Performance Share Award (PSA) counts as three shares times the maximum potential payout toward the total share count. As of December 31, 2023, 248 million shares were still available for award under the plan, including 68 million shares from the Seagen stock plan. This calculation is significant because it reflects how PSAs are treated conservatively in the share reserve, ensuring that the full potential dilution from performance-based awards is accounted for upfront, which impacts the remaining share availability for future grants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> PSAs (FIN_INST)",
        "PSAs (FIN_INST) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5526,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2062,
        "completion_tokens": 143,
        "total_tokens": 2206
      }
    }
  ]
}